,Sentence,ESG BERT Topic 1,ESG BERT Topic 2,ESG BERT Topic 3,Mapped Criteria Topic 1,Mapped Criteria Topic 2,Mapped Criteria Topic 3
Line 1,"Edwards Lifesciences     2021 Sustainability Report2EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORTEdwards Lifesciences is the   global leader  of patient-focused   medical innovations for structural heart   disease and critical care monitoring.
","('Product_Design_And_Lifecycle_Management', 0.3549148440361023)","('Customer_Welfare', 0.10579954087734222)","('Access_And_Affordability', 0.07724731415510178)","('NON-ESG', 0.3549148440361023)","('NON-ESG', 0.10579954087734222)","('NON-ESG', 0.07724731415510178)"
Line 2,"Driven by a passion for patients,   the company is dedicated to improving   and enhancing lives through partnerships   with clinicians and stakeholders across   the global healthcare landscape.Contents   A Message from our Chairman and CEO Our Approach Sustainability Targets Organizational Profile Governance Map Materiality & Stakeholder Engagement 13  Governance Ethics & Compliance 14  Corporate Governance Patients Access to Healthcare 23  Patient Experience & Voice Products Product Safety & Quality 32  Supply Chain Management 37  Product Design & Innovation Workforce Human Capital Management 47  Diversity, Inclusion & Belonging 55  Volunteerism & Giving Environment Metrics-at-a-Glance  Content Index  Report Downloads  EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT OverviewEdwards Life - sciences  As the world has faced extraordinary challenges over the last several years – whether   referring to the pandemic, country conflicts, natural disasters or resource challenges   and shortages – it has created moments, big and small, for Edwards Lifesciences to   lead in ensuring healthy and sustainable relationships with all of our stakeholders as   we focus on and serve patients.
","('Product_Quality_And_Safety', 0.8386816382408142)","('Product_Design_And_Lifecycle_Management', 0.034516558051109314)","('Selling_Practices_And_Product_Labeling', 0.03330003842711449)","(['Product Quality & Recall Management'], 0.8386816382408142)","('NON-ESG', 0.034516558051109314)","('NON-ESG', 0.03330003842711449)"
Line 3,"Driven by a passion for patients,   the company is dedicated to improving   and enhancing lives through partnerships   with clinicians and stakeholders across   the global healthcare landscape.Contents   A Message from our Chairman and CEO Our Approach Sustainability Targets Organizational Profile Governance Map Materiality & Stakeholder Engagement 13  Governance Ethics & Compliance 14  Corporate Governance Patients Access to Healthcare 23  Patient Experience & Voice Products Product Safety & Quality 32  Supply Chain Management 37  Product Design & Innovation Workforce Human Capital Management 47  Diversity, Inclusion & Belonging 55  Volunteerism & Giving Environment Metrics-at-a-Glance  Content Index  Report Downloads  EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT OverviewEdwards Life - sciences  As the world has faced extraordinary challenges over the last several years – whether   referring to the pandemic, country conflicts, natural disasters or resource challenges   and shortages – it has created moments, big and small, for Edwards Lifesciences to   lead in ensuring healthy and sustainable relationships with all of our stakeholders as   we focus on and serve patients.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9573523998260498)","('Employee_Health_And_Safety', 0.004358165431767702)","('Business_Model_Resilience', 0.0031161021906882524)","(['Human Capital Development'], 0.9573523998260498)","('NON-ESG', 0.004358165431767702)","('NON-ESG', 0.0031161021906882524)"
Line 4,"Driven by a passion for patients,   the company is dedicated to improving   and enhancing lives through partnerships   with clinicians and stakeholders across   the global healthcare landscape.Contents   A Message from our Chairman and CEO Our Approach Sustainability Targets Organizational Profile Governance Map Materiality & Stakeholder Engagement 13  Governance Ethics & Compliance 14  Corporate Governance Patients Access to Healthcare 23  Patient Experience & Voice Products Product Safety & Quality 32  Supply Chain Management 37  Product Design & Innovation Workforce Human Capital Management 47  Diversity, Inclusion & Belonging 55  Volunteerism & Giving Environment Metrics-at-a-Glance  Content Index  Report Downloads  EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT OverviewEdwards Life - sciences  As the world has faced extraordinary challenges over the last several years – whether   referring to the pandemic, country conflicts, natural disasters or resource challenges   and shortages – it has created moments, big and small, for Edwards Lifesciences to   lead in ensuring healthy and sustainable relationships with all of our stakeholders as   we focus on and serve patients.
","('Access_And_Affordability', 0.7153768539428711)","('Human_Rights_And_Community_Relations', 0.05437978357076645)","('Employee_Engagement_Inclusion_And_Diversity', 0.02830677106976509)","(['Health Outcome Contribution'], 0.7153768539428711)","('NON-ESG', 0.05437978357076645)","('NON-ESG', 0.02830677106976509)"
Line 5,"When Edwards was established in 2000, we formed the company around a Credo and   Aspirations to define our culture and guide our actions.
","('Human_Rights_And_Community_Relations', 0.5654893517494202)","('Employee_Engagement_Inclusion_And_Diversity', 0.10636775195598602)","('Business_Model_Resilience', 0.037801891565322876)","(['Community Relations'], 0.5654893517494202)","('NON-ESG', 0.10636775195598602)","('NON-ESG', 0.037801891565322876)"
Line 6,"We defined who we are, what we   do and how we serve others: patients, employees, customers, suppliers, communities   and shareholders.
","('Supply_Chain_Management', 0.18176278471946716)","('Human_Rights_And_Community_Relations', 0.17373637855052948)","('Product_Design_And_Lifecycle_Management', 0.1472180038690567)","('NON-ESG', 0.18176278471946716)","('NON-ESG', 0.17373637855052948)","('NON-ESG', 0.1472180038690567)"
Line 7,"We have always operated in a multi-stakeholder model because it is fundamental to our  ability to grow the value of Edwards over the long term.
","('Business_Model_Resilience', 0.42940813302993774)","('Competitive_Behavior', 0.16895067691802979)","('Systemic_Risk_Management', 0.06321602314710617)","('NON-ESG', 0.42940813302993774)","('NON-ESG', 0.16895067691802979)","('NON-ESG', 0.06321602314710617)"
Line 8,"Sustaining the long-term growth  and value creation of our company requires us to integrate sustainability practices into  every corner of Edwards.
","('Business_Model_Resilience', 0.7362088561058044)","('Product_Design_And_Lifecycle_Management', 0.07727909833192825)","('Supply_Chain_Management', 0.03020334057509899)","(['Codes of Business Conduct'], 0.7362088561058044)","('NON-ESG', 0.07727909833192825)","('NON-ESG', 0.03020334057509899)"
Line 9,"We are not singular in emphasis, for example, solely thinking  about the environment, particular social issues or governance; rather, we align our global  company with our strategy and processes to pursue this vision.
","('Human_Rights_And_Community_Relations', 0.8544573187828064)","('Management_Of_Legal_And_Regulatory_Framework', 0.02652939222753048)","('Business_Model_Resilience', 0.0158188808709383)","(['Community Relations'], 0.8544573187828064)","('NON-ESG', 0.02652939222753048)","('NON-ESG', 0.0158188808709383)"
Line 10,"I am pleased to welcome you to Edwards Lifesciences’ 2021 Sustainability Report, which  details the continued progress and commitment of Edwards to address the needs of our  stakeholders globally and to create shared value in the communities in which we operate,  now and for future generations.
","('Human_Rights_And_Community_Relations', 0.83301842212677)","('Business_Model_Resilience', 0.027626875787973404)","('Access_And_Affordability', 0.016322452574968338)","(['Community Relations'], 0.83301842212677)","('NON-ESG', 0.027626875787973404)","('NON-ESG', 0.016322452574968338)"
Line 11,"Throughout 2021, our nearly 16,000 employees worldwide continued to focus on patients  and overcame the challenges of our dynamic environments to ensure our life-saving and  life-enhancing therapies were delivered to patients in need.
","('Access_And_Affordability', 0.6752215623855591)","('Employee_Health_And_Safety', 0.08737753331661224)","('Product_Design_And_Lifecycle_Management', 0.02973841316998005)","(['Health Outcome Contribution'], 0.6752215623855591)","('NON-ESG', 0.08737753331661224)","('NON-ESG', 0.02973841316998005)"
Line 12,"At the same time, our teams achieved key milestones, such as research and development, clinical trials and   evidence generation to support our future therapies, in support of our long-term   innovation strategy.
","('Customer_Welfare', 0.1808992177248001)","('Access_And_Affordability', 0.11648472398519516)","('Business_Model_Resilience', 0.10599986463785172)","('NON-ESG', 0.1808992177248001)","('NON-ESG', 0.11648472398519516)","('NON-ESG', 0.10599986463785172)"
Line 13,"Our Credo and Aspirations help us define our company’s strategic priorities and   objectives.
","('Business_Model_Resilience', 0.5723956823348999)","('Human_Rights_And_Community_Relations', 0.08581553399562836)","('Product_Design_And_Lifecycle_Management', 0.0475623644888401)","(['Codes of Business Conduct'], 0.5723956823348999)","('NON-ESG', 0.08581553399562836)","('NON-ESG', 0.0475623644888401)"
Line 14,"As detailed in this report, our sustainability strategy, including our measurable   sustainability targets, is also fully aligned with our values and business strategy.
","('Business_Model_Resilience', 0.7849782705307007)","('Product_Design_And_Lifecycle_Management', 0.024452850222587585)","('Physical_Impacts_Of_Climate_Change', 0.02374431863427162)","(['Codes of Business Conduct'], 0.7849782705307007)","('NON-ESG', 0.024452850222587585)","('NON-ESG', 0.02374431863427162)"
Line 15,"Following the United Nations Sustainable Development Goals (UN SDG), we focus our   efforts on those goals where we believe we can have the greatest impact – UN SDG 3:  Good Health and Well-Being; UN SDG 8: Decent Work and Economic Growth; and   UN SDG 12: Responsible Consumption and Production.
","('Human_Rights_And_Community_Relations', 0.6175478100776672)","('Access_And_Affordability', 0.12758153676986694)","('Ecological_Impacts', 0.03998834267258644)","(['Community Relations'], 0.6175478100776672)","('NON-ESG', 0.12758153676986694)","('NON-ESG', 0.03998834267258644)"
Line 16,"We made marked progress over the last year in the growth of our global teams while   also continuing a focus on diversity, inclusion and belonging, as well as community   engagement, at our global facilities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9708979725837708)","('Human_Rights_And_Community_Relations', 0.0037001515738666058)","('Employee_Health_And_Safety', 0.0020886417478322983)","(['Human Capital Development'], 0.9708979725837708)","('NON-ESG', 0.0037001515738666058)","('NON-ESG', 0.0020886417478322983)"
Line 17,"Notably in this year’s report, we are establishing   a target to achieve carbon neutrality by 2030 and 1.5° C science-based targets.
","('GHG_Emissions', 0.7285287380218506)","('Management_Of_Legal_And_Regulatory_Framework', 0.059705644845962524)","('Ecological_Impacts', 0.0471457876265049)","(['Climate Change'], 0.7285287380218506)","('NON-ESG', 0.059705644845962524)","('NON-ESG', 0.0471457876265049)"
Line 18,"Through   expansion of our global headquarters in Irvine, Calif., and construction or expansion   of our manufacturing facilities in Ireland and elsewhere around the world, we have   approached these projects with consideration for the environment.
","('Business_Model_Resilience', 0.3485313951969147)","('Product_Design_And_Lifecycle_Management', 0.2421150654554367)","('Supply_Chain_Management', 0.1385791003704071)","('NON-ESG', 0.3485313951969147)","('NON-ESG', 0.2421150654554367)","('NON-ESG', 0.1385791003704071)"
Line 19,"The new carbon   neutrality target broadens our thoughtful focus to all areas of our operations as we   deliver on our patient-focused innovation strategy.
","('Business_Model_Resilience', 0.3936316668987274)","('Product_Design_And_Lifecycle_Management', 0.09233495593070984)","('Competitive_Behavior', 0.0697791799902916)","('NON-ESG', 0.3936316668987274)","('NON-ESG', 0.09233495593070984)","('NON-ESG', 0.0697791799902916)"
Line 20,"We believe that by taking a long-term view and approach to our strategy and work,   and continuing to maintain focused on the key stakeholders with whom we are engaged,  we are creating a sustainable culture that will grow and thrive  even when faced with   unpredictable challenges.
","('Business_Model_Resilience', 0.35848525166511536)","('Human_Rights_And_Community_Relations', 0.1888173520565033)","('Employee_Engagement_Inclusion_And_Diversity', 0.10419605672359467)","('NON-ESG', 0.35848525166511536)","('NON-ESG', 0.1888173520565033)","('NON-ESG', 0.10419605672359467)"
Line 21,"I am proud of our strong team, community-minded employees  and patient-focused culture.
","('Human_Rights_And_Community_Relations', 0.7809724807739258)","('Employee_Engagement_Inclusion_And_Diversity', 0.05721134692430496)","('Employee_Health_And_Safety', 0.02506296895444393)","(['Community Relations'], 0.7809724807739258)","('NON-ESG', 0.05721134692430496)","('NON-ESG', 0.02506296895444393)"
Line 22,"We look forward to continuing our journey at Edwards to focus, measure and communicate   about the ways in which we make a sustainable impact.
","('Product_Design_And_Lifecycle_Management', 0.32685136795043945)","('Business_Model_Resilience', 0.19887201488018036)","('Ecological_Impacts', 0.06591647118330002)","('NON-ESG', 0.32685136795043945)","('NON-ESG', 0.19887201488018036)","('NON-ESG', 0.06591647118330002)"
Line 23,"Thank you for your interest in  our efforts, and we look forward to continued engagement with our global stakeholders  to form trusted partnerships to act together with purpose, and help even more patients  around the world.
","('Access_And_Affordability', 0.6617888808250427)","('Human_Rights_And_Community_Relations', 0.0910462737083435)","('Management_Of_Legal_And_Regulatory_Framework', 0.024380959570407867)","(['Health Outcome Contribution'], 0.6617888808250427)","('NON-ESG', 0.0910462737083435)","('NON-ESG', 0.024380959570407867)"
Line 24,"Michael A.
","('Management_Of_Legal_And_Regulatory_Framework', 0.12631754577159882)","('Business_Ethics', 0.09247645735740662)","('Employee_Engagement_Inclusion_And_Diversity', 0.0611029788851738)","('NON-ESG', 0.12631754577159882)","('NON-ESG', 0.09247645735740662)","('NON-ESG', 0.0611029788851738)"
Line 25,"Mussallem   Chairman & Chief Executive Officer   Letter from the   Chairman and CEO EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT OverviewEdwards Lifesciences is the global leader in patient-focused medical innovations for  structural heart disease and critical care monitoring.
","('Customer_Welfare', 0.12188035994768143)","('Product_Quality_And_Safety', 0.10389610379934311)","('Product_Design_And_Lifecycle_Management', 0.10194013267755508)","('NON-ESG', 0.12188035994768143)","('NON-ESG', 0.10389610379934311)","('NON-ESG', 0.10194013267755508)"
Line 26,"We are driven by a passion for patients  and are dedicated to improving and enhancing lives through partnerships with clinicians  and stakeholders across the global healthcare landscape.
","('Access_And_Affordability', 0.824303925037384)","('Human_Rights_And_Community_Relations', 0.03339413180947304)","('Employee_Engagement_Inclusion_And_Diversity', 0.01507310289889574)","(['Health Outcome Contribution'], 0.824303925037384)","('NON-ESG', 0.03339413180947304)","('NON-ESG', 0.01507310289889574)"
Line 27,"Edwards Lifesciences continues to focus on investing in our people, our innovative   technologies and our growth, and even with the challenges of the last several years, has  remained dedicated to helping as many patients as possible.
","('Access_And_Affordability', 0.338582307100296)","('Product_Design_And_Lifecycle_Management', 0.10499928146600723)","('Employee_Engagement_Inclusion_And_Diversity', 0.10449695587158203)","('NON-ESG', 0.338582307100296)","('NON-ESG', 0.10499928146600723)","('NON-ESG', 0.10449695587158203)"
Line 28,"We recognize that our work  impacts many stakeholders around the world, and we are committed to contributing   value to the communities in which we operate.
","('Human_Rights_And_Community_Relations', 0.9564127326011658)","('Access_And_Affordability', 0.005136637482792139)","('Employee_Engagement_Inclusion_And_Diversity', 0.002743134507909417)","(['Community Relations'], 0.9564127326011658)","('NON-ESG', 0.005136637482792139)","('NON-ESG', 0.002743134507909417)"
Line 29,"At Edwards, our Credo defines our culture, strategic priorities, and our vision for   sustainability and long-term value creation.
","('Business_Model_Resilience', 0.6438206434249878)","('Product_Design_And_Lifecycle_Management', 0.09208383411169052)","('Human_Rights_And_Community_Relations', 0.033253517001867294)","(['Codes of Business Conduct'], 0.6438206434249878)","('NON-ESG', 0.09208383411169052)","('NON-ESG', 0.033253517001867294)"
Line 30,"Our environmental, social and governance  (ESG) or sustainability targets are closely aligned with our corporate aspirations and   are intended to address those topics that have been assessed to be of most importance   to Edwards and its stakeholders.
","('Human_Rights_And_Community_Relations', 0.3189760744571686)","('Business_Model_Resilience', 0.26643845438957214)","('Management_Of_Legal_And_Regulatory_Framework', 0.08165577054023743)","('NON-ESG', 0.3189760744571686)","('NON-ESG', 0.26643845438957214)","('NON-ESG', 0.08165577054023743)"
Line 31,"We are proud to share our progress toward those   targets, shown in the table below.The Edwards Lifesciences 2021 Sustainability Report has been prepared in   accordance with the Global Reporting Initiative (GRI) Standards and with reference  to the United Nations’ 17 Sustainable Development Goals (UN SDGs).
","('Business_Model_Resilience', 0.2283490002155304)","('Management_Of_Legal_And_Regulatory_Framework', 0.10072941333055496)","('Product_Design_And_Lifecycle_Management', 0.07818035781383514)","('NON-ESG', 0.2283490002155304)","('NON-ESG', 0.10072941333055496)","('NON-ESG', 0.07818035781383514)"
Line 32,"Based on   our assessment of the SDGs, we have focused our efforts on those areas where   we believe we can have the most significant and meaningful impact:  UN SGD 3: Good Health and Well-Being - Ensure healthy lives and promote   well-being for all at all ages UN SGD 8:  Decent Work and Economic Growth - Promote inclusive and   sustainable economic growth, employment and decent work for all UN SGD 12:  Responsible Consumption and Production - Ensure sustainable   consumption and production patterns.
","('Employee_Health_And_Safety', 0.569794774055481)","('Access_And_Affordability', 0.16078101098537445)","('Human_Rights_And_Community_Relations', 0.052852973341941833)","(['Operational Eco-Efficiency'], 0.569794774055481)","('NON-ESG', 0.16078101098537445)","('NON-ESG', 0.052852973341941833)"
Line 33,"Our   Approach EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Sustainability T argets •Remove barriers along the patient journey   to continuously increase treatment rates   for all indicated severe aortic stenosis   patients  Ensure that our therapies are addressing   the needs of patients through an   increasingly collaborative  patient   engagement process   Empower and activate patients by   meaningfully increasing awareness of   structural heart disease globally by 2024Transforming patient   lives with breakthrough   medical technologies Edwards is driven by a  passion to help patients,  partnering with clinicians   to develop innovative   technologies in the areas   of structural heart disease  and critical care monitoring.
","('Access_And_Affordability', 0.38498497009277344)","('Employee_Health_And_Safety', 0.23594649136066437)","('Product_Quality_And_Safety', 0.05813222378492355)","('NON-ESG', 0.38498497009277344)","('NON-ESG', 0.23594649136066437)","('NON-ESG', 0.05813222378492355)"
Line 34,"Our   Approach EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Sustainability T argets •Remove barriers along the patient journey   to continuously increase treatment rates   for all indicated severe aortic stenosis   patients  Ensure that our therapies are addressing   the needs of patients through an   increasingly collaborative  patient   engagement process   Empower and activate patients by   meaningfully increasing awareness of   structural heart disease globally by 2024Transforming patient   lives with breakthrough   medical technologies Edwards is driven by a  passion to help patients,  partnering with clinicians   to develop innovative   technologies in the areas   of structural heart disease  and critical care monitoring.
","('Access_And_Affordability', 0.5297778844833374)","('Critical_Incident_Risk_Management', 0.07473572343587875)","('Customer_Welfare', 0.0585918165743351)","(['Health Outcome Contribution'], 0.5297778844833374)","('NON-ESG', 0.07473572343587875)","('NON-ESG', 0.0585918165743351)"
Line 35,"We put patients first,   working to produce   better technologies that   enable better outcomes   for patients.Our Aspirationsmet                   in progress                 not met Patients treated with   Transcatheter Therapies600K+ EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Sustainability Targets •Drive continuous improvement  efforts to   ensure no patient safety-related class 1   product removals No significant disruption of product   availability   Achieve a 35% reduction in recordable   injury rates by Achieve ISO 14001 and 45001 certification   at all manufacturing plants by By 2021, aim to achieve information security and  privacy certifications for our digital and connected  medical device platforms:    •  UL2900 certification for our new medical   devices release, such as next generation   HemoSphere monitoring platform   •  HITRUST certification for our upcoming Cloud  portal that will process regulated patient  health information of our customersmet                   in progress                 not met Excelling as a trusted   partner through   distinguished quality   and integrity Edwards conducts business  ethically and with integrity,  providing the highest level   of care and respect for our  partners.
","('Product_Quality_And_Safety', 0.7510061264038086)","('Product_Design_And_Lifecycle_Management', 0.09076668322086334)","('Selling_Practices_And_Product_Labeling', 0.034658871591091156)","(['Product Quality & Recall Management'], 0.7510061264038086)","('NON-ESG', 0.09076668322086334)","('NON-ESG', 0.034658871591091156)"
Line 36,"We put patients first,   working to produce   better technologies that   enable better outcomes   for patients.Our Aspirationsmet                   in progress                 not met Patients treated with   Transcatheter Therapies600K+ EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Sustainability Targets •Drive continuous improvement  efforts to   ensure no patient safety-related class 1   product removals No significant disruption of product   availability   Achieve a 35% reduction in recordable   injury rates by Achieve ISO 14001 and 45001 certification   at all manufacturing plants by By 2021, aim to achieve information security and  privacy certifications for our digital and connected  medical device platforms:    •  UL2900 certification for our new medical   devices release, such as next generation   HemoSphere monitoring platform   •  HITRUST certification for our upcoming Cloud  portal that will process regulated patient  health information of our customersmet                   in progress                 not met Excelling as a trusted   partner through   distinguished quality   and integrity Edwards conducts business  ethically and with integrity,  providing the highest level   of care and respect for our  partners.
","('Data_Security', 0.8983655571937561)","('Customer_Privacy', 0.04641485959291458)","('Business_Ethics', 0.005350431893020868)","(['Information Security/Cybersecurity & System Availability'], 0.8983655571937561)","('NON-ESG', 0.04641485959291458)","('NON-ESG', 0.005350431893020868)"
Line 37,"We put patients first,   working to produce   better technologies that   enable better outcomes   for patients.Our Aspirationsmet                   in progress                 not met Patients treated with   Transcatheter Therapies600K+ EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Sustainability Targets •Drive continuous improvement  efforts to   ensure no patient safety-related class 1   product removals No significant disruption of product   availability   Achieve a 35% reduction in recordable   injury rates by Achieve ISO 14001 and 45001 certification   at all manufacturing plants by By 2021, aim to achieve information security and  privacy certifications for our digital and connected  medical device platforms:    •  UL2900 certification for our new medical   devices release, such as next generation   HemoSphere monitoring platform   •  HITRUST certification for our upcoming Cloud  portal that will process regulated patient  health information of our customersmet                   in progress                 not met Excelling as a trusted   partner through   distinguished quality   and integrity Edwards conducts business  ethically and with integrity,  providing the highest level   of care and respect for our  partners.
","('Business_Ethics', 0.8584710955619812)","('Human_Rights_And_Community_Relations', 0.018356503918766975)","('Customer_Privacy', 0.016563938930630684)","(['Business Ethics'], 0.8584710955619812)","('NON-ESG', 0.018356503918766975)","('NON-ESG', 0.016563938930630684)"
Line 38,"We are committed  to the quality and safety   of our products, driving   innovation and promoting  resource efficiency.Our Aspirations EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Sustainability Targets •By 2022, all global employees to have completed   unconscious bias training, and new hires within   six months of employment Year-over-year positive trending globally   of women in leadership positions Year-over-year positive trending in U.S. of   ethnically diverse talent in leadership positions Annual top talent retention resulting in voluntary   turnover less than high performing benchmarks Highly engaged workforce that exceeds industry,   region and high performing benchmarks for   employee engagementmet                   in progress                 not met Fostering an   inclusive culture   where all employees   grow and thrive Fulfilling our mission to   help patients requires a  strong, healthy and talented  workforce.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9671475887298584)","('Product_Design_And_Lifecycle_Management', 0.00352309993468225)","('Employee_Health_And_Safety', 0.0023754655849188566)","(['Human Capital Development'], 0.9671475887298584)","('NON-ESG', 0.00352309993468225)","('NON-ESG', 0.0023754655849188566)"
Line 39,"We are committed  to the quality and safety   of our products, driving   innovation and promoting  resource efficiency.Our Aspirations EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Sustainability Targets •By 2022, all global employees to have completed   unconscious bias training, and new hires within   six months of employment Year-over-year positive trending globally   of women in leadership positions Year-over-year positive trending in U.S. of   ethnically diverse talent in leadership positions Annual top talent retention resulting in voluntary   turnover less than high performing benchmarks Highly engaged workforce that exceeds industry,   region and high performing benchmarks for   employee engagementmet                   in progress                 not met Fostering an   inclusive culture   where all employees   grow and thrive Fulfilling our mission to   help patients requires a  strong, healthy and talented  workforce.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9706442952156067)","('Employee_Health_And_Safety', 0.0031719645485281944)","('Customer_Welfare', 0.0018789074383676052)","(['Human Capital Development'], 0.9706442952156067)","('NON-ESG', 0.0031719645485281944)","('NON-ESG', 0.0018789074383676052)"
Line 40,"Edwards recruits  top candidates, offers   employee wellness and   engagement programs and  fosters a diverse and inclusive  culture to help employees   deliver their best.Our Aspirations EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Sustainability Targets New Targets•Drive Edwards’ aspiration of 100% global   employee participation in charitable activity   with participation goals of 100% for the Senior  Leadership Team (SLT) and an increase in global  participation as measured by the Employee   Engagement survey  Every Heartbeat Matters will improve the lives of  2.5 million more underserved structural heart and  critical care patients by the end of 2025  Electronic instructions-for-use roll-out to   all applicable business regions by end of By 2025, reduce our environmental footprint   according to Edwards’ EHS plan:  •  10% reduction in waste generation intensity  •  10% reduction in water withdrawal intensity Achieve carbon neutrality by 2030   and 1.5˚C science-based targets Reduce product distribution air miles traveled by  an additional 1.5 million by 2023 vs 2018 baseline Passionate engagement  that strengthens our  communities Edwards is committed to  strengthening the health   of our global communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9628902077674866)","('Human_Rights_And_Community_Relations', 0.004073505289852619)","('Employee_Health_And_Safety', 0.0029109350871294737)","(['Human Capital Development'], 0.9628902077674866)","('NON-ESG', 0.004073505289852619)","('NON-ESG', 0.0029109350871294737)"
Line 41,"Edwards recruits  top candidates, offers   employee wellness and   engagement programs and  fosters a diverse and inclusive  culture to help employees   deliver their best.Our Aspirations EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Sustainability Targets New Targets•Drive Edwards’ aspiration of 100% global   employee participation in charitable activity   with participation goals of 100% for the Senior  Leadership Team (SLT) and an increase in global  participation as measured by the Employee   Engagement survey  Every Heartbeat Matters will improve the lives of  2.5 million more underserved structural heart and  critical care patients by the end of 2025  Electronic instructions-for-use roll-out to   all applicable business regions by end of By 2025, reduce our environmental footprint   according to Edwards’ EHS plan:  •  10% reduction in waste generation intensity  •  10% reduction in water withdrawal intensity Achieve carbon neutrality by 2030   and 1.5˚C science-based targets Reduce product distribution air miles traveled by  an additional 1.5 million by 2023 vs 2018 baseline Passionate engagement  that strengthens our  communities Edwards is committed to  strengthening the health   of our global communities.
","('Energy_Management', 0.36761513352394104)","('Access_And_Affordability', 0.19039230048656464)","('Product_Design_And_Lifecycle_Management', 0.09683545678853989)","('NON-ESG', 0.36761513352394104)","('NON-ESG', 0.19039230048656464)","('NON-ESG', 0.09683545678853989)"
Line 42,"Edwards recruits  top candidates, offers   employee wellness and   engagement programs and  fosters a diverse and inclusive  culture to help employees   deliver their best.Our Aspirations EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Sustainability Targets New Targets•Drive Edwards’ aspiration of 100% global   employee participation in charitable activity   with participation goals of 100% for the Senior  Leadership Team (SLT) and an increase in global  participation as measured by the Employee   Engagement survey  Every Heartbeat Matters will improve the lives of  2.5 million more underserved structural heart and  critical care patients by the end of 2025  Electronic instructions-for-use roll-out to   all applicable business regions by end of By 2025, reduce our environmental footprint   according to Edwards’ EHS plan:  •  10% reduction in waste generation intensity  •  10% reduction in water withdrawal intensity Achieve carbon neutrality by 2030   and 1.5˚C science-based targets Reduce product distribution air miles traveled by  an additional 1.5 million by 2023 vs 2018 baseline Passionate engagement  that strengthens our  communities Edwards is committed to  strengthening the health   of our global communities.
","('Human_Rights_And_Community_Relations', 0.9142960906028748)","('Access_And_Affordability', 0.01688297837972641)","('Critical_Incident_Risk_Management', 0.00631234934553504)","(['Community Relations'], 0.9142960906028748)","('NON-ESG', 0.01688297837972641)","('NON-ESG', 0.00631234934553504)"
Line 43,"With patients as our top   priority, we work to increase  access to our innovative   therapies, improve efficiency  of healthcare processes,   improve awareness of   and treatment for life-   threatening diseases and  provide opportunities for our  employees to give back.Our Aspirations met                   in progress                 not met EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORTWhile acting as a trusted partner in a responsible manner   has always been a key tenet at Edwards, we began formally   reporting our sustainability progress in 2014.
","('Access_And_Affordability', 0.758579432964325)","('Employee_Health_And_Safety', 0.0414295420050621)","('Product_Quality_And_Safety', 0.0356680303812027)","(['Health Outcome Contribution'], 0.758579432964325)","('NON-ESG', 0.0414295420050621)","('NON-ESG', 0.0356680303812027)"
Line 44,"With patients as our top   priority, we work to increase  access to our innovative   therapies, improve efficiency  of healthcare processes,   improve awareness of   and treatment for life-   threatening diseases and  provide opportunities for our  employees to give back.Our Aspirations met                   in progress                 not met EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORTWhile acting as a trusted partner in a responsible manner   has always been a key tenet at Edwards, we began formally   reporting our sustainability progress in 2014.
","('Business_Model_Resilience', 0.38017553091049194)","('Systemic_Risk_Management', 0.11406207829713821)","('Supply_Chain_Management', 0.07901927828788757)","('NON-ESG', 0.38017553091049194)","('NON-ESG', 0.11406207829713821)","('NON-ESG', 0.07901927828788757)"
Line 45,"To guide our ESG  strategy and disclosure, in 2015, we established a Sustainability  Council comprised of senior leaders from across the organization.
","('Business_Model_Resilience', 0.5619258284568787)","('Systemic_Risk_Management', 0.07309579849243164)","('Director_Removal', 0.0635480210185051)","(['Codes of Business Conduct'], 0.5619258284568787)","('NON-ESG', 0.07309579849243164)","('NON-ESG', 0.0635480210185051)"
Line 46,"Each council member has a sponsor from the Edwards   Leadership Team who oversees the inclusion of sustainability  within their part of the company.
","('Business_Model_Resilience', 0.19974075257778168)","('Director_Removal', 0.19765181839466095)","('Employee_Engagement_Inclusion_And_Diversity', 0.14256396889686584)","('NON-ESG', 0.19974075257778168)","('NON-ESG', 0.19765181839466095)","('NON-ESG', 0.14256396889686584)"
Line 47,"In 2016, we conducted our   first ESG materiality assessment, which allowed us to identify and  prioritize our management of key environmental, social and   governance topics.
","('Business_Model_Resilience', 0.4564996659755707)","('Human_Rights_And_Community_Relations', 0.17322205007076263)","('Systemic_Risk_Management', 0.05761786550283432)","('NON-ESG', 0.4564996659755707)","('NON-ESG', 0.17322205007076263)","('NON-ESG', 0.05761786550283432)"
Line 48,"We then set sustainability targets for each   of our most important topics, which align naturally with our   Aspirations.
","('Business_Model_Resilience', 0.49520358443260193)","('Product_Design_And_Lifecycle_Management', 0.06584315001964569)","('Supply_Chain_Management', 0.06583698093891144)","('NON-ESG', 0.49520358443260193)","('NON-ESG', 0.06584315001964569)","('NON-ESG', 0.06583698093891144)"
Line 49,"Our team continues to assess and report progress on  our targets annually.
","('Human_Rights_And_Community_Relations', 0.2428792417049408)","('Management_Of_Legal_And_Regulatory_Framework', 0.1394568383693695)","('Systemic_Risk_Management', 0.10916256904602051)","('NON-ESG', 0.2428792417049408)","('NON-ESG', 0.1394568383693695)","('NON-ESG', 0.10916256904602051)"
Line 50,"In 2019, we refreshed the materiality assessment using the Six  Capitals of Integrated Reporting in prioritization of the identified   important topics.
","('Management_Of_Legal_And_Regulatory_Framework', 0.32762065529823303)","('Systemic_Risk_Management', 0.20146040618419647)","('Business_Model_Resilience', 0.11451824754476547)","('NON-ESG', 0.32762065529823303)","('NON-ESG', 0.20146040618419647)","('NON-ESG', 0.11451824754476547)"
Line 51,"More information on our materiality refresh   can be found in our Materiality & Stakeholder Engagement    section.
","('Business_Model_Resilience', 0.5114551186561584)","('Human_Rights_And_Community_Relations', 0.17962758243083954)","('Management_Of_Legal_And_Regulatory_Framework', 0.03259653225541115)","(['Codes of Business Conduct'], 0.5114551186561584)","('NON-ESG', 0.17962758243083954)","('NON-ESG', 0.03259653225541115)"
Line 52,"In 2021, we further integrated sustainability factors, including    our target setting process, into our overall corporate strategic  planning process and initiated a readiness assessment for   integrated reporting.
","('Business_Model_Resilience', 0.7585992813110352)","('Product_Design_And_Lifecycle_Management', 0.031840112060308456)","('Physical_Impacts_Of_Climate_Change', 0.030605709180235863)","(['Codes of Business Conduct'], 0.7585992813110352)","('NON-ESG', 0.031840112060308456)","('NON-ESG', 0.030605709180235863)"
Line 53,"This report has been prepared in accordance with the Global  Reporting Initiative (GRI) Standards (Core option).
","('Management_Of_Legal_And_Regulatory_Framework', 0.7374817728996277)","('Product_Quality_And_Safety', 0.0385981984436512)","('Access_And_Affordability', 0.029811551794409752)","(['Corporate Governance'], 0.7374817728996277)","('NON-ESG', 0.0385981984436512)","('NON-ESG', 0.029811551794409752)"
Line 54,"This report  covers all global Edwards subsidiaries.
","('Business_Model_Resilience', 0.2925405204296112)","('Systemic_Risk_Management', 0.12563352286815643)","('Director_Removal', 0.1212538331747055)","('NON-ESG', 0.2925405204296112)","('NON-ESG', 0.12563352286815643)","('NON-ESG', 0.1212538331747055)"
Line 55,"We also evaluated the  SASB Standards for Medical Equipment and Supplies and have  incorporated certain metrics into this year’s report.
","('Product_Quality_And_Safety', 0.2657347321510315)","('Product_Design_And_Lifecycle_Management', 0.1702357679605484)","('Supply_Chain_Management', 0.09340690821409225)","('NON-ESG', 0.2657347321510315)","('NON-ESG', 0.1702357679605484)","('NON-ESG', 0.09340690821409225)"
Line 56,"Please see  our Content Index for more details.
","('Data_Security', 0.28392481803894043)","('Customer_Privacy', 0.10498251765966415)","('Management_Of_Legal_And_Regulatory_Framework', 0.10085476189851761)","('NON-ESG', 0.28392481803894043)","('NON-ESG', 0.10498251765966415)","('NON-ESG', 0.10085476189851761)"
Line 57,"We annually report our  climate and water impacts to CDP and respond to several sus- tainability rating and ranking surveys, including DJSI.
","('Water_And_Wastewater_Management', 0.9324986934661865)","('Ecological_Impacts', 0.01166839525103569)","('GHG_Emissions', 0.01066376268863678)","(['Operational Eco-Efficiency'], 0.9324986934661865)","('NON-ESG', 0.01166839525103569)","('NON-ESG', 0.01066376268863678)"
Line 58,"We publish  periodic philanthropy reports on our corporate giving initiatives.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5870245099067688)","('Business_Ethics', 0.06673917919397354)","('Human_Rights_And_Community_Relations', 0.05106257647275925)","(['Corporate Governance'], 0.5870245099067688)","('NON-ESG', 0.06673917919397354)","('NON-ESG', 0.05106257647275925)"
Line 59,"In addition, we publish our Sustainability Metrics at a Glance,  which offers a multi-page snapshot of the metrics most used by  external stakeholders.
","('Business_Model_Resilience', 0.37411919236183167)","('Supply_Chain_Management', 0.15271377563476562)","('Systemic_Risk_Management', 0.1142105683684349)","('NON-ESG', 0.37411919236183167)","('NON-ESG', 0.15271377563476562)","('NON-ESG', 0.1142105683684349)"
Line 60,"We use an interactive Governance Map   that outlines our accountability process for material topics.• Delivering exceptional  shareholder value By delivering on our   focused company strategy  and implementing   sustainability practices,   Edwards positions itself   for long-term profitability  that will benefit our   stakeholders and also   our bottom line.Our Aspirations Sustainability Targets  met                   in progress                 not met Integrate sustainability factors in   the strategic planning process annually Include sustainability targets in the   CEO’s performance goals annually New Target Incorporate sustainability targets into the   Senior Leadership Team annual performance   objectives by 2022  EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT OverviewOrganizational Profile Edwards was established as an independent public company in 2000, and since then   the company has grown to more than $5 billion in revenue in 2021 with product sales in   approximately 100 countries.
","('Business_Model_Resilience', 0.6857219934463501)","('Systemic_Risk_Management', 0.05997314676642418)","('Director_Removal', 0.031509339809417725)","(['Codes of Business Conduct'], 0.6857219934463501)","('NON-ESG', 0.05997314676642418)","('NON-ESG', 0.031509339809417725)"
Line 61,"We use an interactive Governance Map   that outlines our accountability process for material topics.• Delivering exceptional  shareholder value By delivering on our   focused company strategy  and implementing   sustainability practices,   Edwards positions itself   for long-term profitability  that will benefit our   stakeholders and also   our bottom line.Our Aspirations Sustainability Targets  met                   in progress                 not met Integrate sustainability factors in   the strategic planning process annually Include sustainability targets in the   CEO’s performance goals annually New Target Incorporate sustainability targets into the   Senior Leadership Team annual performance   objectives by 2022  EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT OverviewOrganizational Profile Edwards was established as an independent public company in 2000, and since then   the company has grown to more than $5 billion in revenue in 2021 with product sales in   approximately 100 countries.
","('Product_Design_And_Lifecycle_Management', 0.9235649108886719)","('Product_Quality_And_Safety', 0.013769950717687607)","('Customer_Welfare', 0.009801634587347507)","(['Product Stewardship'], 0.9235649108886719)","('NON-ESG', 0.013769950717687607)","('NON-ESG', 0.009801634587347507)"
Line 62,"We are dedicated to the development of medical technologies   that improve both patient outcomes and speed of recovery.
","('Employee_Health_And_Safety', 0.6743752956390381)","('Access_And_Affordability', 0.06503628194332123)","('Critical_Incident_Risk_Management', 0.05375424772500992)","(['Operational Eco-Efficiency'], 0.6743752956390381)","('NON-ESG', 0.06503628194332123)","('NON-ESG', 0.05375424772500992)"
Line 63,"Our technologies include   transcatheter and surgical heart valve therapies and critical care technologies, such as:  •  Transcatheter Aortic Valve Replacement (TAVR) – In partnership with physicians   worldwide, Edwards continues to lead the development of minimally-invasive heart  valve technologies enabling a streamlined procedure with excellent outcomes, rapid  discharge and improved quality of life for patients with aortic stenosis.
","('Employee_Health_And_Safety', 0.5108910799026489)","('Access_And_Affordability', 0.10680485516786575)","('Product_Quality_And_Safety', 0.0484628863632679)","(['Operational Eco-Efficiency'], 0.5108910799026489)","('NON-ESG', 0.10680485516786575)","('NON-ESG', 0.0484628863632679)"
Line 64,"Through   significant investment in technology advancement and clinical evidence, Edwards  strives to further expand the treatment options for patients with aortic stenosis.
","('Employee_Health_And_Safety', 0.3539629578590393)","('Access_And_Affordability', 0.119719959795475)","('Product_Quality_And_Safety', 0.10388264805078506)","('NON-ESG', 0.3539629578590393)","('NON-ESG', 0.119719959795475)","('NON-ESG', 0.10388264805078506)"
Line 65,"•  Transcatheter Mitral and Tricuspid Therapies (TMTT) – Edwards is making   significant investments in the development of a differentiated portfolio of therapy   options designed to treat mitral and tricuspid valve diseases.
","('Employee_Health_And_Safety', 0.24591320753097534)","('Systemic_Risk_Management', 0.11548592150211334)","('Access_And_Affordability', 0.07718052715063095)","('NON-ESG', 0.24591320753097534)","('NON-ESG', 0.11548592150211334)","('NON-ESG', 0.07718052715063095)"
Line 66,"•  Surgical Structural Heart (Surgical) – Edwards is committed to being the partner   of choice for cardiac surgeons and helping transform patients’ lives by advancing   surgical structural heart innovations.
","('Access_And_Affordability', 0.27720004320144653)","('Employee_Health_And_Safety', 0.13374829292297363)","('Critical_Incident_Risk_Management', 0.0857214629650116)","('NON-ESG', 0.27720004320144653)","('NON-ESG', 0.13374829292297363)","('NON-ESG', 0.0857214629650116)"
Line 67,"Edwards is the world’s leading manufacturer   of tissue heart valves and surgical heart valve repair therapies, which are used to treat   a patient’s diseased heart valve.
","('Employee_Health_And_Safety', 0.29347172379493713)","('Access_And_Affordability', 0.09658412635326385)","('Critical_Incident_Risk_Management', 0.09323272109031677)","('NON-ESG', 0.29347172379493713)","('NON-ESG', 0.09658412635326385)","('NON-ESG', 0.09323272109031677)"
Line 68,"•  Critical Care – Edwards is a world leader in advanced hemodynamic monitoring   systems used to measure a patient’s heart function and fluid status in surgical and   intensive care settings.
","('Employee_Health_And_Safety', 0.5713822245597839)","('Access_And_Affordability', 0.06412632763385773)","('Critical_Incident_Risk_Management', 0.050146255642175674)","(['Operational Eco-Efficiency'], 0.5713822245597839)","('NON-ESG', 0.06412632763385773)","('NON-ESG', 0.050146255642175674)"
Line 69,"Its complete hemodynamic portfolio helps clinicians make   proactive clinical decisions and plays an important role in enhancing patient recovery.
","('Access_And_Affordability', 0.3725097179412842)","('Customer_Welfare', 0.11461580544710159)","('Critical_Incident_Risk_Management', 0.04664768651127815)","('NON-ESG', 0.3725097179412842)","('NON-ESG', 0.11461580544710159)","('NON-ESG', 0.04664768651127815)"
Line 70,"Every year, Edwards Lifesciences continues to innovate life-saving therapies.
","('Product_Design_And_Lifecycle_Management', 0.3614535927772522)","('Access_And_Affordability', 0.12672172486782074)","('Customer_Welfare', 0.10102596133947372)","('NON-ESG', 0.3614535927772522)","('NON-ESG', 0.12672172486782074)","('NON-ESG', 0.10102596133947372)"
Line 71,"In 2021, Edwards Lifesciences introduced several products for commercial use.
","('Product_Design_And_Lifecycle_Management', 0.9380507469177246)","('Customer_Welfare', 0.011162768118083477)","('Product_Quality_And_Safety', 0.006466854363679886)","(['Product Stewardship'], 0.9380507469177246)","('NON-ESG', 0.011162768118083477)","('NON-ESG', 0.006466854363679886)"
Line 72,"•  Chinese sales initiated for the INSPIRIS RESILIA aortic surgical valve   •  Japanese approval of the MITRIS RESILIA Mitral Valve   •  Japanese approval to begin treating patients at low surgical risk with the   SAPIEN 3 valve •  U.S. Food and Drug Administration (FDA) clearance for Hypotension Prediction    Index software for noninvasive Acumen IQ Cuff  •  FDA approval for the use of the Edwards SAPIEN 3 transcatheter valve with   the Alterra adaptive prestent (SAPIEN 3 with Alterra) for patients with severe   pulmonary regurgitation.
","('Employee_Health_And_Safety', 0.18246090412139893)","('Access_And_Affordability', 0.1352006047964096)","('Product_Quality_And_Safety', 0.12489078938961029)","('NON-ESG', 0.18246090412139893)","('NON-ESG', 0.1352006047964096)","('NON-ESG', 0.12489078938961029)"
Line 73,"•  Chinese sales initiated for the INSPIRIS RESILIA aortic surgical valve   •  Japanese approval of the MITRIS RESILIA Mitral Valve   •  Japanese approval to begin treating patients at low surgical risk with the   SAPIEN 3 valve •  U.S. Food and Drug Administration (FDA) clearance for Hypotension Prediction    Index software for noninvasive Acumen IQ Cuff  •  FDA approval for the use of the Edwards SAPIEN 3 transcatheter valve with   the Alterra adaptive prestent (SAPIEN 3 with Alterra) for patients with severe   pulmonary regurgitation.
","('Access_And_Affordability', 0.1349310576915741)","('Systemic_Risk_Management', 0.10305086523294449)","('Air_Quality', 0.06434213370084763)","('NON-ESG', 0.1349310576915741)","('NON-ESG', 0.10305086523294449)","('NON-ESG', 0.06434213370084763)"
Line 74,"Edwards has continued our focus on innovation.
","('Product_Design_And_Lifecycle_Management', 0.4203662574291229)","('Business_Model_Resilience', 0.14021968841552734)","('Supply_Chain_Management', 0.07366382330656052)","('NON-ESG', 0.4203662574291229)","('NON-ESG', 0.14021968841552734)","('NON-ESG', 0.07366382330656052)"
Line 75,"Please see our Newsroom for updates   on our latest innovations and approvals, as well as our Investor Relations site for quarterly  Fact Sheets.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3728688955307007)","('Competitive_Behavior', 0.16802410781383514)","('Business_Model_Resilience', 0.12278082221746445)","('NON-ESG', 0.3728688955307007)","('NON-ESG', 0.16802410781383514)","('NON-ESG', 0.12278082221746445)"
Line 76,"Edwards is incorporated in Delaware and headquartered in Irvine, California, USA.
","('Management_Of_Legal_And_Regulatory_Framework', 0.16812001168727875)","('Business_Model_Resilience', 0.123684361577034)","('Competitive_Behavior', 0.1110171228647232)","('NON-ESG', 0.16812001168727875)","('NON-ESG', 0.123684361577034)","('NON-ESG', 0.1110171228647232)"
Line 77,"We operate major manufacturing facilities in the United States, Puerto Rico, the   Dominican Republic, Costa Rica, Singapore and Ireland.
","('Product_Design_And_Lifecycle_Management', 0.739546000957489)","('Supply_Chain_Management', 0.053994666785001755)","('Customer_Welfare', 0.02875450626015663)","(['Product Stewardship'], 0.739546000957489)","('NON-ESG', 0.053994666785001755)","('NON-ESG', 0.02875450626015663)"
Line 78,"We also have a significant   employee presence at regional locations in Europe and Japan, with an office in   Ireland where a manufacturing facility was opened in 2021 with plans to increase the  workforce to 850 people in the coming years.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8154557347297668)","('Labor_Practices', 0.03781260922551155)","('Employee_Health_And_Safety', 0.0345376580953598)","(['Human Capital Development'], 0.8154557347297668)","('NON-ESG', 0.03781260922551155)","('NON-ESG', 0.0345376580953598)"
Line 79,"None of our North American employees   are represented by a labor union.
","('Labor_Practices', 0.9660221338272095)","('Director_Removal', 0.004522635135799646)","('Employee_Engagement_Inclusion_And_Diversity', 0.003762470558285713)","(['Labor Practice Indicators'], 0.9660221338272095)","('NON-ESG', 0.004522635135799646)","('NON-ESG', 0.003762470558285713)"
Line 80,"In various countries outside of North America, we   interact with trade unions and work councils that represent a limited number   of employees.2021 Sales by Product Line 2021 Sales by Geographic Region n	United States    n Europe     n Japan    n Rest of World65%17% 16% 2%n   TAVR n   Surgical n  Critical Care n  TMTT57% 10%23% 10% EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT OverviewEdwards by the Numbers Customers  Across the U.S. and international markets, our customers include physicians, medical professionals, hospitals and group   purchasing organizations.
","('Labor_Practices', 0.441281795501709)","('Competitive_Behavior', 0.12240611761808395)","('Product_Quality_And_Safety', 0.07991169393062592)","('NON-ESG', 0.441281795501709)","('NON-ESG', 0.12240611761808395)","('NON-ESG', 0.07991169393062592)"
Line 81,"In various countries outside of North America, we   interact with trade unions and work councils that represent a limited number   of employees.2021 Sales by Product Line 2021 Sales by Geographic Region n	United States    n Europe     n Japan    n Rest of World65%17% 16% 2%n   TAVR n   Surgical n  Critical Care n  TMTT57% 10%23% 10% EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT OverviewEdwards by the Numbers Customers  Across the U.S. and international markets, our customers include physicians, medical professionals, hospitals and group   purchasing organizations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.15463590621948242)","('Customer_Welfare', 0.1361759454011917)","('Competitive_Behavior', 0.08688255399465561)","('NON-ESG', 0.15463590621948242)","('NON-ESG', 0.1361759454011917)","('NON-ESG', 0.08688255399465561)"
Line 82,"In 2021, we derived 57 percent of our sales from the U.S. and 43 percent from international markets.
","('Competitive_Behavior', 0.26088324189186096)","('Customer_Welfare', 0.10962552577257156)","('Product_Design_And_Lifecycle_Management', 0.10796467214822769)","('NON-ESG', 0.26088324189186096)","('NON-ESG', 0.10962552577257156)","('NON-ESG', 0.10796467214822769)"
Line 83,"We source about 70 percent of our   manufacturing materials from key and   strategic suppliers.
","('Supply_Chain_Management', 0.5576750040054321)","('Product_Design_And_Lifecycle_Management', 0.20661337673664093)","('Waste_And_Hazardous_Materials_Management', 0.04604736715555191)","(['Supply Chain Management'], 0.5576750040054321)","('NON-ESG', 0.20661337673664093)","('NON-ESG', 0.04604736715555191)"
Line 84,"We only add suppliers   if new technology or capability is required   for our business and not already present in   our supplier base.
","('Supply_Chain_Management', 0.9278847575187683)","('Product_Design_And_Lifecycle_Management', 0.01011575385928154)","('Labor_Practices', 0.005565391853451729)","(['Supply Chain Management'], 0.9278847575187683)","('NON-ESG', 0.01011575385928154)","('NON-ESG', 0.005565391853451729)"
Line 85,"New suppliers undergo   a thorough due diligence process, including  screening for adverse conditions or events.
","('Supply_Chain_Management', 0.882581889629364)","('Systemic_Risk_Management', 0.024968059733510017)","('Labor_Practices', 0.011174418032169342)","(['Supply Chain Management'], 0.882581889629364)","('NON-ESG', 0.024968059733510017)","('NON-ESG', 0.011174418032169342)"
Line 86,"We prioritize partnerships with suppliers   headquartered in countries that enforce   stringent standards and regulations to help   reduce risks of non-compliance in our   supply chain.
","('Supply_Chain_Management', 0.930566132068634)","('Labor_Practices', 0.00813683494925499)","('Systemic_Risk_Management', 0.0052411602810025215)","(['Supply Chain Management'], 0.930566132068634)","('NON-ESG', 0.00813683494925499)","('NON-ESG', 0.0052411602810025215)"
Line 87,"For example, we source bovine  pericardial tissue exclusively from the U.S.   and Australia.
","('Employee_Health_And_Safety', 0.4917999505996704)","('Critical_Incident_Risk_Management', 0.07886853814125061)","('Access_And_Affordability', 0.07310274988412857)","('NON-ESG', 0.4917999505996704)","('NON-ESG', 0.07886853814125061)","('NON-ESG', 0.07310274988412857)"
Line 88,"Our largest indirect suppliers   provide telecommunication services, food   and catering services, office supplies,   uniforms, lab products and cloud software.
","('Product_Design_And_Lifecycle_Management', 0.5490312576293945)","('Supply_Chain_Management', 0.1403302699327469)","('Energy_Management', 0.0714888945221901)","(['Product Stewardship'], 0.5490312576293945)","('NON-ESG', 0.1403302699327469)","('NON-ESG', 0.0714888945221901)"
Line 89,"Please see our topic disclosures and governance  map for more on Supply Chain management.Total Number of Operations 65 (7 manufacturing locations) Total Number of Employees as of December 31, 2021  15,700   (Including Part-Time and Temporary Employees)  Global Employees by Gender in 2021 59% Female      41% MaleDirect Suppliers Our primary direct materials suppliers provide:  •  Bovine pericardial tissue  •  Chemicals  •  Contract manufacturing  •  Electronic assemblies and cables  •  Extruded tubing and extrusions  •  Guidewires  •  Injection molded components  •  Packaging materials  •  Precision machining components EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORTCorporate Governance Environmental Health & Safety Ethics & Compliance Product Safety & QualityFoundationSupply  Chain Management Talent ManagementGovernance Map We use a Governance Map to show the process used to   establish accountability for each material topic in one   overarching, interactive graphic.
","('Supply_Chain_Management', 0.9035457968711853)","('Labor_Practices', 0.020106090232729912)","('Product_Design_And_Lifecycle_Management', 0.009226327762007713)","(['Supply Chain Management'], 0.9035457968711853)","('NON-ESG', 0.020106090232729912)","('NON-ESG', 0.009226327762007713)"
Line 90,"Please see our topic disclosures and governance  map for more on Supply Chain management.Total Number of Operations 65 (7 manufacturing locations) Total Number of Employees as of December 31, 2021  15,700   (Including Part-Time and Temporary Employees)  Global Employees by Gender in 2021 59% Female      41% MaleDirect Suppliers Our primary direct materials suppliers provide:  •  Bovine pericardial tissue  •  Chemicals  •  Contract manufacturing  •  Electronic assemblies and cables  •  Extruded tubing and extrusions  •  Guidewires  •  Injection molded components  •  Packaging materials  •  Precision machining components EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORTCorporate Governance Environmental Health & Safety Ethics & Compliance Product Safety & QualityFoundationSupply  Chain Management Talent ManagementGovernance Map We use a Governance Map to show the process used to   establish accountability for each material topic in one   overarching, interactive graphic.
","('Product_Quality_And_Safety', 0.8667157292366028)","('Product_Design_And_Lifecycle_Management', 0.047524429857730865)","('Employee_Health_And_Safety', 0.01316829863935709)","(['Product Quality & Recall Management'], 0.8667157292366028)","('NON-ESG', 0.047524429857730865)","('NON-ESG', 0.01316829863935709)"
Line 91,"Each section describes   who is involved when we set, execute and communicate   our strategy for each of our material topics.
","('Management_Of_Legal_And_Regulatory_Framework', 0.22400306165218353)","('Business_Model_Resilience', 0.1652880758047104)","('Director_Removal', 0.13729733228683472)","('NON-ESG', 0.22400306165218353)","('NON-ESG', 0.1652880758047104)","('NON-ESG', 0.13729733228683472)"
Line 92,"Review our governance structures and practices   on our website by clicking on the pie chart.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7493857145309448)","('Business_Ethics', 0.06253732740879059)","('Human_Rights_And_Community_Relations', 0.027944087982177734)","(['Corporate Governance'], 0.7493857145309448)","('NON-ESG', 0.06253732740879059)","('NON-ESG', 0.027944087982177734)"
Line 93,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORTMateriality & Stakeholder Engagement  Value Chain Edwards Lifesciences’ Credo reinforces our dedication   to providing innovative solutions for people fighting   cardiovascular disease.
","('Business_Model_Resilience', 0.47125646471977234)","('Supply_Chain_Management', 0.09904562681913376)","('Product_Design_And_Lifecycle_Management', 0.08161674439907074)","('NON-ESG', 0.47125646471977234)","('NON-ESG', 0.09904562681913376)","('NON-ESG', 0.08161674439907074)"
Line 94,"We believe that the management   of our material topics supports this mission through our   aspiration focused on delivering exceptional value to  Edwards’ Aspirations guide us in our work to positively   impact patient lives.
","('Access_And_Affordability', 0.6139234900474548)","('Human_Rights_And_Community_Relations', 0.12046240270137787)","('Business_Model_Resilience', 0.027758870273828506)","(['Health Outcome Contribution'], 0.6139234900474548)","('NON-ESG', 0.12046240270137787)","('NON-ESG', 0.027758870273828506)"
Line 95,"In 2016, we conducted a materiality  assessment to objectively determine what ESG topics   were important to our stakeholders, and to inform and   drive our sustainability strategy, reporting, and actions   moving forward.
","('Business_Model_Resilience', 0.7216983437538147)","('Physical_Impacts_Of_Climate_Change', 0.04447881877422333)","('Systemic_Risk_Management', 0.034283339977264404)","(['Codes of Business Conduct'], 0.7216983437538147)","('NON-ESG', 0.04447881877422333)","('NON-ESG', 0.034283339977264404)"
Line 96,"This assessment engaged more than   60 internal and external stakeholders.
","('Human_Rights_And_Community_Relations', 0.26727062463760376)","('Management_Of_Legal_And_Regulatory_Framework', 0.18469463288784027)","('Business_Model_Resilience', 0.09904523193836212)","('NON-ESG', 0.26727062463760376)","('NON-ESG', 0.18469463288784027)","('NON-ESG', 0.09904523193836212)"
Line 97,"In 2019, our   Sustainability Council completed a refresh of that   assessment to identify and prioritize the most important  topics for achieving our ESG commitments.
","('Business_Model_Resilience', 0.7356257438659668)","('Systemic_Risk_Management', 0.03306194022297859)","('Physical_Impacts_Of_Climate_Change', 0.03149816766381264)","(['Codes of Business Conduct'], 0.7356257438659668)","('NON-ESG', 0.03306194022297859)","('NON-ESG', 0.03149816766381264)"
Line 98,"We engaged  multiple stakeholder groups and conducted surveys   for employees and patients and received nearly 1,000   responses.
","('Human_Rights_And_Community_Relations', 0.5501307249069214)","('Employee_Engagement_Inclusion_And_Diversity', 0.07465440779924393)","('Access_And_Affordability', 0.062450435012578964)","(['Community Relations'], 0.5501307249069214)","('NON-ESG', 0.07465440779924393)","('NON-ESG', 0.062450435012578964)"
Line 99,"Such in-depth analysis delivered a   comprehensive materiality assessment, which provided   confidence in the results and insight into areas of   importance and emphasis.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2714776396751404)","('Business_Model_Resilience', 0.20175126194953918)","('Ecological_Impacts', 0.07979218661785126)","('NON-ESG', 0.2714776396751404)","('NON-ESG', 0.20175126194953918)","('NON-ESG', 0.07979218661785126)"
Line 100,"Our materiality process:    Note: To learn more about our original materiality   assessment process, please see our 2017 Sustainability  Report.
","('Business_Model_Resilience', 0.2080778330564499)","('Systemic_Risk_Management', 0.1358748972415924)","('Supply_Chain_Management', 0.10755603760480881)","('NON-ESG', 0.2080778330564499)","('NON-ESG', 0.1358748972415924)","('NON-ESG', 0.10755603760480881)"
Line 101,"Materiality Matrix  Learn more about the results of our assessment on ESG topics of importance to our stakeholders, and our business,   by clicking on the matrix below.
","('Business_Model_Resilience', 0.6383417248725891)","('Systemic_Risk_Management', 0.07113302499055862)","('Human_Rights_And_Community_Relations', 0.04890035465359688)","(['Codes of Business Conduct'], 0.6383417248725891)","('NON-ESG', 0.07113302499055862)","('NON-ESG', 0.04890035465359688)"
Line 102,"our stakeholders.
","('Human_Rights_And_Community_Relations', 0.7340198755264282)","('Management_Of_Legal_And_Regulatory_Framework', 0.023381512612104416)","('Business_Ethics', 0.023337962105870247)","(['Community Relations'], 0.7340198755264282)","('NON-ESG', 0.023381512612104416)","('NON-ESG', 0.023337962105870247)"
Line 103,"For each topic, Edwards also considers  where impacts directly occur throughout our   manufacturing processes, geographic footprint and   stakeholder relationships.
","('Business_Model_Resilience', 0.3273012936115265)","('Human_Rights_And_Community_Relations', 0.3157419264316559)","('Systemic_Risk_Management', 0.035181377083063126)","('NON-ESG', 0.3273012936115265)","('NON-ESG', 0.3157419264316559)","('NON-ESG', 0.035181377083063126)"
Line 104,"The map demonstrating our  understanding of our impacts across our value chain can be  found on pages 18 and 19 in our 2017 Sustainability Report.3Impact MappingBenchmarking & Executive EducationIDENTIFICA TION 1 2Stakeholder Engagement Validation Workshop 4 5Vision &  Goal Setting 6VALIDATIONPRIORITIZA TION STRA TEGIC INTEGRAT ION Synthesis & Analysi s EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Edwards Lifesciences is committed to responsible and ethical business practices.
","('Business_Ethics', 0.40359193086624146)","('Business_Model_Resilience', 0.14777518808841705)","('Human_Rights_And_Community_Relations', 0.0492979921400547)","('NON-ESG', 0.40359193086624146)","('NON-ESG', 0.14777518808841705)","('NON-ESG', 0.0492979921400547)"
Line 105,"The Governance section of our 2021 Sustainability Report contains our management   approach and annual performance for the following material topics:  •  Ethics & Compliance  •  Corporate Governance Governance Ethics & Compliance Edwards Lifesciences’ global ethics and compliance program supports our   commitment to excelling as a trusted partner through distinguished quality   and integrity and delivering exceptional value to our stakeholders.
","('Business_Ethics', 0.9712812900543213)","('Management_Of_Legal_And_Regulatory_Framework', 0.004407812841236591)","('Product_Quality_And_Safety', 0.0022202348336577415)","(['Business Ethics'], 0.9712812900543213)","('NON-ESG', 0.004407812841236591)","('NON-ESG', 0.0022202348336577415)"
Line 106,"Definition   Driving a culture of integrity that promotes ethical behavior and compliance   with our code of conduct, as well as with relevant laws and regulations, including   anti-bribery and corruption.
","('Business_Ethics', 0.974083662033081)","('Management_Of_Legal_And_Regulatory_Framework', 0.0023882535751909018)","('Competitive_Behavior', 0.002221109578385949)","(['Business Ethics'], 0.974083662033081)","('NON-ESG', 0.0023882535751909018)","('NON-ESG', 0.002221109578385949)"
Line 107,"Management Approach   At Edwards Lifesciences, our business, strategy and aspirations are built upon a  strong culture of integrity.
","('Business_Ethics', 0.8433462381362915)","('Human_Rights_And_Community_Relations', 0.021964991465210915)","('Employee_Engagement_Inclusion_And_Diversity', 0.01906404085457325)","(['Business Ethics'], 0.8433462381362915)","('NON-ESG', 0.021964991465210915)","('NON-ESG', 0.01906404085457325)"
Line 108,"Edwards is committed to conducting our work according  to the highest standards of business ethics.
","('Business_Ethics', 0.964930534362793)","('Customer_Privacy', 0.002982524922117591)","('Product_Quality_And_Safety', 0.00279249157756567)","(['Business Ethics'], 0.964930534362793)","('NON-ESG', 0.002982524922117591)","('NON-ESG', 0.00279249157756567)"
Line 109,"We value trusted relationships with our  many stakeholders and recognize that our ability to improve patient lives around   the world is dependent upon our reputation and credibility.
","('Human_Rights_And_Community_Relations', 0.28174811601638794)","('Access_And_Affordability', 0.2556491792201996)","('Management_Of_Legal_And_Regulatory_Framework', 0.07580940425395966)","('NON-ESG', 0.28174811601638794)","('NON-ESG', 0.2556491792201996)","('NON-ESG', 0.07580940425395966)"
Line 110,"Governance Map Corporate Governance Environmental Health & Safety Ethics & Compliance Product Safety & QualityFoundationSupply  Chain Management Talent Managementclick to viewEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Global Ethics and Compliance Program Our Global Ethics and Compliance Program (the Program) establishes a comprehensive  framework for promoting compliance with applicable laws, regulations, and standards   of conduct, and reinforces our culture of integrity.
","('Business_Ethics', 0.9677144885063171)","('Management_Of_Legal_And_Regulatory_Framework', 0.004645243752747774)","('Product_Quality_And_Safety', 0.0036976635456085205)","(['Business Ethics'], 0.9677144885063171)","('NON-ESG', 0.004645243752747774)","('NON-ESG', 0.0036976635456085205)"
Line 111,"Our Board of Directors and senior  leadership are committed to upholding our ethical culture and to supporting our Global  Ethics and Compliance Program.
","('Business_Ethics', 0.9671453833580017)","('Product_Quality_And_Safety', 0.0027219061739742756)","('Management_Of_Legal_And_Regulatory_Framework', 0.002518564462661743)","(['Business Ethics'], 0.9671453833580017)","('NON-ESG', 0.0027219061739742756)","('NON-ESG', 0.002518564462661743)"
Line 112,"1.
","('Competitive_Behavior', 0.08736830949783325)","('Energy_Management', 0.08274902403354645)","('Management_Of_Legal_And_Regulatory_Framework', 0.0740576833486557)","('NON-ESG', 0.08736830949783325)","('NON-ESG', 0.08274902403354645)","('NON-ESG', 0.0740576833486557)"
Line 113,"Governance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35481375455856323)","('Human_Rights_And_Community_Relations', 0.21645507216453552)","('Competitive_Behavior', 0.04825617000460625)","('NON-ESG', 0.35481375455856323)","('NON-ESG', 0.21645507216453552)","('NON-ESG', 0.04825617000460625)"
Line 114,"Edwards’ Senior Vice President and Chief Responsibility Officer (CRO)  leads Edwards’ Global Ethics and Compliance Program as well as its Sustainability  Program.
","('Business_Ethics', 0.9649658203125)","('Management_Of_Legal_And_Regulatory_Framework', 0.004143965430557728)","('Product_Quality_And_Safety', 0.0033668039832264185)","(['Business Ethics'], 0.9649658203125)","('NON-ESG', 0.004143965430557728)","('NON-ESG', 0.0033668039832264185)"
Line 115,"The CRO reports directly to the Audit Committee of the Edwards Board   of Directors and provides regular updates on the Program to the Compensation   and Governance Committee and the Executive Leadership Team (ELT).
","('Director_Removal', 0.7343636155128479)","('Management_Of_Legal_And_Regulatory_Framework', 0.0607445053756237)","('Business_Ethics', 0.020843828096985817)","(['Anti-Crime Policy & Measures'], 0.7343636155128479)","('NON-ESG', 0.0607445053756237)","('NON-ESG', 0.020843828096985817)"
Line 116,"A Corporate  Compliance Committee chaired by the CRO and comprised of a cross-section of   senior leaders is tasked with assisting the CRO with implementation of the Program  and meets regularly to discuss matters related to compliance risk and program   effectiveness.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8417531251907349)","('Business_Ethics', 0.054547715932130814)","('Systemic_Risk_Management', 0.01427583396434784)","(['Corporate Governance'], 0.8417531251907349)","('NON-ESG', 0.054547715932130814)","('NON-ESG', 0.01427583396434784)"
Line 117,"Each region also has a dedicated regional compliance officer (RCO)  who reports to the CRO and has responsibility for implementation and oversight   of the Program.
","('Management_Of_Legal_And_Regulatory_Framework', 0.901361882686615)","('Human_Rights_And_Community_Relations', 0.0215341504663229)","('Ecological_Impacts', 0.007340584881603718)","(['Corporate Governance'], 0.901361882686615)","('NON-ESG', 0.0215341504663229)","('NON-ESG', 0.007340584881603718)"
Line 118,"Each RCO chairs a regional compliance committee of regional   leaders.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8174285292625427)","('Business_Ethics', 0.030581600964069366)","('Director_Removal', 0.02268877997994423)","(['Corporate Governance'], 0.8174285292625427)","('NON-ESG', 0.030581600964069366)","('NON-ESG', 0.02268877997994423)"
Line 119,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 120,"Global Business Practices Standards.
","('Business_Ethics', 0.749387800693512)","('Product_Quality_And_Safety', 0.059642378240823746)","('Management_Of_Legal_And_Regulatory_Framework', 0.03518213331699371)","(['Business Ethics'], 0.749387800693512)","('NON-ESG', 0.059642378240823746)","('NON-ESG', 0.03518213331699371)"
Line 121,"Edwards’ Global Business Practices Standards  (known as the “Titanium Book”) serve as the foundation for Edwards’ Global Ethics  and Compliance Program.
","('Business_Ethics', 0.9668165445327759)","('Management_Of_Legal_And_Regulatory_Framework', 0.0037401074077934027)","('Product_Quality_And_Safety', 0.0033439809922128916)","(['Business Ethics'], 0.9668165445327759)","('NON-ESG', 0.0037401074077934027)","('NON-ESG', 0.0033439809922128916)"
Line 122,"The Titanium Book is considered our “Credo in action”   and sets forth our values and expectations of all employees with regards to:   •  The Marketplace:  We will conduct our business with honesty and integrity,   as well as obey all laws and regulations.
","('Business_Ethics', 0.9365514516830444)","('Labor_Practices', 0.006657199934124947)","('Employee_Engagement_Inclusion_And_Diversity', 0.00520702451467514)","(['Business Ethics'], 0.9365514516830444)","('NON-ESG', 0.006657199934124947)","('NON-ESG', 0.00520702451467514)"
Line 123,"•  Our Employees:  We will treat our colleagues with fairness and respect in   a safe work environment.
","('Business_Ethics', 0.47187623381614685)","('Labor_Practices', 0.16815535724163055)","('Human_Rights_And_Community_Relations', 0.08807703107595444)","('NON-ESG', 0.47187623381614685)","('NON-ESG', 0.16815535724163055)","('NON-ESG', 0.08807703107595444)"
Line 124,"•  Our Community:  We are committed to being productive and respectful   members of the communities where we do business.
","('Human_Rights_And_Community_Relations', 0.9430224299430847)","('Employee_Engagement_Inclusion_And_Diversity', 0.006946915294975042)","('Access_And_Affordability', 0.0058396607637405396)","(['Community Relations'], 0.9430224299430847)","('NON-ESG', 0.006946915294975042)","('NON-ESG', 0.0058396607637405396)"
Line 125,"•  Our Company and Shareholders:  We will act in the best interests of Edwards   and its shareholders, communicate effectively with our shareholders and   protect the Company’s assets.
","('Business_Model_Resilience', 0.3078348636627197)","('Management_Of_Legal_And_Regulatory_Framework', 0.1329113394021988)","('Director_Removal', 0.10233192890882492)","('NON-ESG', 0.3078348636627197)","('NON-ESG', 0.1329113394021988)","('NON-ESG', 0.10233192890882492)"
Line 126,"The Standards apply globally to all Edwards businesses and subsidiaries and to all   employees, members of the Boards of Directors and agents of Edwards.
","('Director_Removal', 0.5727935433387756)","('Business_Ethics', 0.09171590209007263)","('Management_Of_Legal_And_Regulatory_Framework', 0.06100020930171013)","(['Anti-Crime Policy & Measures'], 0.5727935433387756)","('NON-ESG', 0.09171590209007263)","('NON-ESG', 0.06100020930171013)"
Line 127,"The Standards  are available in eight languages; and all professional employees are required to certify  annually that they have read and agree to follow the Standards.
","('Management_Of_Legal_And_Regulatory_Framework', 0.24445340037345886)","('Product_Quality_And_Safety', 0.23534078896045685)","('Labor_Practices', 0.14664849638938904)","('NON-ESG', 0.24445340037345886)","('NON-ESG', 0.23534078896045685)","('NON-ESG', 0.14664849638938904)"
Line 128,"3.
","('Competitive_Behavior', 0.1465800553560257)","('Customer_Welfare', 0.10041514039039612)","('Product_Design_And_Lifecycle_Management', 0.07025990635156631)","('NON-ESG', 0.1465800553560257)","('NON-ESG', 0.10041514039039612)","('NON-ESG', 0.07025990635156631)"
Line 129,"Edwards’ Speak-Up Program.
","('Human_Rights_And_Community_Relations', 0.22619406878948212)","('Business_Ethics', 0.13503997027873993)","('Management_Of_Legal_And_Regulatory_Framework', 0.07037857174873352)","('NON-ESG', 0.22619406878948212)","('NON-ESG', 0.13503997027873993)","('NON-ESG', 0.07037857174873352)"
Line 130,"The Titanium Book clearly states that ethical   business conduct is the responsibility of every Edwards employee and that our   employees are expected to raise any questions or concerns they may have about  potential misconduct.
","('Business_Ethics', 0.9532380104064941)","('Employee_Health_And_Safety', 0.004836550913751125)","('Customer_Privacy', 0.003704408183693886)","(['Business Ethics'], 0.9532380104064941)","('NON-ESG', 0.004836550913751125)","('NON-ESG', 0.003704408183693886)"
Line 131,"Employees have several communication channels   available to them for raising ethical questions or concerns, which are outlined   not only in our Standards but also on the employee intranet, posters, wallet cards   and other communications.
","('Business_Ethics', 0.9323651790618896)","('Management_Of_Legal_And_Regulatory_Framework', 0.00938512571156025)","('Product_Quality_And_Safety', 0.008517574518918991)","(['Business Ethics'], 0.9323651790618896)","('NON-ESG', 0.00938512571156025)","('NON-ESG', 0.008517574518918991)"
Line 132,"Our Speak Up tool, the Edwards Integrity Helpline,   is available to both employees and external parties, and allows for anonymous   reporting.
","('Business_Ethics', 0.4853874742984772)","('Data_Security', 0.33305397629737854)","('Customer_Privacy', 0.05612558126449585)","('NON-ESG', 0.4853874742984772)","('NON-ESG', 0.33305397629737854)","('NON-ESG', 0.05612558126449585)"
Line 133,"It can be accessed globally by telephone or a web portal and is available  24 hours a day, 7 days a week.
","('Access_And_Affordability', 0.23589523136615753)","('Energy_Management', 0.13109879195690155)","('Management_Of_Legal_And_Regulatory_Framework', 0.06740697473287582)","('NON-ESG', 0.23589523136615753)","('NON-ESG', 0.13109879195690155)","('NON-ESG', 0.06740697473287582)"
Line 134,"Edwards strictly prohibits retaliation against any   employee who raised a concern in good faith.
","('Business_Ethics', 0.8735880255699158)","('Labor_Practices', 0.024866538122296333)","('Management_Of_Legal_And_Regulatory_Framework', 0.011516722850501537)","(['Business Ethics'], 0.8735880255699158)","('NON-ESG', 0.024866538122296333)","('NON-ESG', 0.011516722850501537)"
Line 135,"4.
","('Competitive_Behavior', 0.1400022953748703)","('GHG_Emissions', 0.0895392969250679)","('Customer_Welfare', 0.0845675989985466)","('NON-ESG', 0.1400022953748703)","('NON-ESG', 0.0895392969250679)","('NON-ESG', 0.0845675989985466)"
Line 136,"Training and Communications.
","('Human_Rights_And_Community_Relations', 0.2258942425251007)","('Employee_Engagement_Inclusion_And_Diversity', 0.10350368171930313)","('Employee_Health_And_Safety', 0.09324271976947784)","('NON-ESG', 0.2258942425251007)","('NON-ESG', 0.10350368171930313)","('NON-ESG', 0.09324271976947784)"
Line 137,"Edwards employees must complete a training  program designed to ensure they understand and comply with our Global Business  Practices Standards, policies and procedures, and Anti-Bribery and Corruption  Training.
","('Business_Ethics', 0.9754485487937927)","('Management_Of_Legal_And_Regulatory_Framework', 0.0026802970096468925)","('Product_Quality_And_Safety', 0.002036922611296177)","(['Business Ethics'], 0.9754485487937927)","('NON-ESG', 0.0026802970096468925)","('NON-ESG', 0.002036922611296177)"
Line 138,"We expect our employees to be able to recognize and appropriately   respond to potential compliance risks and ethical issues.
","('Business_Ethics', 0.928095281124115)","('Management_Of_Legal_And_Regulatory_Framework', 0.013773181475698948)","('Product_Quality_And_Safety', 0.007306278217583895)","(['Business Ethics'], 0.928095281124115)","('NON-ESG', 0.013773181475698948)","('NON-ESG', 0.007306278217583895)"
Line 139,"Training is delivered  through a combination of live sessions and targeted on-line training modules   that are regularly reviewed and updated.
","('Access_And_Affordability', 0.5446420311927795)","('Product_Quality_And_Safety', 0.09025802463293076)","('Management_Of_Legal_And_Regulatory_Framework', 0.05899990722537041)","(['Health Outcome Contribution'], 0.5446420311927795)","('NON-ESG', 0.09025802463293076)","('NON-ESG', 0.05899990722537041)"
Line 140,"5.
","('Competitive_Behavior', 0.15210691094398499)","('Energy_Management', 0.09276141971349716)","('Customer_Welfare', 0.08200553804636002)","('NON-ESG', 0.15210691094398499)","('NON-ESG', 0.09276141971349716)","('NON-ESG', 0.08200553804636002)"
Line 141,"Risk Assessments, Auditing & Monitoring.
","('Systemic_Risk_Management', 0.5139855742454529)","('Business_Ethics', 0.15535451471805573)","('Management_Of_Legal_And_Regulatory_Framework', 0.11450372636318207)","(['Risk & Crisis Management'], 0.5139855742454529)","('NON-ESG', 0.15535451471805573)","('NON-ESG', 0.11450372636318207)"
Line 142,"Edwards regularly assesses the   compliance risks that are facing the company and continuously updates and   improves its Global Ethics and Compliance Program to address those risks.
","('Business_Ethics', 0.9542241096496582)","('Management_Of_Legal_And_Regulatory_Framework', 0.009999209083616734)","('Systemic_Risk_Management', 0.003711896948516369)","(['Business Ethics'], 0.9542241096496582)","('NON-ESG', 0.009999209083616734)","('NON-ESG', 0.003711896948516369)"
Line 143,"In addition, Edwards implements audit and monitoring plans to assess overall   compliance and to identify any potential weaknesses in the program and/or   need for corrective actions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4949226975440979)","('Business_Ethics', 0.13443510234355927)","('Systemic_Risk_Management', 0.08757009357213974)","('NON-ESG', 0.4949226975440979)","('NON-ESG', 0.13443510234355927)","('NON-ESG', 0.08757009357213974)"
Line 144,"Anti-Corruption Edwards adheres to all applicable anti-corruption laws and regulations, including but  not limited to the US Foreign Corrupt Practices Act and UK Bribery Act, and we expect  all third parties doing business on our behalf to uphold the same high standards.
","('Business_Ethics', 0.9756984114646912)","('Management_Of_Legal_And_Regulatory_Framework', 0.003267996245995164)","('Competitive_Behavior', 0.0021889929194003344)","(['Business Ethics'], 0.9756984114646912)","('NON-ESG', 0.003267996245995164)","('NON-ESG', 0.0021889929194003344)"
Line 145,"Edwards’ employees must complete annual training on anti-bribery and corruption.
","('Business_Ethics', 0.9726311564445496)","('Competitive_Behavior', 0.002788765588775277)","('Management_Of_Legal_And_Regulatory_Framework', 0.0026835554745048285)","(['Business Ethics'], 0.9726311564445496)","('NON-ESG', 0.002788765588775277)","('NON-ESG', 0.0026835554745048285)"
Line 146,"Edwards has also established a number of other internal controls to prevent bribery  and corruption, including:  •  Risk assessments and related monitoring  •  Internal audits on financial controls pertaining to anti-bribery and corruption   •  Investigations of all reports of potential violationsEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Third-Party Management Our third-party management program includes rigorous due diligence, training and  monitoring to ensure compliance with anti-corruption laws and to promptly identify  and remediate any potential issues.
","('Business_Ethics', 0.9766804575920105)","('Management_Of_Legal_And_Regulatory_Framework', 0.0022862160112708807)","('Data_Security', 0.0018122975016012788)","(['Business Ethics'], 0.9766804575920105)","('NON-ESG', 0.0022862160112708807)","('NON-ESG', 0.0018122975016012788)"
Line 147,"Edwards has also established a number of other internal controls to prevent bribery  and corruption, including:  •  Risk assessments and related monitoring  •  Internal audits on financial controls pertaining to anti-bribery and corruption   •  Investigations of all reports of potential violationsEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Third-Party Management Our third-party management program includes rigorous due diligence, training and  monitoring to ensure compliance with anti-corruption laws and to promptly identify  and remediate any potential issues.
","('Critical_Incident_Risk_Management', 0.5426266193389893)","('Physical_Impacts_Of_Climate_Change', 0.0602085255086422)","('Management_Of_Legal_And_Regulatory_Framework', 0.049919359385967255)","(['Risk & Crisis Management'], 0.5426266193389893)","('NON-ESG', 0.0602085255086422)","('NON-ESG', 0.049919359385967255)"
Line 148,"Interactions with Healthcare Professionals Edwards’ collaboration with physicians is essential for the safe and effective use of   our products as well as the continued innovation of our technologies and therapies.
","('Product_Design_And_Lifecycle_Management', 0.8931971788406372)","('Customer_Welfare', 0.021350786089897156)","('Selling_Practices_And_Product_Labeling', 0.018222497776150703)","(['Product Stewardship'], 0.8931971788406372)","('NON-ESG', 0.021350786089897156)","('NON-ESG', 0.018222497776150703)"
Line 149,"We have implemented a comprehensive framework of policies and procedures   intended to ensure that our interactions with healthcare professionals are ethical,   professional and free from even the appearance of improper inducement.
","('Business_Ethics', 0.9505798816680908)","('Competitive_Behavior', 0.004848539363592863)","('Labor_Practices', 0.004680343437939882)","(['Business Ethics'], 0.9505798816680908)","('NON-ESG', 0.004848539363592863)","('NON-ESG', 0.004680343437939882)"
Line 150,"We never   want the actions of our employees (or third parties) to interfere with the independent   medical judgment of healthcare professionals or the best interests of patients.
","('Business_Ethics', 0.4128904938697815)","('Management_Of_Legal_And_Regulatory_Framework', 0.11539622396230698)","('Labor_Practices', 0.08631512522697449)","('NON-ESG', 0.4128904938697815)","('NON-ESG', 0.11539622396230698)","('NON-ESG', 0.08631512522697449)"
Line 151,"Edwards complies with all applicable disclosure requirements and is transparent   about its relationships with healthcare professionals.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7251220345497131)","('Business_Ethics', 0.036961931735277176)","('Access_And_Affordability', 0.03147469088435173)","(['Corporate Governance'], 0.7251220345497131)","('NON-ESG', 0.036961931735277176)","('NON-ESG', 0.03147469088435173)"
Line 152,"In 2008, Edwards became the   first of our peer group to disclose payment voluntarily and publicly to physicians in   the United States.
","('Management_Of_Legal_And_Regulatory_Framework', 0.45422497391700745)","('Business_Ethics', 0.2580842077732086)","('Systemic_Risk_Management', 0.06141263619065285)","('NON-ESG', 0.45422497391700745)","('NON-ESG', 0.2580842077732086)","('NON-ESG', 0.06141263619065285)"
Line 153,"Now, in accordance with the U.S. Affordable Care Act, we report   all financial relationships with U.S. physicians and teaching hospitals through the   Open Payments system on the Centers for Medicare and Medicaid Services’ website.
","('Access_And_Affordability', 0.550332248210907)","('Management_Of_Legal_And_Regulatory_Framework', 0.16929268836975098)","('Energy_Management', 0.02655263990163803)","(['Health Outcome Contribution'], 0.550332248210907)","('NON-ESG', 0.16929268836975098)","('NON-ESG', 0.02655263990163803)"
Line 154,"We also comply with all tracking and disclosure requirements that apply to medical   device manufacturers around the world.
","('Product_Design_And_Lifecycle_Management', 0.20125138759613037)","('Product_Quality_And_Safety', 0.1938144713640213)","('Supply_Chain_Management', 0.10687822848558426)","('NON-ESG', 0.20125138759613037)","('NON-ESG', 0.1938144713640213)","('NON-ESG', 0.10687822848558426)"
Line 155,"Responsible Marketing  As a global leader, we deliver advanced products and services that are valued for   their innovation, features, quality and performance.
","('Product_Design_And_Lifecycle_Management', 0.9606391191482544)","('Product_Quality_And_Safety', 0.005043534561991692)","('Customer_Welfare', 0.0039734686724841595)","(['Product Stewardship'], 0.9606391191482544)","('NON-ESG', 0.005043534561991692)","('NON-ESG', 0.0039734686724841595)"
Line 156,"We comply with all applicable   legal and regulatory requirements and ensure that our marketing and promotional   communications are truthful, accurate and not misleading.
","('Management_Of_Legal_And_Regulatory_Framework', 0.34021589159965515)","('Business_Ethics', 0.22115865349769592)","('Selling_Practices_And_Product_Labeling', 0.12670277059078217)","('NON-ESG', 0.34021589159965515)","('NON-ESG', 0.22115865349769592)","('NON-ESG', 0.12670277059078217)"
Line 157,"We do not promote   products for uses that have not been approved by the appropriate regulatory   authority and we do not disparage the products or services of our competitors.
","('Product_Design_And_Lifecycle_Management', 0.41276514530181885)","('Selling_Practices_And_Product_Labeling', 0.23600178956985474)","('Product_Quality_And_Safety', 0.13730327785015106)","('NON-ESG', 0.41276514530181885)","('NON-ESG', 0.23600178956985474)","('NON-ESG', 0.13730327785015106)"
Line 158,"Annual Performance   Global Business Practice Standards We require all professional employees to complete an annual online certification   of their commitment to follow the Global Business Practices Standards.
","('Business_Ethics', 0.38109689950942993)","('Product_Quality_And_Safety', 0.20940135419368744)","('Management_Of_Legal_And_Regulatory_Framework', 0.13338404893875122)","('NON-ESG', 0.38109689950942993)","('NON-ESG', 0.20940135419368744)","('NON-ESG', 0.13338404893875122)"
Line 159,"In 2021,   99.6 percent of Edwards’ professional employees completed the certification.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6000267863273621)","('Labor_Practices', 0.23321504890918732)","('Employee_Health_And_Safety', 0.021687420085072517)","(['Human Capital Development'], 0.6000267863273621)","('NON-ESG', 0.23321504890918732)","('NON-ESG', 0.021687420085072517)"
Line 160,"Global Ethics and Compliance Program In 2021, we held our ninth annual Titanium Day event.
","('Business_Ethics', 0.9572915434837341)","('Management_Of_Legal_And_Regulatory_Framework', 0.0077576893381774426)","('Director_Removal', 0.003640902228653431)","(['Business Ethics'], 0.9572915434837341)","('NON-ESG', 0.0077576893381774426)","('NON-ESG', 0.003640902228653431)"
Line 161,"On this day, we celebrate   Edwards’ Credo by reinforcing our commitment to conducting business according to   the high standards of business integrity and ethics through education and awareness.
","('Business_Ethics', 0.9659718871116638)","('Competitive_Behavior', 0.0037090450059622526)","('Product_Quality_And_Safety', 0.003120484296232462)","(['Business Ethics'], 0.9659718871116638)","('NON-ESG', 0.0037090450059622526)","('NON-ESG', 0.003120484296232462)"
Line 162,"Although typically these events are conducted live at multiple sites around the world,   in 2021 we moved to an online platform due to COVID-19 related precautions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3787754774093628)","('Competitive_Behavior', 0.10147122293710709)","('Business_Model_Resilience', 0.068263478577137)","('NON-ESG', 0.3787754774093628)","('NON-ESG', 0.10147122293710709)","('NON-ESG', 0.068263478577137)"
Line 163,"Nonetheless, we connected with thousands of employees across multiple geographies  through leadership presentations, panel discussions, videos and engaging educational  activities focused on our Global Business Practices Standards (or “Titanium Book”).
","('Business_Ethics', 0.5489180088043213)","('Product_Quality_And_Safety', 0.1892031729221344)","('Management_Of_Legal_And_Regulatory_Framework', 0.04519200697541237)","(['Business Ethics'], 0.5489180088043213)","('NON-ESG', 0.1892031729221344)","('NON-ESG', 0.04519200697541237)"
Line 164,"In early 2022, we received our sixth consecutive recognition as one of the World’s   Most Ethical Companies.
","('Business_Ethics', 0.410854697227478)","('Business_Model_Resilience', 0.07160279154777527)","('Director_Removal', 0.06973294168710709)","('NON-ESG', 0.410854697227478)","('NON-ESG', 0.07160279154777527)","('NON-ESG', 0.06973294168710709)"
Line 165,"Leadership Training In 2019, we developed an online learning module on ethical decision-making for   managers, rolling out the training in the U.S. in early 2020, and achieved a 94 percent  completion rate.
","('Business_Ethics', 0.20136219263076782)","('Employee_Engagement_Inclusion_And_Diversity', 0.16039153933525085)","('Human_Rights_And_Community_Relations', 0.11851813644170761)","('NON-ESG', 0.20136219263076782)","('NON-ESG', 0.16039153933525085)","('NON-ESG', 0.11851813644170761)"
Line 166,"We then met our target to have 100 percent of managers complete   the learning module on ethical decision making by 2020.
","('Business_Ethics', 0.7937510013580322)","('Competitive_Behavior', 0.04630846530199051)","('Human_Rights_And_Community_Relations', 0.023850660771131516)","(['Business Ethics'], 0.7937510013580322)","('NON-ESG', 0.04630846530199051)","('NON-ESG', 0.023850660771131516)"
Line 167,"This course was assigned to   all new managers at Edwards hired in 2021.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4006601870059967)","('Director_Removal', 0.2273416519165039)","('Labor_Practices', 0.06493355333805084)","('NON-ESG', 0.4006601870059967)","('NON-ESG', 0.2273416519165039)","('NON-ESG', 0.06493355333805084)"
Line 168,"Corruption and Bribery In 2020, we launched a comprehensive review of our Global Ethics and Compliance   Program with particular emphasis on anti-bribery and anti-corruption.
","('Business_Ethics', 0.9767112731933594)","('Management_Of_Legal_And_Regulatory_Framework', 0.002306432696059346)","('Competitive_Behavior', 0.0019290087511762977)","(['Business Ethics'], 0.9767112731933594)","('NON-ESG', 0.002306432696059346)","('NON-ESG', 0.0019290087511762977)"
Line 169,"Learnings from  that review identified opportunities for training enhancements.
","('Access_And_Affordability', 0.45132699608802795)","('Employee_Engagement_Inclusion_And_Diversity', 0.12060573697090149)","('Product_Quality_And_Safety', 0.0631132647395134)","('NON-ESG', 0.45132699608802795)","('NON-ESG', 0.12060573697090149)","('NON-ESG', 0.0631132647395134)"
Line 170,"In 2021, we developed  an enhanced online global learning module on anti-bribery and anti-corruption   required for all professional employees.
","('Business_Ethics', 0.9741792678833008)","('Competitive_Behavior', 0.0027298221830278635)","('Management_Of_Legal_And_Regulatory_Framework', 0.002337162848562002)","(['Business Ethics'], 0.9741792678833008)","('NON-ESG', 0.0027298221830278635)","('NON-ESG', 0.002337162848562002)"
Line 171,"We will continue to further enhance and improve   our program, while also ensuring we are well positioned for sustainable growth.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT World’s Most Ethical Companies: For the sixth year in a row, Edwards   Lifesciences was recognized by the Ethisphere Institute, a global leader in   defining and advancing the standards of ethical business practices, as one   of the Ethisphere’s World’s Most Ethical Companies®.
","('Business_Ethics', 0.7702323198318481)","('Product_Quality_And_Safety', 0.03156972676515579)","('Data_Security', 0.018953684717416763)","(['Business Ethics'], 0.7702323198318481)","('NON-ESG', 0.03156972676515579)","('NON-ESG', 0.018953684717416763)"
Line 172,"Edwards is the only   honoree in the medical technology industry, underscoring our commitment   to leading with integrity and prioritizing ethical business practices.
","('Business_Ethics', 0.954863965511322)","('Competitive_Behavior', 0.004500062204897404)","('Product_Quality_And_Safety', 0.0033547591883689165)","(['Business Ethics'], 0.954863965511322)","('NON-ESG', 0.004500062204897404)","('NON-ESG', 0.0033547591883689165)"
Line 173,"Newsweek’s America’s Most Responsible Companies:  Newsweek partnered   with global data research firm Statista Inc.
","('Systemic_Risk_Management', 0.46806246042251587)","('Business_Model_Resilience', 0.19052541255950928)","('Competitive_Behavior', 0.0513373501598835)","('NON-ESG', 0.46806246042251587)","('NON-ESG', 0.19052541255950928)","('NON-ESG', 0.0513373501598835)"
Line 174,"to publish its third ranking of   America’s Most Responsible Companies 2022.
","('Business_Model_Resilience', 0.3239825963973999)","('Systemic_Risk_Management', 0.11701905727386475)","('Supply_Chain_Management', 0.07371477782726288)","('NON-ESG', 0.3239825963973999)","('NON-ESG', 0.11701905727386475)","('NON-ESG', 0.07371477782726288)"
Line 175,"Statista worked from a universe  of 2,000 public companies to determine which firms were top-performing when   it came to doing good.
","('Systemic_Risk_Management', 0.4594879150390625)","('Competitive_Behavior', 0.21852484345436096)","('Business_Model_Resilience', 0.09456345438957214)","('NON-ESG', 0.4594879150390625)","('NON-ESG', 0.21852484345436096)","('NON-ESG', 0.09456345438957214)"
Line 176,"Results are based on publicly available key performance   indicators derived from Corporate Social Responsibility  Reports, Sustainability  Reports, and Corporate Citizenship Reports as well as an independent survey  among 11,000 U.S. citizens about their perceptions of the companies related to  corporate social responsibility.
","('Human_Rights_And_Community_Relations', 0.8909704685211182)","('Business_Model_Resilience', 0.01256613526493311)","('Management_Of_Legal_And_Regulatory_Framework', 0.00875591766089201)","(['Community Relations'], 0.8909704685211182)","('NON-ESG', 0.01256613526493311)","('NON-ESG', 0.00875591766089201)"
Line 177,"The final list recognizes the top 499 most   responsible companies in the United States, spanning 14 industries.
","('Supply_Chain_Management', 0.23522333800792694)","('Systemic_Risk_Management', 0.16774412989616394)","('Business_Model_Resilience', 0.1284918636083603)","('NON-ESG', 0.23522333800792694)","('NON-ESG', 0.16774412989616394)","('NON-ESG', 0.1284918636083603)"
Line 178,"Edwards  ranked #277 overall.
","('Systemic_Risk_Management', 0.2324926108121872)","('Competitive_Behavior', 0.16173817217350006)","('Data_Security', 0.04606934264302254)","('NON-ESG', 0.2324926108121872)","('NON-ESG', 0.16173817217350006)","('NON-ESG', 0.04606934264302254)"
Line 179,"HIGHLIGHT STORY Edwards Receives Top Ethics   and Citizenship Recognitions Edwards Named One of America’s Most JUST Companies Edwards Lifesciences was honored by being recognized as one of America’s Most   JUST Companies, according to  JUST Capital,  a non-profit that ranks the largest   publicly traded corporations in the United States on the issues Americans care about  most.
","('Business_Ethics', 0.4409455955028534)","('Business_Model_Resilience', 0.07569380849599838)","('Systemic_Risk_Management', 0.06972134113311768)","('NON-ESG', 0.4409455955028534)","('NON-ESG', 0.07569380849599838)","('NON-ESG', 0.06972134113311768)"
Line 180,"Edwards ranked #86 overall out of 954 for America’s best corporate citizens.
","('Systemic_Risk_Management', 0.22300414741039276)","('Business_Ethics', 0.1430777609348297)","('Business_Model_Resilience', 0.1317683607339859)","('NON-ESG', 0.22300414741039276)","('NON-ESG', 0.1430777609348297)","('NON-ESG', 0.1317683607339859)"
Line 181,"Edwards was recognized, for the fifth consecutive year, for outperforming its peers   on the criteria deemed to be most important, including providing workers with good   benefits and supporting work-life balance; giving back to local communities;   diversity, equity, and inclusion; leadership integrity and more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9690120816230774)","('Human_Rights_And_Community_Relations', 0.004174540285021067)","('Employee_Health_And_Safety', 0.003043605713173747)","(['Human Capital Development'], 0.9690120816230774)","('NON-ESG', 0.004174540285021067)","('NON-ESG', 0.003043605713173747)"
Line 182,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Corporate Governance Edwards Lifesciences’ work to improve corporate governance supports our aspiration   of delivering exceptional shareholder value.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3045276999473572)","('Competitive_Behavior', 0.1823156327009201)","('Business_Model_Resilience', 0.13027802109718323)","('NON-ESG', 0.3045276999473572)","('NON-ESG', 0.1823156327009201)","('NON-ESG', 0.13027802109718323)"
Line 183,"Definition   Corporate governance is a system of rules, procedures, practices, policies, and   relationships by which a company is controlled and operates.
","('Management_Of_Legal_And_Regulatory_Framework', 0.41457611322402954)","('Business_Ethics', 0.3342058062553406)","('Director_Removal', 0.05018775537610054)","('NON-ESG', 0.41457611322402954)","('NON-ESG', 0.3342058062553406)","('NON-ESG', 0.05018775537610054)"
Line 184,"Management Approach         It is important to be accurate, clear, and transparent in disclosures regarding corporate  decision-making, organizational process, and company operations.
","('Business_Ethics', 0.8185470700263977)","('Management_Of_Legal_And_Regulatory_Framework', 0.07330983877182007)","('Director_Removal', 0.016096672043204308)","(['Business Ethics'], 0.8185470700263977)","('NON-ESG', 0.07330983877182007)","('NON-ESG', 0.016096672043204308)"
Line 185,"Good corporate  governance involves balancing the interests of a company’s many stakeholders,   including shareholders, employees, customers, the community and a vital stakeholder  group for Edwards—patients.
","('Human_Rights_And_Community_Relations', 0.3250958323478699)","('Business_Ethics', 0.14097419381141663)","('Competitive_Behavior', 0.11153141409158707)","('NON-ESG', 0.3250958323478699)","('NON-ESG', 0.14097419381141663)","('NON-ESG', 0.11153141409158707)"
Line 186,"Through our corporate governance practices,   the Board of Directors and management   create a responsible organization from the top,   setting the tone of our patient-focused culture,   and supporting our strong reputation.
","('Director_Removal', 0.668513298034668)","('Business_Ethics', 0.040182314813137054)","('Business_Model_Resilience', 0.03547363728284836)","(['Anti-Crime Policy & Measures'], 0.668513298034668)","('NON-ESG', 0.040182314813137054)","('NON-ESG', 0.03547363728284836)"
Line 187,"This   begins with our Chairman and CEO, who   regularly meets with key stakeholders,   including investors, customers, patients,   employees and legislators, to discuss   their needs and share our progress.
","('Business_Model_Resilience', 0.1665448397397995)","('Management_Of_Legal_And_Regulatory_Framework', 0.129418283700943)","('Human_Rights_And_Community_Relations', 0.12271657586097717)","('NON-ESG', 0.1665448397397995)","('NON-ESG', 0.129418283700943)","('NON-ESG', 0.12271657586097717)"
Line 188,"In addition, our CEO includes   sustainability targets in his   performance goals annually.
","('Business_Model_Resilience', 0.32448408007621765)","('Supply_Chain_Management', 0.09460807591676712)","('Product_Design_And_Lifecycle_Management', 0.08039160072803497)","('NON-ESG', 0.32448408007621765)","('NON-ESG', 0.09460807591676712)","('NON-ESG', 0.08039160072803497)"
Line 189,"Our   Board of Directors and management   strive to implement policies and   processes that promote ethical and   sustainable corporate governance   practices for the benefit of all stakeholders.
","('Business_Ethics', 0.5632809400558472)","('Management_Of_Legal_And_Regulatory_Framework', 0.1971363127231598)","('Director_Removal', 0.04906788840889931)","(['Business Ethics'], 0.5632809400558472)","('NON-ESG', 0.1971363127231598)","('NON-ESG', 0.04906788840889931)"
Line 190,"Corporate Governance Environmental Health & Safety Ethics & Compliance Product Safety & QualityFoundationSupply  Chain Management Talent Management  Governance Map                   click to view  Our Board of Directors A talented and knowledgeable team of directors oversees our organization.
","('Business_Ethics', 0.8285051584243774)","('Product_Quality_And_Safety', 0.03012351505458355)","('Management_Of_Legal_And_Regulatory_Framework', 0.028310826048254967)","(['Business Ethics'], 0.8285051584243774)","('NON-ESG', 0.03012351505458355)","('NON-ESG', 0.028310826048254967)"
Line 191,"Our Corporate Governance Guidelines outline expectations for Board service that  demonstrate our commitment to ethical and effective corporate governance.
","('Business_Ethics', 0.8317596316337585)","('Management_Of_Legal_And_Regulatory_Framework', 0.059796009212732315)","('Competitive_Behavior', 0.019737115129828453)","(['Business Ethics'], 0.8317596316337585)","('NON-ESG', 0.059796009212732315)","('NON-ESG', 0.019737115129828453)"
Line 192,"These guidelines cover topics, such as:   •  Board size and composition  •  Director selection and qualification  •  Director responsibilities and operation of the Board  •  Director access to management and independent advisors  •  Responsibilities of Board committees   •  Board oversight for strategic planning and fiduciary responsibility  •  Director compensation  •  Director orientation and continuing education  •  Succession planning  •  Recoupment of performance-based compensation  •  Process for performance and annual evaluations of the Board Our Board members oversee corporate strategy, financial and operational risk,   information security and cybersecurity, and sustainability, among other matters.
","('Director_Removal', 0.725611686706543)","('Employee_Engagement_Inclusion_And_Diversity', 0.05011982470750809)","('Management_Of_Legal_And_Regulatory_Framework', 0.03832298517227173)","(['Anti-Crime Policy & Measures'], 0.725611686706543)","('NON-ESG', 0.05011982470750809)","('NON-ESG', 0.03832298517227173)"
Line 193,"These guidelines cover topics, such as:   •  Board size and composition  •  Director selection and qualification  •  Director responsibilities and operation of the Board  •  Director access to management and independent advisors  •  Responsibilities of Board committees   •  Board oversight for strategic planning and fiduciary responsibility  •  Director compensation  •  Director orientation and continuing education  •  Succession planning  •  Recoupment of performance-based compensation  •  Process for performance and annual evaluations of the Board Our Board members oversee corporate strategy, financial and operational risk,   information security and cybersecurity, and sustainability, among other matters.
","('Data_Security', 0.5415748953819275)","('Systemic_Risk_Management', 0.16085828840732574)","('Business_Model_Resilience', 0.0913618728518486)","(['Information Security/Cybersecurity & System Availability'], 0.5415748953819275)","('NON-ESG', 0.16085828840732574)","('NON-ESG', 0.0913618728518486)"
Line 194,"At Edwards, the directors evaluate the Board’s leadership structure on a regular   basis to ensure that the approach continues to provide independent oversight of   the company and serves the best interests of all stakeholders.
","('Director_Removal', 0.7060695290565491)","('Management_Of_Legal_And_Regulatory_Framework', 0.05109400302171707)","('Business_Ethics', 0.032596804201602936)","(['Anti-Crime Policy & Measures'], 0.7060695290565491)","('NON-ESG', 0.05109400302171707)","('NON-ESG', 0.032596804201602936)"
Line 195,"This includes a robust  director evaluation and Board refreshment process.
","('Director_Removal', 0.6292327046394348)","('Management_Of_Legal_And_Regulatory_Framework', 0.14764542877674103)","('Business_Ethics', 0.028434863314032555)","(['Anti-Crime Policy & Measures'], 0.6292327046394348)","('NON-ESG', 0.14764542877674103)","('NON-ESG', 0.028434863314032555)"
Line 196,"Our Board strives to maintain   a highly independent, balanced and diverse group of directors that collectively   possesses the expertise to provide proper oversight of management.
","('Director_Removal', 0.6264893412590027)","('Employee_Engagement_Inclusion_And_Diversity', 0.08906593173742294)","('Business_Model_Resilience', 0.03159867227077484)","(['Anti-Crime Policy & Measures'], 0.6264893412590027)","('NON-ESG', 0.08906593173742294)","('NON-ESG', 0.03159867227077484)"
Line 197,"After the   company’s 2021 annual stockholders’ meeting, 87.5 percent of the Board was   independent, 37.5 percent of the Board were women, and 25 percent of the Board  were ethnically diverse.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9693183302879333)","('Human_Rights_And_Community_Relations', 0.0022492094431072474)","('Labor_Practices', 0.002029124414548278)","(['Human Capital Development'], 0.9693183302879333)","('NON-ESG', 0.0022492094431072474)","('NON-ESG', 0.002029124414548278)"
Line 198,"The average age of our directors was 65 years and the   average tenure was seven years.
","('Director_Removal', 0.6802142858505249)","('Employee_Engagement_Inclusion_And_Diversity', 0.059523675590753555)","('Labor_Practices', 0.025734245777130127)","(['Anti-Crime Policy & Measures'], 0.6802142858505249)","('NON-ESG', 0.059523675590753555)","('NON-ESG', 0.025734245777130127)"
Line 199,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Our Chief Executive Officer also serves, and has served, as the Chairman of the Board  of the company since the company went public more than 22 years ago.
","('Business_Model_Resilience', 0.29228734970092773)","('Director_Removal', 0.2391071319580078)","('Product_Design_And_Lifecycle_Management', 0.08039827644824982)","('NON-ESG', 0.29228734970092773)","('NON-ESG', 0.2391071319580078)","('NON-ESG', 0.08039827644824982)"
Line 200,"Our Board  believes this has been, and continues to be, an effective approach for our company as  Edwards has experienced strong financial and operational growth under this leader- ship structure, most recently providing a cumulative total shareholder return of 315  percent to shareholders from 2016 to 2021.
","('Business_Model_Resilience', 0.48254695534706116)","('Director_Removal', 0.15328587591648102)","('Systemic_Risk_Management', 0.05676601082086563)","('NON-ESG', 0.48254695534706116)","('NON-ESG', 0.15328587591648102)","('NON-ESG', 0.05676601082086563)"
Line 201,"Edwards’ 2022 Proxy Statement further  describes our corporate governance policies and practices.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7256737351417542)","('Business_Ethics', 0.06927938014268875)","('Director_Removal', 0.04152768477797508)","(['Corporate Governance'], 0.7256737351417542)","('NON-ESG', 0.06927938014268875)","('NON-ESG', 0.04152768477797508)"
Line 202,"Our Board has established two committees: 1.
","('Director_Removal', 0.4203872084617615)","('Management_Of_Legal_And_Regulatory_Framework', 0.21213239431381226)","('Business_Ethics', 0.04353989660739899)","('NON-ESG', 0.4203872084617615)","('NON-ESG', 0.21213239431381226)","('NON-ESG', 0.04353989660739899)"
Line 203,"Audit Committee – assists our Board in fulfilling its oversight responsibilities   relating to, among other matters, the following:  •  Integrity of the company’s financial statements;  •  Compliance with legal and regulatory requirements;  •  Monitoring the independent registered public accounting firm’s qualifications,  performance and independence;  •  The performance of the company’s internal audit function;  •  The company’s investment and hedging activities; and  •  Enterprise-wide risk and management practices related to those risks, including,  but not limited to, manufacturing processes and supplier quality, product   development processes and systems, continuity of the company’s operations   and information technology infrastructure and cybersecurity and information   security risks.
","('Business_Ethics', 0.7325812578201294)","('Management_Of_Legal_And_Regulatory_Framework', 0.1805640608072281)","('Systemic_Risk_Management', 0.012607715092599392)","(['Business Ethics'], 0.7325812578201294)","('NON-ESG', 0.1805640608072281)","('NON-ESG', 0.012607715092599392)"
Line 204,"Audit Committee – assists our Board in fulfilling its oversight responsibilities   relating to, among other matters, the following:  •  Integrity of the company’s financial statements;  •  Compliance with legal and regulatory requirements;  •  Monitoring the independent registered public accounting firm’s qualifications,  performance and independence;  •  The performance of the company’s internal audit function;  •  The company’s investment and hedging activities; and  •  Enterprise-wide risk and management practices related to those risks, including,  but not limited to, manufacturing processes and supplier quality, product   development processes and systems, continuity of the company’s operations   and information technology infrastructure and cybersecurity and information   security risks.
","('Product_Design_And_Lifecycle_Management', 0.30503302812576294)","('Data_Security', 0.2283840924501419)","('Supply_Chain_Management', 0.11907923966646194)","('NON-ESG', 0.30503302812576294)","('NON-ESG', 0.2283840924501419)","('NON-ESG', 0.11907923966646194)"
Line 205,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 206,"Compensation and Governance Committee – is responsible for, among other  things, the following:  •  Determining the compensation of executive officers and recommending to   our Board the compensation of nonemployee directors;  •  Overseeing management of succession planning, attraction and retention   of talent, and risks related to the design of executive compensation programs   and arrangements;  •  Developing and recommending to the Board corporate governance guidelines; •  Identifying, evaluating and recommending individuals qualified to be directors   to the Board;  •  Overseeing the evaluation of the Board and management;   •  Overseeing the company’s principles, programs and practices on sustainability   topics, including environmental and social affairs; and  •  Overseeing the company’s program for engaging with shareholders on corporate   governance and other matters relating to the meetings of the company’s shareholders.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6200346946716309)","('Director_Removal', 0.1426493227481842)","('Labor_Practices', 0.05753396824002266)","(['Human Capital Development'], 0.6200346946716309)","('NON-ESG', 0.1426493227481842)","('NON-ESG', 0.05753396824002266)"
Line 207,"Compensation and Governance Committee – is responsible for, among other  things, the following:  •  Determining the compensation of executive officers and recommending to   our Board the compensation of nonemployee directors;  •  Overseeing management of succession planning, attraction and retention   of talent, and risks related to the design of executive compensation programs   and arrangements;  •  Developing and recommending to the Board corporate governance guidelines; •  Identifying, evaluating and recommending individuals qualified to be directors   to the Board;  •  Overseeing the evaluation of the Board and management;   •  Overseeing the company’s principles, programs and practices on sustainability   topics, including environmental and social affairs; and  •  Overseeing the company’s program for engaging with shareholders on corporate   governance and other matters relating to the meetings of the company’s shareholders.
","('Director_Removal', 0.3733105957508087)","('Management_Of_Legal_And_Regulatory_Framework', 0.166887566447258)","('Human_Rights_And_Community_Relations', 0.11737257242202759)","('NON-ESG', 0.3733105957508087)","('NON-ESG', 0.166887566447258)","('NON-ESG', 0.11737257242202759)"
Line 208,"Additionally, our Board, led by the Compensation and Governance Committee, is   responsible for assessing, identifying, evaluating, and, ultimately, recommending to  shareholders, individuals qualified to be directors of the company.
","('Director_Removal', 0.7957711219787598)","('Management_Of_Legal_And_Regulatory_Framework', 0.02743338793516159)","('Business_Ethics', 0.015869520604610443)","(['Anti-Crime Policy & Measures'], 0.7957711219787598)","('NON-ESG', 0.02743338793516159)","('NON-ESG', 0.015869520604610443)"
Line 209,"The Compensation   and Governance Committee maintains formal criteria for selecting director nominees   who will best serve the interests of Edwards and its stakeholders.
","('Director_Removal', 0.6761196851730347)","('Management_Of_Legal_And_Regulatory_Framework', 0.1134505346417427)","('Business_Ethics', 0.023579321801662445)","(['Anti-Crime Policy & Measures'], 0.6761196851730347)","('NON-ESG', 0.1134505346417427)","('NON-ESG', 0.023579321801662445)"
Line 210,"These written   membership criteria state that Edwards “seeks a board with diversity of background  among its members as determined by the Board in its business judgment, which may   include diversity of experience, gender, race, ethnic or national origin, age or other   factors as the Board determines appropriate.” The director nominations process also   includes a review of current director skills against an established skills matrix and   consideration of each director’s retirement horizon, as well as the feedback received  through the Board’s self-evaluation and peer evaluation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9659155011177063)","('Director_Removal', 0.002882395638152957)","('Business_Model_Resilience', 0.0025715294759720564)","(['Human Capital Development'], 0.9659155011177063)","('NON-ESG', 0.002882395638152957)","('NON-ESG', 0.0025715294759720564)"
Line 211,"These written   membership criteria state that Edwards “seeks a board with diversity of background  among its members as determined by the Board in its business judgment, which may   include diversity of experience, gender, race, ethnic or national origin, age or other   factors as the Board determines appropriate.” The director nominations process also   includes a review of current director skills against an established skills matrix and   consideration of each director’s retirement horizon, as well as the feedback received  through the Board’s self-evaluation and peer evaluation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7524484992027283)","('Competitive_Behavior', 0.04805999994277954)","('Business_Ethics', 0.034383561462163925)","(['Corporate Governance'], 0.7524484992027283)","('NON-ESG', 0.04805999994277954)","('NON-ESG', 0.034383561462163925)"
Line 212,"Please see pages 6-7 of our   2022 Proxy Statement for a more in-depth description of the criteria.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7927077412605286)","('Business_Model_Resilience', 0.024109212681651115)","('Competitive_Behavior', 0.022292491048574448)","(['Corporate Governance'], 0.7927077412605286)","('NON-ESG', 0.024109212681651115)","('NON-ESG', 0.022292491048574448)"
Line 213,"Visit our Governance page to find the written charters, including a description of the   full responsibilities of the committees.
","('Management_Of_Legal_And_Regulatory_Framework', 0.739450991153717)","('Director_Removal', 0.08993382006883621)","('Human_Rights_And_Community_Relations', 0.018574608489871025)","(['Corporate Governance'], 0.739450991153717)","('NON-ESG', 0.08993382006883621)","('NON-ESG', 0.018574608489871025)"
Line 214,"ESG  targets included   in 100%  of ELT performance goalsEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT CEO Pay Ratio Edwards believes incentive-based executive compensation programs can mitigate  risks and foster long-term value creation and sustainable growth.
","('Systemic_Risk_Management', 0.4085381329059601)","('Management_Of_Legal_And_Regulatory_Framework', 0.1361984759569168)","('Business_Ethics', 0.11713942885398865)","('NON-ESG', 0.4085381329059601)","('NON-ESG', 0.1361984759569168)","('NON-ESG', 0.11713942885398865)"
Line 215,"We design our  compensation programs to align with the interests of our shareholders.
","('Labor_Practices', 0.26440316438674927)","('Management_Of_Legal_And_Regulatory_Framework', 0.24377033114433289)","('Employee_Engagement_Inclusion_And_Diversity', 0.09539517015218735)","('NON-ESG', 0.26440316438674927)","('NON-ESG', 0.24377033114433289)","('NON-ESG', 0.09539517015218735)"
Line 216,"Pursuant to  the Securities Exchange Act of 1934, as amended, our Proxy Statement contains the  ratio of the total annual compensation of our CEO to the median of the total annual  compensation of all our employees (excluding our CEO), which is reported in the   annual performance section of this report.
","('Labor_Practices', 0.8156300187110901)","('Employee_Engagement_Inclusion_And_Diversity', 0.032426461577415466)","('Business_Ethics', 0.025140680372714996)","(['Labor Practice Indicators'], 0.8156300187110901)","('NON-ESG', 0.032426461577415466)","('NON-ESG', 0.025140680372714996)"
Line 217,"Page 60 of our 2022 Proxy Statement  specifies our methodology for calculating this figure.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5002021789550781)","('Competitive_Behavior', 0.22494801878929138)","('Business_Ethics', 0.02899751625955105)","(['Corporate Governance'], 0.5002021789550781)","('NON-ESG', 0.22494801878929138)","('NON-ESG', 0.02899751625955105)"
Line 218,"Governance for Sustainability Our Compensation and Governance Committee maintains formal oversight   responsibilities over Edwards’ sustainability principles, environmental and social   affairs and regularly reports and discusses the company’s progress on these topics   with the full Board.
","('Management_Of_Legal_And_Regulatory_Framework', 0.45467090606689453)","('Human_Rights_And_Community_Relations', 0.262388676404953)","('Director_Removal', 0.05438263714313507)","('NON-ESG', 0.45467090606689453)","('NON-ESG', 0.262388676404953)","('NON-ESG', 0.05438263714313507)"
Line 219,"Our Chairman and CEO also has performance management   objectives for improving our sustainability strategy, metrics and disclosures.
","('Business_Model_Resilience', 0.5237582921981812)","('Product_Design_And_Lifecycle_Management', 0.06514100730419159)","('Supply_Chain_Management', 0.05576672777533531)","(['Codes of Business Conduct'], 0.5237582921981812)","('NON-ESG', 0.06514100730419159)","('NON-ESG', 0.05576672777533531)"
Line 220,"A cross-functional Sustainability Council develops and drives the implementation   of these initiatives using a robust management framework.
","('Management_Of_Legal_And_Regulatory_Framework', 0.29661694169044495)","('Business_Model_Resilience', 0.11926598846912384)","('Human_Rights_And_Community_Relations', 0.06925860047340393)","('NON-ESG', 0.29661694169044495)","('NON-ESG', 0.11926598846912384)","('NON-ESG', 0.06925860047340393)"
Line 221,"Led by our CRO, the  Council is comprised of senior leaders from various functions across the organization.
","('Director_Removal', 0.5610504746437073)","('Employee_Engagement_Inclusion_And_Diversity', 0.08607964962720871)","('Management_Of_Legal_And_Regulatory_Framework', 0.0638149231672287)","(['Anti-Crime Policy & Measures'], 0.5610504746437073)","('NON-ESG', 0.08607964962720871)","('NON-ESG', 0.0638149231672287)"
Line 222,"Council members represent their areas of responsibility and collaborate to identify  priorities, set sustainability targets and implement strategies to improve performance  against achieving those targets.
","('Business_Model_Resilience', 0.2971956729888916)","('Management_Of_Legal_And_Regulatory_Framework', 0.18629276752471924)","('Human_Rights_And_Community_Relations', 0.09961956739425659)","('NON-ESG', 0.2971956729888916)","('NON-ESG', 0.18629276752471924)","('NON-ESG', 0.09961956739425659)"
Line 223,"They meet regularly to review Edwards’ progress and   develop implementation strategies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3297277092933655)","('Human_Rights_And_Community_Relations', 0.2919051945209503)","('Business_Model_Resilience', 0.05756762996315956)","('NON-ESG', 0.3297277092933655)","('NON-ESG', 0.2919051945209503)","('NON-ESG', 0.05756762996315956)"
Line 224,"Our CRO reports on the Council’s activities to our  Compensation and Governance Committee, and to our ELT.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7806464433670044)","('Director_Removal', 0.06470169126987457)","('Human_Rights_And_Community_Relations', 0.031582172960042953)","(['Corporate Governance'], 0.7806464433670044)","('NON-ESG', 0.06470169126987457)","('NON-ESG', 0.031582172960042953)"
Line 225,"This year we are also   aiming to incorporate sustainability targets into the Senior Leadership Team’s annual  performance objectives.
","('Business_Model_Resilience', 0.5094251036643982)","('Systemic_Risk_Management', 0.06935102492570877)","('Physical_Impacts_Of_Climate_Change', 0.05789143592119217)","(['Codes of Business Conduct'], 0.5094251036643982)","('NON-ESG', 0.06935102492570877)","('NON-ESG', 0.05789143592119217)"
Line 226,"Enterprise Risk Management Enterprise risk is assessed and prioritized using quantitative and qualitative inputs   on multiple key dimensions, including, among other things:  •  Patient safety  •  Business and financial metrics  •  Operational risks (disruptive events) •  Reputation and brand  •  Legal and regulatory  •  Talent and employee wellness Our Strategic Planning process, in part, considers risks and opportunities to Edwards   on a seven-year time horizon.
","('Systemic_Risk_Management', 0.8838454484939575)","('Business_Ethics', 0.026055369526147842)","('Business_Model_Resilience', 0.01328052207827568)","(['Risk & Crisis Management'], 0.8838454484939575)","('NON-ESG', 0.026055369526147842)","('NON-ESG', 0.01328052207827568)"
Line 227,"Our Enterprise Risk Council reviews and prioritizes our   top risks quarterly and reviews updates provided to the Board and management.
","('Systemic_Risk_Management', 0.902140736579895)","('Business_Model_Resilience', 0.026511892676353455)","('Physical_Impacts_Of_Climate_Change', 0.008068633265793324)","(['Risk & Crisis Management'], 0.902140736579895)","('NON-ESG', 0.026511892676353455)","('NON-ESG', 0.008068633265793324)"
Line 228,"The  Council discusses enterprise risk at each regularly scheduled Board meeting to inform   the Board on the latest posture of key risks.
","('Systemic_Risk_Management', 0.9352349638938904)","('Business_Model_Resilience', 0.012839426286518574)","('Physical_Impacts_Of_Climate_Change', 0.009002046659588814)","(['Risk & Crisis Management'], 0.9352349638938904)","('NON-ESG', 0.012839426286518574)","('NON-ESG', 0.009002046659588814)"
Line 229,"We have a strong business continuity   program with standardized plans across global manufacturing sites.
","('Systemic_Risk_Management', 0.2388719916343689)","('Competitive_Behavior', 0.19709976017475128)","('Business_Ethics', 0.07933934032917023)","('NON-ESG', 0.2388719916343689)","('NON-ESG', 0.19709976017475128)","('NON-ESG', 0.07933934032917023)"
Line 230,"We routinely   run exercises to test readiness.
","('Employee_Health_And_Safety', 0.1414433866739273)","('Product_Design_And_Lifecycle_Management', 0.14001627266407013)","('Critical_Incident_Risk_Management', 0.13205234706401825)","('NON-ESG', 0.1414433866739273)","('NON-ESG', 0.14001627266407013)","('NON-ESG', 0.13205234706401825)"
Line 231,"Incorporating sustainability factors into our risk   assessments provides us with a more robust understanding of potential risks to the  company.
","('Systemic_Risk_Management', 0.9185410141944885)","('Business_Model_Resilience', 0.02064122073352337)","('Physical_Impacts_Of_Climate_Change', 0.011249048635363579)","(['Risk & Crisis Management'], 0.9185410141944885)","('NON-ESG', 0.02064122073352337)","('NON-ESG', 0.011249048635363579)"
Line 232,"We have an agile crisis management process that leverages insight and   leadership from an experienced and cohesive management team.
","('Systemic_Risk_Management', 0.6313599944114685)","('Business_Model_Resilience', 0.08326553553342819)","('Critical_Incident_Risk_Management', 0.07572826743125916)","(['Risk & Crisis Management'], 0.6313599944114685)","('NON-ESG', 0.08326553553342819)","('NON-ESG', 0.07572826743125916)"
Line 233,"Please see our   Governance Map for more details.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6939202547073364)","('Competitive_Behavior', 0.05007585883140564)","('Human_Rights_And_Community_Relations', 0.036970026791095734)","(['Corporate Governance'], 0.6939202547073364)","('NON-ESG', 0.05007585883140564)","('NON-ESG', 0.036970026791095734)"
Line 234,"Annually, and as needed, the Audit Committee, the CFO and the Senior Vice President   of Enterprise Risk Management consider various potential risks to the company,   including those related to financial reporting, product development, continuity of   operations, regulatory compliance, succession planning, physical facilities and other  topics.
","('Systemic_Risk_Management', 0.5263413190841675)","('Management_Of_Legal_And_Regulatory_Framework', 0.24679851531982422)","('Business_Ethics', 0.073269784450531)","(['Risk & Crisis Management'], 0.5263413190841675)","('NON-ESG', 0.24679851531982422)","('NON-ESG', 0.073269784450531)"
Line 235,"The full Board of Directors and the Senior Vice President of Enterprise Risk   Management also consider potential risks to the strategic plan in connection with   the annual strategic review.
","('Systemic_Risk_Management', 0.8044272661209106)","('Business_Model_Resilience', 0.09741935133934021)","('Physical_Impacts_Of_Climate_Change', 0.017595605924725533)","(['Risk & Crisis Management'], 0.8044272661209106)","('NON-ESG', 0.09741935133934021)","('NON-ESG', 0.017595605924725533)"
Line 236,"Edwards is aware that changing weather patterns may cause business interruptions.
","('Physical_Impacts_Of_Climate_Change', 0.46603578329086304)","('Business_Model_Resilience', 0.27723774313926697)","('Systemic_Risk_Management', 0.04065543785691261)","('NON-ESG', 0.46603578329086304)","('NON-ESG', 0.27723774313926697)","('NON-ESG', 0.04065543785691261)"
Line 237,"In response, we incorporate the potential impact of floods, wildfires and other weather  events into our assessments.
","('Physical_Impacts_Of_Climate_Change', 0.7666020393371582)","('Critical_Incident_Risk_Management', 0.09186505526304245)","('Business_Model_Resilience', 0.019961396232247353)","(['Climate Change'], 0.7666020393371582)","('NON-ESG', 0.09186505526304245)","('NON-ESG', 0.019961396232247353)"
Line 238,"We have established emergency response systems and  business recovery processes and test them regularly.
","('Critical_Incident_Risk_Management', 0.9742810726165771)","('Air_Quality', 0.0027495904359966516)","('Employee_Health_And_Safety', 0.0022876595612615347)","(['Risk & Crisis Management'], 0.9742810726165771)","('NON-ESG', 0.0027495904359966516)","('NON-ESG', 0.0022876595612615347)"
Line 239,"We work with our insurance   provider to ensure our global facilities have appropriate weather damage-prevention  features and resilient infrastructure.
","('Business_Model_Resilience', 0.8757104277610779)","('Physical_Impacts_Of_Climate_Change', 0.026604916900396347)","('Systemic_Risk_Management', 0.01279428880661726)","(['Codes of Business Conduct'], 0.8757104277610779)","('NON-ESG', 0.026604916900396347)","('NON-ESG', 0.01279428880661726)"
Line 240,"We continue to review and assess the risk factors  outlined in the Task Force for Climate-related Financial Disclosures (TCFD) for material  relevance to Edwards and, where needed, to shape appropriate mitigation strategies.
","('Physical_Impacts_Of_Climate_Change', 0.9338454008102417)","('Business_Model_Resilience', 0.01940094120800495)","('GHG_Emissions', 0.006885658483952284)","(['Climate Change'], 0.9338454008102417)","('NON-ESG', 0.01940094120800495)","('NON-ESG', 0.006885658483952284)"
Line 241,"For more information, please see “Risk Factors” on page 12 of our  2021 Annual Report   and “Board Role in Risk Oversight” on page 14 of our 2022 Proxy Statement.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Cybersecurity Our Audit Committee regularly reviews cybersecurity and information security   risks, and our Information Security team, overseen by the Chief Information   Security Officer, works to maintain best-in-class cyber and information security  practices with the objective of strengthening cyber resiliency.
","('Data_Security', 0.9519230723381042)","('Systemic_Risk_Management', 0.00803455151617527)","('Business_Ethics', 0.0035646576434373856)","(['Information Security/Cybersecurity & System Availability'], 0.9519230723381042)","('NON-ESG', 0.00803455151617527)","('NON-ESG', 0.0035646576434373856)"
Line 242,"For more information, please see “Risk Factors” on page 12 of our  2021 Annual Report   and “Board Role in Risk Oversight” on page 14 of our 2022 Proxy Statement.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Cybersecurity Our Audit Committee regularly reviews cybersecurity and information security   risks, and our Information Security team, overseen by the Chief Information   Security Officer, works to maintain best-in-class cyber and information security  practices with the objective of strengthening cyber resiliency.
","('Business_Model_Resilience', 0.8160592913627625)","('Physical_Impacts_Of_Climate_Change', 0.030913367867469788)","('Supply_Chain_Management', 0.019391288980841637)","(['Codes of Business Conduct'], 0.8160592913627625)","('NON-ESG', 0.030913367867469788)","('NON-ESG', 0.019391288980841637)"
Line 243,"The team operates   our Information Security Program, which follows the principles of industry standards  such as the NIST Cybersecurity Framework, ISO 27002 Standard, CIS Framework,  SANS Top 20 Controls and OWASP Top 10, among others.
","('Data_Security', 0.946715235710144)","('Systemic_Risk_Management', 0.006619526073336601)","('Business_Ethics', 0.005708070006221533)","(['Information Security/Cybersecurity & System Availability'], 0.946715235710144)","('NON-ESG', 0.006619526073336601)","('NON-ESG', 0.005708070006221533)"
Line 244,"These frameworks allow  us to apply our priorities in a consistent and risk-based manner.
","('Systemic_Risk_Management', 0.7389746904373169)","('Business_Model_Resilience', 0.06730712950229645)","('Management_Of_Legal_And_Regulatory_Framework', 0.04166446253657341)","(['Risk & Crisis Management'], 0.7389746904373169)","('NON-ESG', 0.06730712950229645)","('NON-ESG', 0.04166446253657341)"
Line 245,"We leverage these  frameworks to ensure security controls aligned with best practices are consistently  deployed across the business.
","('Data_Security', 0.8912646770477295)","('Business_Ethics', 0.023129316046833992)","('Systemic_Risk_Management', 0.0170148778706789)","(['Information Security/Cybersecurity & System Availability'], 0.8912646770477295)","('NON-ESG', 0.023129316046833992)","('NON-ESG', 0.0170148778706789)"
Line 246,"In addition, we work with trusted and leading third   parties to help us assess and strengthen our cybersecurity program maturity and   continually enhance our processes.
","('Data_Security', 0.6565101146697998)","('Systemic_Risk_Management', 0.1274743676185608)","('Business_Model_Resilience', 0.044260453432798386)","(['Information Security/Cybersecurity & System Availability'], 0.6565101146697998)","('NON-ESG', 0.1274743676185608)","('NON-ESG', 0.044260453432798386)"
Line 247,"To prepare for potential cybersecurity incidents, we maintain both a business   continuity plan and cyber incident response plan with formalized workflows,   playbooks and simulation exercises conducted periodically and involving our CEO.
","('Critical_Incident_Risk_Management', 0.8569653034210205)","('Data_Security', 0.03308141604065895)","('Physical_Impacts_Of_Climate_Change', 0.017467524856328964)","(['Risk & Crisis Management'], 0.8569653034210205)","('NON-ESG', 0.03308141604065895)","('NON-ESG', 0.017467524856328964)"
Line 248,"We also engage external partners in conducting various audits and tests on our IT   infrastructure to proactively identify potential vulnerabilities.
","('Data_Security', 0.5902309417724609)","('Systemic_Risk_Management', 0.15270285308361053)","('Business_Ethics', 0.08552335947751999)","(['Information Security/Cybersecurity & System Availability'], 0.5902309417724609)","('NON-ESG', 0.15270285308361053)","('NON-ESG', 0.08552335947751999)"
Line 249,"The Information Security team is an affiliated member and active contributor to   improvements in the information security industry through the following   Information Security Committees:  •  National Health Information Sharing and Analysis Center (NH-ISAC)  •  Medical Device Innovation, Safety and Security (MDISS)  •  Advanced Med Tech (AdvaMed) Security Group We achieved UL2900 certification for our new medical devices release, such as our  next generation HemoSphere monitoring platform.
","('Data_Security', 0.9547801613807678)","('Customer_Privacy', 0.006190847139805555)","('Business_Ethics', 0.0029682046733796597)","(['Information Security/Cybersecurity & System Availability'], 0.9547801613807678)","('NON-ESG', 0.006190847139805555)","('NON-ESG', 0.0029682046733796597)"
Line 250,"We further aim to achieve   HITRIST certification for our upcoming Cloud portal for our digital and connected  medical device platforms, which will process the regulated patient health information  of our customers and patients.
","('Customer_Privacy', 0.4250893294811249)","('Data_Security', 0.33427974581718445)","('Energy_Management', 0.02331923320889473)","('NON-ESG', 0.4250893294811249)","('NON-ESG', 0.33427974581718445)","('NON-ESG', 0.02331923320889473)"
Line 251,"Edwards works to further strengthen our response and recovery mechanisms   as a part of our cyber resiliency strategy.
","('Business_Model_Resilience', 0.9030176997184753)","('Physical_Impacts_Of_Climate_Change', 0.013687905855476856)","('Systemic_Risk_Management', 0.007166821975260973)","(['Codes of Business Conduct'], 0.9030176997184753)","('NON-ESG', 0.013687905855476856)","('NON-ESG', 0.007166821975260973)"
Line 252,"Our Information Security policies are published in an employee handbook and on   our web portal.
","('Data_Security', 0.9415185451507568)","('Customer_Privacy', 0.013403656892478466)","('Director_Removal', 0.0051069618202745914)","(['Information Security/Cybersecurity & System Availability'], 0.9415185451507568)","('NON-ESG', 0.013403656892478466)","('NON-ESG', 0.0051069618202745914)"
Line 253,"Every new employee receives these policies, and Edwards conducts  regular robust information security awareness and training campaigns for our  employees regarding cybersecurity.
","('Data_Security', 0.9619494676589966)","('Systemic_Risk_Management', 0.0031474174465984106)","('Director_Removal', 0.0030284239910542965)","(['Information Security/Cybersecurity & System Availability'], 0.9619494676589966)","('NON-ESG', 0.0031474174465984106)","('NON-ESG', 0.0030284239910542965)"
Line 254,"We also provide communication hotlines for  employees and external users to report any security incidents they see and escalate  them right away.
","('Data_Security', 0.9546923637390137)","('Systemic_Risk_Management', 0.004043946508318186)","('Customer_Privacy', 0.003864903701469302)","(['Information Security/Cybersecurity & System Availability'], 0.9546923637390137)","('NON-ESG', 0.004043946508318186)","('NON-ESG', 0.003864903701469302)"
Line 255,"In addition, we provide product security disclosures and contact   information to report any product vulnerabilities.
","('Data_Security', 0.8834795951843262)","('Customer_Privacy', 0.029720811173319817)","('Product_Quality_And_Safety', 0.009089833125472069)","(['Information Security/Cybersecurity & System Availability'], 0.8834795951843262)","('NON-ESG', 0.029720811173319817)","('NON-ESG', 0.009089833125472069)"
Line 256,"Respecting the General Data Protection Regulation Edwards respects the privacy rights of everyone who interacts with us and we are  committed to compliance with applicable privacy and data protection requirements.
","('Data_Security', 0.785323977470398)","('Customer_Privacy', 0.11700820922851562)","('Business_Model_Resilience', 0.006456692703068256)","(['Information Security/Cybersecurity & System Availability'], 0.785323977470398)","('NON-ESG', 0.11700820922851562)","('NON-ESG', 0.006456692703068256)"
Line 257,"Privacy Edwards does not sell or otherwise provide personal information to third parties   for the third parties’ marketing purposes.
","('Customer_Privacy', 0.9569815993309021)","('Data_Security', 0.009638546034693718)","('Selling_Practices_And_Product_Labeling', 0.002859226893633604)","(['Privacy Protection'], 0.9569815993309021)","('NON-ESG', 0.009638546034693718)","('NON-ESG', 0.002859226893633604)"
Line 258,"For more information, please see our   Privacy Statement.
","('Customer_Privacy', 0.8068034052848816)","('Data_Security', 0.0788063034415245)","('Human_Rights_And_Community_Relations', 0.009113674983382225)","(['Privacy Protection'], 0.8068034052848816)","('NON-ESG', 0.0788063034415245)","('NON-ESG', 0.009113674983382225)"
Line 259,"Approach to Taxation Edwards is committed to responsible tax management and transparency across   our extensive global operations and business activity.
","('Business_Ethics', 0.5634593367576599)","('Management_Of_Legal_And_Regulatory_Framework', 0.33382394909858704)","('Director_Removal', 0.011246913112699986)","(['Business Ethics'], 0.5634593367576599)","('NON-ESG', 0.33382394909858704)","('NON-ESG', 0.011246913112699986)"
Line 260,"With sales in more than   100 countries, our tax contribution is substantial and global in scope, which has   a significant impact on communities throughout the world.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9700624346733093)","('Energy_Management', 0.003436371451243758)","('Director_Removal', 0.0024023002479225397)","(['Corporate Governance'], 0.9700624346733093)","('NON-ESG', 0.003436371451243758)","('NON-ESG', 0.0024023002479225397)"
Line 261,"Our approach to taxes is grounded in three principles: 1) compliance with local and  international laws and regulations; 2) a commitment to business excellence that  aims to maximize efficiencies and competitiveness; and 3) consideration of the   interests of multiple stakeholders, including governments and tax authorities,   customers, shareholders and the communities where we operate our business.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9435724020004272)","('Competitive_Behavior', 0.016697075217962265)","('Business_Ethics', 0.0060446360148489475)","(['Corporate Governance'], 0.9435724020004272)","('NON-ESG', 0.016697075217962265)","('NON-ESG', 0.0060446360148489475)"
Line 262,"For more information, please see our Position Statement on Tax.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9564224481582642)","('Energy_Management', 0.00486739631742239)","('Labor_Practices', 0.0031748369801789522)","(['Corporate Governance'], 0.9564224481582642)","('NON-ESG', 0.00486739631742239)","('NON-ESG', 0.0031748369801789522)"
Line 263,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Governance for Sustainability We continue to align our sustainability efforts with our patient-focused innovation   strategy, guided by our Aspirations and our Credo.
","('Business_Model_Resilience', 0.3389172852039337)","('Product_Design_And_Lifecycle_Management', 0.2617558538913727)","('Supply_Chain_Management', 0.06976494938135147)","('NON-ESG', 0.3389172852039337)","('NON-ESG', 0.2617558538913727)","('NON-ESG', 0.06976494938135147)"
Line 264,"In 2021, we again met our target to   integrate sustainability factors into the strategic planning process annually, furthering   our alignment of sustainability targets with our overall corporate goals.
","('Business_Model_Resilience', 0.7271304726600647)","('Product_Design_And_Lifecycle_Management', 0.042244184762239456)","('Physical_Impacts_Of_Climate_Change', 0.03272600471973419)","(['Codes of Business Conduct'], 0.7271304726600647)","('NON-ESG', 0.042244184762239456)","('NON-ESG', 0.03272600471973419)"
Line 265,"Enterprise Risk Management Edwards’ Board of Directors and ELT continually refine and strengthen our enterprise   risk management (ERM) process, aiming to better identify emerging risks and minimize  impact.
","('Systemic_Risk_Management', 0.9268656969070435)","('Business_Model_Resilience', 0.017567269504070282)","('Physical_Impacts_Of_Climate_Change', 0.010545644909143448)","(['Risk & Crisis Management'], 0.9268656969070435)","('NON-ESG', 0.017567269504070282)","('NON-ESG', 0.010545644909143448)"
Line 266,"In 2021, we continued to integrate sustainability factors into our ERM process by  incorporating ESG considerations into our Strategic Planning process, reviewing our   climate risks, and refining business continuity plans.
","('Physical_Impacts_Of_Climate_Change', 0.7891982793807983)","('Business_Model_Resilience', 0.10483936220407486)","('Systemic_Risk_Management', 0.030368389561772346)","(['Climate Change'], 0.7891982793807983)","('NON-ESG', 0.10483936220407486)","('NON-ESG', 0.030368389561772346)"
Line 267,"Using the TCFD’s risk assessment  framework, we assessed risks and provided an overview to our enterprise risk council.
","('Systemic_Risk_Management', 0.9247255325317383)","('Business_Model_Resilience', 0.013783454895019531)","('Physical_Impacts_Of_Climate_Change', 0.009866753593087196)","(['Risk & Crisis Management'], 0.9247255325317383)","('NON-ESG', 0.013783454895019531)","('NON-ESG', 0.009866753593087196)"
Line 268,"Additionally, Edwards conducted multiple business continuity exercises in 2021, which   focused on natural disaster risk.
","('Critical_Incident_Risk_Management', 0.9706354141235352)","('Employee_Health_And_Safety', 0.005314320791512728)","('Air_Quality', 0.002666159998625517)","(['Risk & Crisis Management'], 0.9706354141235352)","('NON-ESG', 0.005314320791512728)","('NON-ESG', 0.002666159998625517)"
Line 269,"For more information, please see “Risk Factors” on   page 12 of our 2021 Annual Report.
","('Systemic_Risk_Management', 0.8460992574691772)","('Physical_Impacts_Of_Climate_Change', 0.03265973553061485)","('Business_Model_Resilience', 0.028026219457387924)","(['Risk & Crisis Management'], 0.8460992574691772)","('NON-ESG', 0.03265973553061485)","('NON-ESG', 0.028026219457387924)"
Line 270,"In 2021, the COVID-19 pandemic continued to be a key risk that has impacted companies  and organizations around the world.
","('Physical_Impacts_Of_Climate_Change', 0.5157639980316162)","('Critical_Incident_Risk_Management', 0.18646344542503357)","('Air_Quality', 0.06266502290964127)","(['Climate Change'], 0.5157639980316162)","('NON-ESG', 0.18646344542503357)","('NON-ESG', 0.06266502290964127)"
Line 271,"Edwards’ ERM program continued to provide risk  leadership as the company has managed through the pandemic.
","('Systemic_Risk_Management', 0.8883022665977478)","('Physical_Impacts_Of_Climate_Change', 0.03562529757618904)","('Business_Model_Resilience', 0.013689568266272545)","(['Risk & Crisis Management'], 0.8883022665977478)","('NON-ESG', 0.03562529757618904)","('NON-ESG', 0.013689568266272545)"
Line 272,"In this capacity, the ERM  program has provided insight into the company’s COVID-19 road map, response plans   and protocols.
","('Critical_Incident_Risk_Management', 0.7812252640724182)","('Physical_Impacts_Of_Climate_Change', 0.04212428256869316)","('Air_Quality', 0.02397961914539337)","(['Risk & Crisis Management'], 0.7812252640724182)","('NON-ESG', 0.04212428256869316)","('NON-ESG', 0.02397961914539337)"
Line 273,"Cybersecurity Edwards experienced no cyber breaches or incidents that had a material impact in 2021.
","('Data_Security', 0.9510617256164551)","('Systemic_Risk_Management', 0.006275815889239311)","('Physical_Impacts_Of_Climate_Change', 0.004729859996587038)","(['Information Security/Cybersecurity & System Availability'], 0.9510617256164551)","('NON-ESG', 0.006275815889239311)","('NON-ESG', 0.004729859996587038)"
Line 274,"Attempted cyber-attacks on our network were detected and responded to in a timely  manner.
","('Data_Security', 0.9450291395187378)","('Physical_Impacts_Of_Climate_Change', 0.006059085484594107)","('Systemic_Risk_Management', 0.005489501170814037)","(['Information Security/Cybersecurity & System Availability'], 0.9450291395187378)","('NON-ESG', 0.006059085484594107)","('NON-ESG', 0.005489501170814037)"
Line 275,"We have not incurred material expenses from information security breaches   or security breach penalties or settlements over the last three years.
","('Data_Security', 0.9351834058761597)","('Business_Ethics', 0.011937633156776428)","('Systemic_Risk_Management', 0.005987965036183596)","(['Information Security/Cybersecurity & System Availability'], 0.9351834058761597)","('NON-ESG', 0.011937633156776428)","('NON-ESG', 0.005987965036183596)"
Line 276,"In March 2022, we achieved UL2900 certification for our new medical devices release,  such as our next generation HemoSphere monitoring platform.
","('Product_Design_And_Lifecycle_Management', 0.42746254801750183)","('Product_Quality_And_Safety', 0.16887803375720978)","('Customer_Welfare', 0.09048344194889069)","('NON-ESG', 0.42746254801750183)","('NON-ESG', 0.16887803375720978)","('NON-ESG', 0.09048344194889069)"
Line 277,"Looking forward, our   Information Security Program is focusing on implementing new digital products with   HITRUST certification.
","('Data_Security', 0.8328670859336853)","('Product_Design_And_Lifecycle_Management', 0.029193183407187462)","('Customer_Privacy', 0.015685057267546654)","(['Information Security/Cybersecurity & System Availability'], 0.8328670859336853)","('NON-ESG', 0.029193183407187462)","('NON-ESG', 0.015685057267546654)"
Line 278,"We are also focusing on further building cyber resiliency   throughout our value chain.
","('Business_Model_Resilience', 0.8993083238601685)","('Physical_Impacts_Of_Climate_Change', 0.015062826685607433)","('Supply_Chain_Management', 0.011848988942801952)","(['Codes of Business Conduct'], 0.8993083238601685)","('NON-ESG', 0.015062826685607433)","('NON-ESG', 0.011848988942801952)"
Line 279,"We are closely monitoring new and emerging cybersecurity   regulations around the world, assessing their potential impacts to our business and   responding accordingly.Annual Performance Edwards continually strengthens our governance structures to promote business   success and drive our culture of responsibility.
","('Management_Of_Legal_And_Regulatory_Framework', 0.519776463508606)","('Systemic_Risk_Management', 0.14171673357486725)","('Business_Model_Resilience', 0.09122393280267715)","(['Corporate Governance'], 0.519776463508606)","('NON-ESG', 0.14171673357486725)","('NON-ESG', 0.09122393280267715)"
Line 280,"Board of Directors Our Board remains committed to ensuring we have the appropriate skills, experience  and diversity to independently guide and oversee Edwards’ long-term strategy.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9397606253623962)","('Director_Removal', 0.008182534016668797)","('Business_Model_Resilience', 0.004523375537246466)","(['Human Capital Development'], 0.9397606253623962)","('NON-ESG', 0.008182534016668797)","('NON-ESG', 0.004523375537246466)"
Line 281,"The  diverse range of qualifications and skills represented by our directors are provided on  page 7 of our 2022 Proxy Statement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9697850942611694)","('Business_Model_Resilience', 0.002260526642203331)","('Employee_Health_And_Safety', 0.0022221857216209173)","(['Human Capital Development'], 0.9697850942611694)","('NON-ESG', 0.002260526642203331)","('NON-ESG', 0.0022221857216209173)"
Line 282,"None of our directors serve on more than two  other public companies and all are committed to fulfilling their board responsibilities.
","('Director_Removal', 0.7860768437385559)","('Management_Of_Legal_And_Regulatory_Framework', 0.02328241430222988)","('Labor_Practices', 0.018879976123571396)","(['Anti-Crime Policy & Measures'], 0.7860768437385559)","('NON-ESG', 0.02328241430222988)","('NON-ESG', 0.018879976123571396)"
Line 283,"For more information, please see our 2022 Proxy Statement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3091364800930023)","('Competitive_Behavior', 0.14738544821739197)","('Business_Model_Resilience', 0.13502338528633118)","('NON-ESG', 0.3091364800930023)","('NON-ESG', 0.14738544821739197)","('NON-ESG', 0.13502338528633118)"
Line 284,"Engaging our Shareholders Throughout 2021, we continued our stakeholder engagement practices with   our shareholders and incorporated feedback into our decision-making processes.
","('Business_Model_Resilience', 0.16658498346805573)","('Human_Rights_And_Community_Relations', 0.15669819712638855)","('Director_Removal', 0.14556460082530975)","('NON-ESG', 0.16658498346805573)","('NON-ESG', 0.15669819712638855)","('NON-ESG', 0.14556460082530975)"
Line 285,"For information on Edwards’ engagement with shareholders, please see our   2022 Proxy Statement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3089906871318817)","('Competitive_Behavior', 0.140093594789505)","('Business_Model_Resilience', 0.11754295229911804)","('NON-ESG', 0.3089906871318817)","('NON-ESG', 0.140093594789505)","('NON-ESG', 0.11754295229911804)"
Line 286,"Additional information about Edwards’ corporate governance  practices can be found in our Bylaws, Corporate Governance Guidelines and the   Charters of the Audit Committee and the Compensation and Governance Committee.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7322708964347839)","('Business_Ethics', 0.13272994756698608)","('Director_Removal', 0.029104802757501602)","(['Corporate Governance'], 0.7322708964347839)","('NON-ESG', 0.13272994756698608)","('NON-ESG', 0.029104802757501602)"
Line 287,"Visit our Governance page to find the written bylaws, guidelines and charters.
","('Management_Of_Legal_And_Regulatory_Framework', 0.889691948890686)","('Director_Removal', 0.01929672807455063)","('Business_Ethics', 0.01640784926712513)","(['Corporate Governance'], 0.889691948890686)","('NON-ESG', 0.01929672807455063)","('NON-ESG', 0.01640784926712513)"
Line 288,"Status of Pay-for-Performance, Executive Compensation   and CEO Pay Ratio In 2021, approximately 91 percent of the target total direct compensation of our CEO,  and an average of 79 percent of the target total direct compensation of our other  Named Executive Officers, was performance-based.
","('Labor_Practices', 0.891345739364624)","('Employee_Engagement_Inclusion_And_Diversity', 0.02621815726161003)","('Business_Ethics', 0.012296359986066818)","(['Labor Practice Indicators'], 0.891345739364624)","('NON-ESG', 0.02621815726161003)","('NON-ESG', 0.012296359986066818)"
Line 289,"For more information, please   see our 2022 Proxy Statement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3091364800930023)","('Competitive_Behavior', 0.14738544821739197)","('Business_Model_Resilience', 0.13502338528633118)","('NON-ESG', 0.3091364800930023)","('NON-ESG', 0.14738544821739197)","('NON-ESG', 0.13502338528633118)"
Line 290,"Based on the SEC rules for CEO pay ratio disclosure and applying the methodology   described on page 60 of the 2022 Proxy Statement, we determined that our CEO’s   total compensation for 2021 was $13,613,305, and the median of the total 2021   compensation of all our employees (excluding our CEO) was $73,036.
","('Labor_Practices', 0.9128532409667969)","('Employee_Engagement_Inclusion_And_Diversity', 0.01732214167714119)","('Director_Removal', 0.009794535115361214)","(['Labor Practice Indicators'], 0.9128532409667969)","('NON-ESG', 0.01732214167714119)","('NON-ESG', 0.009794535115361214)"
Line 291,"Accordingly,   we estimate the ratio of our CEO’s total compensation for 2021 to the median of the  total 2021 compensation of all our employees (excluding our CEO) to be 186 to 1.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Patients Access to Healthcare Edwards Lifesciences’ work to improve access to healthcare supports our Aspirations    of transforming patient lives with breakthrough medical technologies and passionate   engagement that strengthens our communities.
","('Access_And_Affordability', 0.33678680658340454)","('Employee_Engagement_Inclusion_And_Diversity', 0.19242353737354279)","('Labor_Practices', 0.07840259373188019)","('NON-ESG', 0.33678680658340454)","('NON-ESG', 0.19242353737354279)","('NON-ESG', 0.07840259373188019)"
Line 292,"Definition   Supporting the provision of quality care to underserved and diverse patients in   global communities; helping to remove regulatory, geographic and economic barriers   to treatment, ensuring patients have access to new therapies; participating in public   policy development; providing financial contributions in support of Edwards’ goals   and aspirations; and developing innovations that allow our products to improve the   efficiency, safety and effectiveness of healthcare processes.Management Approach   Edwards Lifesciences believes patients should have access to high-quality care   and new therapies that deliver value, and that patient care can always be improved.
","('Access_And_Affordability', 0.8691070079803467)","('Product_Quality_And_Safety', 0.020692119374871254)","('Energy_Management', 0.012553001753985882)","(['Health Outcome Contribution'], 0.8691070079803467)","('NON-ESG', 0.020692119374871254)","('NON-ESG', 0.012553001753985882)"
Line 293,"Definition   Supporting the provision of quality care to underserved and diverse patients in   global communities; helping to remove regulatory, geographic and economic barriers   to treatment, ensuring patients have access to new therapies; participating in public   policy development; providing financial contributions in support of Edwards’ goals   and aspirations; and developing innovations that allow our products to improve the   efficiency, safety and effectiveness of healthcare processes.Management Approach   Edwards Lifesciences believes patients should have access to high-quality care   and new therapies that deliver value, and that patient care can always be improved.
","('Access_And_Affordability', 0.8464716672897339)","('Product_Quality_And_Safety', 0.015405687503516674)","('Employee_Health_And_Safety', 0.013307301327586174)","(['Health Outcome Contribution'], 0.8464716672897339)","('NON-ESG', 0.015405687503516674)","('NON-ESG', 0.013307301327586174)"
Line 294,"Unfortunately, patients in today’s global healthcare system often face numerous  barriers to treatment.
","('Access_And_Affordability', 0.6497745513916016)","('Employee_Health_And_Safety', 0.08256587386131287)","('Critical_Incident_Risk_Management', 0.05407106503844261)","(['Health Outcome Contribution'], 0.6497745513916016)","('NON-ESG', 0.08256587386131287)","('NON-ESG', 0.05407106503844261)"
Line 295,"These can include lack of disease awareness, restricted access  to coverage, geographic barriers or challenging referral pathways.
","('Access_And_Affordability', 0.48944091796875)","('Employee_Engagement_Inclusion_And_Diversity', 0.08955240994691849)","('Systemic_Risk_Management', 0.059094708412885666)","('NON-ESG', 0.48944091796875)","('NON-ESG', 0.08955240994691849)","('NON-ESG', 0.059094708412885666)"
Line 296,"Edwards’ focus on  improving access to care contributes to a more sustainable healthcare system and  addresses unmet patient needs.
","('Access_And_Affordability', 0.9149534702301025)","('Critical_Incident_Risk_Management', 0.010640015825629234)","('Human_Rights_And_Community_Relations', 0.0069557311944663525)","(['Health Outcome Contribution'], 0.9149534702301025)","('NON-ESG', 0.010640015825629234)","('NON-ESG', 0.0069557311944663525)"
Line 297,"It is our goal to make the patient experience better, reduce overall healthcare costs  and continuously improve quality of care.
","('Access_And_Affordability', 0.6361145973205566)","('Employee_Health_And_Safety', 0.06848932057619095)","('Energy_Management', 0.03580985963344574)","(['Health Outcome Contribution'], 0.6361145973205566)","('NON-ESG', 0.06848932057619095)","('NON-ESG', 0.03580985963344574)"
Line 298,"We address this in our target to remove  barriers along the patient journey to continuously increase treatment rates for all  indicated severe aortic stenosis patients.
","('Employee_Health_And_Safety', 0.4840109646320343)","('Access_And_Affordability', 0.0771576315164566)","('Product_Quality_And_Safety', 0.07299621403217316)","('NON-ESG', 0.4840109646320343)","('NON-ESG', 0.0771576315164566)","('NON-ESG', 0.07299621403217316)"
Line 299,"This target aligns with the UN SDG 3:   Good Health & Well-Being.
","('Access_And_Affordability', 0.468837171792984)","('Employee_Health_And_Safety', 0.19652238488197327)","('Human_Rights_And_Community_Relations', 0.0743478536605835)","('NON-ESG', 0.468837171792984)","('NON-ESG', 0.19652238488197327)","('NON-ESG', 0.0743478536605835)"
Line 300,"Our programs began with the recognition that patients, providers and healthcare  systems have come to increasingly recognize the value of non-clinical health   outcome measures such as quality of life, which can lead to meaningful changes   in healthcare status.
","('Access_And_Affordability', 0.6270910501480103)","('Employee_Health_And_Safety', 0.0778542011976242)","('Product_Quality_And_Safety', 0.04173573851585388)","(['Health Outcome Contribution'], 0.6270910501480103)","('NON-ESG', 0.0778542011976242)","('NON-ESG', 0.04173573851585388)"
Line 301,"Furthermore, with a growing aging population, longer life-expectancy, growth   of evidence-based treatment options and constrained budgets, governments   and other payers globally are increasingly focused on covering and paying for   technologies that are cost-effective and/or cost-saving.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Global Health Economics & Reimbursement (GHER) Edwards envisions a future where all patients in need have access to cardiovascular   care.
","('Access_And_Affordability', 0.8775706887245178)","('Employee_Health_And_Safety', 0.013036840595304966)","('Product_Quality_And_Safety', 0.012551356106996536)","(['Health Outcome Contribution'], 0.8775706887245178)","('NON-ESG', 0.013036840595304966)","('NON-ESG', 0.012551356106996536)"
Line 302,"To that end, it is important that our treatments are cost effective for healthcare  systems.
","('Access_And_Affordability', 0.5115292072296143)","('Energy_Management', 0.09286251664161682)","('Customer_Welfare', 0.08065023273229599)","(['Health Outcome Contribution'], 0.5115292072296143)","('NON-ESG', 0.09286251664161682)","('NON-ESG', 0.08065023273229599)"
Line 303,"Cardiovascular care innovations can pose a challenge when healthcare systems   are unequipped to quickly adopt new technologies.
","('Product_Design_And_Lifecycle_Management', 0.36561980843544006)","('Business_Model_Resilience', 0.10330306738615036)","('Energy_Management', 0.09850481897592545)","('NON-ESG', 0.36561980843544006)","('NON-ESG', 0.10330306738615036)","('NON-ESG', 0.09850481897592545)"
Line 304,"Edwards seeks to bridge this gap   by providing health economic data and tools to hospitals and healthcare systems   implementing our therapies.
","('Access_And_Affordability', 0.4271898865699768)","('Energy_Management', 0.057118140161037445)","('Data_Security', 0.04680999740958214)","('NON-ESG', 0.4271898865699768)","('NON-ESG', 0.057118140161037445)","('NON-ESG', 0.04680999740958214)"
Line 305,"Edwards employs a GHER team whose mission is to increase patient access by developing   and defining the related clinical and economic data that healthcare decision-makers  need.
","('Access_And_Affordability', 0.7795815467834473)","('Customer_Welfare', 0.030884193256497383)","('Product_Quality_And_Safety', 0.015664640814065933)","(['Health Outcome Contribution'], 0.7795815467834473)","('NON-ESG', 0.030884193256497383)","('NON-ESG', 0.015664640814065933)"
Line 306,"Our dedicated GHER staff supports customers’ and healthcare systems’ efforts to  improve patient outcomes and reduce costs.
","('Access_And_Affordability', 0.6549776792526245)","('Employee_Health_And_Safety', 0.05397381633520126)","('Customer_Welfare', 0.03911749646067619)","(['Health Outcome Contribution'], 0.6549776792526245)","('NON-ESG', 0.05397381633520126)","('NON-ESG', 0.03911749646067619)"
Line 307,"We work directly with healthcare systems  to provide the clinical and economic data that supports equitable access, coverage and  payment so that our technologies can be available to patients in need.
","('Access_And_Affordability', 0.8860872387886047)","('Product_Quality_And_Safety', 0.012324566952884197)","('Human_Rights_And_Community_Relations', 0.009835310280323029)","(['Health Outcome Contribution'], 0.8860872387886047)","('NON-ESG', 0.012324566952884197)","('NON-ESG', 0.009835310280323029)"
Line 308,"Improving Access to Care Together with continued support from Edwards Lifesciences, the American Heart   Association’s (AHA) quality improvement initiative addresses the need for   improvements in identification of patients with aortic stenosis and adherence to   treatment guidelines.
","('Access_And_Affordability', 0.4441046714782715)","('Employee_Health_And_Safety', 0.15029430389404297)","('Product_Quality_And_Safety', 0.08285600692033768)","('NON-ESG', 0.4441046714782715)","('NON-ESG', 0.15029430389404297)","('NON-ESG', 0.08285600692033768)"
Line 309,"This initiative around structural heart disease has an intensive   approach to aortic stenosis in a select number of communities.
","('Employee_Health_And_Safety', 0.5348343849182129)","('Access_And_Affordability', 0.0670129582285881)","('Critical_Incident_Risk_Management', 0.06226668506860733)","(['Operational Eco-Efficiency'], 0.5348343849182129)","('NON-ESG', 0.0670129582285881)","('NON-ESG', 0.06226668506860733)"
Line 310,"These locations are   the front lines to identify best practices for in-patient and out-patient settings alike.
","('Access_And_Affordability', 0.6705844402313232)","('Human_Rights_And_Community_Relations', 0.05350037291646004)","('Product_Quality_And_Safety', 0.027760492637753487)","(['Health Outcome Contribution'], 0.6705844402313232)","('NON-ESG', 0.05350037291646004)","('NON-ESG', 0.027760492637753487)"
Line 311,"The goal is to improve the patient experience from symptom onset to appropriate   diagnosis and follow-through, to timely treatment and disease management.
","('Access_And_Affordability', 0.3170464038848877)","('Employee_Health_And_Safety', 0.18070535361766815)","('Product_Quality_And_Safety', 0.08206683397293091)","('NON-ESG', 0.3170464038848877)","('NON-ESG', 0.18070535361766815)","('NON-ESG', 0.08206683397293091)"
Line 312,"The   program consists of evidence-based measurement development to better identify   and treat patients, as well as multi-media educational resources and self-management  care plans for people living with structural heart disease.
","('Access_And_Affordability', 0.2916715443134308)","('Employee_Health_And_Safety', 0.2358657866716385)","('Product_Quality_And_Safety', 0.07062692195177078)","('NON-ESG', 0.2916715443134308)","('NON-ESG', 0.2358657866716385)","('NON-ESG', 0.07062692195177078)"
Line 313,"This initiative addresses our   target to remove barriers along the patient journey to continuously increase treatment  rates for all indicated symptomatic aortic stenosis patients.
","('Access_And_Affordability', 0.24199135601520538)","('Employee_Health_And_Safety', 0.1861596554517746)","('Product_Quality_And_Safety', 0.09316384047269821)","('NON-ESG', 0.24199135601520538)","('NON-ESG', 0.1861596554517746)","('NON-ESG', 0.09316384047269821)"
Line 314,"This target aligns with    UN SDG 3: Good Health & Well-Being.
","('Access_And_Affordability', 0.4653412401676178)","('Employee_Health_And_Safety', 0.1928529143333435)","('Human_Rights_And_Community_Relations', 0.08053729683160782)","('NON-ESG', 0.4653412401676178)","('NON-ESG', 0.1928529143333435)","('NON-ESG', 0.08053729683160782)"
Line 315,"For more details, please see AHA’s website.Philanthropic Support Edwards is proud to serve patients from diverse backgrounds, all around the world.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5825570225715637)","('Access_And_Affordability', 0.18420374393463135)","('Human_Rights_And_Community_Relations', 0.043213073164224625)","(['Human Capital Development'], 0.5825570225715637)","('NON-ESG', 0.18420374393463135)","('NON-ESG', 0.043213073164224625)"
Line 316,"Through the Edwards Lifesciences Foundation, we support many philanthropic   initiatives that increase access to healthcare for underserved patients.
","('Access_And_Affordability', 0.946358323097229)","('Critical_Incident_Risk_Management', 0.005170092917978764)","('Product_Quality_And_Safety', 0.004539121873676777)","(['Health Outcome Contribution'], 0.946358323097229)","('NON-ESG', 0.005170092917978764)","('NON-ESG', 0.004539121873676777)"
Line 317,"The Foundation  works to expand access to therapies in all geographic areas, including those in emerging  markets, through support of clinical education and medical mission work.
","('Access_And_Affordability', 0.8640715479850769)","('Product_Quality_And_Safety', 0.012903211638331413)","('Customer_Welfare', 0.011096431873738766)","(['Health Outcome Contribution'], 0.8640715479850769)","('NON-ESG', 0.012903211638331413)","('NON-ESG', 0.011096431873738766)"
Line 318,"We aim to  reach underserved regions all around the world, such as Africa, Brazil, China, Dominican  Republic, Haiti, India, Jamaica, Peru, Puerto Rico, Russia and Vietnam.
","('Access_And_Affordability', 0.9334356784820557)","('Product_Quality_And_Safety', 0.005834910087287426)","('Human_Rights_And_Community_Relations', 0.005560374353080988)","(['Health Outcome Contribution'], 0.9334356784820557)","('NON-ESG', 0.005834910087287426)","('NON-ESG', 0.005560374353080988)"
Line 319,"Please see our  Volunteerism & Giving section for more information on Edwards’ philanthropic efforts.
","('Human_Rights_And_Community_Relations', 0.4316747188568115)","('Management_Of_Legal_And_Regulatory_Framework', 0.09600315243005753)","('Access_And_Affordability', 0.07489018887281418)","('NON-ESG', 0.4316747188568115)","('NON-ESG', 0.09600315243005753)","('NON-ESG', 0.07489018887281418)"
Line 320,"Every Heartbeat Matters Our signature philanthropic initiative is Every Heartbeat Matters (EHM).
","('Management_Of_Legal_And_Regulatory_Framework', 0.5608870983123779)","('Human_Rights_And_Community_Relations', 0.05172205716371536)","('Business_Model_Resilience', 0.04158131033182144)","(['Corporate Governance'], 0.5608870983123779)","('NON-ESG', 0.05172205716371536)","('NON-ESG', 0.04158131033182144)"
Line 321,"Launched   in 2014, EHM partners with more than 50 charitable organizations to support the   humanitarian needs of underserved patients globally.
","('Access_And_Affordability', 0.9441685676574707)","('Critical_Incident_Risk_Management', 0.00599833857268095)","('Human_Rights_And_Community_Relations', 0.004434486851096153)","(['Health Outcome Contribution'], 0.9441685676574707)","('NON-ESG', 0.00599833857268095)","('NON-ESG', 0.004434486851096153)"
Line 322,"We are committed to improving  the lives of 2.5 million additional underserved structural heart and critical care patients  by the end of 2025.This target aligns with UN SDG 3: Good Health & Well-Being.
","('Access_And_Affordability', 0.9457278847694397)","('Human_Rights_And_Community_Relations', 0.005038936622440815)","('Critical_Incident_Risk_Management', 0.00473174499347806)","(['Health Outcome Contribution'], 0.9457278847694397)","('NON-ESG', 0.005038936622440815)","('NON-ESG', 0.00473174499347806)"
Line 323,"More on this initiative can be found on our EHM page.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7545043230056763)","('Access_And_Affordability', 0.05110599845647812)","('Human_Rights_And_Community_Relations', 0.04605218395590782)","(['Corporate Governance'], 0.7545043230056763)","('NON-ESG', 0.05110599845647812)","('NON-ESG', 0.04605218395590782)"
Line 324,"A complete list of grantees is  available on our website.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6190823912620544)","('Labor_Practices', 0.06541413813829422)","('Access_And_Affordability', 0.04466079920530319)","(['Corporate Governance'], 0.6190823912620544)","('NON-ESG', 0.06541413813829422)","('NON-ESG', 0.04466079920530319)"
Line 325,"Each partner is required to adhere to our program and   reporting guidelines.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8214669227600098)","('Access_And_Affordability', 0.038292817771434784)","('Human_Rights_And_Community_Relations', 0.022934885695576668)","(['Corporate Governance'], 0.8214669227600098)","('NON-ESG', 0.038292817771434784)","('NON-ESG', 0.022934885695576668)"
Line 326,"In addition to cash donations, we partner with an experienced organization, MAP   International, to offer EHM partners donated products to perform humanitarian   treatment for underserved structural heart and critical care patients outside the U.S. Political Activities As a highly regulated medical technology company, public policy influences our ability  to help patients.
","('Access_And_Affordability', 0.9435605406761169)","('Critical_Incident_Risk_Management', 0.005607428029179573)","('Human_Rights_And_Community_Relations', 0.004650572314858437)","(['Health Outcome Contribution'], 0.9435605406761169)","('NON-ESG', 0.005607428029179573)","('NON-ESG', 0.004650572314858437)"
Line 327,"We are active in the policy making and political process through regular  and constructive engagement with government officials, policymakers and stakeholder  groups.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9116019606590271)","('Human_Rights_And_Community_Relations', 0.01896253228187561)","('Physical_Impacts_Of_Climate_Change', 0.006431340239942074)","(['Corporate Governance'], 0.9116019606590271)","('NON-ESG', 0.01896253228187561)","('NON-ESG', 0.006431340239942074)"
Line 328,"Our goal is to advance sound public policy on areas related to patient-focused  medical innovations for structural heart disease, critical care and surgical monitoring,  and to improve patient outcomes and enhance lives.
","('Access_And_Affordability', 0.37420913577079773)","('Employee_Health_And_Safety', 0.27280062437057495)","('Critical_Incident_Risk_Management', 0.05194447562098503)","('NON-ESG', 0.37420913577079773)","('NON-ESG', 0.27280062437057495)","('NON-ESG', 0.05194447562098503)"
Line 329,"We outline our approach in our Policy on Political Activities and disclose all federal and  state political contributions on our corporate website, which we update twice per year.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Annual Performance   Global Health Economics & Reimbursement Our GHER program strives to provide reimbursement education to individual hospitals   or health systems providing TAVR and other Edwards technologies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.883974552154541)","('Business_Ethics', 0.026722578331828117)","('Labor_Practices', 0.007978085428476334)","(['Corporate Governance'], 0.883974552154541)","('NON-ESG', 0.026722578331828117)","('NON-ESG', 0.007978085428476334)"
Line 330,"While working with  TAVR programs in support of their efforts to deliver quality care remained a top priority   for Edwards throughout 2021, we also focused efforts supporting the appropriate access  for our new Surgical Structural Heart technologies.
","('Access_And_Affordability', 0.5675793886184692)","('Employee_Health_And_Safety', 0.12612248957157135)","('Product_Quality_And_Safety', 0.04672212153673172)","(['Health Outcome Contribution'], 0.5675793886184692)","('NON-ESG', 0.12612248957157135)","('NON-ESG', 0.04672212153673172)"
Line 331,"For example, global markets provide   a significant opportunity to impact patient care.
","('Access_And_Affordability', 0.7873299717903137)","('Employee_Health_And_Safety', 0.02911161631345749)","('Critical_Incident_Risk_Management', 0.02309422381222248)","(['Health Outcome Contribution'], 0.7873299717903137)","('NON-ESG', 0.02911161631345749)","('NON-ESG', 0.02309422381222248)"
Line 332,"In 2021, we first launched our MITRIS   RESILIA valve for mitral valve replacement in Japan.
","('Employee_Health_And_Safety', 0.3003705143928528)","('Product_Quality_And_Safety', 0.07522734999656677)","('Critical_Incident_Risk_Management', 0.06168327108025551)","('NON-ESG', 0.3003705143928528)","('NON-ESG', 0.07522734999656677)","('NON-ESG', 0.06168327108025551)"
Line 333,"Just six months post-launch, the   MITRIS RESILIA valve became the leading mitral valve replacement therapy in Japan.
","('Employee_Health_And_Safety', 0.4508907198905945)","('Product_Quality_And_Safety', 0.07138930261135101)","('Access_And_Affordability', 0.03881777450442314)","('NON-ESG', 0.4508907198905945)","('NON-ESG', 0.07138930261135101)","('NON-ESG', 0.03881777450442314)"
Line 334,"In early 2022, the MITRIS RESILIA valve also received approval from the U.S. FDA.
","('Management_Of_Legal_And_Regulatory_Framework', 0.42612677812576294)","('Selling_Practices_And_Product_Labeling', 0.0992150530219078)","('Product_Quality_And_Safety', 0.09433528780937195)","('NON-ESG', 0.42612677812576294)","('NON-ESG', 0.0992150530219078)","('NON-ESG', 0.09433528780937195)"
Line 335,"We also furthered our work with hospitals on understanding and adopting best   demonstrated quality practices and realizing care efficiencies associated with TAVR   and Surgical Aortic Valve Replacement.
","('Employee_Health_And_Safety', 0.6866282224655151)","('Access_And_Affordability', 0.06671243906021118)","('Product_Quality_And_Safety', 0.0547025129199028)","(['Operational Eco-Efficiency'], 0.6866282224655151)","('NON-ESG', 0.06671243906021118)","('NON-ESG', 0.0547025129199028)"
Line 336,"These efforts continue to increase overall   patient access to care and significantly reduce the costs of care.
","('Access_And_Affordability', 0.9130247235298157)","('Critical_Incident_Risk_Management', 0.007726351730525494)","('Human_Rights_And_Community_Relations', 0.007714560255408287)","(['Health Outcome Contribution'], 0.9130247235298157)","('NON-ESG', 0.007726351730525494)","('NON-ESG', 0.007714560255408287)"
Line 337,"In 2021, Edwards   announced that a cost-effectiveness analysis comparing TAVR to surgery demonstrated  that TAVR with the SAPIEN 3 valve is an economically dominant treatment strategy,   offering improved outcomes and reduced cost.
","('Access_And_Affordability', 0.3023109436035156)","('Employee_Health_And_Safety', 0.10429956018924713)","('Product_Quality_And_Safety', 0.09230832755565643)","('NON-ESG', 0.3023109436035156)","('NON-ESG', 0.10429956018924713)","('NON-ESG', 0.09230832755565643)"
Line 338,"Treatment with the SAPIEN 3 valve   resulted in cost savings of more than $2,000 per patient through the two-year   study period.
","('Access_And_Affordability', 0.48190516233444214)","('Customer_Welfare', 0.08771060407161713)","('Product_Quality_And_Safety', 0.06115923821926117)","('NON-ESG', 0.48190516233444214)","('NON-ESG', 0.08771060407161713)","('NON-ESG', 0.06115923821926117)"
Line 339,"In 2021, Edwards also announced clinical and economic results from the 3M   (multidisciplinary, multimodality, but minimalist) TAVR Economic Study.
","('Competitive_Behavior', 0.17499838769435883)","('Systemic_Risk_Management', 0.15401703119277954)","('Employee_Engagement_Inclusion_And_Diversity', 0.14404720067977905)","('NON-ESG', 0.17499838769435883)","('NON-ESG', 0.15401703119277954)","('NON-ESG', 0.14404720067977905)"
Line 340,"The 3M-   TAVR study demonstrated positive findings supporting similar clinical outcomes   and substantial cost savings associated with minimalist TAVR when compared with   conventional TAVR in patients at intermediate risk for surgery.
","('Access_And_Affordability', 0.30471840500831604)","('Employee_Health_And_Safety', 0.1463804394006729)","('Product_Quality_And_Safety', 0.08255082368850708)","('NON-ESG', 0.30471840500831604)","('NON-ESG', 0.1463804394006729)","('NON-ESG', 0.08255082368850708)"
Line 341,"For example, index   hospitalization costs for patients in the 3M cohort were $10,843 lower per patient,   driven by reductions in procedure duration, anesthesia costs and length of stay.
","('Access_And_Affordability', 0.32649269700050354)","('Employee_Health_And_Safety', 0.17619457840919495)","('Critical_Incident_Risk_Management', 0.07705756276845932)","('NON-ESG', 0.32649269700050354)","('NON-ESG', 0.17619457840919495)","('NON-ESG', 0.07705756276845932)"
Line 342,"Cumulative cost differences out to 30 days post procedure were $11,305 lower in the   3M cohort compared to traditional TAVR.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5776589512825012)","('Energy_Management', 0.08558017760515213)","('Access_And_Affordability', 0.04546164348721504)","(['Corporate Governance'], 0.5776589512825012)","('NON-ESG', 0.08558017760515213)","('NON-ESG', 0.04546164348721504)"
Line 343,"Please see the press release for more details.
","('Management_Of_Legal_And_Regulatory_Framework', 0.20475906133651733)","('Business_Model_Resilience', 0.1225767508149147)","('Customer_Privacy', 0.0934634581208229)","('NON-ESG', 0.20475906133651733)","('NON-ESG', 0.1225767508149147)","('NON-ESG', 0.0934634581208229)"
Line 344,"In support of our Critical Care business, we continued the generation of evidence   necessary to understand how intra-operative hypotension (low blood pressure)   can lead to poor patient outcomes and that our Hypotension Prediction Index (HPI)   technology has proven to reduce intraoperative hypotension.
","('Employee_Health_And_Safety', 0.3123931586742401)","('Access_And_Affordability', 0.1104520633816719)","('Customer_Welfare', 0.08763415366411209)","('NON-ESG', 0.3123931586742401)","('NON-ESG', 0.1104520633816719)","('NON-ESG', 0.08763415366411209)"
Line 345,"In 2021, we initiated   a new study, HPI SMART BP, to evaluate HPI’s impact on patient outcomes with the  first patient enrolled in the fourth quarter of 2021.
","('Access_And_Affordability', 0.6184298992156982)","('Employee_Health_And_Safety', 0.055849507451057434)","('Product_Quality_And_Safety', 0.04338127374649048)","(['Health Outcome Contribution'], 0.6184298992156982)","('NON-ESG', 0.055849507451057434)","('NON-ESG', 0.04338127374649048)"
Line 346,"Social value analysis is a health economics approach that seeks to monetize the health  benefits of a therapy and assess the relative share of those benefits going to society   (as health gains) versus returning to manufacturers (as profits).
","('Competitive_Behavior', 0.24029508233070374)","('Management_Of_Legal_And_Regulatory_Framework', 0.15346433222293854)","('Human_Rights_And_Community_Relations', 0.13621127605438232)","('NON-ESG', 0.24029508233070374)","('NON-ESG', 0.15346433222293854)","('NON-ESG', 0.13621127605438232)"
Line 347,"Published in 2021,   Edwards supported a white paper by the USC Schaeffer Center for Health Policy &   Economics titled “The Social Value of Disseminating Transcatheter Aortic Valve   Replacement”, which estimates TAVR will generate cumulative social value of about  $115 billion between 2011 and 2040 for patients who were medically managed.
","('Employee_Health_And_Safety', 0.41642704606056213)","('Access_And_Affordability', 0.310414582490921)","('Product_Quality_And_Safety', 0.03331305831670761)","('NON-ESG', 0.41642704606056213)","('NON-ESG', 0.310414582490921)","('NON-ESG', 0.03331305831670761)"
Line 348,"Improving Access to Care As a national sponsor, Edwards continues to support the AHA’s quality improvement  initiative Target: Aortic Stenosis.
","('Access_And_Affordability', 0.6853139996528625)","('Employee_Health_And_Safety', 0.07101287692785263)","('Product_Quality_And_Safety', 0.05692753940820694)","(['Health Outcome Contribution'], 0.6853139996528625)","('NON-ESG', 0.07101287692785263)","('NON-ESG', 0.05692753940820694)"
Line 349,"This patient-centered initiative is dedicated to driving  efforts for timely diagnosis and treatment of aortic stenosis, appropriate treatment  and improved quality of care by raising awareness and understanding of aortic stenosis  signs and symptoms, and positively empowering people to better manage their risks  and self-management with patient and caregiver resources.
","('Employee_Health_And_Safety', 0.8291577696800232)","('Access_And_Affordability', 0.02292320691049099)","('Product_Quality_And_Safety', 0.02253524214029312)","(['Operational Eco-Efficiency'], 0.8291577696800232)","('NON-ESG', 0.02292320691049099)","('NON-ESG', 0.02253524214029312)"
Line 350,"According to AHA, the  comprehensive and scalable program raises patient awareness and deepens patient  engagement while delivering guideline-directed, optimal-care standards education.
","('Access_And_Affordability', 0.8618082404136658)","('Product_Quality_And_Safety', 0.015769334509968758)","('Employee_Engagement_Inclusion_And_Diversity', 0.011495450511574745)","(['Health Outcome Contribution'], 0.8618082404136658)","('NON-ESG', 0.015769334509968758)","('NON-ESG', 0.011495450511574745)"
Line 351,"Educational Initiatives for Better Care Following our online “Reach for the Heart” Direct-to-Consumer Disease Awareness  Campaign, Edwards recently launched a nationwide direct-to-consumer unbranded  television advertising campaign, Just Getting Started, to drive awareness of patients   to TAVR therapy.
","('Access_And_Affordability', 0.4161297380924225)","('Customer_Welfare', 0.1871860772371292)","('Selling_Practices_And_Product_Labeling', 0.06624960899353027)","('NON-ESG', 0.4161297380924225)","('NON-ESG', 0.1871860772371292)","('NON-ESG', 0.06624960899353027)"
Line 352,"This advertisement directs the viewer to our educational website   offering a free TAVR Info Kit, which includes:  •  Education on severe aortic stenosis  •  Information on TAVR as a treatment option  •  Videos of patients sharing their experiences with TAVR  •  Discussion guide for talking with your doctor  •  List of hospitals in your area that perform TAVR To learn more about the Just Getting Started campaign visit: JustGettingStarted.com To learn more about the Reach for the Heart campaign visit: Campaign Website: ReachForTheHeart.com Facebook Page: Reach Out: Heart Valve Disease YouTube Channel: Reach Out: Heart Valve DiseaseEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Philanthropic Support Through our philanthropic initiative, EHM, we are committed to improving the lives  of 2.5 million additional underserved structural heart and critical care patients by the  end of 2025.
","('Employee_Health_And_Safety', 0.22609540820121765)","('Access_And_Affordability', 0.18319301307201385)","('Product_Quality_And_Safety', 0.12210898846387863)","('NON-ESG', 0.22609540820121765)","('NON-ESG', 0.18319301307201385)","('NON-ESG', 0.12210898846387863)"
Line 353,"This advertisement directs the viewer to our educational website   offering a free TAVR Info Kit, which includes:  •  Education on severe aortic stenosis  •  Information on TAVR as a treatment option  •  Videos of patients sharing their experiences with TAVR  •  Discussion guide for talking with your doctor  •  List of hospitals in your area that perform TAVR To learn more about the Just Getting Started campaign visit: JustGettingStarted.com To learn more about the Reach for the Heart campaign visit: Campaign Website: ReachForTheHeart.com Facebook Page: Reach Out: Heart Valve Disease YouTube Channel: Reach Out: Heart Valve DiseaseEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Philanthropic Support Through our philanthropic initiative, EHM, we are committed to improving the lives  of 2.5 million additional underserved structural heart and critical care patients by the  end of 2025.
","('Access_And_Affordability', 0.9405127167701721)","('Product_Quality_And_Safety', 0.005287508945912123)","('Critical_Incident_Risk_Management', 0.004914645105600357)","(['Health Outcome Contribution'], 0.9405127167701721)","('NON-ESG', 0.005287508945912123)","('NON-ESG', 0.004914645105600357)"
Line 354,"Since announcing this new commitment in 2020, we have impacted more  than 400,000 underserved patients and we are on track to meet our goal.
","('Access_And_Affordability', 0.944678783416748)","('Human_Rights_And_Community_Relations', 0.005101080518215895)","('Product_Quality_And_Safety', 0.004928295500576496)","(['Health Outcome Contribution'], 0.944678783416748)","('NON-ESG', 0.005101080518215895)","('NON-ESG', 0.004928295500576496)"
Line 355,"This impact  includes each stage of the patient journey:  •  Detecting nearly 160,000 underserved structural heart disease patients  •  Treating more than 135,000 underserved structural heart disease patients  •  Recovering more than 100,000 underserved cardiac and high-risk patients  This success during a particularly challenging time is due to the innovation of our   partners.
","('Access_And_Affordability', 0.945601224899292)","('Product_Quality_And_Safety', 0.0049217878840863705)","('Human_Rights_And_Community_Relations', 0.004489765968173742)","(['Health Outcome Contribution'], 0.945601224899292)","('NON-ESG', 0.0049217878840863705)","('NON-ESG', 0.004489765968173742)"
Line 356,"For example, clinicians stayed up into their nights to connect via video to   guide healthcare workers as they treated patients in other parts of the world; clinical   education forums shifted to virtual learning platforms; and new programs were   established to meet the needs of the world today.
","('Access_And_Affordability', 0.7729373574256897)","('Customer_Welfare', 0.021656399592757225)","('Human_Rights_And_Community_Relations', 0.02087368816137314)","(['Health Outcome Contribution'], 0.7729373574256897)","('NON-ESG', 0.021656399592757225)","('NON-ESG', 0.02087368816137314)"
Line 357,"By partnering with more than   60 patient- and cardiac-focused charitable partners around the world, we have   invested more than $30 million and countless hours of employees’ dedication to   creating the EHM community.
","('Access_And_Affordability', 0.47186100482940674)","('Management_Of_Legal_And_Regulatory_Framework', 0.07638750970363617)","('Human_Rights_And_Community_Relations', 0.07629633694887161)","('NON-ESG', 0.47186100482940674)","('NON-ESG', 0.07638750970363617)","('NON-ESG', 0.07629633694887161)"
Line 358,"For more on the EHM initiative, please see our   Volunteerism & Giving section of this report.
","('Human_Rights_And_Community_Relations', 0.35745641589164734)","('Employee_Health_And_Safety', 0.12506020069122314)","('Employee_Engagement_Inclusion_And_Diversity', 0.11795835196971893)","('NON-ESG', 0.35745641589164734)","('NON-ESG', 0.12506020069122314)","('NON-ESG', 0.11795835196971893)"
Line 359,"Political and Lobbying Expenditures In 2021, Edwards made $90,000 in state political contributions, and the Edwards   PAC made $203,000 in federal contributions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8829138875007629)","('Director_Removal', 0.01905379630625248)","('Labor_Practices', 0.015036533586680889)","(['Corporate Governance'], 0.8829138875007629)","('NON-ESG', 0.01905379630625248)","('NON-ESG', 0.015036533586680889)"
Line 360,"A full list of recipients, contribution  amounts, and policy is available on our website.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7291496396064758)","('Labor_Practices', 0.04846173897385597)","('Director_Removal', 0.030010990798473358)","(['Corporate Governance'], 0.7291496396064758)","('NON-ESG', 0.04846173897385597)","('NON-ESG', 0.030010990798473358)"
Line 361,"Additionally, a portion of our industry  association membership dues were spent on federal lobbying.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8722167015075684)","('Director_Removal', 0.022148147225379944)","('Competitive_Behavior', 0.0168779119849205)","(['Corporate Governance'], 0.8722167015075684)","('NON-ESG', 0.022148147225379944)","('NON-ESG', 0.0168779119849205)"
Line 362,"These include:  •  Advanced Medical Technology Association: $30, •  California Life Sciences Association: $14,Edwards received the highest score in the 2021 CPA-Zicklin Index for political   disclosure and accountability.
","('Management_Of_Legal_And_Regulatory_Framework', 0.615867555141449)","('Business_Ethics', 0.21268416941165924)","('Systemic_Risk_Management', 0.031105605885386467)","(['Corporate Governance'], 0.615867555141449)","('NON-ESG', 0.21268416941165924)","('NON-ESG', 0.031105605885386467)"
Line 363,"Edwards is designated as a “CPA-Zicklin Trendsetter.”   The CPA-Zicklin Index benchmarks the political disclosure and accountability policies  and practices of leading U.S. public companies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8259985446929932)","('Business_Ethics', 0.0614507794380188)","('Systemic_Risk_Management', 0.03305664286017418)","(['Corporate Governance'], 0.8259985446929932)","('NON-ESG', 0.0614507794380188)","('NON-ESG', 0.03305664286017418)"
Line 364,"The Center for Political Accountability  in conjunction with the Zicklin Center for Business Ethics Research at The Wharton  School at the University of Pennsylvania produce the Index annually.HIGHLIGHT STORY EHM Partner Performs Life-Saving   Heart Surgeries in Mongolia Our Every Heartbeat Matter’s partner, Heart Saving Project (HSP), is a   Japanese non-profit organization in which Japanese pediatric cardiologists   and anesthesiologists travel to Mongolia to conduct heart screening and   catheterization for children and to educate local doctors.
","('Business_Ethics', 0.4889976382255554)","('Employee_Health_And_Safety', 0.1465163677930832)","('Access_And_Affordability', 0.05210843309760094)","('NON-ESG', 0.4889976382255554)","('NON-ESG', 0.1465163677930832)","('NON-ESG', 0.05210843309760094)"
Line 365,"The Center for Political Accountability  in conjunction with the Zicklin Center for Business Ethics Research at The Wharton  School at the University of Pennsylvania produce the Index annually.HIGHLIGHT STORY EHM Partner Performs Life-Saving   Heart Surgeries in Mongolia Our Every Heartbeat Matter’s partner, Heart Saving Project (HSP), is a   Japanese non-profit organization in which Japanese pediatric cardiologists   and anesthesiologists travel to Mongolia to conduct heart screening and   catheterization for children and to educate local doctors.
","('Access_And_Affordability', 0.8678967952728271)","('Human_Rights_And_Community_Relations', 0.019338615238666534)","('Critical_Incident_Risk_Management', 0.016521833837032318)","(['Health Outcome Contribution'], 0.8678967952728271)","('NON-ESG', 0.019338615238666534)","('NON-ESG', 0.016521833837032318)"
Line 366,"A long-term goal  of HSP is to train and support pediatric cardiologists in Mongolia on how to  perform life-saving heart surgeries.
","('Employee_Health_And_Safety', 0.3775763213634491)","('Access_And_Affordability', 0.19680297374725342)","('Employee_Engagement_Inclusion_And_Diversity', 0.05653373524546623)","('NON-ESG', 0.3775763213634491)","('NON-ESG', 0.19680297374725342)","('NON-ESG', 0.05653373524546623)"
Line 367,"When COVID-19 prevented in-person  missions,they created new ways to assist in vital surgeries through live,   video-sharing technologies and telemedicine.
","('Employee_Health_And_Safety', 0.39454635977745056)","('Access_And_Affordability', 0.19918711483478546)","('Critical_Incident_Risk_Management', 0.13831311464309692)","('NON-ESG', 0.39454635977745056)","('NON-ESG', 0.19918711483478546)","('NON-ESG', 0.13831311464309692)"
Line 368,"Pictured is a surgery in   process in the city of Ulaanbaatar.
","('Employee_Health_And_Safety', 0.4192836582660675)","('Critical_Incident_Risk_Management', 0.13613028824329376)","('Access_And_Affordability', 0.08519593626260757)","('NON-ESG', 0.4192836582660675)","('NON-ESG', 0.13613028824329376)","('NON-ESG', 0.08519593626260757)"
Line 369,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Patient Experience & Voice Edwards Lifesciences works to improve the patient experience and engage   the patient voice to support our aspiration of transforming patient lives with   breakthrough medical technologies.
","('Access_And_Affordability', 0.24709218740463257)","('Product_Design_And_Lifecycle_Management', 0.16727806627750397)","('Employee_Health_And_Safety', 0.1505620926618576)","('NON-ESG', 0.24709218740463257)","('NON-ESG', 0.16727806627750397)","('NON-ESG', 0.1505620926618576)"
Line 370,"As one of Edwards’ most material sustainability   topics, we continue to evolve our program to better meet the needs of our patients.
","('Access_And_Affordability', 0.34049662947654724)","('Product_Design_And_Lifecycle_Management', 0.13127166032791138)","('Customer_Welfare', 0.0886092483997345)","('NON-ESG', 0.34049662947654724)","('NON-ESG', 0.13127166032791138)","('NON-ESG', 0.0886092483997345)"
Line 371,"Understanding the patient experience and listening to patient voices strengthens   our innovation, production, and delivery of solutions to help those fighting   cardiovascular disease.
","('Access_And_Affordability', 0.3448922634124756)","('Employee_Health_And_Safety', 0.10465892404317856)","('Customer_Welfare', 0.08454061299562454)","('NON-ESG', 0.3448922634124756)","('NON-ESG', 0.10465892404317856)","('NON-ESG', 0.08454061299562454)"
Line 372,"Definition   Continuously improving the patient experience with therapies developed with feedback  and input from patients while empowering patients to support and aid each other.
","('Access_And_Affordability', 0.7972764372825623)","('Human_Rights_And_Community_Relations', 0.0381675660610199)","('Employee_Health_And_Safety', 0.023693498224020004)","(['Health Outcome Contribution'], 0.7972764372825623)","('NON-ESG', 0.0381675660610199)","('NON-ESG', 0.023693498224020004)"
Line 373,"Management Approach    We understand that too often patients do not have influence over the diagnosis of   their condition, the type of treatment they receive or how their care is delivered.
","('Access_And_Affordability', 0.5041817426681519)","('Employee_Health_And_Safety', 0.1357056349515915)","('Product_Quality_And_Safety', 0.06775110214948654)","(['Health Outcome Contribution'], 0.5041817426681519)","('NON-ESG', 0.1357056349515915)","('NON-ESG', 0.06775110214948654)"
Line 374,"Edwards Lifesciences focuses on providing patient-focused innovations that save   and enhance patient lives.
","('Access_And_Affordability', 0.37603482604026794)","('Employee_Health_And_Safety', 0.13938020169734955)","('Product_Design_And_Lifecycle_Management', 0.12148644030094147)","('NON-ESG', 0.37603482604026794)","('NON-ESG', 0.13938020169734955)","('NON-ESG', 0.12148644030094147)"
Line 375,"Patient experience and voice is one of our most material   sustainability topics—excelling in being patient-first is consistent with our Credo.
","('Access_And_Affordability', 0.43168482184410095)","('Employee_Health_And_Safety', 0.11076074093580246)","('Employee_Engagement_Inclusion_And_Diversity', 0.07750231772661209)","('NON-ESG', 0.43168482184410095)","('NON-ESG', 0.11076074093580246)","('NON-ESG', 0.07750231772661209)"
Line 376,"Edwards’ vision to improve the quality of care for millions is led by technology, clinical  evidence and innovative solutions to improve patient care.
","('Access_And_Affordability', 0.7371401190757751)","('Customer_Welfare', 0.03125137463212013)","('Energy_Management', 0.02353760600090027)","(['Health Outcome Contribution'], 0.7371401190757751)","('NON-ESG', 0.03125137463212013)","('NON-ESG', 0.02353760600090027)"
Line 377,"Edwards is a leader among medical technology companies in establishing a formal   patient engagement function designed to lead and empower everyone in the   company to engage with, learn from and support patients and their families to improve  the healthcare experience.
","('Access_And_Affordability', 0.5623762011528015)","('Employee_Engagement_Inclusion_And_Diversity', 0.07313084602355957)","('Employee_Health_And_Safety', 0.05734344199299812)","(['Health Outcome Contribution'], 0.5623762011528015)","('NON-ESG', 0.07313084602355957)","('NON-ESG', 0.05734344199299812)"
Line 378,"We are a leader in our industry in best practices, including  being the first medical device company to publish global guidance on how and why we  work with patient organizations.
","('Access_And_Affordability', 0.14642906188964844)","('Management_Of_Legal_And_Regulatory_Framework', 0.11391038447618484)","('Customer_Welfare', 0.11226082593202591)","('NON-ESG', 0.14642906188964844)","('NON-ESG', 0.11391038447618484)","('NON-ESG', 0.11226082593202591)"
Line 379,"This helps provide disclosure and transparency into   our relationships to prevent potential conflicts of interest.
","('Business_Ethics', 0.9529556035995483)","('Management_Of_Legal_And_Regulatory_Framework', 0.011156531982123852)","('Systemic_Risk_Management', 0.0040810140781104565)","(['Business Ethics'], 0.9529556035995483)","('NON-ESG', 0.011156531982123852)","('NON-ESG', 0.0040810140781104565)"
Line 380,"While Edwards Lifesciences throughout its history has always had a “patients first”   culture and organizational focus, Edwards’ CEO has a performance management   objective tied to increasing employee exposure to patients, which further promotes   a strong culture consistent with the Credo and our Aspirations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7319109439849854)","('Employee_Health_And_Safety', 0.03509113937616348)","('Human_Rights_And_Community_Relations', 0.026649577543139458)","(['Human Capital Development'], 0.7319109439849854)","('NON-ESG', 0.03509113937616348)","('NON-ESG', 0.026649577543139458)"
Line 381,"The Vice President of Medical Affairs and Patient Engagement is responsible for   ensuring that all patient engagement activities are aligned with our Aspirations to  transform patient care through innovative technologies and to attract and engage   talented employees.
","('Access_And_Affordability', 0.5391824245452881)","('Employee_Engagement_Inclusion_And_Diversity', 0.12491815537214279)","('Customer_Welfare', 0.04710657149553299)","(['Health Outcome Contribution'], 0.5391824245452881)","('NON-ESG', 0.12491815537214279)","('NON-ESG', 0.04710657149553299)"
Line 382,"Our global Patient Engagement team creates opportunities   to better incorporate the patient perspective into our business strategy.
","('Access_And_Affordability', 0.6871499419212341)","('Human_Rights_And_Community_Relations', 0.06489420682191849)","('Employee_Health_And_Safety', 0.029438689351081848)","(['Health Outcome Contribution'], 0.6871499419212341)","('NON-ESG', 0.06489420682191849)","('NON-ESG', 0.029438689351081848)"
Line 383,"They   enable meaningful patient-driven innovation by authentically empowering   patients, advocates and healthcare stakeholders to broaden access to treatments  and transform quality of life.
","('Access_And_Affordability', 0.8012262582778931)","('Customer_Welfare', 0.021074367687106133)","('Employee_Engagement_Inclusion_And_Diversity', 0.01946805603802204)","(['Health Outcome Contribution'], 0.8012262582778931)","('NON-ESG', 0.021074367687106133)","('NON-ESG', 0.01946805603802204)"
Line 384,"Evidence indicates that empowered, engaged patients experience better clinical   outcomes.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3320348858833313)","('Access_And_Affordability', 0.16801437735557556)","('Human_Rights_And_Community_Relations', 0.14524297416210175)","('NON-ESG', 0.3320348858833313)","('NON-ESG', 0.16801437735557556)","('NON-ESG', 0.14524297416210175)"
Line 385,"For this reason, Edwards’ Patient Engagement function maintains and   consistently updates an approach to empowering patients, including sponsoring   patient listening sessions, conducting Science of Patient Input (SPI) studies,   supporting patient advocacy groups who represent the patient voice and   collaborating with patients to exercise their voices within the healthcare system.
","('Access_And_Affordability', 0.46162503957748413)","('Human_Rights_And_Community_Relations', 0.22547107934951782)","('Employee_Health_And_Safety', 0.03294549882411957)","('NON-ESG', 0.46162503957748413)","('NON-ESG', 0.22547107934951782)","('NON-ESG', 0.03294549882411957)"
Line 386,"GRAPHIC HERE?
","('Employee_Engagement_Inclusion_And_Diversity', 0.08390643447637558)","('Product_Design_And_Lifecycle_Management', 0.07687296718358994)","('Waste_And_Hazardous_Materials_Management', 0.07423867285251617)","('NON-ESG', 0.08390643447637558)","('NON-ESG', 0.07687296718358994)","('NON-ESG', 0.07423867285251617)"
Line 387,"Growing the Patient Voice through Partnerships When patients use their voices, they do more than just advocate for themselves—  they inspire others to speak up and support each other in working toward healthier  outcomes.
","('Access_And_Affordability', 0.35786235332489014)","('Human_Rights_And_Community_Relations', 0.2948567867279053)","('Employee_Health_And_Safety', 0.046058911830186844)","('NON-ESG', 0.35786235332489014)","('NON-ESG', 0.2948567867279053)","('NON-ESG', 0.046058911830186844)"
Line 388,"We believe in the work undertaken by patient advocacy groups, and we   are proud to support those organizations through resource sharing and charitable  contributions.
","('Access_And_Affordability', 0.7059069275856018)","('Management_Of_Legal_And_Regulatory_Framework', 0.06943826377391815)","('Human_Rights_And_Community_Relations', 0.0688834860920906)","(['Health Outcome Contribution'], 0.7059069275856018)","('NON-ESG', 0.06943826377391815)","('NON-ESG', 0.0688834860920906)"
Line 389,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Edwards Lifesciences provides charitable grants to the American Heart Association   for their Heart Valve Ambassador Program, which connects heart valve patients   to a group of dedicated individuals who offer resources and support, as well as the  Heart Valve Education Center, where patients can connect with and learn from other  patients.
","('Access_And_Affordability', 0.3454737663269043)","('Employee_Health_And_Safety', 0.09823265671730042)","('Critical_Incident_Risk_Management', 0.0690050795674324)","('NON-ESG', 0.3454737663269043)","('NON-ESG', 0.09823265671730042)","('NON-ESG', 0.0690050795674324)"
Line 390,"We also partner with the AHA on Target: Aortic Stenosis.
","('Employee_Health_And_Safety', 0.38585203886032104)","('Access_And_Affordability', 0.07612626999616623)","('Employee_Engagement_Inclusion_And_Diversity', 0.0668753907084465)","('NON-ESG', 0.38585203886032104)","('NON-ESG', 0.07612626999616623)","('NON-ESG', 0.0668753907084465)"
Line 391,"This program   enhances the patient experience from symptom onset to appropriate diagnosis   and follow-through, to timely treatment and disease management.
","('Access_And_Affordability', 0.3327757716178894)","('Employee_Health_And_Safety', 0.18081583082675934)","('Product_Quality_And_Safety', 0.08591650426387787)","('NON-ESG', 0.3327757716178894)","('NON-ESG', 0.18081583082675934)","('NON-ESG', 0.08591650426387787)"
Line 392,"The   program consists of evidence-based measurement development to better   identify and treat patients, as well as multi-media educational resources and   self-management care plans for people living with structural heart disease.
","('Access_And_Affordability', 0.2916715443134308)","('Employee_Health_And_Safety', 0.2358657866716385)","('Product_Quality_And_Safety', 0.07062692195177078)","('NON-ESG', 0.2916715443134308)","('NON-ESG', 0.2358657866716385)","('NON-ESG', 0.07062692195177078)"
Line 393,"The company supports Heart Valve Voice US – a patient-led non-profit that   focuses on improving the diagnosis, treatment and management of heart valve  disease and elevating the patient voice.
","('Employee_Health_And_Safety', 0.35206809639930725)","('Access_And_Affordability', 0.10179710388183594)","('Product_Quality_And_Safety', 0.07007133960723877)","('NON-ESG', 0.35206809639930725)","('NON-ESG', 0.10179710388183594)","('NON-ESG', 0.07007133960723877)"
Line 394,"Heart Valve Voice US is part of Edwards’  international support of Global Heart Hub, a growing global patient advocacy   non-profit federation of heart valve patient organizations reaching patients in  Canada, the United Kingdom, Ireland, Italy, Germany, France, Japan, Australia,  Brazil and several other countries.
","('Access_And_Affordability', 0.21234382688999176)","('Employee_Health_And_Safety', 0.15019069612026215)","('Critical_Incident_Risk_Management', 0.09406019002199173)","('NON-ESG', 0.21234382688999176)","('NON-ESG', 0.15019069612026215)","('NON-ESG', 0.09406019002199173)"
Line 395,"Other patient advocacy programs Edwards supports include:  •  Mended Hearts Trained Accredited Patient Visitor and Peer-to-Peer   Advocate programs  •  Mended Hearts Clinical Trial Awareness campaign that educates,   empowers and encourages valve patients to explore all options  •  Alliance for Aging Research’s annual Heart Valve Disease   Awareness campaign  •  Disease awareness programs led by patient organizations Sepsis   Alliance and Conquering Congenital Heart Disease Additional global patient organization support can be found on our   Patient Voice web page.The Patient Experience The experience for those suffering from cardiovascular disease remains complex and  filled with obstacles.
","('Access_And_Affordability', 0.26642417907714844)","('Employee_Health_And_Safety', 0.1598762720823288)","('Product_Quality_And_Safety', 0.09608927369117737)","('NON-ESG', 0.26642417907714844)","('NON-ESG', 0.1598762720823288)","('NON-ESG', 0.09608927369117737)"
Line 396,"Other patient advocacy programs Edwards supports include:  •  Mended Hearts Trained Accredited Patient Visitor and Peer-to-Peer   Advocate programs  •  Mended Hearts Clinical Trial Awareness campaign that educates,   empowers and encourages valve patients to explore all options  •  Alliance for Aging Research’s annual Heart Valve Disease   Awareness campaign  •  Disease awareness programs led by patient organizations Sepsis   Alliance and Conquering Congenital Heart Disease Additional global patient organization support can be found on our   Patient Voice web page.The Patient Experience The experience for those suffering from cardiovascular disease remains complex and  filled with obstacles.
","('Access_And_Affordability', 0.4432322382926941)","('Employee_Health_And_Safety', 0.20914676785469055)","('Critical_Incident_Risk_Management', 0.05115778371691704)","('NON-ESG', 0.4432322382926941)","('NON-ESG', 0.20914676785469055)","('NON-ESG', 0.05115778371691704)"
Line 397,"The treatment process can be inconsistent from one patient to  the next and evidence indicates that empowered, engaged patients experience better  clinical outcomes.
","('Access_And_Affordability', 0.6792186498641968)","('Product_Quality_And_Safety', 0.046329617500305176)","('Customer_Welfare', 0.03013678267598152)","(['Health Outcome Contribution'], 0.6792186498641968)","('NON-ESG', 0.046329617500305176)","('NON-ESG', 0.03013678267598152)"
Line 398,"For this reason, Edwards’ Patient Engagement function maintains  and consistently updates the company’s approach to empowering patients, including  sponsoring patient listening sessions, conducting Science of Patient Input (SPI) studies,  supporting patient advocacy groups who represent patients’ voices and helping   patients and their care partners exercise their voices to improve the healthcare system.
","('Access_And_Affordability', 0.5607760548591614)","('Human_Rights_And_Community_Relations', 0.17638958990573883)","('Employee_Health_And_Safety', 0.030757881700992584)","(['Health Outcome Contribution'], 0.5607760548591614)","('NON-ESG', 0.17638958990573883)","('NON-ESG', 0.030757881700992584)"
Line 399,"Annually, Edwards hosts The Patient Experience.
","('Access_And_Affordability', 0.660282552242279)","('Employee_Health_And_Safety', 0.04883941262960434)","('Employee_Engagement_Inclusion_And_Diversity', 0.037317946553230286)","(['Health Outcome Contribution'], 0.660282552242279)","('NON-ESG', 0.04883941262960434)","('NON-ESG', 0.037317946553230286)"
Line 400,"This event brings together   patients and their care partners to connect and share their experiences with our   employees and other patients.
","('Access_And_Affordability', 0.4192069172859192)","('Employee_Health_And_Safety', 0.19499753415584564)","('Employee_Engagement_Inclusion_And_Diversity', 0.0743151605129242)","('NON-ESG', 0.4192069172859192)","('NON-ESG', 0.19499753415584564)","('NON-ESG', 0.0743151605129242)"
Line 401,"Before the global COVID-19 pandemic, these events  were held on an annual basis in multiple Edwards locations around the world.
","('Physical_Impacts_Of_Climate_Change', 0.5526658296585083)","('Air_Quality', 0.12170162051916122)","('Critical_Incident_Risk_Management', 0.09235790371894836)","(['Climate Change'], 0.5526658296585083)","('NON-ESG', 0.12170162051916122)","('NON-ESG', 0.09235790371894836)"
Line 402,"During the pandemic, Edwards’ team pivoted to virtual engagements to ensure the  continuity of engagement between patients, care partners and Edwards employees.
","('Access_And_Affordability', 0.38526713848114014)","('Employee_Health_And_Safety', 0.1347048133611679)","('Critical_Incident_Risk_Management', 0.12836195528507233)","('NON-ESG', 0.38526713848114014)","('NON-ESG', 0.1347048133611679)","('NON-ESG', 0.12836195528507233)"
Line 403,"Through this program, Edwards gains important insights into the patient journey,   from symptoms and diagnosis through treatment and recovery, as well as the   concerns and challenges that are faced along the diagnosis and treatment pathway.
","('Access_And_Affordability', 0.364706814289093)","('Employee_Health_And_Safety', 0.30136093497276306)","('Product_Quality_And_Safety', 0.04702337458729744)","('NON-ESG', 0.364706814289093)","('NON-ESG', 0.30136093497276306)","('NON-ESG', 0.04702337458729744)"
Line 404,"This approach supports our target to ensure that our therapies are addressing the   needs of patients through an increasingly collaborative patient engagement process.
","('Access_And_Affordability', 0.8200204968452454)","('Human_Rights_And_Community_Relations', 0.021910004317760468)","('Employee_Engagement_Inclusion_And_Diversity', 0.019428031519055367)","(['Health Outcome Contribution'], 0.8200204968452454)","('NON-ESG', 0.021910004317760468)","('NON-ESG', 0.019428031519055367)"
Line 405,"This target aligns to UN SDG 3:Good Health & Well-Being.
","('Access_And_Affordability', 0.4568932354450226)","('Employee_Health_And_Safety', 0.17113997042179108)","('Human_Rights_And_Community_Relations', 0.09391850233078003)","('NON-ESG', 0.4568932354450226)","('NON-ESG', 0.17113997042179108)","('NON-ESG', 0.09391850233078003)"
Line 406,"Addressing Patient Needs and Connection   Along the Journey to Heart Health Edwards strives to ensure all patients have a voice in shaping their treatment   experience, and we recognize that many patients benefit from minimally invasive   procedures.
","('Access_And_Affordability', 0.5207282900810242)","('Employee_Health_And_Safety', 0.1415121853351593)","('Employee_Engagement_Inclusion_And_Diversity', 0.04154612869024277)","(['Health Outcome Contribution'], 0.5207282900810242)","('NON-ESG', 0.1415121853351593)","('NON-ESG', 0.04154612869024277)"
Line 407,"To increase access to minimally invasive procedures, Edwards drives   innovation in TAVR.
","('Employee_Health_And_Safety', 0.734308123588562)","('Access_And_Affordability', 0.054262496531009674)","('Employee_Engagement_Inclusion_And_Diversity', 0.0423295795917511)","(['Operational Eco-Efficiency'], 0.734308123588562)","('NON-ESG', 0.054262496531009674)","('NON-ESG', 0.0423295795917511)"
Line 408,"TAVR allows physicians to replace heart valves with a catheter   instead of surgically opening the chest.
","('Employee_Health_And_Safety', 0.20381537079811096)","('Access_And_Affordability', 0.16885928809642792)","('Critical_Incident_Risk_Management', 0.10582750290632248)","('NON-ESG', 0.20381537079811096)","('NON-ESG', 0.16885928809642792)","('NON-ESG', 0.10582750290632248)"
Line 409,"To learn more about patient experiences   with Edwards’ heart valves, browse our collection of patient stories.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Our Edwards PatientConnect program extends our support for patients beyond   their TAVR procedure, empowering them through information, resources and   opportunities to participate in peer support, educational programs and advocacy.
","('Access_And_Affordability', 0.5770065188407898)","('Employee_Health_And_Safety', 0.1493222862482071)","('Product_Quality_And_Safety', 0.03155909851193428)","(['Health Outcome Contribution'], 0.5770065188407898)","('NON-ESG', 0.1493222862482071)","('NON-ESG', 0.03155909851193428)"
Line 410,"By cultivating a community of patients who want to stay informed and to share   their experience with others, together we are improving the lives of people living   with heart valve disease.
","('Access_And_Affordability', 0.3131940960884094)","('Employee_Health_And_Safety', 0.26325923204421997)","('Critical_Incident_Risk_Management', 0.06575798243284225)","('NON-ESG', 0.3131940960884094)","('NON-ESG', 0.26325923204421997)","('NON-ESG', 0.06575798243284225)"
Line 411,"Patient Resources After the launch of Edwards’ newly created Patient Support Center (PSC) in 2020,   we saw the need for this patient resource continually increase.
","('Access_And_Affordability', 0.8270460963249207)","('Critical_Incident_Risk_Management', 0.022913023829460144)","('Employee_Health_And_Safety', 0.021360067650675774)","(['Health Outcome Contribution'], 0.8270460963249207)","('NON-ESG', 0.022913023829460144)","('NON-ESG', 0.021360067650675774)"
Line 412,"The PSC is a dedicated  resource for patients or their care partners who have questions related to Edwards’  products or services.
","('Product_Design_And_Lifecycle_Management', 0.7148982882499695)","('Customer_Welfare', 0.08128586411476135)","('Selling_Practices_And_Product_Labeling', 0.05328142270445824)","(['Product Stewardship'], 0.7148982882499695)","('NON-ESG', 0.08128586411476135)","('NON-ESG', 0.05328142270445824)"
Line 413,"We continue to focus on raising patient awareness and ensuring patients have the   resources and access to the therapies they need.
","('Access_And_Affordability', 0.9058770537376404)","('Product_Quality_And_Safety', 0.010380682535469532)","('Human_Rights_And_Community_Relations', 0.008328938856720924)","(['Health Outcome Contribution'], 0.9058770537376404)","('NON-ESG', 0.010380682535469532)","('NON-ESG', 0.008328938856720924)"
Line 414,"To read more about our educational  initiatives for better care and our work to improve access, please see our Annual   Performance in the Access to Healthcare section of this report.
","('Access_And_Affordability', 0.9274953007698059)","('Product_Quality_And_Safety', 0.00810939259827137)","('Human_Rights_And_Community_Relations', 0.00557464174926281)","(['Health Outcome Contribution'], 0.9274953007698059)","('NON-ESG', 0.00810939259827137)","('NON-ESG', 0.00557464174926281)"
Line 415,"Edwards.com offers information on heart valve disease and treatment, as well as   FAQs and a glossary of terminology.
","('Employee_Health_And_Safety', 0.46490755677223206)","('Product_Quality_And_Safety', 0.09459283947944641)","('Access_And_Affordability', 0.05805349722504616)","('NON-ESG', 0.46490755677223206)","('NON-ESG', 0.09459283947944641)","('NON-ESG', 0.05805349722504616)"
Line 416,"Additionally, our Reach for the Heart disease   awareness website, along with NewHeartValve and YourTissueValve websites   provide comprehensive information on aortic stenosis and options for treatment.
","('Employee_Health_And_Safety', 0.3306085169315338)","('Product_Quality_And_Safety', 0.10687478631734848)","('Customer_Welfare', 0.05974173545837402)","('NON-ESG', 0.3306085169315338)","('NON-ESG', 0.10687478631734848)","('NON-ESG', 0.05974173545837402)"
Line 417,"Edwards places a priority on gathering patient insights across the total product   lifecycle, so we invest in patient preference studies among various patient groups   to determine the benefit-risk trade-offs for new therapies.
","('Product_Design_And_Lifecycle_Management', 0.8209243416786194)","('Customer_Welfare', 0.054018303751945496)","('Selling_Practices_And_Product_Labeling', 0.019363468512892723)","(['Product Stewardship'], 0.8209243416786194)","('NON-ESG', 0.054018303751945496)","('NON-ESG', 0.019363468512892723)"
Line 418,"Using qualitative and   quantitative methods, Edwards ensures the patient voice is heard from development   to commercialization of new technologies.
","('Competitive_Behavior', 0.3187396824359894)","('Customer_Welfare', 0.10628216713666916)","('Management_Of_Legal_And_Regulatory_Framework', 0.08749659359455109)","('NON-ESG', 0.3187396824359894)","('NON-ESG', 0.10628216713666916)","('NON-ESG', 0.08749659359455109)"
Line 419,"Patient Voice in Product Design and Development Edwards works to incorporate patients’ input into every stage of our product   development.
","('Product_Design_And_Lifecycle_Management', 0.9493746757507324)","('Customer_Welfare', 0.008387207053601742)","('Product_Quality_And_Safety', 0.005272085312753916)","(['Product Stewardship'], 0.9493746757507324)","('NON-ESG', 0.008387207053601742)","('NON-ESG', 0.005272085312753916)"
Line 420,"By listening to patients and capturing their input through both   qualitative and quantitative methods, we can provide care that meets individual   needs and preferences.
","('Access_And_Affordability', 0.6434180736541748)","('Human_Rights_And_Community_Relations', 0.044345490634441376)","('Customer_Welfare', 0.04381891340017319)","(['Health Outcome Contribution'], 0.6434180736541748)","('NON-ESG', 0.044345490634441376)","('NON-ESG', 0.04381891340017319)"
Line 421,"From early-stage product design to early feasibility studies   and clinical trials, integrating patient input makes our products more effective.
","('Product_Design_And_Lifecycle_Management', 0.913637638092041)","('Customer_Welfare', 0.02016599103808403)","('Selling_Practices_And_Product_Labeling', 0.012999719940125942)","(['Product Stewardship'], 0.913637638092041)","('NON-ESG', 0.02016599103808403)","('NON-ESG', 0.012999719940125942)"
Line 422,"This aligns with our Aspiration to ensure that our therapies are addressing the needs    of patients through an increasingly collaborative patient engagement process,   and that we will also continue to evolve how patient input is integrated into   product development.
","('Product_Design_And_Lifecycle_Management', 0.7779005169868469)","('Customer_Welfare', 0.07997684180736542)","('Selling_Practices_And_Product_Labeling', 0.023718351498246193)","(['Product Stewardship'], 0.7779005169868469)","('NON-ESG', 0.07997684180736542)","('NON-ESG', 0.023718351498246193)"
Line 423,"We look to continue developing quantitative data to evaluate the relative   importance and value of products through the eyes of the patient community.
","('Product_Design_And_Lifecycle_Management', 0.9459080696105957)","('Selling_Practices_And_Product_Labeling', 0.008496111258864403)","('Customer_Welfare', 0.007737583480775356)","(['Product Stewardship'], 0.9459080696105957)","('NON-ESG', 0.008496111258864403)","('NON-ESG', 0.007737583480775356)"
Line 424,"We are the first medical device company to develop and publicly publish these kinds   of studies, leading the charge in improving the patient experience.
","('Access_And_Affordability', 0.1893790066242218)","('Customer_Welfare', 0.13872337341308594)","('Product_Design_And_Lifecycle_Management', 0.08242443203926086)","('NON-ESG', 0.1893790066242218)","('NON-ESG', 0.13872337341308594)","('NON-ESG', 0.08242443203926086)"
Line 425,"Some of our most   recent work studied patient preferences when choosing between aortic stenosis   (AS) treatments, taking into account the risk-benefit analysis that is done when   choosing between two types of valve replacements.
","('Employee_Health_And_Safety', 0.42351260781288147)","('Product_Quality_And_Safety', 0.09533517062664032)","('Customer_Welfare', 0.07318165153265)","('NON-ESG', 0.42351260781288147)","('NON-ESG', 0.09533517062664032)","('NON-ESG', 0.07318165153265)"
Line 426,"The study focused on the patient   experience and how patients weigh the decision on what valve replacement to   pursue, which informs Edwards’ future product development approach.
","('Product_Design_And_Lifecycle_Management', 0.8792279958724976)","('Customer_Welfare', 0.028141893446445465)","('Product_Quality_And_Safety', 0.020016048103570938)","(['Product Stewardship'], 0.8792279958724976)","('NON-ESG', 0.028141893446445465)","('NON-ESG', 0.020016048103570938)"
Line 427,"In 2021, we  broadened our approach globally, studying AS patient preferences in Australia and   Japan to incorporate patient perspectives into market access decisions.
","('Access_And_Affordability', 0.6307036280632019)","('Customer_Welfare', 0.05747878551483154)","('Human_Rights_And_Community_Relations', 0.034069932997226715)","(['Health Outcome Contribution'], 0.6307036280632019)","('NON-ESG', 0.05747878551483154)","('NON-ESG', 0.034069932997226715)"
Line 428,"We also   completed a study aimed to quantify patients’ preferences for benefits and risks   associated with treating degenerative mitral regurgitation via open heart surgical   repair versus a beating-heart surgical approach.
","('Employee_Health_And_Safety', 0.5477782487869263)","('Employee_Engagement_Inclusion_And_Diversity', 0.06208232790231705)","('Access_And_Affordability', 0.0596451461315155)","(['Operational Eco-Efficiency'], 0.5477782487869263)","('NON-ESG', 0.06208232790231705)","('NON-ESG', 0.0596451461315155)"
Line 429,"1   Mack M, Leon M, Thourani R, et al.
","('Management_Of_Legal_And_Regulatory_Framework', 0.20789268612861633)","('Ecological_Impacts', 0.16181403398513794)","('Competitive_Behavior', 0.15524286031723022)","('NON-ESG', 0.20789268612861633)","('NON-ESG', 0.16181403398513794)","('NON-ESG', 0.15524286031723022)"
Line 430,"Transcatheter aortic-valve replacement with a balloon-expandable valve in low- risk patients.
","('Employee_Health_And_Safety', 0.3417338728904724)","('Access_And_Affordability', 0.30653369426727295)","('Product_Quality_And_Safety', 0.04308375343680382)","('NON-ESG', 0.3417338728904724)","('NON-ESG', 0.30653369426727295)","('NON-ESG', 0.04308375343680382)"
Line 431,"N Engl J Med 2019;380:1695-705.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2842995226383209)","('Competitive_Behavior', 0.10552384704351425)","('Ecological_Impacts', 0.07911736518144608)","('NON-ESG', 0.2842995226383209)","('NON-ESG', 0.10552384704351425)","('NON-ESG', 0.07911736518144608)"
Line 432,"2   Wood, D.A.; Lauck, S.B.; Cairns, J.A. et al.
","('Ecological_Impacts', 0.33768120408058167)","('Management_Of_Legal_And_Regulatory_Framework', 0.14898958802223206)","('GHG_Emissions', 0.0834137499332428)","('NON-ESG', 0.33768120408058167)","('NON-ESG', 0.14898958802223206)","('NON-ESG', 0.0834137499332428)"
Line 433,"The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical  Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-volume Transfemoral Transcatheter  Aortic Valve Replacement Centers: The 3M TAVI Study.
","('Employee_Health_And_Safety', 0.43385615944862366)","('Access_And_Affordability', 0.16276825964450836)","('Product_Quality_And_Safety', 0.05861783027648926)","('NON-ESG', 0.43385615944862366)","('NON-ESG', 0.16276825964450836)","('NON-ESG', 0.05861783027648926)"
Line 434,"J Am Coll Cardiol Intv.
","('Management_Of_Legal_And_Regulatory_Framework', 0.34055086970329285)","('Business_Ethics', 0.11374849081039429)","('Competitive_Behavior', 0.08071008324623108)","('NON-ESG', 0.34055086970329285)","('NON-ESG', 0.11374849081039429)","('NON-ESG', 0.08071008324623108)"
Line 435,"2019With TAVR as a treatment option to treat progressive AS disease,   we believe the current paradigm needs a deeper lookEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Annual Performance   As Edwards continues to grow our business and expand across the globe, we consider it a  top priority to maintain a consistent patient-focused culture.
","('Access_And_Affordability', 0.3865393102169037)","('Customer_Welfare', 0.092877596616745)","('Product_Quality_And_Safety', 0.07424398511648178)","('NON-ESG', 0.3865393102169037)","('NON-ESG', 0.092877596616745)","('NON-ESG', 0.07424398511648178)"
Line 436,"We recognize that patient  engagement provides a powerful sense of purpose in our work for many of Edwards’   employees, and we continue to prioritize facilitating connections between patients,   caregivers and our employees.
","('Access_And_Affordability', 0.5660602450370789)","('Human_Rights_And_Community_Relations', 0.09308221936225891)","('Employee_Health_And_Safety', 0.08147179335355759)","(['Health Outcome Contribution'], 0.5660602450370789)","('NON-ESG', 0.09308221936225891)","('NON-ESG', 0.08147179335355759)"
Line 437,"Patient Support Center The Patient Support Center (PSC) was created to provide compassionate, responsive  support that contributes to a consistent, positive experience with the company.
","('Access_And_Affordability', 0.823432207107544)","('Employee_Health_And_Safety', 0.0356757789850235)","('Human_Rights_And_Community_Relations', 0.016364015638828278)","(['Health Outcome Contribution'], 0.823432207107544)","('NON-ESG', 0.0356757789850235)","('NON-ESG', 0.016364015638828278)"
Line 438,"During 2021 as awareness of the PSC grew, inquiries more than doubled compared   to the prior year, with growth in particular in questions about post-procedure topics.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8007111549377441)","('Business_Ethics', 0.03595145791769028)","('Human_Rights_And_Community_Relations', 0.023047156631946564)","(['Corporate Governance'], 0.8007111549377441)","('NON-ESG', 0.03595145791769028)","('NON-ESG', 0.023047156631946564)"
Line 439,"Those inquiring are directed to their physicians for any questions that relate to medical  advice.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5944381952285767)","('Selling_Practices_And_Product_Labeling', 0.04972546547651291)","('Business_Ethics', 0.04114169254899025)","(['Corporate Governance'], 0.5944381952285767)","('NON-ESG', 0.04972546547651291)","('NON-ESG', 0.04114169254899025)"
Line 440,"In 2021, the PSC also began supporting patient inquiries about Edwards’   clinical trials.
","('Competitive_Behavior', 0.18485163152217865)","('Customer_Welfare', 0.11803710460662842)","('Management_Of_Legal_And_Regulatory_Framework', 0.10366982221603394)","('NON-ESG', 0.18485163152217865)","('NON-ESG', 0.11803710460662842)","('NON-ESG', 0.10366982221603394)"
Line 441,"The PSC continued providing an early signal of patient interest and activity for “hot”  topics.
","('Access_And_Affordability', 0.3340055048465729)","('Management_Of_Legal_And_Regulatory_Framework', 0.1646500825881958)","('Competitive_Behavior', 0.06405168771743774)","('NON-ESG', 0.3340055048465729)","('NON-ESG', 0.1646500825881958)","('NON-ESG', 0.06405168771743774)"
Line 442,"For example, when COVID-19 vaccines were approved, we quickly learned that  patients had questions about vaccinations and their heart valves.
","('Employee_Health_And_Safety', 0.30339372158050537)","('Product_Quality_And_Safety', 0.12303077429533005)","('Selling_Practices_And_Product_Labeling', 0.08872723579406738)","('NON-ESG', 0.30339372158050537)","('NON-ESG', 0.12303077429533005)","('NON-ESG', 0.08872723579406738)"
Line 443,"Patient Engagement and Events As a result of COVID-19, we converted our 2020 Patient Experience event to a global,   virtual model in 2021, allowing employees to safely engage with patients through live   videoconferencing.
","('Access_And_Affordability', 0.4976087808609009)","('Customer_Welfare', 0.05602440983057022)","('Human_Rights_And_Community_Relations', 0.048514269292354584)","('NON-ESG', 0.4976087808609009)","('NON-ESG', 0.05602440983057022)","('NON-ESG', 0.048514269292354584)"
Line 444,"While the experiences were different than our in-person Patient   Experience events, the virtual format allowed for more employees to participate, resulting  in more employees hearing patient stories and nearly doubling year-over-year employee  exposure to patients.
","('Access_And_Affordability', 0.2382889837026596)","('Employee_Engagement_Inclusion_And_Diversity', 0.15733957290649414)","('Employee_Health_And_Safety', 0.13127560913562775)","('NON-ESG', 0.2382889837026596)","('NON-ESG', 0.15733957290649414)","('NON-ESG', 0.13127560913562775)"
Line 445,"As part of this inspired pivot, in 2021 we launched a new hybrid patient listening session  framework and hosted six sessions reaching 2,000+ employees.
","('Access_And_Affordability', 0.4926622807979584)","('Management_Of_Legal_And_Regulatory_Framework', 0.07308785617351532)","('Energy_Management', 0.057012900710105896)","('NON-ESG', 0.4926622807979584)","('NON-ESG', 0.07308785617351532)","('NON-ESG', 0.057012900710105896)"
Line 446,"This increased our   employee engagement with patients by 29 percent and allowed us to learn directly from  patients about their journeys with structural heart disease, and better guide a number of  our internal workstreams and efforts to improve patient access, experience and outcomes.
","('Access_And_Affordability', 0.6216326355934143)","('Employee_Health_And_Safety', 0.07098150253295898)","('Product_Quality_And_Safety', 0.04563230276107788)","(['Health Outcome Contribution'], 0.6216326355934143)","('NON-ESG', 0.07098150253295898)","('NON-ESG', 0.04563230276107788)"
Line 447,"In May 2022, we were pleased to be able to host The Patient Experience (TPE) in person at  our global headquarters in Irvine, Calif.
","('Access_And_Affordability', 0.4612346291542053)","('Customer_Welfare', 0.05807843059301376)","('Product_Quality_And_Safety', 0.050536684691905975)","('NON-ESG', 0.4612346291542053)","('NON-ESG', 0.05807843059301376)","('NON-ESG', 0.050536684691905975)"
Line 448,"– the first live event of this type since 2019.
","('Business_Model_Resilience', 0.140351340174675)","('Competitive_Behavior', 0.12407724559307098)","('Management_Of_Legal_And_Regulatory_Framework', 0.08738332241773605)","('NON-ESG', 0.140351340174675)","('NON-ESG', 0.12407724559307098)","('NON-ESG', 0.08738332241773605)"
Line 449,"True to our Credo of creating a community unified in improving the lives of patients all  around the world, TPE has become an important way for us to hear from those who are   directly impacted by our therapies.
","('Access_And_Affordability', 0.873181164264679)","('Human_Rights_And_Community_Relations', 0.017056701704859734)","('Employee_Health_And_Safety', 0.01268964633345604)","(['Health Outcome Contribution'], 0.873181164264679)","('NON-ESG', 0.017056701704859734)","('NON-ESG', 0.01268964633345604)"
Line 450,"During TPE, we learn valuable insights from this   community of patients and caregivers – lessons that ultimately impact what we do at   Edwards, every day.
","('Access_And_Affordability', 0.800622820854187)","('Human_Rights_And_Community_Relations', 0.05308796465396881)","('Employee_Health_And_Safety', 0.016376584768295288)","(['Health Outcome Contribution'], 0.800622820854187)","('NON-ESG', 0.05308796465396881)","('NON-ESG', 0.016376584768295288)"
Line 451,"In early 2022, we returned to our in-person model that was   especially unique because this group of patients included many who were scheduled   to attend in 2020.
","('Access_And_Affordability', 0.5703352093696594)","('Employee_Engagement_Inclusion_And_Diversity', 0.1081409826874733)","('Customer_Welfare', 0.042498182505369186)","(['Health Outcome Contribution'], 0.5703352093696594)","('NON-ESG', 0.1081409826874733)","('NON-ESG', 0.042498182505369186)"
Line 452,"More than 80 patients, care partners and guests attended from   around the U.S. and Canada.
","('Access_And_Affordability', 0.2926189601421356)","('Employee_Health_And_Safety', 0.15720434486865997)","('Customer_Welfare', 0.0649305060505867)","('NON-ESG', 0.2926189601421356)","('NON-ESG', 0.15720434486865997)","('NON-ESG', 0.0649305060505867)"
Line 453,"Elevating Partnerships Focused on Patient Voice Throughout 2021, we were challenged to find new, creative ways to continue our work   in amplifying patient voices in what was largely a virtual engagement environment.
","('Access_And_Affordability', 0.32874977588653564)","('Human_Rights_And_Community_Relations', 0.26882147789001465)","('Employee_Engagement_Inclusion_And_Diversity', 0.1023019477725029)","('NON-ESG', 0.32874977588653564)","('NON-ESG', 0.26882147789001465)","('NON-ESG', 0.1023019477725029)"
Line 454,"To maximize impact, we focused on our established partnerships as an area of opportunity  to increase impact.
","('Access_And_Affordability', 0.3998579978942871)","('Human_Rights_And_Community_Relations', 0.15267866849899292)","('Business_Model_Resilience', 0.05897302180528641)","('NON-ESG', 0.3998579978942871)","('NON-ESG', 0.15267866849899292)","('NON-ESG', 0.05897302180528641)"
Line 455,"The pandemic continued to provide unique opportunities to grow these  partnerships and reach even more patients, including:  •  Through financial support from Edwards, Mended Hearts trained more peer-support  ambassadors to provide support to heart valve patients online and virtually, expanding  their ability to reach more patients than prior years (typically, ambassadors connected  with other patients in the hospital or over the phone)  •  With a grant from Edwards, Heart Valve Voice US, the Global Heart Hub and scores of  patient organizations continued working to reach patients through social and earned  media to educate them on the risks of avoiding heart disease care in the pandemic  •  Patient organizations supported through Edwards Foundation grants voiced their   support for public policies to allow for increased patient access to telehealth services  EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT May 2022, Edwards Lifesciences welcomed 80 visitors, including patients,   their care partners and guests to our Irvine, Calif.
","('Access_And_Affordability', 0.47772344946861267)","('Critical_Incident_Risk_Management', 0.11997592449188232)","('Product_Quality_And_Safety', 0.04501727223396301)","('NON-ESG', 0.47772344946861267)","('NON-ESG', 0.11997592449188232)","('NON-ESG', 0.04501727223396301)"
Line 456,"The pandemic continued to provide unique opportunities to grow these  partnerships and reach even more patients, including:  •  Through financial support from Edwards, Mended Hearts trained more peer-support  ambassadors to provide support to heart valve patients online and virtually, expanding  their ability to reach more patients than prior years (typically, ambassadors connected  with other patients in the hospital or over the phone)  •  With a grant from Edwards, Heart Valve Voice US, the Global Heart Hub and scores of  patient organizations continued working to reach patients through social and earned  media to educate them on the risks of avoiding heart disease care in the pandemic  •  Patient organizations supported through Edwards Foundation grants voiced their   support for public policies to allow for increased patient access to telehealth services  EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT May 2022, Edwards Lifesciences welcomed 80 visitors, including patients,   their care partners and guests to our Irvine, Calif.
","('Access_And_Affordability', 0.8120391368865967)","('Employee_Health_And_Safety', 0.02397451177239418)","('Product_Quality_And_Safety', 0.02082689478993416)","(['Health Outcome Contribution'], 0.8120391368865967)","('NON-ESG', 0.02397451177239418)","('NON-ESG', 0.02082689478993416)"
Line 457,"The pandemic continued to provide unique opportunities to grow these  partnerships and reach even more patients, including:  •  Through financial support from Edwards, Mended Hearts trained more peer-support  ambassadors to provide support to heart valve patients online and virtually, expanding  their ability to reach more patients than prior years (typically, ambassadors connected  with other patients in the hospital or over the phone)  •  With a grant from Edwards, Heart Valve Voice US, the Global Heart Hub and scores of  patient organizations continued working to reach patients through social and earned  media to educate them on the risks of avoiding heart disease care in the pandemic  •  Patient organizations supported through Edwards Foundation grants voiced their   support for public policies to allow for increased patient access to telehealth services  EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT May 2022, Edwards Lifesciences welcomed 80 visitors, including patients,   their care partners and guests to our Irvine, Calif.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3332289755344391)","('Business_Model_Resilience', 0.08906655013561249)","('GHG_Emissions', 0.06487469375133514)","('NON-ESG', 0.3332289755344391)","('NON-ESG', 0.08906655013561249)","('NON-ESG', 0.06487469375133514)"
Line 458,"corporate headquarters   to get an insiders’ look into our more than 60-year history, meet the teams   who made their heart valves and share their inspirational journeys with   our employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.38274526596069336)","('Human_Rights_And_Community_Relations', 0.16798588633537292)","('Business_Model_Resilience', 0.08477573841810226)","('NON-ESG', 0.38274526596069336)","('NON-ESG', 0.16798588633537292)","('NON-ESG', 0.08477573841810226)"
Line 459,"Sarah Sue, a 20-year-old Ohio State University student who attends school   on a volleyball scholarship, was among them.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6730465888977051)","('Access_And_Affordability', 0.04303053393959999)","('Employee_Health_And_Safety', 0.029217079281806946)","(['Human Capital Development'], 0.6730465888977051)","('NON-ESG', 0.04303053393959999)","('NON-ESG', 0.029217079281806946)"
Line 460,"She and her parents, Mike and   Carole, spent an emotional two days getting to know the company behind the  heart valve technology that has forever changed their daughter’s life.
","('Product_Design_And_Lifecycle_Management', 0.23271244764328003)","('Employee_Engagement_Inclusion_And_Diversity', 0.12897570431232452)","('Employee_Health_And_Safety', 0.12667226791381836)","('NON-ESG', 0.23271244764328003)","('NON-ESG', 0.12897570431232452)","('NON-ESG', 0.12667226791381836)"
Line 461,"Sarah Sue is a congenital heart patient who had her first open-heart surgery   soon after birth.
","('Employee_Health_And_Safety', 0.3241850733757019)","('Employee_Engagement_Inclusion_And_Diversity', 0.1663016676902771)","('Access_And_Affordability', 0.09890348464250565)","('NON-ESG', 0.3241850733757019)","('NON-ESG', 0.1663016676902771)","('NON-ESG', 0.09890348464250565)"
Line 462,"She had to have subsequent surgeries, and, in December  2020, she made the decision to have her pulmonary valve replaced in order to  HIGHLIGHT STORY Transforming Lives, One Patient at a Time   continue playing volleyball.
","('Employee_Health_And_Safety', 0.5575994849205017)","('Access_And_Affordability', 0.10188177973031998)","('Employee_Engagement_Inclusion_And_Diversity', 0.06378336250782013)","(['Operational Eco-Efficiency'], 0.5575994849205017)","('NON-ESG', 0.10188177973031998)","('NON-ESG', 0.06378336250782013)"
Line 463,"The transcatheter heart valve therapy had her   back on the court just a few weeks after surgery, playing the game she loves.
","('Employee_Health_And_Safety', 0.4560409486293793)","('Access_And_Affordability', 0.10806666314601898)","('Employee_Engagement_Inclusion_And_Diversity', 0.06828229129314423)","('NON-ESG', 0.4560409486293793)","('NON-ESG', 0.10806666314601898)","('NON-ESG', 0.06828229129314423)"
Line 464,"Now, every time she steps onto the volleyball court, she thanks her new   heart valve, which she affectionately calls Valerie.
","('Employee_Health_And_Safety', 0.22795090079307556)","('Employee_Engagement_Inclusion_And_Diversity', 0.12109559029340744)","('Product_Design_And_Lifecycle_Management', 0.0681169331073761)","('NON-ESG', 0.22795090079307556)","('NON-ESG', 0.12109559029340744)","('NON-ESG', 0.0681169331073761)"
Line 465,"Sarah Sue has become   a patient advocate through her collaboration with the AHA and is able to   bring hope to other families by sharing her journey.
","('Access_And_Affordability', 0.6853413581848145)","('Human_Rights_And_Community_Relations', 0.09352926164865494)","('Employee_Health_And_Safety', 0.041163716465234756)","(['Health Outcome Contribution'], 0.6853413581848145)","('NON-ESG', 0.09352926164865494)","('NON-ESG', 0.041163716465234756)"
Line 466,"with hybrid  events   Employee-to-patient  engagement up   29%  EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Edwards Lifesciences is a leader in patient-focused innovations for structural heart   disease and critical care technologies.
","('Access_And_Affordability', 0.30819740891456604)","('Product_Design_And_Lifecycle_Management', 0.14952777326107025)","('Customer_Welfare', 0.09701132774353027)","('NON-ESG', 0.30819740891456604)","('NON-ESG', 0.14952777326107025)","('NON-ESG', 0.09701132774353027)"
Line 467,"The products section of our 2021 Sustainability   Report contains our management approach and annual performance for the following   material topics:  •  Product Safety & Quality  •  Supply Chain Management  •  Product Design & Innovation Product Safety & Quality Edwards Lifesciences’ work to maintain product safety and quality supports our   aspiration of excelling as a trusted partner through distinguished quality and integrity.
","('Product_Quality_And_Safety', 0.7093763947486877)","('Product_Design_And_Lifecycle_Management', 0.16060812771320343)","('Employee_Health_And_Safety', 0.017144201323390007)","(['Product Quality & Recall Management'], 0.7093763947486877)","('NON-ESG', 0.16060812771320343)","('NON-ESG', 0.017144201323390007)"
Line 468,"Creating safe, quality products is the foundation of both our business success, our   culture, and our purpose.
","('Product_Design_And_Lifecycle_Management', 0.9371135234832764)","('Product_Quality_And_Safety', 0.017266293987631798)","('Selling_Practices_And_Product_Labeling', 0.005740093998610973)","(['Product Stewardship'], 0.9371135234832764)","('NON-ESG', 0.017266293987631798)","('NON-ESG', 0.005740093998610973)"
Line 469,"Our reputation rests on delivering innovative, trustworthy   products that save patient lives.
","('Product_Design_And_Lifecycle_Management', 0.9283002018928528)","('Product_Quality_And_Safety', 0.009804531931877136)","('Customer_Welfare', 0.008506834506988525)","(['Product Stewardship'], 0.9283002018928528)","('NON-ESG', 0.009804531931877136)","('NON-ESG', 0.008506834506988525)"
Line 470,"Definition   Monitoring, managing and reducing negative health and safety impacts of Edwards’   products.
","('Product_Quality_And_Safety', 0.4202065169811249)","('Product_Design_And_Lifecycle_Management', 0.3989451825618744)","('Employee_Health_And_Safety', 0.05082213506102562)","('NON-ESG', 0.4202065169811249)","('NON-ESG', 0.3989451825618744)","('NON-ESG', 0.05082213506102562)"
Line 471,"Maintenance of product quality and ensuring Edwards’ products are free   from any deficiencies or defects.
","('Product_Quality_And_Safety', 0.4280828535556793)","('Product_Design_And_Lifecycle_Management', 0.41998299956321716)","('Selling_Practices_And_Product_Labeling', 0.026586024090647697)","('NON-ESG', 0.4280828535556793)","('NON-ESG', 0.41998299956321716)","('NON-ESG', 0.026586024090647697)"
Line 472,"Products Management Approach   Our products are the essence of our business and enable patients to enjoy long   and healthy lives.
","('Product_Design_And_Lifecycle_Management', 0.9496468901634216)","('Selling_Practices_And_Product_Labeling', 0.007402440533041954)","('Product_Quality_And_Safety', 0.006605762988328934)","(['Product Stewardship'], 0.9496468901634216)","('NON-ESG', 0.007402440533041954)","('NON-ESG', 0.006605762988328934)"
Line 473,"In order to remain a trusted partner to patients and healthcare   professionals, we are committed to maintaining the high quality of our products.
","('Product_Design_And_Lifecycle_Management', 0.9484390020370483)","('Product_Quality_And_Safety', 0.009745847433805466)","('Selling_Practices_And_Product_Labeling', 0.006828141398727894)","(['Product Stewardship'], 0.9484390020370483)","('NON-ESG', 0.009745847433805466)","('NON-ESG', 0.006828141398727894)"
Line 474,"Employees are trained on product safety as part of our Quality Management   System through LearningPath Learning Management Systems or in-person classes.
","('Product_Quality_And_Safety', 0.8620205521583557)","('Employee_Health_And_Safety', 0.04072839394211769)","('Product_Design_And_Lifecycle_Management', 0.015474355779588223)","(['Product Quality & Recall Management'], 0.8620205521583557)","('NON-ESG', 0.04072839394211769)","('NON-ESG', 0.015474355779588223)"
Line 475,"The duration of the training is dependent on each employee’s role and how much   impact they have over product safety.
","('Product_Quality_And_Safety', 0.9079511761665344)","('Employee_Health_And_Safety', 0.01664639078080654)","('Product_Design_And_Lifecycle_Management', 0.01129890140146017)","(['Product Quality & Recall Management'], 0.9079511761665344)","('NON-ESG', 0.01664639078080654)","('NON-ESG', 0.01129890140146017)"
Line 476,"Employees receive annual training and recertification based on potential risk of  the process on product or patient safety associated with their role.
","('Product_Quality_And_Safety', 0.9185250401496887)","('Employee_Health_And_Safety', 0.012916136533021927)","('Product_Design_And_Lifecycle_Management', 0.00956069864332676)","(['Product Quality & Recall Management'], 0.9185250401496887)","('NON-ESG', 0.012916136533021927)","('NON-ESG', 0.00956069864332676)"
Line 477,"We also require  re-training based on different trigger events such as training or document content  change, prolonged absence from executing the task or process, and process or   product non-conformance that requires employee training.
","('Product_Quality_And_Safety', 0.3072430193424225)","('Employee_Health_And_Safety', 0.16397865116596222)","('Employee_Engagement_Inclusion_And_Diversity', 0.09798964112997055)","('NON-ESG', 0.3072430193424225)","('NON-ESG', 0.16397865116596222)","('NON-ESG', 0.09798964112997055)"
Line 478,"Edwards communicates our quality and safety standards to suppliers through the  specifications and requirements in every purchase order as well as in our Supplier  Quality Agreements.
","('Product_Quality_And_Safety', 0.8964530825614929)","('Employee_Health_And_Safety', 0.014136256650090218)","('Product_Design_And_Lifecycle_Management', 0.012442860752344131)","(['Product Quality & Recall Management'], 0.8964530825614929)","('NON-ESG', 0.014136256650090218)","('NON-ESG', 0.012442860752344131)"
Line 479,"To learn more about how we manage product safety and quality    in our value chain, please visit the Supply Chain Management section.
","('Product_Design_And_Lifecycle_Management', 0.6492910385131836)","('Supply_Chain_Management', 0.12150748819112778)","('Product_Quality_And_Safety', 0.08361195772886276)","(['Product Stewardship'], 0.6492910385131836)","('NON-ESG', 0.12150748819112778)","('NON-ESG', 0.08361195772886276)"
Line 480,"The Governance Map  on the next page illustrates our management structure   for product quality and safety.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Governance Map  Regulatory Compliance for Quality As a medical technology company, Edwards must comply with strict regulation   requirements regarding the design, development, manufacture and distribution of   our products and services.
","('Product_Quality_And_Safety', 0.8722026944160461)","('Product_Design_And_Lifecycle_Management', 0.04326840490102768)","('Selling_Practices_And_Product_Labeling', 0.012705041095614433)","(['Product Quality & Recall Management'], 0.8722026944160461)","('NON-ESG', 0.04326840490102768)","('NON-ESG', 0.012705041095614433)"
Line 481,"These include U.S. FDA regulations as well as those set by   international regulatory bodies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9204449653625488)","('Competitive_Behavior', 0.011070347391068935)","('Product_Quality_And_Safety', 0.008430796675384045)","(['Corporate Governance'], 0.9204449653625488)","('NON-ESG', 0.011070347391068935)","('NON-ESG', 0.008430796675384045)"
Line 482,"We undergo frequent audits by these agencies to c   onfirm compliance with all applicable standards and regulations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8270983695983887)","('Business_Ethics', 0.06014501303434372)","('Product_Quality_And_Safety', 0.031784240156412125)","(['Corporate Governance'], 0.8270983695983887)","('NON-ESG', 0.06014501303434372)","('NON-ESG', 0.031784240156412125)"
Line 483,"We have established a companywide Quality System defined in our Edwards Lifesciences  Quality Manual.
","('Product_Quality_And_Safety', 0.36184191703796387)","('Business_Ethics', 0.18039719760417938)","('Systemic_Risk_Management', 0.08147057145833969)","('NON-ESG', 0.36184191703796387)","('NON-ESG', 0.18039719760417938)","('NON-ESG', 0.08147057145833969)"
Line 484,"Edwards’ products and services satisfy customer requirements while  complying with regulatory requirements in every country where Edwards sells products.
","('Product_Design_And_Lifecycle_Management', 0.4595070481300354)","('Product_Quality_And_Safety', 0.20987427234649658)","('Selling_Practices_And_Product_Labeling', 0.116885244846344)","('NON-ESG', 0.4595070481300354)","('NON-ESG', 0.20987427234649658)","('NON-ESG', 0.116885244846344)"
Line 485,"The regulatory requirements we adhere to include, but are not limited to:  •  ISO 13485 Medical Devices – Quality Management Systems –   Requirements for Regulatory Purposes*  •  ISO 14971 Application of Risk Management to Medical Devices  •  U.S. Food, Drug and Cosmetic Act:    • 21 CFR part 11 – Electronic Records; Electronic Signatures    •  21 CFR part 820 – Quality System Regulations  •  (EU) 2017/745, European Medical Device Regulationsclick to view •  Canadian Medical Device Regulations (CMDR)  •  Medical Device Single Audit Program (MDSAP)  •  Japan Pharmaceutical Affairs Law (JPAL)  •  Australian Therapeutic Goods Act 1989 and associated regulations  •  Brazilian Good Manufacturing Practices (RDC ANVISA 16/2013)  •  China Regulations on Supervision and Administration of Medical Devices    (Decree No. 739) Our Quality System enables us to meet regulatory requirements as applicable.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8176736235618591)","('Product_Quality_And_Safety', 0.05317789316177368)","('Business_Ethics', 0.028696760535240173)","(['Corporate Governance'], 0.8176736235618591)","('NON-ESG', 0.05317789316177368)","('NON-ESG', 0.028696760535240173)"
Line 486,"The regulatory requirements we adhere to include, but are not limited to:  •  ISO 13485 Medical Devices – Quality Management Systems –   Requirements for Regulatory Purposes*  •  ISO 14971 Application of Risk Management to Medical Devices  •  U.S. Food, Drug and Cosmetic Act:    • 21 CFR part 11 – Electronic Records; Electronic Signatures    •  21 CFR part 820 – Quality System Regulations  •  (EU) 2017/745, European Medical Device Regulationsclick to view •  Canadian Medical Device Regulations (CMDR)  •  Medical Device Single Audit Program (MDSAP)  •  Japan Pharmaceutical Affairs Law (JPAL)  •  Australian Therapeutic Goods Act 1989 and associated regulations  •  Brazilian Good Manufacturing Practices (RDC ANVISA 16/2013)  •  China Regulations on Supervision and Administration of Medical Devices    (Decree No. 739) Our Quality System enables us to meet regulatory requirements as applicable.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5748720765113831)","('Product_Quality_And_Safety', 0.14890910685062408)","('Business_Ethics', 0.05856885015964508)","(['Corporate Governance'], 0.5748720765113831)","('NON-ESG', 0.14890910685062408)","('NON-ESG', 0.05856885015964508)"
Line 487,"*For manufacturers of medical devices, ISO 13485 is a widely accepted model for   demonstrating compliance to worldwide laws and regulations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8004289269447327)","('Product_Quality_And_Safety', 0.061702337116003036)","('Business_Ethics', 0.0158956628292799)","(['Corporate Governance'], 0.8004289269447327)","('NON-ESG', 0.061702337116003036)","('NON-ESG', 0.0158956628292799)"
Line 488,"The ISO standard meets   the comprehensive requirements for a Quality Management System and ensures a   consistent output.
","('Product_Quality_And_Safety', 0.34898167848587036)","('Management_Of_Legal_And_Regulatory_Framework', 0.21453095972537994)","('Supply_Chain_Management', 0.04428813233971596)","('NON-ESG', 0.34898167848587036)","('NON-ESG', 0.21453095972537994)","('NON-ESG', 0.04428813233971596)"
Line 489,"The Edwards Lifesciences LLC ISO 13485 Certification includes the   design, development, production and distribution of:  •  Biological Surgical Heart Valves and Accessories (Delivery System and Inflation   Device, Handles, Sizers, Trays, Suture Fastener, Heart Support Device)  •  Transcatheter Heart Valve Systems (Biological Heart Valves, Delivery Systems,   Balloon Catheters) and Accessories (Access Devices, Inflation Devices and Crimpers)  •  Transcatheter Valve Repairs and Replacement Systems (Implants, Delivery System) and   Accessories (Insertion Accessories, Loading System, Dilator Kit, Stabilizer, incl.
","('Employee_Health_And_Safety', 0.2960909307003021)","('Product_Design_And_Lifecycle_Management', 0.1405429095029831)","('Access_And_Affordability', 0.10155537724494934)","('NON-ESG', 0.2960909307003021)","('NON-ESG', 0.1405429095029831)","('NON-ESG', 0.10155537724494934)"
Line 490,"The Edwards Lifesciences LLC ISO 13485 Certification includes the   design, development, production and distribution of:  •  Biological Surgical Heart Valves and Accessories (Delivery System and Inflation   Device, Handles, Sizers, Trays, Suture Fastener, Heart Support Device)  •  Transcatheter Heart Valve Systems (Biological Heart Valves, Delivery Systems,   Balloon Catheters) and Accessories (Access Devices, Inflation Devices and Crimpers)  •  Transcatheter Valve Repairs and Replacement Systems (Implants, Delivery System) and   Accessories (Insertion Accessories, Loading System, Dilator Kit, Stabilizer, incl.
","('Product_Design_And_Lifecycle_Management', 0.6495075821876526)","('Employee_Health_And_Safety', 0.062229711562395096)","('Supply_Chain_Management', 0.040789324790239334)","(['Product Stewardship'], 0.6495075821876526)","('NON-ESG', 0.062229711562395096)","('NON-ESG', 0.040789324790239334)"
Line 491,"Base Plate)  •  Annuloplasty Rings and Accessories (Handles, Sizers, and Trays)  •    Biological Pericardial Patches for the Area of Heart Valve Replacement, Repair   and Reconstruction  •  Catheters, Cannula and Occlusion Devices and Accessories (Introducers Sheaths,   Percutaneous Insertion Kits)  •  Hemodynamic Monitoring Equipment and Disposables; Medical Devices used for   the Diagnosis of Coronary Artery Disease; Medical Devices used in the Diagnosis   and Treatment of Peripheral Vascular Disease; and Medical Devices for the   Treatment of Diseases of the Heart and the Central Circulatory System Internal Quality Controls Please review the strategy execution section of our Product Safety & Quality   governance map for information on internal quality controls.
","('Employee_Health_And_Safety', 0.5794921517372131)","('Access_And_Affordability', 0.08027584105730057)","('Critical_Incident_Risk_Management', 0.05279459431767464)","(['Operational Eco-Efficiency'], 0.5794921517372131)","('NON-ESG', 0.08027584105730057)","('NON-ESG', 0.05279459431767464)"
Line 492,"Base Plate)  •  Annuloplasty Rings and Accessories (Handles, Sizers, and Trays)  •    Biological Pericardial Patches for the Area of Heart Valve Replacement, Repair   and Reconstruction  •  Catheters, Cannula and Occlusion Devices and Accessories (Introducers Sheaths,   Percutaneous Insertion Kits)  •  Hemodynamic Monitoring Equipment and Disposables; Medical Devices used for   the Diagnosis of Coronary Artery Disease; Medical Devices used in the Diagnosis   and Treatment of Peripheral Vascular Disease; and Medical Devices for the   Treatment of Diseases of the Heart and the Central Circulatory System Internal Quality Controls Please review the strategy execution section of our Product Safety & Quality   governance map for information on internal quality controls.
","('Product_Quality_And_Safety', 0.9183598160743713)","('Business_Ethics', 0.010770401917397976)","('Employee_Health_And_Safety', 0.008332482539117336)","(['Product Quality & Recall Management'], 0.9183598160743713)","('NON-ESG', 0.010770401917397976)","('NON-ESG', 0.008332482539117336)"
Line 493,"Our Global Product Complaint Handling System collects, analyzes and manages   customer feedback regarding Edwards’ products.
","('Product_Quality_And_Safety', 0.3820596933364868)","('Product_Design_And_Lifecycle_Management', 0.3509973883628845)","('Selling_Practices_And_Product_Labeling', 0.0738821029663086)","('NON-ESG', 0.3820596933364868)","('NON-ESG', 0.3509973883628845)","('NON-ESG', 0.0738821029663086)"
Line 494,"We educate all Edwards employees   regarding their reporting responsibilities, and we require every individual to report   complaints no more than 48 hours after receipt.
","('Business_Ethics', 0.4215446710586548)","('Labor_Practices', 0.2016393393278122)","('Employee_Health_And_Safety', 0.06023690104484558)","('NON-ESG', 0.4215446710586548)","('NON-ESG', 0.2016393393278122)","('NON-ESG', 0.06023690104484558)"
Line 495,"We assess all feedback with the aim   of continually improving our products to meet customer and patient needs.Corporate Governance Environmental Health & Safety Ethics & Compliance Product Safety & QualityFoundationSupply  Chain Management Human Capital  ManagementEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Manufacturing Execution System Edwards has additional quality system and manufacturing initiatives to streamline and  improve our product manufacturing processes.
","('Product_Quality_And_Safety', 0.8417184352874756)","('Product_Design_And_Lifecycle_Management', 0.06299666315317154)","('Employee_Health_And_Safety', 0.015000244602560997)","(['Product Quality & Recall Management'], 0.8417184352874756)","('NON-ESG', 0.06299666315317154)","('NON-ESG', 0.015000244602560997)"
Line 496,"Our Edwards Production System aims to  reduce waste, inventory and cycle times while improving quality, efficiency and overall  product performance.
","('Product_Design_And_Lifecycle_Management', 0.8927608728408813)","('Waste_And_Hazardous_Materials_Management', 0.03540145978331566)","('Product_Quality_And_Safety', 0.008755333721637726)","(['Product Stewardship'], 0.8927608728408813)","('NON-ESG', 0.03540145978331566)","('NON-ESG', 0.008755333721637726)"
Line 497,"This includes key initiatives to our Quality and Global Supply Chain  programs including Smart Factory and Next Gen Quality.
","('Supply_Chain_Management', 0.9488977193832397)","('Product_Design_And_Lifecycle_Management', 0.005331698805093765)","('Labor_Practices', 0.0038335511926561594)","(['Supply Chain Management'], 0.9488977193832397)","('NON-ESG', 0.005331698805093765)","('NON-ESG', 0.0038335511926561594)"
Line 498,"These are deployed in each of   our business units and operation sites that implement a proactive quality focus through  device performance and process controls, with an aspiration of achieving 6 Sigma   productivity.
","('Business_Model_Resilience', 0.4117542803287506)","('Supply_Chain_Management', 0.14856833219528198)","('Systemic_Risk_Management', 0.13120876252651215)","('NON-ESG', 0.4117542803287506)","('NON-ESG', 0.14856833219528198)","('NON-ESG', 0.13120876252651215)"
Line 499,"These programs help increase compliance at our facilities and prepare us   for external audits.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8316053748130798)","('Business_Ethics', 0.09732502698898315)","('Product_Quality_And_Safety', 0.00790482759475708)","(['Corporate Governance'], 0.8316053748130798)","('NON-ESG', 0.09732502698898315)","('NON-ESG', 0.00790482759475708)"
Line 500,"Managing Product Recalls Our Quality System focuses on the implementation of strong design and development  work in our manufacturing processes.
","('Product_Design_And_Lifecycle_Management', 0.9655327200889587)","('Product_Quality_And_Safety', 0.004946823697537184)","('Customer_Welfare', 0.002678793855011463)","(['Product Stewardship'], 0.9655327200889587)","('NON-ESG', 0.004946823697537184)","('NON-ESG', 0.002678793855011463)"
Line 501,"Please refer to our governance map for information  on how Edwards uses feedback mechanisms and conducts corrective actions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9486165642738342)","('Director_Removal', 0.0064940801821649075)","('Business_Ethics', 0.005716264713555574)","(['Corporate Governance'], 0.9486165642738342)","('NON-ESG', 0.0064940801821649075)","('NON-ESG', 0.005716264713555574)"
Line 502,"If we determine a field corrective action is necessary, the Vice President of Quality for the  impacted unit is responsible for promptly executing this action to remediate all affected  products appropriately.
","('Product_Design_And_Lifecycle_Management', 0.4066050946712494)","('Product_Quality_And_Safety', 0.30917954444885254)","('Selling_Practices_And_Product_Labeling', 0.04589662700891495)","('NON-ESG', 0.4066050946712494)","('NON-ESG', 0.30917954444885254)","('NON-ESG', 0.04589662700891495)"
Line 503,"In addition, we have systems in place for necessary actions to   correct and prevent the recurrence of the issue.
","('Systemic_Risk_Management', 0.5429165959358215)","('Management_Of_Legal_And_Regulatory_Framework', 0.07699208706617355)","('Physical_Impacts_Of_Climate_Change', 0.06721875816583633)","(['Risk & Crisis Management'], 0.5429165959358215)","('NON-ESG', 0.07699208706617355)","('NON-ESG', 0.06721875816583633)"
Line 504,"Edwards is committed to resolving any recall issues by following regulations of the   markets/countries impacted and using our expertise in quality management to   implement required actions.
","('Employee_Health_And_Safety', 0.3376830220222473)","('Product_Quality_And_Safety', 0.22389604151248932)","('Critical_Incident_Risk_Management', 0.07793338596820831)","('NON-ESG', 0.3376830220222473)","('NON-ESG', 0.22389604151248932)","('NON-ESG', 0.07793338596820831)"
Line 505,"We have a target to achieve no significant disruption of   product availability, which aligns with UN SDG 3: Good Health and Well-Being.
","('Product_Design_And_Lifecycle_Management', 0.8173317909240723)","('Product_Quality_And_Safety', 0.04628708213567734)","('Customer_Welfare', 0.03690298646688461)","(['Product Stewardship'], 0.8173317909240723)","('NON-ESG', 0.04628708213567734)","('NON-ESG', 0.03690298646688461)"
Line 506,"In the U.S., the FDA categorizes recalls into three classes:  •  Class I: Reasonable probability that the use of the product will cause severe   adverse health consequences or death  •  Class II: Use of the product may cause temporary or medically reversible   adverse health consequences  •  Class III: Use of the product is not likely to cause adverse health consequencesWithin the European Union (EU), manufacturers must submit a field safety notice   to inform the National Competent Authorities of any action taken to reduce risk of   death or serious deterioration in health associated with the use of a medical device   already on the market.
","('Product_Quality_And_Safety', 0.8226129412651062)","('Employee_Health_And_Safety', 0.07255366444587708)","('Selling_Practices_And_Product_Labeling', 0.015355736948549747)","(['Product Quality & Recall Management'], 0.8226129412651062)","('NON-ESG', 0.07255366444587708)","('NON-ESG', 0.015355736948549747)"
Line 507,"In the U.S., the FDA categorizes recalls into three classes:  •  Class I: Reasonable probability that the use of the product will cause severe   adverse health consequences or death  •  Class II: Use of the product may cause temporary or medically reversible   adverse health consequences  •  Class III: Use of the product is not likely to cause adverse health consequencesWithin the European Union (EU), manufacturers must submit a field safety notice   to inform the National Competent Authorities of any action taken to reduce risk of   death or serious deterioration in health associated with the use of a medical device   already on the market.
","('Employee_Health_And_Safety', 0.9719275832176208)","('Critical_Incident_Risk_Management', 0.003361497074365616)","('Product_Design_And_Lifecycle_Management', 0.0023710220120847225)","(['Operational Eco-Efficiency'], 0.9719275832176208)","('NON-ESG', 0.003361497074365616)","('NON-ESG', 0.0023710220120847225)"
Line 508,"A team of Edwards engineers handles requests for information from customers   regarding product quality and safety.
","('Product_Quality_And_Safety', 0.8750439286231995)","('Product_Design_And_Lifecycle_Management', 0.03631070256233215)","('Selling_Practices_And_Product_Labeling', 0.01690633036196232)","(['Product Quality & Recall Management'], 0.8750439286231995)","('NON-ESG', 0.03631070256233215)","('NON-ESG', 0.01690633036196232)"
Line 509,"The Vice President of Product Safety or regional  delegates conduct customer visits to monitor product performance and to track   customer and patient satisfaction.
","('Product_Quality_And_Safety', 0.8706427216529846)","('Product_Design_And_Lifecycle_Management', 0.0266497191041708)","('Selling_Practices_And_Product_Labeling', 0.020947488024830818)","(['Product Quality & Recall Management'], 0.8706427216529846)","('NON-ESG', 0.0266497191041708)","('NON-ESG', 0.020947488024830818)"
Line 510,"Managing Clinical Research Edwards is committed to following all ethical considerations and regulatory   requirements while conducting clinical research.
","('Business_Ethics', 0.5334253311157227)","('Management_Of_Legal_And_Regulatory_Framework', 0.24283237755298615)","('Competitive_Behavior', 0.07916855812072754)","(['Business Ethics'], 0.5334253311157227)","('NON-ESG', 0.24283237755298615)","('NON-ESG', 0.07916855812072754)"
Line 511,"We carry out our research,   including the use of any outsourced third-party vendor, in accordance with the   recommendations guiding physicians in biomedical research involving human   subjects adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964,   and all subsequent updates.
","('Access_And_Affordability', 0.19496461749076843)","('Customer_Welfare', 0.12362870573997498)","('Employee_Engagement_Inclusion_And_Diversity', 0.11083716154098511)","('NON-ESG', 0.19496461749076843)","('NON-ESG', 0.12362870573997498)","('NON-ESG', 0.11083716154098511)"
Line 512,"We conduct research in accordance with Good Clinical   Practice and applicable regulatory requirements to ensure patient safety.
","('Product_Quality_And_Safety', 0.8693653345108032)","('Employee_Health_And_Safety', 0.018745940178632736)","('Customer_Welfare', 0.012091699987649918)","(['Product Quality & Recall Management'], 0.8693653345108032)","('NON-ESG', 0.018745940178632736)","('NON-ESG', 0.012091699987649918)"
Line 513,"Examples   of such regulations include, but are not limited to:  United States of America:   •  21 CFR: Part 50 (Protection of Human Subjects), Part 803 (Medical Device   Reporting), Part 812 (Investigational Device Exemptions), Part 814   (Premarket Approval of Medical Devices), Part 822 (Post Market Surveillance)   • ICH E6 – Good Clinical Practice  European Union:   •  ISO 14155 Clinical Investigation of Medical Devices for Human Subjects –   Good Clinical Practice   •  (EU) 2017/745, European Medical Device Regulations MDD 93/42/EEC   •  MEDDEV 2.7.1 revision 4 Clinical Investigations: Serious Adverse Event   Reporting under Directives 90/385/EEC and 93/42/EEC  Japan:   • Japan Pharmaceutical Law (JPAL) Medical Device Ordinances  China:   • National Medical Products Administration (NMPA)EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Annual Performance   Edwards Lifesciences’ performance highlights our relentless focus on managing and   improving our quality control systems.
","('Competitive_Behavior', 0.21773377060890198)","('Product_Quality_And_Safety', 0.18055865168571472)","('Management_Of_Legal_And_Regulatory_Framework', 0.11311832070350647)","('NON-ESG', 0.21773377060890198)","('NON-ESG', 0.18055865168571472)","('NON-ESG', 0.11311832070350647)"
Line 514,"Examples   of such regulations include, but are not limited to:  United States of America:   •  21 CFR: Part 50 (Protection of Human Subjects), Part 803 (Medical Device   Reporting), Part 812 (Investigational Device Exemptions), Part 814   (Premarket Approval of Medical Devices), Part 822 (Post Market Surveillance)   • ICH E6 – Good Clinical Practice  European Union:   •  ISO 14155 Clinical Investigation of Medical Devices for Human Subjects –   Good Clinical Practice   •  (EU) 2017/745, European Medical Device Regulations MDD 93/42/EEC   •  MEDDEV 2.7.1 revision 4 Clinical Investigations: Serious Adverse Event   Reporting under Directives 90/385/EEC and 93/42/EEC  Japan:   • Japan Pharmaceutical Law (JPAL) Medical Device Ordinances  China:   • National Medical Products Administration (NMPA)EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Annual Performance   Edwards Lifesciences’ performance highlights our relentless focus on managing and   improving our quality control systems.
","('Product_Quality_And_Safety', 0.5936527252197266)","('Business_Ethics', 0.1233324259519577)","('Competitive_Behavior', 0.036419935524463654)","(['Product Quality & Recall Management'], 0.5936527252197266)","('NON-ESG', 0.1233324259519577)","('NON-ESG', 0.036419935524463654)"
Line 515,"Our target is to drive continuous improvement   efforts to eliminate patient safety-related Class I product removals.
","('Product_Quality_And_Safety', 0.8380425572395325)","('Product_Design_And_Lifecycle_Management', 0.0383819043636322)","('Selling_Practices_And_Product_Labeling', 0.03206013888120651)","(['Product Quality & Recall Management'], 0.8380425572395325)","('NON-ESG', 0.0383819043636322)","('NON-ESG', 0.03206013888120651)"
Line 516,"This target aligns   to UN SDG 3: Good Health & Well-Being.
","('Access_And_Affordability', 0.4568932354450226)","('Employee_Health_And_Safety', 0.17113997042179108)","('Human_Rights_And_Community_Relations', 0.09391850233078003)","('NON-ESG', 0.4568932354450226)","('NON-ESG', 0.17113997042179108)","('NON-ESG', 0.09391850233078003)"
Line 517,"Improving Patient Safety through Device Tracking In 2013, the U.S. FDA established a Unique Device Identification (UDI) system that   enables more comprehensive tracking of medical devices.
","('Product_Quality_And_Safety', 0.7248666882514954)","('Employee_Health_And_Safety', 0.13768988847732544)","('Product_Design_And_Lifecycle_Management', 0.02046212926506996)","(['Product Quality & Recall Management'], 0.7248666882514954)","('NON-ESG', 0.13768988847732544)","('NON-ESG', 0.02046212926506996)"
Line 518,"UDI system implementation   will continue according to established compliance dates based primarily on device   classification.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9195743203163147)","('Business_Ethics', 0.014277255162596703)","('Product_Quality_And_Safety', 0.009198987856507301)","(['Corporate Governance'], 0.9195743203163147)","('NON-ESG', 0.014277255162596703)","('NON-ESG', 0.009198987856507301)"
Line 519,"Using UDI numbers reduces the chance of patient misidentification of   products.
","('Product_Design_And_Lifecycle_Management', 0.35987311601638794)","('Product_Quality_And_Safety', 0.22114968299865723)","('Selling_Practices_And_Product_Labeling', 0.11236301064491272)","('NON-ESG', 0.35987311601638794)","('NON-ESG', 0.22114968299865723)","('NON-ESG', 0.11236301064491272)"
Line 520,"Next Generation Quality  In 2021, Edwards launched the Next Gen Quality program, which will strategically   transform our quality system to support growth and drive scalability, adapt quickly to the  changing regulatory landscape, and deliver innovative technologies with unparalleled  quality and speed.
","('Systemic_Risk_Management', 0.3179173767566681)","('Management_Of_Legal_And_Regulatory_Framework', 0.22669489681720734)","('Business_Ethics', 0.09039265662431717)","('NON-ESG', 0.3179173767566681)","('NON-ESG', 0.22669489681720734)","('NON-ESG', 0.09039265662431717)"
Line 521,"Next Gen Quality focuses on several processes including: streamlining    design control processes to be fit for purpose; improving new material qualification  through the use of automation and standardization; optimizing incoming components   inspection process; and simplifying our internal regulatory approval process.
","('Product_Quality_And_Safety', 0.4518607556819916)","('Management_Of_Legal_And_Regulatory_Framework', 0.18674366176128387)","('Product_Design_And_Lifecycle_Management', 0.10248610377311707)","('NON-ESG', 0.4518607556819916)","('NON-ESG', 0.18674366176128387)","('NON-ESG', 0.10248610377311707)"
Line 522,"Throughout 2021 and in 2022, Edwards has made significant progress in advancing our  Next Gen Quality objectives.
","('Business_Model_Resilience', 0.22100967168807983)","('Product_Design_And_Lifecycle_Management', 0.1650076061487198)","('Product_Quality_And_Safety', 0.1414220631122589)","('NON-ESG', 0.22100967168807983)","('NON-ESG', 0.1650076061487198)","('NON-ESG', 0.1414220631122589)"
Line 523,"We standardized roles and responsibilities; made procedural  updates to simplify product development workflows; and improved the quality training  curriculum and certification standards.
","('Product_Quality_And_Safety', 0.621136486530304)","('Access_And_Affordability', 0.059623271226882935)","('Product_Design_And_Lifecycle_Management', 0.05523037537932396)","(['Product Quality & Recall Management'], 0.621136486530304)","('NON-ESG', 0.059623271226882935)","('NON-ESG', 0.05523037537932396)"
Line 524,"Our Quality Labs focused on automating systems   to shorten the timeline for approval while adopting new industry standards.
","('Management_Of_Legal_And_Regulatory_Framework', 0.43569299578666687)","('Product_Quality_And_Safety', 0.21033969521522522)","('Systemic_Risk_Management', 0.05344492569565773)","('NON-ESG', 0.43569299578666687)","('NON-ESG', 0.21033969521522522)","('NON-ESG', 0.05344492569565773)"
Line 525,"Quality   control inspection process improvements were made across many of our manufacturing  sites, utilizing risk management, Critical Control Point methodology, and automated data  capture technology.
","('Business_Ethics', 0.47042930126190186)","('Systemic_Risk_Management', 0.18657061457633972)","('Product_Quality_And_Safety', 0.10654400289058685)","('NON-ESG', 0.47042930126190186)","('NON-ESG', 0.18657061457633972)","('NON-ESG', 0.10654400289058685)"
Line 526,"With a strong culture of quality, all Edwards employees are empowered  to challenge our systems, identify opportunities, and prioritize continuous improvement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8301455974578857)","('Employee_Health_And_Safety', 0.02524913288652897)","('Business_Ethics', 0.015317440032958984)","(['Human Capital Development'], 0.8301455974578857)","('NON-ESG', 0.02524913288652897)","('NON-ESG', 0.015317440032958984)"
Line 527,"Our commitment to Edwards’ patient-focused innovation strategy remains top of mind   as we continue to transform our quality system for the future.
","('Access_And_Affordability', 0.2775653898715973)","('Product_Design_And_Lifecycle_Management', 0.1227639764547348)","('Customer_Welfare', 0.08533558994531631)","('NON-ESG', 0.2775653898715973)","('NON-ESG', 0.1227639764547348)","('NON-ESG', 0.08533558994531631)"
Line 528,"Product Recalls In 2021, Edwards did not have any Class I recalls resulting in device retrievals.
","('Product_Quality_And_Safety', 0.5188795328140259)","('Selling_Practices_And_Product_Labeling', 0.20044146478176117)","('Product_Design_And_Lifecycle_Management', 0.058420006185770035)","(['Product Quality & Recall Management'], 0.5188795328140259)","('NON-ESG', 0.20044146478176117)","('NON-ESG', 0.058420006185770035)"
Line 529,"Edwards   provides complete information on recalls through the FDA’s publicly available database    for medical device recalls.Edwards requires all applicable clinical research to have independent Ethics or   Institutional Review Board approval and oversight as well as patient authorization   to participate in research – via a signed patient informed consent form – prior to   initiation of research activities.
","('Product_Quality_And_Safety', 0.33385351300239563)","('Management_Of_Legal_And_Regulatory_Framework', 0.18163828551769257)","('Competitive_Behavior', 0.06978867948055267)","('NON-ESG', 0.33385351300239563)","('NON-ESG', 0.18163828551769257)","('NON-ESG', 0.06978867948055267)"
Line 530,"We employ the routine use of independent Data  Safety Monitoring Boards and Clinical Event Committees in accordance with FDA  Guidance for Clinical Trial Sponsors – Establishment and Operation of Clinical   Trial Data Monitoring Committees.
","('Product_Quality_And_Safety', 0.6144976019859314)","('Competitive_Behavior', 0.06913352012634277)","('Customer_Welfare', 0.04626055434346199)","(['Product Quality & Recall Management'], 0.6144976019859314)","('NON-ESG', 0.06913352012634277)","('NON-ESG', 0.04626055434346199)"
Line 531,"Edwards also follows Section 801 of the FDA   Amendments Act (FDAAA 801 and the Final Rule) for public protocol registration   of clinical trials and subsequent reporting of clinical trial results.
","('Competitive_Behavior', 0.31894493103027344)","('Management_Of_Legal_And_Regulatory_Framework', 0.22167572379112244)","('Product_Quality_And_Safety', 0.05393967777490616)","('NON-ESG', 0.31894493103027344)","('NON-ESG', 0.22167572379112244)","('NON-ESG', 0.05393967777490616)"
Line 532,"There are   multiple ways to report product or research grievances directly to Edwards,   including the Edwards.com contact us webpage.
","('Business_Ethics', 0.32275593280792236)","('Management_Of_Legal_And_Regulatory_Framework', 0.21814243495464325)","('Competitive_Behavior', 0.11986205726861954)","('NON-ESG', 0.32275593280792236)","('NON-ESG', 0.21814243495464325)","('NON-ESG', 0.11986205726861954)"
Line 533,"This page also provides a way   for patients and healthcare providers to find privacy information and request   product information or removal of personal data.
","('Customer_Privacy', 0.9644922018051147)","('Data_Security', 0.006235727574676275)","('Selling_Practices_And_Product_Labeling', 0.0025995024479925632)","(['Privacy Protection'], 0.9644922018051147)","('NON-ESG', 0.006235727574676275)","('NON-ESG', 0.0025995024479925632)"
Line 534,"~2 ,000  Engineers 7Manufacturing   Locations Around   the World Resilient Supply ChainEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT HIGHLIGHT STORY Edwards MITRIS RESILIA Valve Receives   FDA Approval for Mitral Replacement Surgeries This highlight story and referenced news release includes forward-looking statements within   the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the   Securities Exchange Act of 1934, as amended.
","('Business_Model_Resilience', 0.8677181601524353)","('Supply_Chain_Management', 0.02321017161011696)","('Product_Design_And_Lifecycle_Management', 0.01902170479297638)","(['Codes of Business Conduct'], 0.8677181601524353)","('NON-ESG', 0.02321017161011696)","('NON-ESG', 0.01902170479297638)"
Line 535,"These forward-looking statements include, but   are not limited to, statements made by Dr. Accola and Mr. Chopra and statements regarding   expected product benefits, patient outcomes, future plans related to the product lines, objectives  and expectations and other statements that are not historical facts.
","('Selling_Practices_And_Product_Labeling', 0.6166558265686035)","('Product_Design_And_Lifecycle_Management', 0.11518996953964233)","('Customer_Welfare', 0.07077351957559586)","(['Marketing Practices'], 0.6166558265686035)","('NON-ESG', 0.11518996953964233)","('NON-ESG', 0.07077351957559586)"
Line 536,"Forward-looking statements  are based on estimates and assumptions made by management of the company and are believed   to be reasonable, though they are inherently uncertain and difficult to predict.
","('Systemic_Risk_Management', 0.30574849247932434)","('Management_Of_Legal_And_Regulatory_Framework', 0.16095738112926483)","('Competitive_Behavior', 0.1512356549501419)","('NON-ESG', 0.30574849247932434)","('NON-ESG', 0.16095738112926483)","('NON-ESG', 0.1512356549501419)"
Line 537,"Our forward-   looking statements speak only as of the date on which they are made, and we do not undertake   any obligation to update any forward-looking statement to reflect events or circumstances after   the date of the statement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3780578076839447)","('Business_Model_Resilience', 0.12807749211788177)","('Director_Removal', 0.07249177247285843)","('NON-ESG', 0.3780578076839447)","('NON-ESG', 0.12807749211788177)","('NON-ESG', 0.07249177247285843)"
Line 538,"Investors are cautioned not to unduly rely on such forward-looking  statements.Forward-looking statements involve risks and uncertainties that could cause results to differ  materially from those expressed or implied by the forward-looking statements based on a   number of factors as detailed in the company’s filings with the U.S. Securities and Exchange  Commission, including its Annual Report on Form 10-K for the year ended December 31, 2021.
","('Systemic_Risk_Management', 0.8118522763252258)","('Business_Ethics', 0.03754774108529091)","('Competitive_Behavior', 0.02899489551782608)","(['Risk & Crisis Management'], 0.8118522763252258)","('NON-ESG', 0.03754774108529091)","('NON-ESG', 0.02899489551782608)"
Line 539,"These filings, along with important safety information about our products, may be found   at Edwards.com.
","('Product_Quality_And_Safety', 0.8649922013282776)","('Selling_Practices_And_Product_Labeling', 0.0365690179169178)","('Employee_Health_And_Safety', 0.012613648548722267)","(['Product Quality & Recall Management'], 0.8649922013282776)","('NON-ESG', 0.0365690179169178)","('NON-ESG', 0.012613648548722267)"
Line 540,"Edwards, Edwards Lifesciences, the stylized E logo, Carpentier-Edwards, Carpentier-Edwards  PERIMOUNT, MITRIS, MITRIS RESILIA, PERIMOUNT, and RESILIA are trademarks of Edwards   Lifesciences Corporation.
","('Product_Design_And_Lifecycle_Management', 0.16576631367206573)","('Business_Model_Resilience', 0.13429591059684753)","('Competitive_Behavior', 0.09734072536230087)","('NON-ESG', 0.16576631367206573)","('NON-ESG', 0.13429591059684753)","('NON-ESG', 0.09734072536230087)"
Line 541,"All other trademarks are the property of their respective owners.
","('Customer_Privacy', 0.36981719732284546)","('Competitive_Behavior', 0.16144846379756927)","('Business_Ethics', 0.05697965994477272)","('NON-ESG', 0.36981719732284546)","('NON-ESG', 0.16144846379756927)","('NON-ESG', 0.05697965994477272)"
Line 542,"This statement is made on behalf of Edwards Lifesciences Corporation and its subsidiaries.
","('Product_Design_And_Lifecycle_Management', 0.25175511837005615)","('Management_Of_Legal_And_Regulatory_Framework', 0.13271301984786987)","('Business_Model_Resilience', 0.08058653026819229)","('NON-ESG', 0.25175511837005615)","('NON-ESG', 0.13271301984786987)","('NON-ESG', 0.08058653026819229)"
Line 543,"In early 2022, Edwards Lifesciences received approval from the U.S. Food   and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve   replacement specifically designed for the heart’s mitral position.
","('Employee_Health_And_Safety', 0.1591874212026596)","('Customer_Welfare', 0.11123096942901611)","('Product_Quality_And_Safety', 0.09960062801837921)","('NON-ESG', 0.1591874212026596)","('NON-ESG', 0.11123096942901611)","('NON-ESG', 0.09960062801837921)"
Line 544,"This therapy   is the company’s latest innovation offering advanced RESILIA tissue with an   anti-calcification technology that also allows devices to be stored under dry   packaging conditions, facilitating ease of use.
","('Product_Design_And_Lifecycle_Management', 0.7869019508361816)","('Waste_And_Hazardous_Materials_Management', 0.05552689731121063)","('Customer_Welfare', 0.02310577966272831)","(['Product Stewardship'], 0.7869019508361816)","('NON-ESG', 0.05552689731121063)","('NON-ESG', 0.02310577966272831)"
Line 545,"RESILIA tissue is bovine pericardial tissue and serves as the platform for  Edwards’ new class of valves.
","('Employee_Health_And_Safety', 0.2115928679704666)","('Access_And_Affordability', 0.10970745235681534)","('Waste_And_Hazardous_Materials_Management', 0.08240993320941925)","('NON-ESG', 0.2115928679704666)","('NON-ESG', 0.10970745235681534)","('NON-ESG', 0.08240993320941925)"
Line 546,"“For patients who need mitral valve replacement,   the advanced MITRIS RESILIA valve is based on a trusted pericardial valve   platform, designed to mimic the native valve and incorporating tissue with   integrity-preservation technology that will potentially allow the valve to last   longer,” said Kevin Accola, M.D., Cardiovascular Surgeon, AdventHealth   Orlando.Edwards is dedicated to partnering with clinicians to develop patient-  centric innovations for complex surgical structural heart procedures that   improve long-term care and outcomes for patients.
","('Employee_Health_And_Safety', 0.3999975621700287)","('Access_And_Affordability', 0.13742442429065704)","('Critical_Incident_Risk_Management', 0.05763442441821098)","('NON-ESG', 0.3999975621700287)","('NON-ESG', 0.13742442429065704)","('NON-ESG', 0.05763442441821098)"
Line 547,"“For patients who need mitral valve replacement,   the advanced MITRIS RESILIA valve is based on a trusted pericardial valve   platform, designed to mimic the native valve and incorporating tissue with   integrity-preservation technology that will potentially allow the valve to last   longer,” said Kevin Accola, M.D., Cardiovascular Surgeon, AdventHealth   Orlando.Edwards is dedicated to partnering with clinicians to develop patient-  centric innovations for complex surgical structural heart procedures that   improve long-term care and outcomes for patients.
","('Access_And_Affordability', 0.8606346249580383)","('Employee_Health_And_Safety', 0.018279513344168663)","('Human_Rights_And_Community_Relations', 0.014706326648592949)","(['Health Outcome Contribution'], 0.8606346249580383)","('NON-ESG', 0.018279513344168663)","('NON-ESG', 0.014706326648592949)"
Line 548,"The introduction of the   MITRIS RESILIA valve completes the portfolio of surgical heart valve   innovations incorporating the advanced RESILIA tissue, including an aortic   valve, an aortic valved conduit and now a mitral valve.
","('Employee_Health_And_Safety', 0.3835972845554352)","('Access_And_Affordability', 0.08322805166244507)","('Customer_Welfare', 0.054691385477781296)","('NON-ESG', 0.3835972845554352)","('NON-ESG', 0.08322805166244507)","('NON-ESG', 0.054691385477781296)"
Line 549,"Edwards continues   to invest in innovations in the surgical structural heart field.
","('Product_Design_And_Lifecycle_Management', 0.38374024629592896)","('Access_And_Affordability', 0.09576920419931412)","('Customer_Welfare', 0.083639957010746)","('NON-ESG', 0.38374024629592896)","('NON-ESG', 0.09576920419931412)","('NON-ESG', 0.083639957010746)"
Line 550,"In addition to FDA approval, the MITRIS RESILIA valve has also received   regulatory approval in Japan, Canada, and other countries globally.
","('Management_Of_Legal_And_Regulatory_Framework', 0.584341287612915)","('Competitive_Behavior', 0.08987309038639069)","('GHG_Emissions', 0.04820013418793678)","(['Corporate Governance'], 0.584341287612915)","('NON-ESG', 0.08987309038639069)","('NON-ESG', 0.04820013418793678)"
Line 551,"For more information, please see the related press release and product page.
","('Product_Design_And_Lifecycle_Management', 0.5988322496414185)","('Selling_Practices_And_Product_Labeling', 0.21881835162639618)","('Product_Quality_And_Safety', 0.03641842305660248)","(['Product Stewardship'], 0.5988322496414185)","('NON-ESG', 0.21881835162639618)","('NON-ESG', 0.03641842305660248)"
Line 552,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Supply Chain Management Edwards Lifesciences’ supply chain management practices focus on product   lifecycle, design and innovation, and product stewardship, supporting our aspiration   of transforming patient lives with breakthrough medical technologies.
","('Supply_Chain_Management', 0.4381372034549713)","('Product_Design_And_Lifecycle_Management', 0.42627671360969543)","('Business_Model_Resilience', 0.015965742990374565)","('NON-ESG', 0.4381372034549713)","('NON-ESG', 0.42627671360969543)","('NON-ESG', 0.015965742990374565)"
Line 553,"Definition   Monitoring and assessing the product quality, safety, social and environmental   performance of Edwards’ suppliers, and maintaining responsible procurement practices.
","('Product_Design_And_Lifecycle_Management', 0.4594930112361908)","('Product_Quality_And_Safety', 0.40062904357910156)","('Selling_Practices_And_Product_Labeling', 0.0292414128780365)","('NON-ESG', 0.4594930112361908)","('NON-ESG', 0.40062904357910156)","('NON-ESG', 0.0292414128780365)"
Line 554,"Governance Map The governance map illustrates our Supply Chain Management structure.
","('Supply_Chain_Management', 0.9500795006752014)","('Product_Design_And_Lifecycle_Management', 0.005748482421040535)","('Business_Model_Resilience', 0.0038041993975639343)","(['Supply Chain Management'], 0.9500795006752014)","('NON-ESG', 0.005748482421040535)","('NON-ESG', 0.0038041993975639343)"
Line 555,"Corporate Governance Environmental Health & Safety Ethics & Compliance Product Safety & QualityFoundationSupply  Chain Management Human Capital  Managementclick to view Procurement Practices  With more than 300 direct material suppliers for all of our global products, Edwards   is selective when evaluating and adding new suppliers to our portfolio.
","('Product_Design_And_Lifecycle_Management', 0.4511062204837799)","('Product_Quality_And_Safety', 0.33275464177131653)","('Supply_Chain_Management', 0.04944111034274101)","('NON-ESG', 0.4511062204837799)","('NON-ESG', 0.33275464177131653)","('NON-ESG', 0.04944111034274101)"
Line 556,"To limit risk   exposure, we avoid adding new direct materials suppliers, only adding them when there  is a clear business case, such as new technology or new capability or capacity needs.
","('Supply_Chain_Management', 0.9269905090332031)","('Product_Design_And_Lifecycle_Management', 0.010860486887395382)","('Systemic_Risk_Management', 0.005980533082038164)","(['Supply Chain Management'], 0.9269905090332031)","('NON-ESG', 0.010860486887395382)","('NON-ESG', 0.005980533082038164)"
Line 557,"In the few cases where we add suppliers, we follow a rigorous process that includes   extensive due diligence.
","('Supply_Chain_Management', 0.749041736125946)","('Labor_Practices', 0.028599323704838753)","('Management_Of_Legal_And_Regulatory_Framework', 0.023392613977193832)","(['Supply Chain Management'], 0.749041736125946)","('NON-ESG', 0.028599323704838753)","('NON-ESG', 0.023392613977193832)"
Line 558,"As a result, we have designated and prioritized a significant   reduction of our direct materials supplier base over the upcoming years.
","('Supply_Chain_Management', 0.9326979517936707)","('Product_Design_And_Lifecycle_Management', 0.011075279675424099)","('Business_Model_Resilience', 0.004484793171286583)","(['Supply Chain Management'], 0.9326979517936707)","('NON-ESG', 0.011075279675424099)","('NON-ESG', 0.004484793171286583)"
Line 559,"In 2021, Edwards developed a Supplier Code of Conduct that sets forth expectations   for suppliers working with Edwards.
","('Supply_Chain_Management', 0.9370220303535461)","('Labor_Practices', 0.010826540179550648)","('Systemic_Risk_Management', 0.004074482712894678)","(['Supply Chain Management'], 0.9370220303535461)","('NON-ESG', 0.010826540179550648)","('NON-ESG', 0.004074482712894678)"
Line 560,"As a next step, we are working toward supplier   acknowledgement of the requirements of the Code.
","('Supply_Chain_Management', 0.9395104646682739)","('Labor_Practices', 0.008048951625823975)","('Product_Design_And_Lifecycle_Management', 0.004123675171285868)","(['Supply Chain Management'], 0.9395104646682739)","('NON-ESG', 0.008048951625823975)","('NON-ESG', 0.004123675171285868)"
Line 561,"The Code also ties our expectations  to our Credo and the importance of business integrity, in addition to the following:Management Approach Supply Chain Management We create industry-leading therapies for cardiovascular disease through   partnerships with our suppliers.
","('Supply_Chain_Management', 0.9520106911659241)","('Labor_Practices', 0.0037385413888841867)","('Waste_And_Hazardous_Materials_Management', 0.003550521796569228)","(['Supply Chain Management'], 0.9520106911659241)","('NON-ESG', 0.0037385413888841867)","('NON-ESG', 0.003550521796569228)"
Line 562,"We strive to improve our supplier base annually   by ensuring our best suppliers work on our new products, continuing to rationalize   and reduce our supply base and improving performance.
","('Product_Design_And_Lifecycle_Management', 0.5142266154289246)","('Supply_Chain_Management', 0.34844139218330383)","('Customer_Welfare', 0.013711289502680302)","(['Product Stewardship'], 0.5142266154289246)","('NON-ESG', 0.34844139218330383)","('NON-ESG', 0.013711289502680302)"
Line 563,"We know supply chain performance directly impacts innovation and the quality   of our products, so we insist on high product quality and safety at every level.
","('Product_Design_And_Lifecycle_Management', 0.8426663875579834)","('Product_Quality_And_Safety', 0.07784717530012131)","('Selling_Practices_And_Product_Labeling', 0.008004596456885338)","(['Product Stewardship'], 0.8426663875579834)","('NON-ESG', 0.07784717530012131)","('NON-ESG', 0.008004596456885338)"
Line 564,"Our Global Supply Chain and Product Quality departments collaborate with our   key partner suppliers on risk management, improvement action plans and   consistent high product quality.
","('Product_Design_And_Lifecycle_Management', 0.862998902797699)","('Supply_Chain_Management', 0.043775442987680435)","('Product_Quality_And_Safety', 0.020702103152871132)","(['Product Stewardship'], 0.862998902797699)","('NON-ESG', 0.043775442987680435)","('NON-ESG', 0.020702103152871132)"
Line 565,"Our supplier partnerships are essential in   delivering the quality products that drive Edwards’ success.
","('Product_Design_And_Lifecycle_Management', 0.9241744875907898)","('Supply_Chain_Management', 0.015765689313411713)","('Product_Quality_And_Safety', 0.00985325500369072)","(['Product Stewardship'], 0.9241744875907898)","('NON-ESG', 0.015765689313411713)","('NON-ESG', 0.00985325500369072)"
Line 566,"We continuously   strive to improve our procurement practices and expand supplier engagement.
","('Supply_Chain_Management', 0.9344210624694824)","('Product_Design_And_Lifecycle_Management', 0.008899851702153683)","('Business_Model_Resilience', 0.005559498909860849)","(['Supply Chain Management'], 0.9344210624694824)","('NON-ESG', 0.008899851702153683)","('NON-ESG', 0.005559498909860849)"
Line 567,"Edwards’ Supply Chain segmentation has established the top 15 strategic direct   materials suppliers.
","('Supply_Chain_Management', 0.9491614103317261)","('Product_Design_And_Lifecycle_Management', 0.004375896416604519)","('Physical_Impacts_Of_Climate_Change', 0.004062514286488295)","(['Supply Chain Management'], 0.9491614103317261)","('NON-ESG', 0.004375896416604519)","('NON-ESG', 0.004062514286488295)"
Line 568,"Edwards Supply Chain holds an annual Partner Forum to facilitate  sustainability reviews and further alignment, share progress on sustainability targets   and practices, and set expectations for the coming year.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT intellectual property, reducing the chance that sustainability violations will impact   our stakeholders and business.
","('Supply_Chain_Management', 0.8956326246261597)","('Product_Design_And_Lifecycle_Management', 0.030074886977672577)","('Business_Model_Resilience', 0.010477363131940365)","(['Supply Chain Management'], 0.8956326246261597)","('NON-ESG', 0.030074886977672577)","('NON-ESG', 0.010477363131940365)"
Line 569,"Approximately 80 percent of Edwards’ annual spend  comes from lower-risk locations.
","('Systemic_Risk_Management', 0.3995214104652405)","('Supply_Chain_Management', 0.11055947840213776)","('Access_And_Affordability', 0.06484811753034592)","('NON-ESG', 0.3995214104652405)","('NON-ESG', 0.11055947840213776)","('NON-ESG', 0.06484811753034592)"
Line 570,"We assign all suppliers in our system a Risk level by our Quality organization.
","('Supply_Chain_Management', 0.9420695304870605)","('Systemic_Risk_Management', 0.0055792988277971745)","('Waste_And_Hazardous_Materials_Management', 0.0046636066399514675)","(['Supply Chain Management'], 0.9420695304870605)","('NON-ESG', 0.0055792988277971745)","('NON-ESG', 0.0046636066399514675)"
Line 571,"Suppliers are designated either a Risk level 1, 2 or 3 rating.
","('Supply_Chain_Management', 0.9097480773925781)","('Systemic_Risk_Management', 0.01890752650797367)","('Physical_Impacts_Of_Climate_Change', 0.007005432620644569)","(['Supply Chain Management'], 0.9097480773925781)","('NON-ESG', 0.01890752650797367)","('NON-ESG', 0.007005432620644569)"
Line 572,"Risk level 1 represents the  “highest risk” for suppliers that could impact patient safety or product performance.
","('Product_Quality_And_Safety', 0.6541243195533752)","('Product_Design_And_Lifecycle_Management', 0.21180559694766998)","('Employee_Health_And_Safety', 0.017610007897019386)","(['Product Quality & Recall Management'], 0.6541243195533752)","('NON-ESG', 0.21180559694766998)","('NON-ESG', 0.017610007897019386)"
Line 573,"We must classify Risk level 1 suppliers as “Approved” in our Quality System to conduct  any business with them.
","('Supply_Chain_Management', 0.9321349859237671)","('Waste_And_Hazardous_Materials_Management', 0.006393722258508205)","('Systemic_Risk_Management', 0.006383386440575123)","(['Supply Chain Management'], 0.9321349859237671)","('NON-ESG', 0.006393722258508205)","('NON-ESG', 0.006383386440575123)"
Line 574,"We conduct audits in accordance with our quality system requirements.
","('Business_Ethics', 0.40482521057128906)","('Management_Of_Legal_And_Regulatory_Framework', 0.3572068214416504)","('Product_Quality_And_Safety', 0.06706667691469193)","('NON-ESG', 0.40482521057128906)","('NON-ESG', 0.3572068214416504)","('NON-ESG', 0.06706667691469193)"
Line 575,"These audits  target the highest-risk suppliers to assess their quality systems, supporting Edwards’  compliance with applicable regulations for medical device production.
","('Supply_Chain_Management', 0.7741156220436096)","('Product_Design_And_Lifecycle_Management', 0.03589308634400368)","('Product_Quality_And_Safety', 0.033215757459402084)","(['Supply Chain Management'], 0.7741156220436096)","('NON-ESG', 0.03589308634400368)","('NON-ESG', 0.033215757459402084)"
Line 576,"Approval is  granted upon completion of an audit, a corrective action plan and a part qualification  process.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7217088341712952)","('Business_Ethics', 0.1462075263261795)","('Product_Quality_And_Safety', 0.02100486122071743)","(['Corporate Governance'], 0.7217088341712952)","('NON-ESG', 0.1462075263261795)","('NON-ESG', 0.02100486122071743)"
Line 577,"Our established decision tree process considers the potential impact of supplied  materials to patient safety and product performance, assigning the risk level per part  number sourced.
","('Product_Quality_And_Safety', 0.5120066404342651)","('Product_Design_And_Lifecycle_Management', 0.35837534070014954)","('Selling_Practices_And_Product_Labeling', 0.01746792159974575)","(['Product Quality & Recall Management'], 0.5120066404342651)","('NON-ESG', 0.35837534070014954)","('NON-ESG', 0.01746792159974575)"
Line 578,"Additionally, we established similar decision trees for service suppliers  falling within the requirements of our quality management system, to receive   qualification and monitoring.
","('Supply_Chain_Management', 0.8996282815933228)","('Labor_Practices', 0.009949556551873684)","('Product_Design_And_Lifecycle_Management', 0.008564421907067299)","(['Supply Chain Management'], 0.8996282815933228)","('NON-ESG', 0.009949556551873684)","('NON-ESG', 0.008564421907067299)"
Line 579,"Localizing Supply and Distribution Edwards strives to protect both the environment and our bottom line by sourcing   materials as close as possible to our manufacturing sites.
","('Supply_Chain_Management', 0.9408890008926392)","('Product_Design_And_Lifecycle_Management', 0.00847820658236742)","('Water_And_Wastewater_Management', 0.0043282476253807545)","(['Supply Chain Management'], 0.9408890008926392)","('NON-ESG', 0.00847820658236742)","('NON-ESG', 0.0043282476253807545)"
Line 580,"Where feasible, we   strategically align distribution facilities with the global markets we serve, reducing  transportation costs and environmental impacts.
","('Energy_Management', 0.3470411002635956)","('Product_Design_And_Lifecycle_Management', 0.23516835272312164)","('Supply_Chain_Management', 0.16361315548419952)","('NON-ESG', 0.3470411002635956)","('NON-ESG', 0.23516835272312164)","('NON-ESG', 0.16361315548419952)"
Line 581,"Our new target for 2023 is to   reduce product distribution air miles traveled by an additional 1.5 million compared   to our 2018 baseline, to decrease freight and distribution costs.
","('Air_Quality', 0.9581135511398315)","('Energy_Management', 0.00965894665569067)","('Critical_Incident_Risk_Management', 0.002808311954140663)","(['Operational Eco-Efficiency'], 0.9581135511398315)","('NON-ESG', 0.00965894665569067)","('NON-ESG', 0.002808311954140663)"
Line 582,"Supplier Sustainability We have a number of sustainability considerations throughout Edwards’ supply chain:  •  Product Quality – Across all sites, we continue to focus on improved process   capability, yield improvement and scrap reduction, allowing for a smaller amount   of product disposal on an annualized basis.
","('Product_Design_And_Lifecycle_Management', 0.9551770091056824)","('Product_Quality_And_Safety', 0.008121407590806484)","('Supply_Chain_Management', 0.004440721124410629)","(['Product Stewardship'], 0.9551770091056824)","('NON-ESG', 0.008121407590806484)","('NON-ESG', 0.004440721124410629)"
Line 583,"•  Patient Safety and Impact – We upgraded our new product development   process and simplified our Quality System, allowing for continued focus on product   improvement and building quality at the source during product development   and launch.
","('Product_Quality_And_Safety', 0.5575965046882629)","('Product_Design_And_Lifecycle_Management', 0.2921384871006012)","('Selling_Practices_And_Product_Labeling', 0.029938774183392525)","(['Product Quality & Recall Management'], 0.5575965046882629)","('NON-ESG', 0.2921384871006012)","('NON-ESG', 0.029938774183392525)"
Line 584,"•  Labor and employment standards, prohibition of child labor,   human trafficking, and fair working conditions  • Data privacy and confidentiality  • Environmental standards With our global Part Qualification Process, we collaborate with suppliers on product  manufacturability, while improving product quality and cost.
","('Labor_Practices', 0.7487386465072632)","('Product_Quality_And_Safety', 0.05814148858189583)","('Business_Ethics', 0.053842321038246155)","(['Labor Practice Indicators'], 0.7487386465072632)","('NON-ESG', 0.05814148858189583)","('NON-ESG', 0.053842321038246155)"
Line 585,"Our global supplier   capacity framework helps our suppliers plan their capacity for growth.
","('Supply_Chain_Management', 0.9376528263092041)","('Energy_Management', 0.0052572982385754585)","('Physical_Impacts_Of_Climate_Change', 0.004796587862074375)","(['Supply Chain Management'], 0.9376528263092041)","('NON-ESG', 0.0052572982385754585)","('NON-ESG', 0.004796587862074375)"
Line 586,"We also review  sustainability and business continuity planning in Quarterly Business Reviews with   our top strategic and key suppliers to align on key initiatives.
","('Supply_Chain_Management', 0.8424219489097595)","('Product_Design_And_Lifecycle_Management', 0.0557846799492836)","('Business_Model_Resilience', 0.019533969461917877)","(['Supply Chain Management'], 0.8424219489097595)","('NON-ESG', 0.0557846799492836)","('NON-ESG', 0.019533969461917877)"
Line 587,"These processes keep our  strategic and key suppliers engaged and informed on our goals and expectations.
","('Supply_Chain_Management', 0.8972668647766113)","('Product_Design_And_Lifecycle_Management', 0.02604665420949459)","('Business_Model_Resilience', 0.011328062042593956)","(['Supply Chain Management'], 0.8972668647766113)","('NON-ESG', 0.02604665420949459)","('NON-ESG', 0.011328062042593956)"
Line 588,"Assessing and Monitoring Supply Chain Risk Before partnering with any new suppliers, Edwards conducts a comprehensive   supplier evaluation and supplier on-boarding process.
","('Supply_Chain_Management', 0.9433184862136841)","('Labor_Practices', 0.006601477507501841)","('Physical_Impacts_Of_Climate_Change', 0.003799465484917164)","(['Supply Chain Management'], 0.9433184862136841)","('NON-ESG', 0.006601477507501841)","('NON-ESG', 0.003799465484917164)"
Line 589,"Direct materials suppliers also   require on-site assessment of facilities, quality control systems, and Quality System   audits.
","('Supply_Chain_Management', 0.6780884265899658)","('Product_Quality_And_Safety', 0.06731420010328293)","('Waste_And_Hazardous_Materials_Management', 0.03442898020148277)","(['Supply Chain Management'], 0.6780884265899658)","('NON-ESG', 0.06731420010328293)","('NON-ESG', 0.03442898020148277)"
Line 590,"Once Edwards approves a supplier, we periodically conduct follow-up supplier   audits and performance reviews to promote continual adherence to our standards.
","('Supply_Chain_Management', 0.9024532437324524)","('Labor_Practices', 0.01019769161939621)","('Systemic_Risk_Management', 0.009426791220903397)","(['Supply Chain Management'], 0.9024532437324524)","('NON-ESG', 0.01019769161939621)","('NON-ESG', 0.009426791220903397)"
Line 591,"For every new part, the supplier completes a form through which they disclose the   material content of the products.
","('Product_Design_And_Lifecycle_Management', 0.8686246871948242)","('Selling_Practices_And_Product_Labeling', 0.043533045798540115)","('Product_Quality_And_Safety', 0.012981605716049671)","(['Product Stewardship'], 0.8686246871948242)","('NON-ESG', 0.043533045798540115)","('NON-ESG', 0.012981605716049671)"
Line 592,"Edwards also has a global supply risk management and governance process that   includes a global risk assessment process to evaluate potential supply risks on key   components and suppliers.
","('Supply_Chain_Management', 0.9450689554214478)","('Product_Design_And_Lifecycle_Management', 0.0047602783888578415)","('Waste_And_Hazardous_Materials_Management', 0.004751828499138355)","(['Supply Chain Management'], 0.9450689554214478)","('NON-ESG', 0.0047602783888578415)","('NON-ESG', 0.004751828499138355)"
Line 593,"These include risks due to location, material content and  country regulations, as well as sole source risks.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8348363041877747)","('Supply_Chain_Management', 0.016863496974110603)","('Selling_Practices_And_Product_Labeling', 0.013446725904941559)","(['Corporate Governance'], 0.8348363041877747)","('NON-ESG', 0.016863496974110603)","('NON-ESG', 0.013446725904941559)"
Line 594,"We prefer doing business in countries  with higher ethical standards and protections for information technology and  n	North America   n Asia     n Europe    n Latin America/Caribbean9% 72%11%8%Direct Suppliers   by RegionEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT  •  Lean Manufacturing Efforts – We identify manufacturing lines each year for   reconfiguration to determine where and how we can eliminate waste and increase  outputs with the same number of people, reducing environmental impact.
","('Waste_And_Hazardous_Materials_Management', 0.5813718438148499)","('Product_Quality_And_Safety', 0.12923523783683777)","('Business_Ethics', 0.06071579083800316)","(['Operational Eco-Efficiency'], 0.5813718438148499)","('NON-ESG', 0.12923523783683777)","('NON-ESG', 0.06071579083800316)"
Line 595,"•  Product Design & Innovation – We build collaborative, long-term relationships   with strategic and key suppliers who support our vision for innovation and engage  our partner suppliers during the product innovation stage.
","('Product_Design_And_Lifecycle_Management', 0.9544596076011658)","('Supply_Chain_Management', 0.0066407001577317715)","('Customer_Welfare', 0.0042145755141973495)","(['Product Stewardship'], 0.9544596076011658)","('NON-ESG', 0.0066407001577317715)","('NON-ESG', 0.0042145755141973495)"
Line 596,"Because we want our suppliers to be long-term partners, Edwards values suppliers   who exhibit sustainable practices.
","('Supply_Chain_Management', 0.6580588817596436)","('Product_Design_And_Lifecycle_Management', 0.19883154332637787)","('Water_And_Wastewater_Management', 0.011830287054181099)","(['Supply Chain Management'], 0.6580588817596436)","('NON-ESG', 0.19883154332637787)","('NON-ESG', 0.011830287054181099)"
Line 597,"Edwards requires all suppliers to employ ethical and  responsible business practices.
","('Supply_Chain_Management', 0.3999139070510864)","('Business_Ethics', 0.16016267240047455)","('Human_Rights_And_Community_Relations', 0.08608976751565933)","('NON-ESG', 0.3999139070510864)","('NON-ESG', 0.16016267240047455)","('NON-ESG', 0.08608976751565933)"
Line 598,"We adhere to the California Transparency in Supply  Chains Act of 2010 by disclosing our actions to prevent human trafficking and slavery.
","('Business_Ethics', 0.5065529942512512)","('Labor_Practices', 0.15647989511489868)","('Employee_Health_And_Safety', 0.04792869836091995)","(['Business Ethics'], 0.5065529942512512)","('NON-ESG', 0.15647989511489868)","('NON-ESG', 0.04792869836091995)"
Line 599,"Our Responsible Supply Chain Policy outlines our approach and expectations for   suppliers, including:  • Fair labor practices  • Protection of human rights  • Environmental responsibility  • Socially responsible behavior  • Workplace health and safety  • Legal compliance  • Ethical practices Edwards has developed supplier metrics to measure quality levels and other   expectations for each of our preferred suppliers.
","('Supply_Chain_Management', 0.42987969517707825)","('Labor_Practices', 0.3674389123916626)","('Employee_Health_And_Safety', 0.0310367438942194)","('NON-ESG', 0.42987969517707825)","('NON-ESG', 0.3674389123916626)","('NON-ESG', 0.0310367438942194)"
Line 600,"These include:  •  ISO 13485 Certification where applicable  • Minimum scar-free rates  •  Completion of comprehensive quality • Minimum performance on good    audit with no critical findings   delivery and service levels  • Minimum lot acceptance rates We gather supplier metrics through the Due Diligence Questionnaire (DDQ).
","('Supply_Chain_Management', 0.9353146553039551)","('Product_Design_And_Lifecycle_Management', 0.010443496517837048)","('Labor_Practices', 0.005254771560430527)","(['Supply Chain Management'], 0.9353146553039551)","('NON-ESG', 0.010443496517837048)","('NON-ESG', 0.005254771560430527)"
Line 601,"All   Regulated Suppliers and high-spend Non-Regulated Suppliers must undergo an   additional evaluation through the DDQ.
","('Supply_Chain_Management', 0.8404186964035034)","('GHG_Emissions', 0.016736621037125587)","('Water_And_Wastewater_Management', 0.014702100306749344)","(['Supply Chain Management'], 0.8404186964035034)","('NON-ESG', 0.016736621037125587)","('NON-ESG', 0.014702100306749344)"
Line 602,"The DDQ requires suppliers to respond to   questions in four main topic areas: environmental considerations, public disclosures,  employee health & safety, and other topics of concern.
","('Employee_Health_And_Safety', 0.9340488910675049)","('Product_Quality_And_Safety', 0.011188625358045101)","('Product_Design_And_Lifecycle_Management', 0.0069015249609947205)","(['Operational Eco-Efficiency'], 0.9340488910675049)","('NON-ESG', 0.011188625358045101)","('NON-ESG', 0.0069015249609947205)"
Line 603,"We accept or deny suppliers  based on their responses to the DDQ.
","('Supply_Chain_Management', 0.9167309403419495)","('Labor_Practices', 0.008502832613885403)","('Product_Design_And_Lifecycle_Management', 0.006790039129555225)","(['Supply Chain Management'], 0.9167309403419495)","('NON-ESG', 0.008502832613885403)","('NON-ESG', 0.006790039129555225)"
Line 604,"There are four questions in the DDQ that we consider “drop out” criteria.
","('Employee_Engagement_Inclusion_And_Diversity', 0.30065304040908813)","('Business_Ethics', 0.09756460785865784)","('Competitive_Behavior', 0.07807392627000809)","('NON-ESG', 0.30065304040908813)","('NON-ESG', 0.09756460785865784)","('NON-ESG', 0.07807392627000809)"
Line 605,"These   questions must be answered favorably in order for the supplier to be considered an   Edwards supplier partner.
","('Supply_Chain_Management', 0.9307604432106018)","('Labor_Practices', 0.00961764995008707)","('Water_And_Wastewater_Management', 0.004736978095024824)","(['Supply Chain Management'], 0.9307604432106018)","('NON-ESG', 0.00961764995008707)","('NON-ESG', 0.004736978095024824)"
Line 606,"A negative response on these criteria will result in an   automatic “drop out.” These “drop out” minimum criteria are: •  Environment.
","('Business_Ethics', 0.2645334005355835)","('Employee_Engagement_Inclusion_And_Diversity', 0.12165181338787079)","('Systemic_Risk_Management', 0.07883767783641815)","('NON-ESG', 0.2645334005355835)","('NON-ESG', 0.12165181338787079)","('NON-ESG', 0.07883767783641815)"
Line 607,"The supplier must comply with all product-related hazardous   materials and trade regulations, such as WEE, RoHS, REACH, TSCA, BPA, DEHP,   ODS and others.
","('Waste_And_Hazardous_Materials_Management', 0.2622259557247162)","('Product_Quality_And_Safety', 0.2425932139158249)","('Product_Design_And_Lifecycle_Management', 0.22323672473430634)","('NON-ESG', 0.2622259557247162)","('NON-ESG', 0.2425932139158249)","('NON-ESG', 0.22323672473430634)"
Line 608,"•  Employment and Safety.
","('Employee_Health_And_Safety', 0.9602851271629333)","('Employee_Engagement_Inclusion_And_Diversity', 0.008048919029533863)","('Labor_Practices', 0.005729655269533396)","(['Operational Eco-Efficiency'], 0.9602851271629333)","('NON-ESG', 0.008048919029533863)","('NON-ESG', 0.005729655269533396)"
Line 609,"The supplier must comply with all employment laws   and regulations and industry employment practices, as applicable to the countries   in which they operate.
","('Labor_Practices', 0.9051448106765747)","('Management_Of_Legal_And_Regulatory_Framework', 0.017943568527698517)","('Employee_Engagement_Inclusion_And_Diversity', 0.01507591549307108)","(['Labor Practice Indicators'], 0.9051448106765747)","('NON-ESG', 0.017943568527698517)","('NON-ESG', 0.01507591549307108)"
Line 610,"•  Human Rights.
","('Human_Rights_And_Community_Relations', 0.9410151243209839)","('Labor_Practices', 0.006611318327486515)","('Critical_Incident_Risk_Management', 0.0038839257322251797)","(['Community Relations'], 0.9410151243209839)","('NON-ESG', 0.006611318327486515)","('NON-ESG', 0.0038839257322251797)"
Line 611,"Per our Code of Conduct, Edwards respects the human rights of   all workers and does not tolerate any form of human rights or labor abuses in its   supply chain.
","('Labor_Practices', 0.730726957321167)","('Human_Rights_And_Community_Relations', 0.15571022033691406)","('Employee_Health_And_Safety', 0.017546432092785835)","(['Labor Practice Indicators'], 0.730726957321167)","('NON-ESG', 0.15571022033691406)","('NON-ESG', 0.017546432092785835)"
Line 612,"The supplier must comply with the UK Modern Day Slavery regulations,  U.S. Human Trafficking regulations and California (USA) Transparency in Supply  Chains Act.
","('Supply_Chain_Management', 0.9035401940345764)","('Labor_Practices', 0.016550211235880852)","('Systemic_Risk_Management', 0.007693072780966759)","(['Supply Chain Management'], 0.9035401940345764)","('NON-ESG', 0.016550211235880852)","('NON-ESG', 0.007693072780966759)"
Line 613,"•  Child Labor.
","('Labor_Practices', 0.9612607359886169)","('Waste_And_Hazardous_Materials_Management', 0.003697769483551383)","('Human_Rights_And_Community_Relations', 0.003375792410224676)","(['Labor Practice Indicators'], 0.9612607359886169)","('NON-ESG', 0.003697769483551383)","('NON-ESG', 0.003375792410224676)"
Line 614,"The supplier must not employ children under 16 years of age in job   tasks that may have higher safety and health risks than adults.
","('Employee_Health_And_Safety', 0.9770968556404114)","('Critical_Incident_Risk_Management', 0.0023856586776673794)","('Product_Quality_And_Safety', 0.0021825151052325964)","(['Operational Eco-Efficiency'], 0.9770968556404114)","('NON-ESG', 0.0023856586776673794)","('NON-ESG', 0.0021825151052325964)"
Line 615,"Any other DDQ responses that are answered unfavorably will be evaluated on an   individual basis with consideration for overall company reputation and risk.
","('Systemic_Risk_Management', 0.7481173872947693)","('Business_Ethics', 0.10873114317655563)","('Competitive_Behavior', 0.03279967978596687)","(['Risk & Crisis Management'], 0.7481173872947693)","('NON-ESG', 0.10873114317655563)","('NON-ESG', 0.03279967978596687)"
Line 616,"To read more  about the Supplier EHS Assessment approach, please refer to our 2021 EHS Report.
","('Supply_Chain_Management', 0.9220300316810608)","('Energy_Management', 0.009147298522293568)","('Labor_Practices', 0.007420651149004698)","(['Supply Chain Management'], 0.9220300316810608)","('NON-ESG', 0.009147298522293568)","('NON-ESG', 0.007420651149004698)"
Line 617,"Supplier Partnerships for Innovation Edwards builds collaborative, long-term relationships with strategic and key suppliers  who support our vision for innovation and engage our partner suppliers during the   product innovation stage.
","('Product_Design_And_Lifecycle_Management', 0.6647261381149292)","('Supply_Chain_Management', 0.20111486315727234)","('Customer_Welfare', 0.01528199017047882)","(['Product Stewardship'], 0.6647261381149292)","('NON-ESG', 0.20111486315727234)","('NON-ESG', 0.01528199017047882)"
Line 618,"Through our Value Engineering capability, we ask our strategic  and key suppliers to provide insight into the design and manufacturing of new products.
","('Product_Design_And_Lifecycle_Management', 0.9624831080436707)","('Supply_Chain_Management', 0.0043277861550450325)","('Product_Quality_And_Safety', 0.0030315218027681112)","(['Product Stewardship'], 0.9624831080436707)","('NON-ESG', 0.0043277861550450325)","('NON-ESG', 0.0030315218027681112)"
Line 619,"This includes supply chain employees on most research and development product teams  to facilitate supplier selection and early supplier involvement.
","('Supply_Chain_Management', 0.8968021869659424)","('Product_Design_And_Lifecycle_Management', 0.026295172050595284)","('Labor_Practices', 0.006715606898069382)","(['Supply Chain Management'], 0.8968021869659424)","('NON-ESG', 0.026295172050595284)","('NON-ESG', 0.006715606898069382)"
Line 620,"In this way, we enable our  research and development teams to collaborate with suppliers throughout the product  development process.
","('Product_Design_And_Lifecycle_Management', 0.9467954635620117)","('Supply_Chain_Management', 0.007514982018619776)","('Product_Quality_And_Safety', 0.006847593002021313)","(['Product Stewardship'], 0.9467954635620117)","('NON-ESG', 0.007514982018619776)","('NON-ESG', 0.006847593002021313)"
Line 621,"Edwards is a member of the Medical Device Industry Supply Chain council, an   informal network that identifies opportunities to improve the medical devices supply  chain.
","('Supply_Chain_Management', 0.9416734576225281)","('Product_Design_And_Lifecycle_Management', 0.0062199304811656475)","('Waste_And_Hazardous_Materials_Management', 0.0055693211033940315)","(['Supply Chain Management'], 0.9416734576225281)","('NON-ESG', 0.0062199304811656475)","('NON-ESG', 0.0055693211033940315)"
Line 622,"Edwards provides in-depth views of supply chains, sharing strategic and tactical  approaches to address challenges and opportunities, and positively influences the   industry standard for operational efficiency and effectiveness.
","('Supply_Chain_Management', 0.957533597946167)","('Systemic_Risk_Management', 0.0038292703684419394)","('Product_Design_And_Lifecycle_Management', 0.0034755056258291006)","(['Supply Chain Management'], 0.957533597946167)","('NON-ESG', 0.0038292703684419394)","('NON-ESG', 0.0034755056258291006)"
Line 623,"To read more about the  supply chain council, please visit their website.
","('Supply_Chain_Management', 0.938798725605011)","('Product_Design_And_Lifecycle_Management', 0.005794635973870754)","('Physical_Impacts_Of_Climate_Change', 0.00528427679091692)","(['Supply Chain Management'], 0.938798725605011)","('NON-ESG', 0.005794635973870754)","('NON-ESG', 0.00528427679091692)"
Line 624,"Intellectual Property Protecting intellectual property is important to maintaining Edwards’ leadership   position in medical technology innovation.
","('Competitive_Behavior', 0.5339561700820923)","('Business_Ethics', 0.10708249360322952)","('Data_Security', 0.054719239473342896)","(['Business Ethics'], 0.5339561700820923)","('NON-ESG', 0.10708249360322952)","('NON-ESG', 0.054719239473342896)"
Line 625,"The strength of our proprietary technology EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT fuels our research and the development of new, patient-focused solutions.
","('Product_Design_And_Lifecycle_Management', 0.663968026638031)","('Business_Model_Resilience', 0.07856877148151398)","('Customer_Welfare', 0.046610549092292786)","(['Product Stewardship'], 0.663968026638031)","('NON-ESG', 0.07856877148151398)","('NON-ESG', 0.046610549092292786)"
Line 626,"Edwards  owns more than 6,000 issued patents and pending patent applications in both the U.S.  and foreign jurisdictions.
","('Competitive_Behavior', 0.8953750133514404)","('Management_Of_Legal_And_Regulatory_Framework', 0.021745171397924423)","('Product_Quality_And_Safety', 0.00978965125977993)","(['Business Ethics'], 0.8953750133514404)","('NON-ESG', 0.021745171397924423)","('NON-ESG', 0.00978965125977993)"
Line 627,"We monitor our competitors to identify possible infringement,  protect our patents and take appropriate action when required.
","('Competitive_Behavior', 0.8642399907112122)","('Business_Ethics', 0.03937827795743942)","('Management_Of_Legal_And_Regulatory_Framework', 0.01632867380976677)","(['Business Ethics'], 0.8642399907112122)","('NON-ESG', 0.03937827795743942)","('NON-ESG', 0.01632867380976677)"
Line 628,"We actively generate  new intellectual property (IP) and pursue the acquisition of complementary IP across  our businesses.
","('Competitive_Behavior', 0.4462757110595703)","('Customer_Privacy', 0.14712221920490265)","('Data_Security', 0.08728854358196259)","('NON-ESG', 0.4462757110595703)","('NON-ESG', 0.14712221920490265)","('NON-ESG', 0.08728854358196259)"
Line 629,"We consider safeguarding Edwards’ IP in awarding business to preferred  partner suppliers.
","('Supply_Chain_Management', 0.32517296075820923)","('Competitive_Behavior', 0.14083221554756165)","('Business_Ethics', 0.06818681210279465)","('NON-ESG', 0.32517296075820923)","('NON-ESG', 0.14083221554756165)","('NON-ESG', 0.06818681210279465)"
Line 630,"Chemical and Material Stewardship Edwards Lifesciences is committed to the long-term health of patients.
","('Product_Design_And_Lifecycle_Management', 0.3799675703048706)","('Access_And_Affordability', 0.14828777313232422)","('Ecological_Impacts', 0.08830928057432175)","('NON-ESG', 0.3799675703048706)","('NON-ESG', 0.14828777313232422)","('NON-ESG', 0.08830928057432175)"
Line 631,"Our goal   is to ensure that our products are fully compliant with chemical regulations and   requirements.
","('Product_Quality_And_Safety', 0.4542207717895508)","('Product_Design_And_Lifecycle_Management', 0.25735586881637573)","('Selling_Practices_And_Product_Labeling', 0.12238303571939468)","('NON-ESG', 0.4542207717895508)","('NON-ESG', 0.25735586881637573)","('NON-ESG', 0.12238303571939468)"
Line 632,"Our procedures assess the maxterials in our products and allow for   continuous improvements in removing banned materials.
","('Product_Design_And_Lifecycle_Management', 0.9470618367195129)","('Product_Quality_And_Safety', 0.010220491327345371)","('Selling_Practices_And_Product_Labeling', 0.007964537478983402)","(['Product Stewardship'], 0.9470618367195129)","('NON-ESG', 0.010220491327345371)","('NON-ESG', 0.007964537478983402)"
Line 633,"Safety procedures protect   our employees by limiting exposure to potentially harmful chemicals.
","('Product_Quality_And_Safety', 0.4982762932777405)","('Employee_Health_And_Safety', 0.3494913876056671)","('Waste_And_Hazardous_Materials_Management', 0.025832587853074074)","('NON-ESG', 0.4982762932777405)","('NON-ESG', 0.3494913876056671)","('NON-ESG', 0.025832587853074074)"
Line 634,"The Product Stewardship team provides quarterly updates on the status of each   business unit’s activities and updates on new or revised chemical regulations that   will impact Edwards Lifesciences.
","('Management_Of_Legal_And_Regulatory_Framework', 0.20746666193008423)","('Product_Quality_And_Safety', 0.1907735913991928)","('Product_Design_And_Lifecycle_Management', 0.18845650553703308)","('NON-ESG', 0.20746666193008423)","('NON-ESG', 0.1907735913991928)","('NON-ESG', 0.18845650553703308)"
Line 635,"Edwards strives for 100 percent compliance with various materials regulations   ranging from restricting the use of certain hazardous substances in medical devices   to product labeling.
","('Selling_Practices_And_Product_Labeling', 0.5229567885398865)","('Product_Quality_And_Safety', 0.19741374254226685)","('Waste_And_Hazardous_Materials_Management', 0.07641319930553436)","(['Marketing Practices'], 0.5229567885398865)","('NON-ESG', 0.19741374254226685)","('NON-ESG', 0.07641319930553436)"
Line 636,"For example, Europe’s Restriction of Hazardous Substances (RoHS)  directive restricts hazardous substances used in electrical and electronic equipment,  whereas China’s RoHS requires these products to be labeled appropriately.
","('Waste_And_Hazardous_Materials_Management', 0.8882660865783691)","('Selling_Practices_And_Product_Labeling', 0.017907315865159035)","('Product_Quality_And_Safety', 0.01735653541982174)","(['Operational Eco-Efficiency'], 0.8882660865783691)","('NON-ESG', 0.017907315865159035)","('NON-ESG', 0.01735653541982174)"
Line 637,"Our focus extends to our supply chain, where we require compliance with all applicable  regulations for chemical and materials use.
","('Supply_Chain_Management', 0.8630974292755127)","('Product_Design_And_Lifecycle_Management', 0.04105941578745842)","('Waste_And_Hazardous_Materials_Management', 0.011460044421255589)","(['Supply Chain Management'], 0.8630974292755127)","('NON-ESG', 0.04105941578745842)","('NON-ESG', 0.011460044421255589)"
Line 638,"Hazardous materials regulations can evolve quickly.
","('Waste_And_Hazardous_Materials_Management', 0.9604827165603638)","('Air_Quality', 0.003439556574448943)","('Product_Quality_And_Safety', 0.0031492530833929777)","(['Operational Eco-Efficiency'], 0.9604827165603638)","('NON-ESG', 0.003439556574448943)","('NON-ESG', 0.0031492530833929777)"
Line 639,"For example, REACH adds new   substances of very high concern to its list every six months.
","('Selling_Practices_And_Product_Labeling', 0.2722610831260681)","('Product_Quality_And_Safety', 0.14856234192848206)","('Waste_And_Hazardous_Materials_Management', 0.13909007608890533)","('NON-ESG', 0.2722610831260681)","('NON-ESG', 0.14856234192848206)","('NON-ESG', 0.13909007608890533)"
Line 640,"Edwards monitors these  changes and, when we identify a pending restriction that might impact our business,   we act immediately by briefing our Steering Committee for Product Stewardship and  begin assessing our products.
","('Product_Design_And_Lifecycle_Management', 0.8890047669410706)","('Selling_Practices_And_Product_Labeling', 0.026186758652329445)","('Product_Quality_And_Safety', 0.023815538734197617)","(['Product Stewardship'], 0.8890047669410706)","('NON-ESG', 0.026186758652329445)","('NON-ESG', 0.023815538734197617)"
Line 641,"Conflict Minerals We use 3TG (tantalum, tin/tungsten and gold) for the functionality and production of  certain of our parts and products.
","('Product_Design_And_Lifecycle_Management', 0.858435332775116)","('Waste_And_Hazardous_Materials_Management', 0.022006383165717125)","('Supply_Chain_Management', 0.020572196692228317)","(['Product Stewardship'], 0.858435332775116)","('NON-ESG', 0.022006383165717125)","('NON-ESG', 0.020572196692228317)"
Line 642,"We have issued a Conflict Minerals Policy Statement  and established a conflict mineral program to identify 3TGs in our products, to obtain  responses from our direct and indirect suppliers to assess where the materials have been HIGHLIGHT STORY 2021 Edwards Annual Supplier Partner Forum At its annual Partner Forum, Global Supply Chain hosted key and strategic   suppliers for information sharing and networking and to hear about current   and upcoming business priorities at Edwards.
","('Supply_Chain_Management', 0.9290755987167358)","('Product_Design_And_Lifecycle_Management', 0.01216896902769804)","('Waste_And_Hazardous_Materials_Management', 0.004875850398093462)","(['Supply Chain Management'], 0.9290755987167358)","('NON-ESG', 0.01216896902769804)","('NON-ESG', 0.004875850398093462)"
Line 643,"Awards were also presented   to suppliers based on performance.
","('Supply_Chain_Management', 0.9047911167144775)","('Labor_Practices', 0.008848655968904495)","('Product_Design_And_Lifecycle_Management', 0.006998257711529732)","(['Supply Chain Management'], 0.9047911167144775)","('NON-ESG', 0.008848655968904495)","('NON-ESG', 0.006998257711529732)"
Line 644,"The Partner Forum topics included updates from each of the Edwards   Business Unit’s R&D departments including live demonstrations of our   new products.
","('Product_Design_And_Lifecycle_Management', 0.958861231803894)","('Product_Quality_And_Safety', 0.006070742849260569)","('Customer_Welfare', 0.003737444756552577)","(['Product Stewardship'], 0.958861231803894)","('NON-ESG', 0.006070742849260569)","('NON-ESG', 0.003737444756552577)"
Line 645,"There was a Listening Session where a patient talked about  her experience before and after receiving an Edwards valve replacement.
","('Employee_Health_And_Safety', 0.6368767619132996)","('Employee_Engagement_Inclusion_And_Diversity', 0.07343879342079163)","('Access_And_Affordability', 0.05658305063843727)","(['Operational Eco-Efficiency'], 0.6368767619132996)","('NON-ESG', 0.07343879342079163)","('NON-ESG', 0.05658305063843727)"
Line 646,"Suppliers who directly contributed to the patient’s implant were invited   on stage.
","('Customer_Welfare', 0.2373284101486206)","('Access_And_Affordability', 0.22418944537639618)","('Supply_Chain_Management', 0.0553220771253109)","('NON-ESG', 0.2373284101486206)","('NON-ESG', 0.22418944537639618)","('NON-ESG', 0.0553220771253109)"
Line 647,"There were also presentations discussing planned initiatives for  2022 and our expectations of suppliers for the year.
","('Supply_Chain_Management', 0.6637815237045288)","('GHG_Emissions', 0.0563812181353569)","('Management_Of_Legal_And_Regulatory_Framework', 0.038926754146814346)","(['Supply Chain Management'], 0.6637815237045288)","('NON-ESG', 0.0563812181353569)","('NON-ESG', 0.038926754146814346)"
Line 648,"After the Forum, supplier feedback expressed excitement about the   direction Edwards is heading and clear expectations on how each can   contribute to raising the bar going forward.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Annual Performance   Supply Chain Management In 2021, we continued to focus on strengthening our procurement practices.
","('Supply_Chain_Management', 0.9502398371696472)","('Product_Design_And_Lifecycle_Management', 0.006326428148895502)","('Labor_Practices', 0.0034569515846669674)","(['Supply Chain Management'], 0.9502398371696472)","('NON-ESG', 0.006326428148895502)","('NON-ESG', 0.0034569515846669674)"
Line 649,"We put   forth a significant effort to uplift supplier performance in our top strategic and key   suppliers, who account for a significant percentage of our direct material spend.
","('Supply_Chain_Management', 0.9369615316390991)","('Product_Design_And_Lifecycle_Management', 0.009375348687171936)","('Labor_Practices', 0.004833797924220562)","(['Supply Chain Management'], 0.9369615316390991)","('NON-ESG', 0.009375348687171936)","('NON-ESG', 0.004833797924220562)"
Line 650,"We   completed and documented technical assessments to help identify gaps in supplier   capability and maturity.
","('Supply_Chain_Management', 0.942772626876831)","('Business_Model_Resilience', 0.006747945211827755)","('Product_Design_And_Lifecycle_Management', 0.0062396833673119545)","(['Supply Chain Management'], 0.942772626876831)","('NON-ESG', 0.006747945211827755)","('NON-ESG', 0.0062396833673119545)"
Line 651,"These technical assessments then allowed us to develop   improvement plans to bolster supply chain resilience and partnership.
","('Supply_Chain_Management', 0.7997528314590454)","('Business_Model_Resilience', 0.08489957451820374)","('Product_Design_And_Lifecycle_Management', 0.020158110186457634)","(['Supply Chain Management'], 0.7997528314590454)","('NON-ESG', 0.08489957451820374)","('NON-ESG', 0.020158110186457634)"
Line 652,"In 2020, we engaged a third party to evaluate our direct suppliers and multiple   diversity categories were identified, such as small, disadvantaged businesses.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9659311771392822)","('Customer_Welfare', 0.002369327237829566)","('Competitive_Behavior', 0.0023492067120969296)","(['Human Capital Development'], 0.9659311771392822)","('NON-ESG', 0.002369327237829566)","('NON-ESG', 0.0023492067120969296)"
Line 653,"We   are now tracking our U.S. suppliers utilizing a diversity metric dashboard.
","('Employee_Engagement_Inclusion_And_Diversity', 0.730340838432312)","('Supply_Chain_Management', 0.06331390142440796)","('Labor_Practices', 0.02300817146897316)","(['Human Capital Development'], 0.730340838432312)","('NON-ESG', 0.06331390142440796)","('NON-ESG', 0.02300817146897316)"
Line 654,"Going forward,  we are working closely with Edwards’ VP of Diversity, Inclusion & Belonging to set new   goals specific to supplier diversity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9737555384635925)","('Employee_Health_And_Safety', 0.0023115049116313457)","('Human_Rights_And_Community_Relations', 0.001896224799565971)","(['Human Capital Development'], 0.9737555384635925)","('NON-ESG', 0.0023115049116313457)","('NON-ESG', 0.001896224799565971)"
Line 655,"We also achieved our target of successfully deploying   our Sustainability Program and Review process to strategic suppliers in 2020 and 2021.
","('Supply_Chain_Management', 0.8947327733039856)","('Product_Design_And_Lifecycle_Management', 0.03178577497601509)","('Business_Model_Resilience', 0.006771155167371035)","(['Supply Chain Management'], 0.8947327733039856)","('NON-ESG', 0.03178577497601509)","('NON-ESG', 0.006771155167371035)"
Line 656,"We look forward to engaging our key suppliers in this process throughout 2022.
","('Supply_Chain_Management', 0.9128026366233826)","('Product_Design_And_Lifecycle_Management', 0.01738240011036396)","('Business_Model_Resilience', 0.006160830147564411)","(['Supply Chain Management'], 0.9128026366233826)","('NON-ESG', 0.01738240011036396)","('NON-ESG', 0.006160830147564411)"
Line 657,"In 2021, we completed the integration of MedAccred into our quality system, a medical   device industry-managed supply chain oversight program that identifies and verifies   compliance to critical manufacturing process requirements.
","('Supply_Chain_Management', 0.9445775151252747)","('Product_Design_And_Lifecycle_Management', 0.006287530530244112)","('Waste_And_Hazardous_Materials_Management', 0.004500537179410458)","(['Supply Chain Management'], 0.9445775151252747)","('NON-ESG', 0.006287530530244112)","('NON-ESG', 0.004500537179410458)"
Line 658,"This quality improvement  program aims to enhance patient safety, improve device quality, and reduce recalls.
","('Product_Quality_And_Safety', 0.8189602494239807)","('Employee_Health_And_Safety', 0.07003438472747803)","('Access_And_Affordability', 0.010505488142371178)","(['Product Quality & Recall Management'], 0.8189602494239807)","('NON-ESG', 0.07003438472747803)","('NON-ESG', 0.010505488142371178)"
Line 659,"We will also begin leveraging MedAccred existing audits for sterilization.
","('Employee_Health_And_Safety', 0.39671605825424194)","('Access_And_Affordability', 0.19219253957271576)","('Product_Quality_And_Safety', 0.11433974653482437)","('NON-ESG', 0.39671605825424194)","('NON-ESG', 0.19219253957271576)","('NON-ESG', 0.11433974653482437)"
Line 660,"Additionally,  through MedAccred, Edwards has been asked to participate in an FDA working group   focused on supply chain resiliency in medical devices, which kicked off in 2022.
","('Supply_Chain_Management', 0.8490332961082458)","('Business_Model_Resilience', 0.05175195261836052)","('Product_Design_And_Lifecycle_Management', 0.021090246737003326)","(['Supply Chain Management'], 0.8490332961082458)","('NON-ESG', 0.05175195261836052)","('NON-ESG', 0.021090246737003326)"
Line 661,"In 2021, our top strategic suppliers completed supplier management training   initiatives for improved quality performance, including development of improvement   and implementation plans.
","('Supply_Chain_Management', 0.9424085021018982)","('Product_Design_And_Lifecycle_Management', 0.00901124719530344)","('Business_Model_Resilience', 0.004267338663339615)","(['Supply Chain Management'], 0.9424085021018982)","('NON-ESG', 0.00901124719530344)","('NON-ESG', 0.004267338663339615)"
Line 662,"In 2022, we will expand the program to our top 40 suppliers.
","('Supply_Chain_Management', 0.9171864986419678)","('Product_Design_And_Lifecycle_Management', 0.010482527315616608)","('GHG_Emissions', 0.006769668310880661)","(['Supply Chain Management'], 0.9171864986419678)","('NON-ESG', 0.010482527315616608)","('NON-ESG', 0.006769668310880661)"
Line 663,"Supply Chain Resilience  Edwards responded quickly and efficiently to supply chain needs in response to the   COVID-19 pandemic.
","('Supply_Chain_Management', 0.943462073802948)","('Business_Model_Resilience', 0.007186391390860081)","('Physical_Impacts_Of_Climate_Change', 0.00634570699185133)","(['Supply Chain Management'], 0.943462073802948)","('NON-ESG', 0.007186391390860081)","('NON-ESG', 0.00634570699185133)"
Line 664,"Like many companies, our team had to adjust to remote working   environments when necessary, leveraging technology to keep us connected with each  other and our suppliers.
","('Supply_Chain_Management', 0.8346256017684937)","('Product_Design_And_Lifecycle_Management', 0.05281760171055794)","('Energy_Management', 0.015516180545091629)","(['Supply Chain Management'], 0.8346256017684937)","('NON-ESG', 0.05281760171055794)","('NON-ESG', 0.015516180545091629)"
Line 665,"We focused on resilience and communication to ensure stability  and long-term partnership.
","('Business_Model_Resilience', 0.8943306803703308)","('Physical_Impacts_Of_Climate_Change', 0.016542116180062294)","('Product_Design_And_Lifecycle_Management', 0.009955162182450294)","(['Codes of Business Conduct'], 0.8943306803703308)","('NON-ESG', 0.016542116180062294)","('NON-ESG', 0.009955162182450294)"
Line 666,"sourced and publish an annual Conflict Minerals Report disclosing our findings.
","('Supply_Chain_Management', 0.3209584951400757)","('Human_Rights_And_Community_Relations', 0.13771720230579376)","('GHG_Emissions', 0.06462976336479187)","('NON-ESG', 0.3209584951400757)","('NON-ESG', 0.13771720230579376)","('NON-ESG', 0.06462976336479187)"
Line 667,"Each  year, we work with a third-party consultant to monitor our progress, analyze data and  identify strategies to improve our program.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2285182774066925)","('Human_Rights_And_Community_Relations', 0.21716968715190887)","('Business_Model_Resilience', 0.12373548001050949)","('NON-ESG', 0.2285182774066925)","('NON-ESG', 0.21716968715190887)","('NON-ESG', 0.12373548001050949)"
Line 668,"Please see our Responsible Supply Chain   page for supply chain policy statements and conflict minerals reports.
","('Supply_Chain_Management', 0.9445033073425293)","('Product_Design_And_Lifecycle_Management', 0.005895131267607212)","('Physical_Impacts_Of_Climate_Change', 0.004417985212057829)","(['Supply Chain Management'], 0.9445033073425293)","('NON-ESG', 0.005895131267607212)","('NON-ESG', 0.004417985212057829)"
Line 669,"HIGHLIGHT STORY Edwards Sets Carbon Neutrality Target As we pursue our patient-focused innovation strategy, Edwards   understands the importance of addressing climate change and is committed  to driving a meaningful reduction in our greenhouse gas (GHG) emissions.
","('GHG_Emissions', 0.9681714177131653)","('Ecological_Impacts', 0.004376664292067289)","('Physical_Impacts_Of_Climate_Change', 0.00349115370772779)","(['Climate Change'], 0.9681714177131653)","('NON-ESG', 0.004376664292067289)","('NON-ESG', 0.00349115370772779)"
Line 670,"In early 2022, Edwards set a new target to achieve carbon neutrality by the  year 2030 and a commitment to set and achieve SBTi-recognized reduction  targets for both our Scope 1, 2 and Scope 3 GHG emissions.
","('GHG_Emissions', 0.96827232837677)","('Ecological_Impacts', 0.004394088871777058)","('Air_Quality', 0.0033295410685241222)","(['Climate Change'], 0.96827232837677)","('NON-ESG', 0.004394088871777058)","('NON-ESG', 0.0033295410685241222)"
Line 671,"As part of our commitment to achieve carbon neutrality by 2030, we plan to  transition the majority of our global electricity demand to renewable sources  over the course of the next seven years through a variety of methods, including  onsite and offsite renewable energy generation.
","('Energy_Management', 0.9748406410217285)","('Management_Of_Legal_And_Regulatory_Framework', 0.0038691037334501743)","('Product_Design_And_Lifecycle_Management', 0.002031944692134857)","(['Operational Eco-Efficiency'], 0.9748406410217285)","('NON-ESG', 0.0038691037334501743)","('NON-ESG', 0.002031944692134857)"
Line 672,"We intend to establish a science-based target with SBTi in line with a 1.5°C   scenario and are currently engaged with SBTi for approval on specific reduction  targets for GHG emissions from our Scope 1 and 2 direct operations and Scope 3  value stream.
","('GHG_Emissions', 0.9684883952140808)","('Air_Quality', 0.003982985857874155)","('Ecological_Impacts', 0.0030130366794764996)","(['Climate Change'], 0.9684883952140808)","('NON-ESG', 0.003982985857874155)","('NON-ESG', 0.0030130366794764996)"
Line 673,"1 Includes commitment to set and achieve SBTi-recognized Scope 1 and 2 and Scope 3 science-based targets 2 2020 baseline year 3 Waste and water targets were achieved in 2021; new targets currently under evaluationCarbon neutral by   2030 and 1.5˚C   science-based   targets110% reduction in  waste generation   intensity by 20252,310% reduction in  waste withdrawl   intensity by 20252,3ISO 14001 & 45001   certification at all   manufactoring plants35% reduction in   recordable incident  rate by EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT HIGHLIGHT STORY New Ireland Manufacturing Facility LEED   Gold Certified In 2021, Edwards opened its newest manufacturing plant in Limerick,   Ireland.
","('Waste_And_Hazardous_Materials_Management', 0.975527286529541)","('Water_And_Wastewater_Management', 0.003792171599343419)","('Air_Quality', 0.0022928062826395035)","(['Operational Eco-Efficiency'], 0.975527286529541)","('NON-ESG', 0.003792171599343419)","('NON-ESG', 0.0022928062826395035)"
Line 674,"1 Includes commitment to set and achieve SBTi-recognized Scope 1 and 2 and Scope 3 science-based targets 2 2020 baseline year 3 Waste and water targets were achieved in 2021; new targets currently under evaluationCarbon neutral by   2030 and 1.5˚C   science-based   targets110% reduction in  waste generation   intensity by 20252,310% reduction in  waste withdrawl   intensity by 20252,3ISO 14001 & 45001   certification at all   manufactoring plants35% reduction in   recordable incident  rate by EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT HIGHLIGHT STORY New Ireland Manufacturing Facility LEED   Gold Certified In 2021, Edwards opened its newest manufacturing plant in Limerick,   Ireland.
","('Product_Design_And_Lifecycle_Management', 0.46710801124572754)","('Product_Quality_And_Safety', 0.1529274433851242)","('Energy_Management', 0.0679483711719513)","('NON-ESG', 0.46710801124572754)","('NON-ESG', 0.1529274433851242)","('NON-ESG', 0.0679483711719513)"
Line 675,"The facility operates on 100% renewable electricity, primarily  from wind energy, and is Edward’s first LEED Gold certified, carbon neutral,  and zero waste-to-landfill manufacturing plant, and Ireland’s first   medical device manufacturing plant to achieve LEED Gold V4 certification.
","('Energy_Management', 0.5531795024871826)","('Waste_And_Hazardous_Materials_Management', 0.22849877178668976)","('Product_Design_And_Lifecycle_Management', 0.03971776366233826)","(['Operational Eco-Efficiency'], 0.5531795024871826)","('NON-ESG', 0.22849877178668976)","('NON-ESG', 0.03971776366233826)"
Line 676,"The new Ireland plant combines innovative design with critical   functionality and features obstacle-free clean rooms and recreational  spaces for our employees to enjoy.
","('Ecological_Impacts', 0.13706932961940765)","('Waste_And_Hazardous_Materials_Management', 0.12225247919559479)","('Access_And_Affordability', 0.07945194840431213)","('NON-ESG', 0.13706932961940765)","('NON-ESG', 0.12225247919559479)","('NON-ESG', 0.07945194840431213)"
Line 677,"The building has capacity for three   ISO 7 clean rooms, laboratories, a cafeteria, gym, and external   athletic courts.
","('Access_And_Affordability', 0.444756418466568)","('Employee_Engagement_Inclusion_And_Diversity', 0.10116749256849289)","('Customer_Welfare', 0.043285075575113297)","('NON-ESG', 0.444756418466568)","('NON-ESG', 0.10116749256849289)","('NON-ESG', 0.043285075575113297)"
Line 678,"We continued our extensive expansion to our Irvine headquarters during  2021, including the completion of our new LEED Platinum Entry Pavilion,  LEED Gold Dream Big Complex, and LEED Gold Café and Conference Center.
","('Management_Of_Legal_And_Regulatory_Framework', 0.25300490856170654)","('Product_Design_And_Lifecycle_Management', 0.0864938348531723)","('Access_And_Affordability', 0.07940856367349625)","('NON-ESG', 0.25300490856170654)","('NON-ESG', 0.0864938348531723)","('NON-ESG', 0.07940856367349625)"
Line 679,"LEED, Leadership in Energy and Environmental Design, is the most widely  used green building rating system in the world and provides a framework  for healthy, highly efficient, and cost-saving green buildings.Risk mitigation methods included enhancements of supply network systems and   continuity during uncertain times for many of our suppliers.
","('Supply_Chain_Management', 0.938596248626709)","('Energy_Management', 0.005936949513852596)","('Product_Design_And_Lifecycle_Management', 0.005587384104728699)","(['Supply Chain Management'], 0.938596248626709)","('NON-ESG', 0.005936949513852596)","('NON-ESG', 0.005587384104728699)"
Line 680,"Additionally, our strategic   and key suppliers keep us informed of any potential impacts to the supply chain during  Quarterly Business Reviews.
","('Supply_Chain_Management', 0.9488397836685181)","('Physical_Impacts_Of_Climate_Change', 0.004271091893315315)","('Product_Design_And_Lifecycle_Management', 0.004246898926794529)","(['Supply Chain Management'], 0.9488397836685181)","('NON-ESG', 0.004271091893315315)","('NON-ESG', 0.004246898926794529)"
Line 681,"We also presented three suppliers with a formal award at our  annual supplier forum recognizing their responsiveness to Edwards during the pandemic.
","('Supply_Chain_Management', 0.9301931262016296)","('Physical_Impacts_Of_Climate_Change', 0.009042236022651196)","('Systemic_Risk_Management', 0.006085044238716364)","(['Supply Chain Management'], 0.9301931262016296)","('NON-ESG', 0.009042236022651196)","('NON-ESG', 0.006085044238716364)"
Line 682,"Distribution Network Optimization During 2021, Edwards continued to address climate-related risks through our global   product distribution strategy.
","('Physical_Impacts_Of_Climate_Change', 0.6441609263420105)","('Supply_Chain_Management', 0.09840612858533859)","('Business_Model_Resilience', 0.05175773426890373)","(['Climate Change'], 0.6441609263420105)","('NON-ESG', 0.09840612858533859)","('NON-ESG', 0.05175773426890373)"
Line 683,"Our medical device products have low energy demand;   however, we continued to transform our distribution network to provide our products   to global customers through more efficient delivery methods.
","('Product_Design_And_Lifecycle_Management', 0.9521424174308777)","('Energy_Management', 0.010432693175971508)","('Customer_Welfare', 0.004855444189161062)","(['Product Stewardship'], 0.9521424174308777)","('NON-ESG', 0.010432693175971508)","('NON-ESG', 0.004855444189161062)"
Line 684,"In 2021, we exceeded our  target to reduce product distribution air miles traveled by 3 million compared to our   2018 baseline despite pandemic-related logistical challenges.
","('Air_Quality', 0.9707820415496826)","('Energy_Management', 0.0027267164550721645)","('Critical_Incident_Risk_Management', 0.002556872321292758)","(['Operational Eco-Efficiency'], 0.9707820415496826)","('NON-ESG', 0.0027267164550721645)","('NON-ESG', 0.002556872321292758)"
Line 685,"We have since established   a new target to reduce product distribution air miles traveled by an additional 1.5 million   by 2023.
","('Air_Quality', 0.971757709980011)","('Energy_Management', 0.0037931203842163086)","('Water_And_Wastewater_Management', 0.0020086292643100023)","(['Operational Eco-Efficiency'], 0.971757709980011)","('NON-ESG', 0.0037931203842163086)","('NON-ESG', 0.0020086292643100023)"
Line 686,"New Goal: By 2023, reduce product distribution air miles traveled by an additional   1.5 million vs.
","('Air_Quality', 0.9662961363792419)","('Energy_Management', 0.005074691027402878)","('GHG_Emissions', 0.00303792767226696)","(['Operational Eco-Efficiency'], 0.9662961363792419)","('NON-ESG', 0.005074691027402878)","('NON-ESG', 0.00303792767226696)"
Line 687,"our 2018 baseline.ution air miles reduced in 2020 were 7.9 million,   achieving an 80% overall reduction (as compared to 2018 baseline) We continue to focus on long-term changes in the way we distribute products globally.
","('Product_Design_And_Lifecycle_Management', 0.35586851835250854)","('Energy_Management', 0.21549884974956512)","('Air_Quality', 0.13425002992153168)","('NON-ESG', 0.35586851835250854)","('NON-ESG', 0.21549884974956512)","('NON-ESG', 0.13425002992153168)"
Line 688,"Our product distribution strategy aims to improve normal business shipments by shifting  away from air shipments or sourcing closer to the point of demand.
","('Product_Design_And_Lifecycle_Management', 0.9468454122543335)","('Selling_Practices_And_Product_Labeling', 0.0072052497416734695)","('Customer_Welfare', 0.006884210743010044)","(['Product Stewardship'], 0.9468454122543335)","('NON-ESG', 0.0072052497416734695)","('NON-ESG', 0.006884210743010044)"
Line 689,"This includes utilizing  more localized ground transportation and ocean liners with temperature-controlled   containers.
","('Energy_Management', 0.5847676992416382)","('Air_Quality', 0.14775019884109497)","('Water_And_Wastewater_Management', 0.07357323169708252)","(['Operational Eco-Efficiency'], 0.5847676992416382)","('NON-ESG', 0.14775019884109497)","('NON-ESG', 0.07357323169708252)"
Line 690,"Through these methods, we can achieve cost efficiencies and carbon footprint  reduction, and we expect further optimization in product lines through 2023.
","('Product_Design_And_Lifecycle_Management', 0.9361750483512878)","('Energy_Management', 0.012643817812204361)","('Customer_Welfare', 0.006702579092234373)","(['Product Stewardship'], 0.9361750483512878)","('NON-ESG', 0.012643817812204361)","('NON-ESG', 0.006702579092234373)"
Line 691,"Conflict Minerals For the 2021 reporting period, Edwards conducted two stages of reasonable country   of origin inquiry (RCOI), supplier and smelter, in accordance with the Conflict Minerals   Rule and the Organization for Economic Cooperation and Development (OECD) Due   Diligence Guidance.
","('Supply_Chain_Management', 0.5950815677642822)","('Waste_And_Hazardous_Materials_Management', 0.06566830724477768)","('GHG_Emissions', 0.05777031555771828)","(['Supply Chain Management'], 0.5950815677642822)","('NON-ESG', 0.06566830724477768)","('NON-ESG', 0.05777031555771828)"
Line 692,"We designed our supplier RCOI process to identify the smelters in our supply chain and to  determine whether the 3TG in our in-scope products originated in a covered country.
","('Product_Design_And_Lifecycle_Management', 0.5899897813796997)","('Supply_Chain_Management', 0.2636394202709198)","('Energy_Management', 0.01575806923210621)","(['Product Stewardship'], 0.5899897813796997)","('NON-ESG', 0.2636394202709198)","('NON-ESG', 0.01575806923210621)"
Line 693,"Edwards’ suppliers that provided product level responses identified 15 smelters in their  CMRT responses during the 2021 reporting period that included 3 gold refiners, 1 tantalum  smelter and 11 tin smelters.
","('Product_Design_And_Lifecycle_Management', 0.8328383564949036)","('Supply_Chain_Management', 0.02839624509215355)","('Energy_Management', 0.024016929790377617)","(['Product Stewardship'], 0.8328383564949036)","('NON-ESG', 0.02839624509215355)","('NON-ESG', 0.024016929790377617)"
Line 694,"All the smelters and refiners identified by our suppliers for the  2021 reporting period have been audited and recognized as conformant by the Responsible  Mineral Assurance Process.
","('Supply_Chain_Management', 0.8606389164924622)","('Labor_Practices', 0.013513716869056225)","('Management_Of_Legal_And_Regulatory_Framework', 0.01189027912914753)","(['Supply Chain Management'], 0.8606389164924622)","('NON-ESG', 0.013513716869056225)","('NON-ESG', 0.01189027912914753)"
Line 695,"Please see the Edwards’ Conflict Minerals Report for the 2021  fiscal year, as filed with the Securities and Exchange Commission on May 31, 2022.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Product Design & Innovation At Edwards, we constantly innovate to better meet the needs of patients with   cardiovascular disease.
","('Product_Design_And_Lifecycle_Management', 0.9465967416763306)","('Product_Quality_And_Safety', 0.009036310017108917)","('Customer_Welfare', 0.007329703774303198)","(['Product Stewardship'], 0.9465967416763306)","('NON-ESG', 0.009036310017108917)","('NON-ESG', 0.007329703774303198)"
Line 696,"Our focus on innovation allows us to develop life-saving   products and therapies that transform the lives of patients around the world.
","('Product_Design_And_Lifecycle_Management', 0.9505870938301086)","('Customer_Welfare', 0.00605811970308423)","('Product_Quality_And_Safety', 0.00505052087828517)","(['Product Stewardship'], 0.9505870938301086)","('NON-ESG', 0.00605811970308423)","('NON-ESG', 0.00505052087828517)"
Line 697,"Definition   Designing products to better meet the needs of patients; investing in research and   development; and employing innovative methods and solutions to improve design   and performance of products.
","('Product_Design_And_Lifecycle_Management', 0.9655570387840271)","('Product_Quality_And_Safety', 0.0042601171880960464)","('Selling_Practices_And_Product_Labeling', 0.0030888791661709547)","(['Product Stewardship'], 0.9655570387840271)","('NON-ESG', 0.0042601171880960464)","('NON-ESG', 0.0030888791661709547)"
Line 698,"Management Approach Product design and innovation continues to set Edwards apart.
","('Product_Design_And_Lifecycle_Management', 0.9587724804878235)","('Business_Model_Resilience', 0.004089812282472849)","('Product_Quality_And_Safety', 0.003833972616121173)","(['Product Stewardship'], 0.9587724804878235)","('NON-ESG', 0.004089812282472849)","('NON-ESG', 0.003833972616121173)"
Line 699,"Our patient-  focused innovation strategy is unwavering, differentiated and global.
","('Business_Model_Resilience', 0.34637588262557983)","('Product_Design_And_Lifecycle_Management', 0.22316186130046844)","('Competitive_Behavior', 0.057035740464925766)","('NON-ESG', 0.34637588262557983)","('NON-ESG', 0.22316186130046844)","('NON-ESG', 0.057035740464925766)"
Line 700,"We are   uniquely focused.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2672154903411865)","('Business_Model_Resilience', 0.16225478053092957)","('Product_Design_And_Lifecycle_Management', 0.14829251170158386)","('NON-ESG', 0.2672154903411865)","('NON-ESG', 0.16225478053092957)","('NON-ESG', 0.14829251170158386)"
Line 701,"At a time when medical technology companies are diversifying,   we remain laser-focused on innovations for structural heart disease and critical   care monitoring.
","('Access_And_Affordability', 0.24828386306762695)","('Critical_Incident_Risk_Management', 0.12787997722625732)","('Customer_Welfare', 0.10596418380737305)","('NON-ESG', 0.24828386306762695)","('NON-ESG', 0.12787997722625732)","('NON-ESG', 0.10596418380737305)"
Line 702,"We bring our decades of expertise and clinical knowledge to   better advance potential solutions.
","('Business_Model_Resilience', 0.1495470404624939)","('Employee_Engagement_Inclusion_And_Diversity', 0.12937235832214355)","('Customer_Welfare', 0.11047482490539551)","('NON-ESG', 0.1495470404624939)","('NON-ESG', 0.12937235832214355)","('NON-ESG', 0.11047482490539551)"
Line 703,"Another key element of our strategy is bold innovation, and we are pursuing a rich   pipeline.
","('Business_Model_Resilience', 0.45411983132362366)","('Product_Design_And_Lifecycle_Management', 0.12405426800251007)","('Competitive_Behavior', 0.0662931576371193)","('NON-ESG', 0.45411983132362366)","('NON-ESG', 0.12405426800251007)","('NON-ESG', 0.0662931576371193)"
Line 704,"We know that change doesn’t come easily and must be supported with   strong evidence.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2381616234779358)","('Business_Model_Resilience', 0.12341960519552231)","('Systemic_Risk_Management', 0.07056403905153275)","('NON-ESG', 0.2381616234779358)","('NON-ESG', 0.12341960519552231)","('NON-ESG', 0.07056403905153275)"
Line 705,"We are focused on innovations that change the practice of medicine,  supported by rigorous clinical trials to achieve best-in-class outcomes.
","('Competitive_Behavior', 0.3681708872318268)","('Customer_Welfare', 0.09957429766654968)","('Business_Model_Resilience', 0.06322077661752701)","('NON-ESG', 0.3681708872318268)","('NON-ESG', 0.09957429766654968)","('NON-ESG', 0.06322077661752701)"
Line 706,"Leadership is the third key component of our innovation strategy.
","('Employee_Engagement_Inclusion_And_Diversity', 0.31143927574157715)","('Business_Model_Resilience', 0.27069902420043945)","('Product_Design_And_Lifecycle_Management', 0.06903032958507538)","('NON-ESG', 0.31143927574157715)","('NON-ESG', 0.27069902420043945)","('NON-ESG', 0.06903032958507538)"
Line 707,"We believe that   when you are the first, you become a key contributor to shaping value creation and   tackling unknown problems from multiple perspectives, including patient needs,   regulatory issues, commercial and time constraints and more.
","('Management_Of_Legal_And_Regulatory_Framework', 0.890397846698761)","('Systemic_Risk_Management', 0.01389872096478939)","('Physical_Impacts_Of_Climate_Change', 0.011265396140515804)","(['Corporate Governance'], 0.890397846698761)","('NON-ESG', 0.01389872096478939)","('NON-ESG', 0.011265396140515804)"
Line 708,"Our products and   services address patient illnesses that are vastly undertreated.
","('Employee_Health_And_Safety', 0.7890325784683228)","('Access_And_Affordability', 0.03364476561546326)","('Product_Quality_And_Safety', 0.03119809180498123)","(['Operational Eco-Efficiency'], 0.7890325784683228)","('NON-ESG', 0.03364476561546326)","('NON-ESG', 0.03119809180498123)"
Line 709,"Developing the safest,  most efficacious products grounded with robust evidence is at the heart of our   mission to improve patients’ lives.
","('Product_Design_And_Lifecycle_Management', 0.5933703184127808)","('Customer_Welfare', 0.1066669225692749)","('Product_Quality_And_Safety', 0.10408219695091248)","(['Product Stewardship'], 0.5933703184127808)","('NON-ESG', 0.1066669225692749)","('NON-ESG', 0.10408219695091248)"
Line 710,"Edwards is a highly cross-functional organization that strives to include and respect   diverse perspectives and is willing to explore novel solutions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6681126952171326)","('Human_Rights_And_Community_Relations', 0.059284813702106476)","('Business_Model_Resilience', 0.0416376069188118)","(['Human Capital Development'], 0.6681126952171326)","('NON-ESG', 0.059284813702106476)","('NON-ESG', 0.0416376069188118)"
Line 711,"Our culture allows us   to be patient focused and employ a global innovation mindset while remaining agile   and curious.
","('Business_Model_Resilience', 0.6123808026313782)","('Product_Design_And_Lifecycle_Management', 0.08183495700359344)","('Employee_Engagement_Inclusion_And_Diversity', 0.06843230873346329)","(['Codes of Business Conduct'], 0.6123808026313782)","('NON-ESG', 0.08183495700359344)","('NON-ESG', 0.06843230873346329)"
Line 712,"Dreaming big, owning failures and challenging the system must also   include a tolerance of risk, whether it be to new approaches to product design,   cutting-edge trial methodologies allowing us to go to market faster or new proctoring  techniques to support heart valve implants during a pandemic.
","('Product_Design_And_Lifecycle_Management', 0.6654148101806641)","('Product_Quality_And_Safety', 0.13359548151493073)","('Employee_Health_And_Safety', 0.027630669996142387)","(['Product Stewardship'], 0.6654148101806641)","('NON-ESG', 0.13359548151493073)","('NON-ESG', 0.027630669996142387)"
Line 713,"Our approach to a patient-focused innovation strategy is outlined through our   commitment to innovation, leadership, and our singular focus.
","('Business_Model_Resilience', 0.24284285306930542)","('Product_Design_And_Lifecycle_Management', 0.1430772989988327)","('Employee_Engagement_Inclusion_And_Diversity', 0.09918196499347687)","('NON-ESG', 0.24284285306930542)","('NON-ESG', 0.1430772989988327)","('NON-ESG', 0.09918196499347687)"
Line 714,"Patient- Focused innovation Strategy To deliver on our commitments to high-quality products, Edwards employs a rigorous  design and product development process that incorporates multiple design and   management reviews as stage gates when designing new products.
","('Product_Design_And_Lifecycle_Management', 0.962493896484375)","('Product_Quality_And_Safety', 0.005414105486124754)","('Selling_Practices_And_Product_Labeling', 0.0030774418264627457)","(['Product Stewardship'], 0.962493896484375)","('NON-ESG', 0.005414105486124754)","('NON-ESG', 0.0030774418264627457)"
Line 715,"Quality Manage- ment System requirements are also integral to the design process to ensure quality   and manage risk.
","('Systemic_Risk_Management', 0.31063640117645264)","('Supply_Chain_Management', 0.21393266320228577)","('Business_Model_Resilience', 0.11128561198711395)","('NON-ESG', 0.31063640117645264)","('NON-ESG', 0.21393266320228577)","('NON-ESG', 0.11128561198711395)"
Line 716,"To learn more about the Quality Management Systems, please visit  the Product Safety & Quality section.
","('Product_Quality_And_Safety', 0.902161717414856)","('Product_Design_And_Lifecycle_Management', 0.02197537198662758)","('Employee_Health_And_Safety', 0.012695514596998692)","(['Product Quality & Recall Management'], 0.902161717414856)","('NON-ESG', 0.02197537198662758)","('NON-ESG', 0.012695514596998692)"
Line 717,"Strategy and Execution The Executive Leadership Team (ELT) critiques our portfolio strategy in various annual  meetings, including strategy meetings, our Annual Operating Plan (AOP) reviews and  other ELT meetings that occur throughout the year.
","('Director_Removal', 0.37398117780685425)","('Business_Model_Resilience', 0.24639582633972168)","('Employee_Engagement_Inclusion_And_Diversity', 0.0571712888777256)","('NON-ESG', 0.37398117780685425)","('NON-ESG', 0.24639582633972168)","('NON-ESG', 0.0571712888777256)"
Line 718,"Annually, the Board approves the  Company’s Strategic Imperatives, and it is from these Strategic Imperatives that our  key operating drivers (KODs) – quantifiable strategic milestones that include financial  objectives and are tracked using a points system across our entire organization –   are derived.
","('Business_Model_Resilience', 0.8379828333854675)","('Physical_Impacts_Of_Climate_Change', 0.020123058930039406)","('Systemic_Risk_Management', 0.016307538375258446)","(['Codes of Business Conduct'], 0.8379828333854675)","('NON-ESG', 0.020123058930039406)","('NON-ESG', 0.016307538375258446)"
Line 719,"The KODs contemplate near and long-term objectives of our multi-year   strategy, which outlines our portfolio, pipeline innovation and overall innovation   strategy.
","('Business_Model_Resilience', 0.3977428376674652)","('Product_Design_And_Lifecycle_Management', 0.22301208972930908)","('Supply_Chain_Management', 0.07497979700565338)","('NON-ESG', 0.3977428376674652)","('NON-ESG', 0.22301208972930908)","('NON-ESG', 0.07497979700565338)"
Line 720,"We use KODs to translate these strategic goals into quantifiable metrics to   be achieved in any given year.
","('Business_Model_Resilience', 0.6800341606140137)","('Systemic_Risk_Management', 0.09272795170545578)","('Supply_Chain_Management', 0.022576432675123215)","(['Codes of Business Conduct'], 0.6800341606140137)","('NON-ESG', 0.09272795170545578)","('NON-ESG', 0.022576432675123215)"
Line 721,"Product design and innovation goals are central to our strategy execution.
","('Product_Design_And_Lifecycle_Management', 0.9488337635993958)","('Business_Model_Resilience', 0.007435193285346031)","('Customer_Welfare', 0.005075056571513414)","(['Product Stewardship'], 0.9488337635993958)","('NON-ESG', 0.007435193285346031)","('NON-ESG', 0.005075056571513414)"
Line 722,"Excluding   the sales representatives out in the field, all Edwards employees in every business unit,  region and function, including our ELT, have compensation tied to our KODs, a key   component in our annual employee incentive plan.
","('Labor_Practices', 0.8272645473480225)","('Employee_Engagement_Inclusion_And_Diversity', 0.05870155990123749)","('Employee_Health_And_Safety', 0.029598025605082512)","(['Labor Practice Indicators'], 0.8272645473480225)","('NON-ESG', 0.05870155990123749)","('NON-ESG', 0.029598025605082512)"
Line 723,"All employees are updated on KOD  progress quarterly though all-employee meetings and separate business team meetings.
","('Labor_Practices', 0.352996826171875)","('Director_Removal', 0.2870854139328003)","('Employee_Engagement_Inclusion_And_Diversity', 0.06314762681722641)","('NON-ESG', 0.352996826171875)","('NON-ESG', 0.2870854139328003)","('NON-ESG', 0.06314762681722641)"
Line 724,"We report on our KOD progress in the Annual Performance section of this report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.324379563331604)","('Systemic_Risk_Management', 0.12742598354816437)","('Human_Rights_And_Community_Relations', 0.09812039136886597)","('NON-ESG', 0.324379563331604)","('NON-ESG', 0.12742598354816437)","('NON-ESG', 0.09812039136886597)"
Line 725,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT    In 2021  Edwards invests 17%+  of annual sales    into product  innovationThroughout the design and innovation process from conception, prototype, first   in human, clinical trials, regulatory approval and product launch or roll out, each   business leadership team is deeply involved in our pipeline innovation strategy as well   as detailed design decisions.
","('Product_Design_And_Lifecycle_Management', 0.892739474773407)","('Customer_Welfare', 0.022449973970651627)","('Product_Quality_And_Safety', 0.015642520040273666)","(['Product Stewardship'], 0.892739474773407)","('NON-ESG', 0.022449973970651627)","('NON-ESG', 0.015642520040273666)"
Line 726,"Through our product development process, these leaders   participate in all stages of product development from concept selection through   to launch.
","('Product_Design_And_Lifecycle_Management', 0.9329096674919128)","('Product_Quality_And_Safety', 0.01347170677036047)","('Customer_Welfare', 0.00984159018844366)","(['Product Stewardship'], 0.9329096674919128)","('NON-ESG', 0.01347170677036047)","('NON-ESG', 0.00984159018844366)"
Line 727,"At Edwards, we regularly evaluate the need for new policies, procedures and   programs to improve our approach to design and innovation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9018311500549316)","('Human_Rights_And_Community_Relations', 0.019917909055948257)","('Director_Removal', 0.008142723701894283)","(['Corporate Governance'], 0.9018311500549316)","('NON-ESG', 0.019917909055948257)","('NON-ESG', 0.008142723701894283)"
Line 728,"We must continue to   develop and commercialize new products and technologies to remain competitive in   the cardiovascular medical technology industry.
","('Product_Design_And_Lifecycle_Management', 0.943692684173584)","('Customer_Welfare', 0.00799406599253416)","('Product_Quality_And_Safety', 0.0057232012040913105)","(['Product Stewardship'], 0.943692684173584)","('NON-ESG', 0.00799406599253416)","('NON-ESG', 0.0057232012040913105)"
Line 729,"We believe that we are competitive   primarily because we deliver excellent clinical outcomes that are supported by   extensive data, and innovative features that enhance patient benefit, product   performance and reliability.
","('Product_Design_And_Lifecycle_Management', 0.6801072955131531)","('Competitive_Behavior', 0.08938789367675781)","('Customer_Welfare', 0.0649411752820015)","(['Product Stewardship'], 0.6801072955131531)","('NON-ESG', 0.08938789367675781)","('NON-ESG', 0.0649411752820015)"
Line 730,"These differentiated clinical outcomes are in part due   to the level of customer and clinical support we provide.
","('Access_And_Affordability', 0.27599895000457764)","('Product_Quality_And_Safety', 0.11006490886211395)","('Customer_Welfare', 0.09287897497415543)","('NON-ESG', 0.27599895000457764)","('NON-ESG', 0.11006490886211395)","('NON-ESG', 0.09287897497415543)"
Line 731,"Product Development Process Our product development process is a streamlined and flexible approach to accommodate  the needs of each business area and all new products.
","('Product_Design_And_Lifecycle_Management', 0.9583820700645447)","('Product_Quality_And_Safety', 0.006533516105264425)","('Customer_Welfare', 0.003241676138713956)","(['Product Stewardship'], 0.9583820700645447)","('NON-ESG', 0.006533516105264425)","('NON-ESG', 0.003241676138713956)"
Line 732,"The process includes a core team  comprising an independent reviewer and delegates from multiple functions, if applicable.
","('Management_Of_Legal_And_Regulatory_Framework', 0.33273813128471375)","('Director_Removal', 0.28223079442977905)","('Human_Rights_And_Community_Relations', 0.04009320214390755)","('NON-ESG', 0.33273813128471375)","('NON-ESG', 0.28223079442977905)","('NON-ESG', 0.04009320214390755)"
Line 733,"When sufficient technical information is available, a design review can take place.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1572696417570114)","('Product_Quality_And_Safety', 0.1292451173067093)","('Product_Design_And_Lifecycle_Management', 0.11929196119308472)","('NON-ESG', 0.1572696417570114)","('NON-ESG', 0.1292451173067093)","('NON-ESG', 0.11929196119308472)"
Line 734,"After   the design review approval, and when all design and development plan deliverables are  completed and approved, a gate review is held at the end of each phase.
","('Business_Model_Resilience', 0.2717352509498596)","('Product_Design_And_Lifecycle_Management', 0.12581460177898407)","('Management_Of_Legal_And_Regulatory_Framework', 0.09375348687171936)","('NON-ESG', 0.2717352509498596)","('NON-ESG', 0.12581460177898407)","('NON-ESG', 0.09375348687171936)"
Line 735,"Managing Regulatory Changes The cardiovascular segment of the medical technology industry is dynamic and subject  to significant change due to cost-of-care considerations, regulatory reform, industry  and customer consolidation and evolving patient needs.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9625656008720398)","('Competitive_Behavior', 0.0037413218524307013)","('Business_Ethics', 0.0028898948803544044)","(['Corporate Governance'], 0.9625656008720398)","('NON-ESG', 0.0037413218524307013)","('NON-ESG', 0.0028898948803544044)"
Line 736,"The ability to provide products  and technologies that demonstrate value and improve clinical outcomes is becoming  increasingly important for medical technology manufacturers.Notable new challenges include a changing regulatory landscape, such as Europe’s   conversion from the outdated 1992 Medical Device Directive to the 2021 Medical   Device Regulation.
","('Product_Design_And_Lifecycle_Management', 0.3647017776966095)","('Product_Quality_And_Safety', 0.14193877577781677)","('Management_Of_Legal_And_Regulatory_Framework', 0.10663170367479324)","('NON-ESG', 0.3647017776966095)","('NON-ESG', 0.14193877577781677)","('NON-ESG', 0.10663170367479324)"
Line 737,"The updated regulations present new timeline considerations   when introducing innovation to Europe, historically and most likely first region for   market entry.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8385161757469177)","('Competitive_Behavior', 0.03940877690911293)","('Business_Model_Resilience', 0.01257714256644249)","(['Corporate Governance'], 0.8385161757469177)","('NON-ESG', 0.03940877690911293)","('NON-ESG', 0.01257714256644249)"
Line 738,"Packaging Design & Innovation Product protection of life-saving devices is essential, and we realize that packaging  solutions can be optimized as we continue to deepen our understanding of our global  supply chains and expand on our knowledge of materials and designs.
","('Product_Design_And_Lifecycle_Management', 0.919408917427063)","('Supply_Chain_Management', 0.023650066927075386)","('Energy_Management', 0.005719935987144709)","(['Product Stewardship'], 0.919408917427063)","('NON-ESG', 0.023650066927075386)","('NON-ESG', 0.005719935987144709)"
Line 739,"Edwards strives  to maximize the value and function of our products from design to end-of-life.
","('Product_Design_And_Lifecycle_Management', 0.9606273174285889)","('Business_Model_Resilience', 0.003397244494408369)","('Product_Quality_And_Safety', 0.0033660156186670065)","(['Product Stewardship'], 0.9606273174285889)","('NON-ESG', 0.003397244494408369)","('NON-ESG', 0.0033660156186670065)"
Line 740,"We  continue to strengthen our packaging design process to enable safer, more efficient  and cost-effective product delivery.
","('Product_Design_And_Lifecycle_Management', 0.9654937982559204)","('Product_Quality_And_Safety', 0.004268557298928499)","('Selling_Practices_And_Product_Labeling', 0.003510489361360669)","(['Product Stewardship'], 0.9654937982559204)","('NON-ESG', 0.004268557298928499)","('NON-ESG', 0.003510489361360669)"
Line 741,"This includes exploring sustainable solutions that  decrease environmental impact.
","('Product_Design_And_Lifecycle_Management', 0.7153232097625732)","('Supply_Chain_Management', 0.044241465628147125)","('Business_Model_Resilience', 0.0374317467212677)","(['Product Stewardship'], 0.7153232097625732)","('NON-ESG', 0.044241465628147125)","('NON-ESG', 0.0374317467212677)"
Line 742,"Our medical device products (primarily the heart valves and implantable devices) have  low direct energy and emissions impact and the choice of materials from which they are  constructed is limited and stringently regulated.
","('Product_Design_And_Lifecycle_Management', 0.9159532785415649)","('Energy_Management', 0.02443523332476616)","('Product_Quality_And_Safety', 0.009057068265974522)","(['Product Stewardship'], 0.9159532785415649)","('NON-ESG', 0.02443523332476616)","('NON-ESG', 0.009057068265974522)"
Line 743,"In addition, these devices remain in the  patient, therefore, there is little opportunity for product takeback.
","('Product_Design_And_Lifecycle_Management', 0.6749590635299683)","('Customer_Welfare', 0.09435475617647171)","('Product_Quality_And_Safety', 0.06840316206216812)","(['Product Stewardship'], 0.6749590635299683)","('NON-ESG', 0.09435475617647171)","('NON-ESG', 0.06840316206216812)"
Line 744,"However, we have  initiated new measures to minimize packaging waste associated with our products,  which has the impact of reducing waste and cost, as well as indirect emissions.
","('Waste_And_Hazardous_Materials_Management', 0.9659565091133118)","('Product_Design_And_Lifecycle_Management', 0.007199220359325409)","('Employee_Health_And_Safety', 0.0021399320103228092)","(['Operational Eco-Efficiency'], 0.9659565091133118)","('NON-ESG', 0.007199220359325409)","('NON-ESG', 0.0021399320103228092)"
Line 745,"We are  actively working on sustainable packaging projects focused on reducing the use of foam  on a few existing commercialized cardiovascular product packages.
","('Product_Design_And_Lifecycle_Management', 0.9584441781044006)","('Waste_And_Hazardous_Materials_Management', 0.004224536474794149)","('Customer_Welfare', 0.004043590743094683)","(['Product Stewardship'], 0.9584441781044006)","('NON-ESG', 0.004224536474794149)","('NON-ESG', 0.004043590743094683)"
Line 746,"Edwards realizes that collaboration is the key to driving sustainability within the   medical packaging ecosystem and our commitment and aspirations to lead and   develop sustainable packaging solutions has resulted in Edwards joining the Health  Care Packaging Recycling Council (HPRC) in 2022.
","('Product_Design_And_Lifecycle_Management', 0.9513924717903137)","('Energy_Management', 0.005237289238721132)","('Waste_And_Hazardous_Materials_Management', 0.004881478380411863)","(['Product Stewardship'], 0.9513924717903137)","('NON-ESG', 0.005237289238721132)","('NON-ESG', 0.004881478380411863)"
Line 747,"We remain on track to roll out electronic instructions-for-use to all applicable business  regions by the end of 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5620365738868713)","('Data_Security', 0.07223310321569443)","('Business_Model_Resilience', 0.03605468571186066)","(['Corporate Governance'], 0.5620365738868713)","('NON-ESG', 0.07223310321569443)","('NON-ESG', 0.03605468571186066)"
Line 748,"Both targets align to UN SDG 12: Responsible Consumption  and Production.
","('Energy_Management', 0.9242111444473267)","('GHG_Emissions', 0.009437688626348972)","('Management_Of_Legal_And_Regulatory_Framework', 0.009209073148667812)","(['Operational Eco-Efficiency'], 0.9242111444473267)","('NON-ESG', 0.009437688626348972)","('NON-ESG', 0.009209073148667812)"
Line 749,"The Edwards Product Stewardship Team also evaluates and ensures product   compliance with chemical disclosure and material content regulations such as   REACH, RoHS, California Proposition 65, and WEE.
","('Product_Design_And_Lifecycle_Management', 0.3339206576347351)","('Selling_Practices_And_Product_Labeling', 0.24750620126724243)","('Product_Quality_And_Safety', 0.24066287279129028)","('NON-ESG', 0.3339206576347351)","('NON-ESG', 0.24750620126724243)","('NON-ESG', 0.24066287279129028)"
Line 750,"This includes evaluation of product  compliance with regard to specific chemicals or substances of concern, such as DEHP,  PFOA, BPA, Persistent Organic Pollutants (POPs) and similar adverse compounds.
","('Product_Quality_And_Safety', 0.3817729949951172)","('Selling_Practices_And_Product_Labeling', 0.3209288716316223)","('Product_Design_And_Lifecycle_Management', 0.08098143339157104)","('NON-ESG', 0.3817729949951172)","('NON-ESG', 0.3209288716316223)","('NON-ESG', 0.08098143339157104)"
Line 751,"For more details, please see our Environmental, Health and Safety report.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Edwards Receives Clearance   for Hypotension Prediction   Index Software for Noninvasive   Acumen IQ Cuff In June 2021, Edwards received U.S. FDA clearance   of its Acumen Hypotension Prediction Index (HPI) software with the  Acumen IQ finger cuff.
","('Product_Quality_And_Safety', 0.8296397924423218)","('Selling_Practices_And_Product_Labeling', 0.020842067897319794)","('Customer_Welfare', 0.016962969675660133)","(['Product Quality & Recall Management'], 0.8296397924423218)","('NON-ESG', 0.020842067897319794)","('NON-ESG', 0.016962969675660133)"
Line 752,"This is the first noninvasive solution that unlocks  Acumen HPI software and uses machine learning to alert clinicians of the  likelihood a patient is trending toward hypotension, or low blood pressure.
","('Employee_Health_And_Safety', 0.175535649061203)","('Critical_Incident_Risk_Management', 0.11767461150884628)","('Customer_Welfare', 0.09556379169225693)","('NON-ESG', 0.175535649061203)","('NON-ESG', 0.11767461150884628)","('NON-ESG', 0.09556379169225693)"
Line 753,"Until now, Acumen HPI software has only been available for patients   using an invasive arterial line.
","('Access_And_Affordability', 0.5590783953666687)","('Employee_Health_And_Safety', 0.08475293219089508)","('Product_Quality_And_Safety', 0.04465034604072571)","(['Health Outcome Contribution'], 0.5590783953666687)","('NON-ESG', 0.08475293219089508)","('NON-ESG', 0.04465034604072571)"
Line 754,"“Numerous studies, including our research, have demonstrated an   association between intraoperative hypotension and increased risk of  acute kidney injury, myocardial injury and even death,” said Kamal   Maheshwari, M.D., MPH, anesthesiologist from Cleveland Clinic   Foundation.
","('Employee_Health_And_Safety', 0.954561710357666)","('Critical_Incident_Risk_Management', 0.0046484144404530525)","('Employee_Engagement_Inclusion_And_Diversity', 0.004528832621872425)","(['Operational Eco-Efficiency'], 0.954561710357666)","('NON-ESG', 0.0046484144404530525)","('NON-ESG', 0.004528832621872425)"
Line 755,"“The noninvasive Acumen IQ cuff provides the opportunity   to reduce hypotension in a broader range of patients, including those who  do not require an invasive arterial line.
","('Employee_Health_And_Safety', 0.2589138448238373)","('Access_And_Affordability', 0.1641637235879898)","('Customer_Welfare', 0.0752149373292923)","('NON-ESG', 0.2589138448238373)","('NON-ESG', 0.1641637235879898)","('NON-ESG', 0.0752149373292923)"
Line 756,"The cuff, along with the predictive  capabilities of Acumen HPI software to proactively manage hypotension,  will have a meaningful impact on patients.” In addition to unlocking predictive capabilities, Acumen IQ cuff   provides access to automatically calculated, beat-to-beat hemodynamic   parameters including mean arterial pressure and cardiac output.
","('Access_And_Affordability', 0.14942115545272827)","('Employee_Health_And_Safety', 0.12595289945602417)","('Customer_Welfare', 0.09921015799045563)","('NON-ESG', 0.14942115545272827)","('NON-ESG', 0.12595289945602417)","('NON-ESG', 0.09921015799045563)"
Line 757,"“This latest predictive technology demonstrates our commitment to   patient care and providing clinicians with ‘smart’ monitoring tools that  allow for better prediction and management,” said Katie Szyman,   Edwards’ corporate vice president, critical care.
","('Access_And_Affordability', 0.6412088871002197)","('Customer_Welfare', 0.0428055115044117)","('Critical_Incident_Risk_Management', 0.03631417453289032)","(['Health Outcome Contribution'], 0.6412088871002197)","('NON-ESG', 0.0428055115044117)","('NON-ESG', 0.03631417453289032)"
Line 758,"For more information, please see the related press release and   product page.
","('Product_Design_And_Lifecycle_Management', 0.5988322496414185)","('Selling_Practices_And_Product_Labeling', 0.21881835162639618)","('Product_Quality_And_Safety', 0.03641842305660248)","(['Product Stewardship'], 0.5988322496414185)","('NON-ESG', 0.21881835162639618)","('NON-ESG', 0.03641842305660248)"
Line 759,"HIGHLIGHT STORY Annual Performance Incentivizing Strong Product Design and Innovation Performance measures for incentive compensation are linked to our Strategic   Imperatives through the achievement of KODs. These measures are designed to   create long-term value for all stakeholders and hold executives accountable for   their individual and Edwards’ performance.
","('Product_Design_And_Lifecycle_Management', 0.9277668595314026)","('Business_Model_Resilience', 0.014168722555041313)","('Product_Quality_And_Safety', 0.007684029638767242)","(['Product Stewardship'], 0.9277668595314026)","('NON-ESG', 0.014168722555041313)","('NON-ESG', 0.007684029638767242)"
Line 760,"In 2021, there were four Strategic Imperatives from which the KODs were derived.
","('Business_Model_Resilience', 0.49005845189094543)","('Systemic_Risk_Management', 0.06707113981246948)","('Competitive_Behavior', 0.06201326847076416)","('NON-ESG', 0.49005845189094543)","('NON-ESG', 0.06707113981246948)","('NON-ESG', 0.06201326847076416)"
Line 761,"We do not disclose our KODs in detail because we believe doing so would cause a meaningful  competitive disadvantage.
","('Competitive_Behavior', 0.9573189616203308)","('Systemic_Risk_Management', 0.0052298130467534065)","('Business_Model_Resilience', 0.004081394523382187)","(['Business Ethics'], 0.9573189616203308)","('NON-ESG', 0.0052298130467534065)","('NON-ESG', 0.004081394523382187)"
Line 762,"However, we provide additional transparency on the structure  and outcomes of the 2021 Annual Incentive Plan KODs with specific illustrative examples   of milestones below to indicate the nature and types of milestones included in our KODs.  1.
","('Business_Ethics', 0.43251708149909973)","('Management_Of_Legal_And_Regulatory_Framework', 0.40458446741104126)","('Systemic_Risk_Management', 0.03997274860739708)","('NON-ESG', 0.43251708149909973)","('NON-ESG', 0.40458446741104126)","('NON-ESG', 0.03997274860739708)"
Line 763,"Our first imperative was to lead the global expansion of TAVR and accelerate the  treatment of aortic stenosis.
","('Employee_Health_And_Safety', 0.3955835998058319)","('Product_Quality_And_Safety', 0.07826835662126541)","('Employee_Engagement_Inclusion_And_Diversity', 0.07631736248731613)","('NON-ESG', 0.3955835998058319)","('NON-ESG', 0.07826835662126541)","('NON-ESG', 0.07631736248731613)"
Line 764,"Since 2020, we have achieved milestones on two   TAVR clinical trials which will lead to expanded indications over time, the EARLY   TAVR and PROGRESS trials.
","('Customer_Welfare', 0.16798098385334015)","('Access_And_Affordability', 0.1605355143547058)","('Competitive_Behavior', 0.14598774909973145)","('NON-ESG', 0.16798098385334015)","('NON-ESG', 0.1605355143547058)","('NON-ESG', 0.14598774909973145)"
Line 765,"We have also reached milestones on the advancement   of our next-gen product portfolio and have strong OUS TAVR growth.
","('Product_Design_And_Lifecycle_Management', 0.9352631568908691)","('Customer_Welfare', 0.00966266542673111)","('Business_Model_Resilience', 0.008828787133097649)","(['Product Stewardship'], 0.9352631568908691)","('NON-ESG', 0.00966266542673111)","('NON-ESG', 0.008828787133097649)"
Line 766,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 767,"Our next imperative was to transform the treatment of mitral and tricuspid valve   disease.
","('Employee_Health_And_Safety', 0.39231616258621216)","('Systemic_Risk_Management', 0.08757730573415756)","('Business_Ethics', 0.06123935058712959)","('NON-ESG', 0.39231616258621216)","('NON-ESG', 0.08757730573415756)","('NON-ESG', 0.06123935058712959)"
Line 768,"We have completed enrollment of the CLASP IID pivotal trial, achieved clinical   enrollment milestones for tricuspid therapies and technical milestones advancing  next-gen mitral and tricuspid therapies  3.
","('Customer_Welfare', 0.20105542242527008)","('Access_And_Affordability', 0.15255489945411682)","('Competitive_Behavior', 0.10261043906211853)","('NON-ESG', 0.20105542242527008)","('NON-ESG', 0.15255489945411682)","('NON-ESG', 0.10261043906211853)"
Line 769,"Our third imperative was to extend our global presence in surgical heart valves   and critical care.
","('Critical_Incident_Risk_Management', 0.2653585374355316)","('Employee_Health_And_Safety', 0.2374608814716339)","('Access_And_Affordability', 0.15253391861915588)","('NON-ESG', 0.2653585374355316)","('NON-ESG', 0.2374608814716339)","('NON-ESG', 0.15253391861915588)"
Line 770,"Since then, we have extended our leadership position in Surgical  Structural Heart through the adoption of premium technologies, developed strong  global growth in Critical Care and Surgical Structural Heart despite the impact of  COVID-19 on hospital staffing.
","('Access_And_Affordability', 0.3216785192489624)","('Critical_Incident_Risk_Management', 0.11911463737487793)","('Employee_Health_And_Safety', 0.10071633756160736)","('NON-ESG', 0.3216785192489624)","('NON-ESG', 0.11911463737487793)","('NON-ESG', 0.10071633756160736)"
Line 771,"We have also carried out advancements of Critical Care  technologies including hardware, algorithm development, and smart recovery   technologies.
","('Critical_Incident_Risk_Management', 0.31669843196868896)","('Supply_Chain_Management', 0.09705932438373566)","('Energy_Management', 0.093325175344944)","('NON-ESG', 0.31669843196868896)","('NON-ESG', 0.09705932438373566)","('NON-ESG', 0.093325175344944)"
Line 772,"4.
","('Competitive_Behavior', 0.1400022953748703)","('GHG_Emissions', 0.0895392969250679)","('Customer_Welfare', 0.0845675989985466)","('NON-ESG', 0.1400022953748703)","('NON-ESG', 0.0895392969250679)","('NON-ESG', 0.0845675989985466)"
Line 773,"Our final imperative was to strengthen capabilities and talent to execute key   initiatives and fortify culture.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8192541599273682)","('Business_Model_Resilience', 0.028712648898363113)","('Access_And_Affordability', 0.01453537680208683)","(['Human Capital Development'], 0.8192541599273682)","('NON-ESG', 0.028712648898363113)","('NON-ESG', 0.01453537680208683)"
Line 774,"Substantial progress has been accomplished on building  or expanding manufacturing facilities to prepare for future growth and patient needs.
","('Access_And_Affordability', 0.43347516655921936)","('Customer_Welfare', 0.09826240688562393)","('Energy_Management', 0.05160442739725113)","('NON-ESG', 0.43347516655921936)","('NON-ESG', 0.09826240688562393)","('NON-ESG', 0.05160442739725113)"
Line 775,"Additionally, we have reached global supply chain milestones through innovative  efforts that enabled continuous production of life-saving heart valve therapies and  critical care technologies.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT In December 2021, Edwards received approval from the U.S. FDA for the   use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive   prestent (SAPIEN 3 with Alterra) for patients with severe pulmonary regurgitation.
","('Supply_Chain_Management', 0.2945309281349182)","('Product_Design_And_Lifecycle_Management', 0.12154161930084229)","('Access_And_Affordability', 0.09617628157138824)","('NON-ESG', 0.2945309281349182)","('NON-ESG', 0.12154161930084229)","('NON-ESG', 0.09617628157138824)"
Line 776,"The Edwards SAPIEN 3 Transcatheter Pulmonary Valve (TPV) system combines the proven  SAPIEN 3 transcatheter heart valve and the Alterra adaptive prestent to expand transcatheter  therapy options for congenital heart valve disease patients.
","('Access_And_Affordability', 0.26291537284851074)","('Employee_Health_And_Safety', 0.23768587410449982)","('Critical_Incident_Risk_Management', 0.08905066549777985)","('NON-ESG', 0.26291537284851074)","('NON-ESG', 0.23768587410449982)","('NON-ESG', 0.08905066549777985)"
Line 777,"The Alterra prestent compensates  for variations in size and morphology of the right ventricular outflow tract to provide a stable  landing zone for the SAPIEN 3 valve.
","('Water_And_Wastewater_Management', 0.6061055660247803)","('Ecological_Impacts', 0.07135304808616638)","('Air_Quality', 0.06913422793149948)","(['Operational Eco-Efficiency'], 0.6061055660247803)","('NON-ESG', 0.07135304808616638)","('NON-ESG', 0.06913422793149948)"
Line 778,"“The FDA approval of the SAPIEN 3 with Alterra is great news for patients around the world,  many of whom have endured numerous surgical procedures to treat their congenital heart  disease,” said Dr. Evan Zahn, M.D., Director of Guerin Family Congenital Heart Program at   the Smidt Heart Institute, Cedars-Sinai Medical Center, and principal investigator for the   ALTERRA clinical trial.
","('Employee_Health_And_Safety', 0.18992890417575836)","('Product_Quality_And_Safety', 0.13654404878616333)","('Access_And_Affordability', 0.0836392417550087)","('NON-ESG', 0.18992890417575836)","('NON-ESG', 0.13654404878616333)","('NON-ESG', 0.0836392417550087)"
Line 779,"“The outstanding outcomes achieved by SAPIEN 3 with Alterra will   expand the range of patients who require pulmonary valve replacement that we can now treat  with minimally invasive therapy.
","('Employee_Health_And_Safety', 0.3388543725013733)","('Access_And_Affordability', 0.2634199261665344)","('Product_Quality_And_Safety', 0.05182155594229698)","('NON-ESG', 0.3388543725013733)","('NON-ESG', 0.2634199261665344)","('NON-ESG', 0.05182155594229698)"
Line 780,"This will result in significant improvements in quality   of life and a reduction in the number of surgeries and procedures that a congenital heart   patient requires over the course of their lifetime.” While pulmonic heart valve replacements represent a small fraction of the heart valve   replacements done each year, it is generally required to replace valves in adolescent and adult  patients suffering from Tetralogy of Fallot or other congenital heart valve defects.
","('Employee_Health_And_Safety', 0.4946105182170868)","('Access_And_Affordability', 0.06885895133018494)","('Critical_Incident_Risk_Management', 0.06588864326477051)","('NON-ESG', 0.4946105182170868)","('NON-ESG', 0.06885895133018494)","('NON-ESG', 0.06588864326477051)"
Line 781,"“Many  of these patients endure repeated open-heart surgeries to address heart conditions present  since birth, which takes a huge toll on their ability to lead normal lives.
","('Employee_Health_And_Safety', 0.2726673483848572)","('Access_And_Affordability', 0.24559856951236725)","('Critical_Incident_Risk_Management', 0.0755007416009903)","('NON-ESG', 0.2726673483848572)","('NON-ESG', 0.24559856951236725)","('NON-ESG', 0.0755007416009903)"
Line 782,"The SAPIEN 3 with  Alterra provides a new treatment option that can reduce the number of invasive procedures  these patients face in their lifetimes,” said Larry Wood, corporate vice president,   transcatheter aortic valve replacement.
","('Employee_Health_And_Safety', 0.5467453598976135)","('Access_And_Affordability', 0.10575559735298157)","('Product_Quality_And_Safety', 0.04388689249753952)","(['Operational Eco-Efficiency'], 0.5467453598976135)","('NON-ESG', 0.10575559735298157)","('NON-ESG', 0.04388689249753952)"
Line 783,"For more information, please see the related press release and product page.
","('Product_Design_And_Lifecycle_Management', 0.5988322496414185)","('Selling_Practices_And_Product_Labeling', 0.21881835162639618)","('Product_Quality_And_Safety', 0.03641842305660248)","(['Product Stewardship'], 0.5988322496414185)","('NON-ESG', 0.21881835162639618)","('NON-ESG', 0.03641842305660248)"
Line 784,"Edwards Receives Approval for SAPIEN 3   with Alterra Prestent for Transcatheter   Pulmonic Valve ReplacementHIGHLIGHT STORY Underlying these Strategic Imperatives are approximately 80   specific KOD metrics and milestones relating to, among other   things, research and development, commercial and financial   milestones in each of the four business units, key initiatives to   increase patient access to our therapies and specific milestones   for global supply chain as it relates to launches of products,   supply, capacity, quality, productivity, service and capabilities.
","('Product_Design_And_Lifecycle_Management', 0.5570704340934753)","('Supply_Chain_Management', 0.1786375194787979)","('Customer_Welfare', 0.07047710567712784)","(['Product Stewardship'], 0.5570704340934753)","('NON-ESG', 0.1786375194787979)","('NON-ESG', 0.07047710567712784)"
Line 785,"Edwards Receives Approval for SAPIEN 3   with Alterra Prestent for Transcatheter   Pulmonic Valve ReplacementHIGHLIGHT STORY Underlying these Strategic Imperatives are approximately 80   specific KOD metrics and milestones relating to, among other   things, research and development, commercial and financial   milestones in each of the four business units, key initiatives to   increase patient access to our therapies and specific milestones   for global supply chain as it relates to launches of products,   supply, capacity, quality, productivity, service and capabilities.
","('Business_Model_Resilience', 0.3127415180206299)","('Supply_Chain_Management', 0.11297938972711563)","('Employee_Engagement_Inclusion_And_Diversity', 0.07544856518507004)","('NON-ESG', 0.3127415180206299)","('NON-ESG', 0.11297938972711563)","('NON-ESG', 0.07544856518507004)"
Line 786,"Approximately 25 percent of the KODs include a financial   component.
","('Systemic_Risk_Management', 0.3040182888507843)","('Management_Of_Legal_And_Regulatory_Framework', 0.2201066017150879)","('Competitive_Behavior', 0.09876348078250885)","('NON-ESG', 0.3040182888507843)","('NON-ESG', 0.2201066017150879)","('NON-ESG', 0.09876348078250885)"
Line 787,"Stakeholder Collaboration   Edwards is also dedicated to collaborating with clinicians to   develop patient-centric innovations for complex surgical   structural heart procedures that improve long-term care and   outcomes for patients.
","('Access_And_Affordability', 0.4682970643043518)","('Employee_Health_And_Safety', 0.17025049030780792)","('Customer_Welfare', 0.05257435515522957)","('NON-ESG', 0.4682970643043518)","('NON-ESG', 0.17025049030780792)","('NON-ESG', 0.05257435515522957)"
Line 788,"For example, in 2021 we launched the   HARPOON Beating Heart Mitral Valve Repair System, which can   help transform care for many patients with degenerative mitral   regurgitation.
","('Employee_Health_And_Safety', 0.27016299962997437)","('Access_And_Affordability', 0.20707963407039642)","('Employee_Engagement_Inclusion_And_Diversity', 0.06559966504573822)","('NON-ESG', 0.27016299962997437)","('NON-ESG', 0.20707963407039642)","('NON-ESG', 0.06559966504573822)"
Line 789,"We believe the demand for surgical structural heart  therapies is growing worldwide and that our innovation strategy  will continue to extend our leadership and patient impact.
","('Access_And_Affordability', 0.3200514316558838)","('Customer_Welfare', 0.14066074788570404)","('Product_Design_And_Lifecycle_Management', 0.07476798444986343)","('NON-ESG', 0.3200514316558838)","('NON-ESG', 0.14066074788570404)","('NON-ESG', 0.07476798444986343)"
Line 790,"Product Design & Innovation in a Pandemic   Our manufacturing operations have continued to respond to   impacts related to COVID-19, and we have been able to supply   our technologies around the world.
","('Product_Design_And_Lifecycle_Management', 0.9606914520263672)","('Supply_Chain_Management', 0.004219194408506155)","('Business_Model_Resilience', 0.0033352139871567488)","(['Product Stewardship'], 0.9606914520263672)","('NON-ESG', 0.004219194408506155)","('NON-ESG', 0.0033352139871567488)"
Line 791,"Across the organization,   we are proactively managing inventory, assessing alternative   logistics options, and closely monitoring the supply of   components.
","('Supply_Chain_Management', 0.9291696548461914)","('Energy_Management', 0.008264429867267609)","('Waste_And_Hazardous_Materials_Management', 0.006477858405560255)","(['Supply Chain Management'], 0.9291696548461914)","('NON-ESG', 0.008264429867267609)","('NON-ESG', 0.006477858405560255)"
Line 792,"In 2021, we continued to advance our portfolio   of catheter-based solutions, such as SAPIEN 3, which has an   estimated cost savings of more than $2,000 per patient and  a significant improvement in quality-adjusted life expectancy  through the two-year study period.
","('Access_And_Affordability', 0.48551979660987854)","('Employee_Health_And_Safety', 0.1239747554063797)","('Customer_Welfare', 0.05459519848227501)","('NON-ESG', 0.48551979660987854)","('NON-ESG', 0.1239747554063797)","('NON-ESG', 0.05459519848227501)"
Line 793,"This improvement reflects   a disciplined approach for advancing the technology, procedural  techniques, and partnership with regulators.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9445452094078064)","('Business_Ethics', 0.0118674635887146)","('Competitive_Behavior', 0.008268202655017376)","(['Corporate Governance'], 0.9445452094078064)","('NON-ESG', 0.0118674635887146)","('NON-ESG', 0.008268202655017376)"
Line 794,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Workforce Edwards Lifesciences’ employees drive our work with their passion for helping others.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5578221678733826)","('Human_Rights_And_Community_Relations', 0.13975027203559875)","('Employee_Health_And_Safety', 0.08097143471240997)","(['Human Capital Development'], 0.5578221678733826)","('NON-ESG', 0.13975027203559875)","('NON-ESG', 0.08097143471240997)"
Line 795,"The Workforce section of our 2021 Sustainability Report covers all of our business   operations and contains our management approach and annual performance for the   following material topics:  •  Human Capital Management  •  Diversity, Inclusion & Belonging  •  Volunteerism & Giving Human Capital Management Edwards Lifesciences focuses on initiatives that continuously innovate and improve   employee recruitment, engagement and retention to support fostering an inclusive   culture where all employees grow and thrive.
","('Employee_Engagement_Inclusion_And_Diversity', 0.976707398891449)","('Employee_Health_And_Safety', 0.0019249289762228727)","('Human_Rights_And_Community_Relations', 0.001453715143725276)","(['Human Capital Development'], 0.976707398891449)","('NON-ESG', 0.0019249289762228727)","('NON-ESG', 0.001453715143725276)"
Line 796,"The Workforce section of our 2021 Sustainability Report covers all of our business   operations and contains our management approach and annual performance for the   following material topics:  •  Human Capital Management  •  Diversity, Inclusion & Belonging  •  Volunteerism & Giving Human Capital Management Edwards Lifesciences focuses on initiatives that continuously innovate and improve   employee recruitment, engagement and retention to support fostering an inclusive   culture where all employees grow and thrive.
","('Business_Model_Resilience', 0.29027891159057617)","('Systemic_Risk_Management', 0.2088225930929184)","('Supply_Chain_Management', 0.159767746925354)","('NON-ESG', 0.29027891159057617)","('NON-ESG', 0.2088225930929184)","('NON-ESG', 0.159767746925354)"
Line 797,"Definition   Developing strategies for attracting, developing and retaining talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8395490646362305)","('Business_Model_Resilience', 0.0155669916421175)","('Business_Ethics', 0.012243345379829407)","(['Human Capital Development'], 0.8395490646362305)","('NON-ESG', 0.0155669916421175)","('NON-ESG', 0.012243345379829407)"
Line 798,"Edwards Lifesciences  strives to maintain and enhance a culture reflective of our Credo and Aspirations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6358080506324768)","('Human_Rights_And_Community_Relations', 0.07678870111703873)","('Business_Model_Resilience', 0.04136032983660698)","(['Human Capital Development'], 0.6358080506324768)","('NON-ESG', 0.07678870111703873)","('NON-ESG', 0.04136032983660698)"
Line 799,"We believe  that fostering a diverse, inclusive culture is critical to our long-term success as we help more  patients around the world.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9516227841377258)","('Access_And_Affordability', 0.005438750144094229)","('Human_Rights_And_Community_Relations', 0.00494175823405385)","(['Human Capital Development'], 0.9516227841377258)","('NON-ESG', 0.005438750144094229)","('NON-ESG', 0.00494175823405385)"
Line 800,"Our commitment to promoting workplace health and safety  serves our Aspiration of fostering an inclusive culture where all employees grow and thrive,  while providing Edwards employees with health resources and safe working conditions.Management Approach   Edwards Lifesciences unites our employees around a common passion for improving  the lives of our patients.
","('Employee_Health_And_Safety', 0.979488730430603)","('Employee_Engagement_Inclusion_And_Diversity', 0.002647633897140622)","('Critical_Incident_Risk_Management', 0.0017904768465086818)","(['Operational Eco-Efficiency'], 0.979488730430603)","('NON-ESG', 0.002647633897140622)","('NON-ESG', 0.0017904768465086818)"
Line 801,"Our top priority is to execute our work with the utmost   precision and care because we know that our therapies have the power to impact   patients’ longevity and quality of life.
","('Access_And_Affordability', 0.5920800566673279)","('Employee_Health_And_Safety', 0.08009219169616699)","('Product_Quality_And_Safety', 0.058245699852705)","(['Health Outcome Contribution'], 0.5920800566673279)","('NON-ESG', 0.08009219169616699)","('NON-ESG', 0.058245699852705)"
Line 802,"Edwards is a growing company, and our culture  is an important factor in attracting and retaining top talent that will continue to   advance our innovative technologies for the patients we serve.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8484147787094116)","('Business_Model_Resilience', 0.01870896853506565)","('Customer_Welfare', 0.014883683063089848)","(['Human Capital Development'], 0.8484147787094116)","('NON-ESG', 0.01870896853506565)","('NON-ESG', 0.014883683063089848)"
Line 803,"Diversity is a vital part of our company culture, and foundational to Edwards’ work   to innovate life-saving therapies for patients.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9647599458694458)","('Employee_Health_And_Safety', 0.0024627726525068283)","('Access_And_Affordability', 0.002437618328258395)","(['Human Capital Development'], 0.9647599458694458)","('NON-ESG', 0.0024627726525068283)","('NON-ESG', 0.002437618328258395)"
Line 804,"Diverse talent is crucial for driving   innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9585235714912415)","('Business_Model_Resilience', 0.002875475911423564)","('Competitive_Behavior', 0.0028496519662439823)","(['Human Capital Development'], 0.9585235714912415)","('NON-ESG', 0.002875475911423564)","('NON-ESG', 0.0028496519662439823)"
Line 805,"We foster a company culture that actively values diversity and is inclusive  of people from a variety of backgrounds and experiences.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9753721356391907)","('Human_Rights_And_Community_Relations', 0.001930826809257269)","('Employee_Health_And_Safety', 0.0017875615740194917)","(['Human Capital Development'], 0.9753721356391907)","('NON-ESG', 0.001930826809257269)","('NON-ESG', 0.0017875615740194917)"
Line 806,"Please see our Diversity,  Inclusion and Belonging  section for more details.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9716441035270691)","('Human_Rights_And_Community_Relations', 0.0022141176741570234)","('Employee_Health_And_Safety', 0.0022134643513709307)","(['Human Capital Development'], 0.9716441035270691)","('NON-ESG', 0.0022141176741570234)","('NON-ESG', 0.0022134643513709307)"
Line 807,"Edwards believes our focus on helping patients begins with the well-being of our   employees.
","('Human_Rights_And_Community_Relations', 0.2844559848308563)","('Employee_Health_And_Safety', 0.24846257269382477)","('Access_And_Affordability', 0.19633950293064117)","('NON-ESG', 0.2844559848308563)","('NON-ESG', 0.24846257269382477)","('NON-ESG', 0.19633950293064117)"
Line 808,"Maintaining a strong and healthy workforce enables us to stay focused on  our goals and dedicate our energies toward the development of life-saving therapies.
","('Employee_Health_And_Safety', 0.4910874664783478)","('Access_And_Affordability', 0.18068541586399078)","('Product_Design_And_Lifecycle_Management', 0.06711599975824356)","('NON-ESG', 0.4910874664783478)","('NON-ESG', 0.18068541586399078)","('NON-ESG', 0.06711599975824356)"
Line 809,"As we continue to grow our global footprint, we work to enhance our talent’s ability  to think and operate on a global scale.
","('Employee_Engagement_Inclusion_And_Diversity', 0.819907009601593)","('Business_Model_Resilience', 0.03105991892516613)","('Competitive_Behavior', 0.01862538419663906)","(['Human Capital Development'], 0.819907009601593)","('NON-ESG', 0.03105991892516613)","('NON-ESG', 0.01862538419663906)"
Line 810,"The high expectations of our partners and the  patients we serve in the midst of a fast-changing world present a challenge as they  require more agile methodologies and mindsets, and new technological skillsets.
","('Business_Model_Resilience', 0.14783106744289398)","('Product_Design_And_Lifecycle_Management', 0.14124000072479248)","('Employee_Engagement_Inclusion_And_Diversity', 0.1295785903930664)","('NON-ESG', 0.14783106744289398)","('NON-ESG', 0.14124000072479248)","('NON-ESG', 0.1295785903930664)"
Line 811,"We aim to foster and recruit talent that can exceed these expectations in fulfilling   the needs of patients.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Governance Map   The governance map below illustrates our Human Capital Management structure.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3174724280834198)","('Business_Model_Resilience', 0.3109978139400482)","('Systemic_Risk_Management', 0.07623998075723648)","('NON-ESG', 0.3174724280834198)","('NON-ESG', 0.3109978139400482)","('NON-ESG', 0.07623998075723648)"
Line 812,"People Strategy As we scale to reach more patients around the world, we have integrated our   Talent & Organization (T&O) Strategy with our Edwards Strategic Planning process.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9106370210647583)","('Business_Model_Resilience', 0.012025149539113045)","('Customer_Welfare', 0.007220507133752108)","(['Human Capital Development'], 0.9106370210647583)","('NON-ESG', 0.012025149539113045)","('NON-ESG', 0.007220507133752108)"
Line 813,"The purpose of our T&O Strategy is to anticipate dynamic global trends related to   our workforce, develop our talent to meet future organizational needs, and positions   us to be well-poised for ongoing market success.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9218845367431641)","('Business_Model_Resilience', 0.013887567445635796)","('Customer_Welfare', 0.005662151612341404)","(['Human Capital Development'], 0.9218845367431641)","('NON-ESG', 0.013887567445635796)","('NON-ESG', 0.005662151612341404)"
Line 814,"The T&O Strategy enables us to   explore external workforce signals, share insights, and identify and build emerging   capabilities across our organization.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8449349403381348)","('Business_Model_Resilience', 0.04128812626004219)","('Customer_Welfare', 0.012005534023046494)","(['Human Capital Development'], 0.8449349403381348)","('NON-ESG', 0.04128812626004219)","('NON-ESG', 0.012005534023046494)"
Line 815,"The T&O Strategy framework takes a   comprehensive approach that includes envisioning the future of our work (the   “what” and “how” we deliver our patient-focused strategy), planning our workforce  (the “who” joining our community of trusted partners), and designing our workplace  (the “where” and “when” work gets done).
","('Employee_Engagement_Inclusion_And_Diversity', 0.48848435282707214)","('Employee_Health_And_Safety', 0.11585382372140884)","('Labor_Practices', 0.0872904360294342)","('NON-ESG', 0.48848435282707214)","('NON-ESG', 0.11585382372140884)","('NON-ESG', 0.0872904360294342)"
Line 816,"This consistent and scalable approach  looks across all our business units, regions, and significant functions to align and   elevate priorities, critical capabilities, and organizational evolutions in line with our  strategic plan.
","('Business_Model_Resilience', 0.8140968084335327)","('Product_Design_And_Lifecycle_Management', 0.020051384344697)","('Systemic_Risk_Management', 0.019312812015414238)","(['Codes of Business Conduct'], 0.8140968084335327)","('NON-ESG', 0.020051384344697)","('NON-ESG', 0.019312812015414238)"
Line 817,"This integrated approach informs our yearly objectives and fuels   our talent roadmap across the strategic horizon.Recruiting Top Talent Attracting, developing, and retaining talent is fundamental to our success.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9267504811286926)","('Business_Model_Resilience', 0.006209672894328833)","('Employee_Health_And_Safety', 0.005553713534027338)","(['Human Capital Development'], 0.9267504811286926)","('NON-ESG', 0.006209672894328833)","('NON-ESG', 0.005553713534027338)"
Line 818,"The   primary goals of our human capital strategy are to attract and maintain a motivated,  professional workforce and to ensure alignment on our patient-focused innovation  strategy.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9219955801963806)","('Business_Model_Resilience', 0.011995909735560417)","('Director_Removal', 0.005570197943598032)","(['Human Capital Development'], 0.9219955801963806)","('NON-ESG', 0.011995909735560417)","('NON-ESG', 0.005570197943598032)"
Line 819,"To attract and recruit top talent, Edwards leverages our strong culture in   addition to providing competitive compensation and benefits packages, including    offering performance-based incentives, stock options, retirement plan options,   remote work options, paid time off, family leave and health, life and disability   insurance.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5176724195480347)","('Labor_Practices', 0.28681501746177673)","('Systemic_Risk_Management', 0.022766271606087685)","(['Human Capital Development'], 0.5176724195480347)","('NON-ESG', 0.28681501746177673)","('NON-ESG', 0.022766271606087685)"
Line 820,"Our target is to have annual top talent retention resulting in voluntary   turnover less than high-performing benchmarks.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8926180005073547)","('Competitive_Behavior', 0.01440240815281868)","('Business_Ethics', 0.00910564512014389)","(['Human Capital Development'], 0.8926180005073547)","('NON-ESG', 0.01440240815281868)","('NON-ESG', 0.00910564512014389)"
Line 821,"Edwards recruits top students from universities across the world to join our team.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7266404032707214)","('Access_And_Affordability', 0.028563499450683594)","('Business_Model_Resilience', 0.018897201865911484)","(['Human Capital Development'], 0.7266404032707214)","('NON-ESG', 0.028563499450683594)","('NON-ESG', 0.018897201865911484)"
Line 822,"Our opportunities for students include:  • Internships  • Edwards Summer Immersion Experience  • BS/MS Development Programs  • MBA Development Programs  • Professional Areas of Development Employee Engagement Survey We believe in empowering our employees and providing avenues that enable their   voices to be heard.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9240372776985168)","('Employee_Health_And_Safety', 0.011534526944160461)","('Access_And_Affordability', 0.006639475002884865)","(['Human Capital Development'], 0.9240372776985168)","('NON-ESG', 0.011534526944160461)","('NON-ESG', 0.006639475002884865)"
Line 823,"We conduct a multilingual global employee survey, called myVoice,   to gather feedback in a confidential manner.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5450407862663269)","('Customer_Privacy', 0.14114700257778168)","('Labor_Practices', 0.07209315896034241)","(['Human Capital Development'], 0.5450407862663269)","('NON-ESG', 0.14114700257778168)","('NON-ESG', 0.07209315896034241)"
Line 824,"We gain insights on various topics including  patient focus, diversity, inclusion and belonging, quality, innovation, and engagement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9734635353088379)","('Human_Rights_And_Community_Relations', 0.0024269199930131435)","('Employee_Health_And_Safety', 0.0023366319946944714)","(['Human Capital Development'], 0.9734635353088379)","('NON-ESG', 0.0024269199930131435)","('NON-ESG', 0.0023366319946944714)"
Line 825,"Edwards partners with a third party to assess how our performance, values and   behaviors drive engagement.
","('Human_Rights_And_Community_Relations', 0.8360694050788879)","('Employee_Engagement_Inclusion_And_Diversity', 0.02691313624382019)","('Access_And_Affordability', 0.012695328332483768)","(['Community Relations'], 0.8360694050788879)","('NON-ESG', 0.02691313624382019)","('NON-ESG', 0.012695328332483768)"
Line 826,"We collect concise and insightful results and put   them into action to make Edwards an even better place to work.
","('Management_Of_Legal_And_Regulatory_Framework', 0.18979817628860474)","('Business_Model_Resilience', 0.12148229032754898)","('Competitive_Behavior', 0.1030043512582779)","('NON-ESG', 0.18979817628860474)","('NON-ESG', 0.12148229032754898)","('NON-ESG', 0.1030043512582779)"
Line 827,"Our survey results   often exceed external benchmarks, and the insights we uncover are used to take specific  action, such as tailored leadership development training.
","('Employee_Engagement_Inclusion_And_Diversity', 0.42240846157073975)","('Business_Model_Resilience', 0.10221995413303375)","('Human_Rights_And_Community_Relations', 0.06666834652423859)","('NON-ESG', 0.42240846157073975)","('NON-ESG', 0.10221995413303375)","('NON-ESG', 0.06666834652423859)"
Line 828,"Our favorable survey results   have also been linked to employee retention.Corporate Governance Environmental Health & Safety Ethics & Compliance Product Safety & QualityFoundationSupply  Chain Management Human  Capital  Managementclick to viewEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Patients First Edwards’ “Patients First” culture in action serves as a force multiplier enabling   Edwards to attract, engage and retain the best and brightest.
","('Product_Quality_And_Safety', 0.7371493577957153)","('Employee_Health_And_Safety', 0.05635916441679001)","('Business_Ethics', 0.05260800942778587)","(['Product Quality & Recall Management'], 0.7371493577957153)","('NON-ESG', 0.05635916441679001)","('NON-ESG', 0.05260800942778587)"
Line 829,"One of our priorities is   to ensure all employees have exposure to patient stories and patient interactions   annually to improve engagement and remind our team that working at Edwards means  making a difference in people’s lives.
","('Human_Rights_And_Community_Relations', 0.35294216871261597)","('Access_And_Affordability', 0.3084145784378052)","('Employee_Engagement_Inclusion_And_Diversity', 0.07732853293418884)","('NON-ESG', 0.35294216871261597)","('NON-ESG', 0.3084145784378052)","('NON-ESG', 0.07732853293418884)"
Line 830,"This target aligns with UN SDG 3: Good Health and  Well-Being.
","('Access_And_Affordability', 0.4046924412250519)","('Employee_Health_And_Safety', 0.27372032403945923)","('Human_Rights_And_Community_Relations', 0.06704744696617126)","('NON-ESG', 0.4046924412250519)","('NON-ESG', 0.27372032403945923)","('NON-ESG', 0.06704744696617126)"
Line 831,"Our CEO conducts quarterly employee meetings, and always concludes   with a patient video or testimony.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4208843410015106)","('Business_Ethics', 0.15724033117294312)","('Competitive_Behavior', 0.05070614069700241)","('NON-ESG', 0.4208843410015106)","('NON-ESG', 0.15724033117294312)","('NON-ESG', 0.05070614069700241)"
Line 832,"Many of the leaders throughout Edwards include in  their all-hands meetings a patient video or story, as well.
","('Employee_Engagement_Inclusion_And_Diversity', 0.17773665487766266)","('Access_And_Affordability', 0.1773422807455063)","('Employee_Health_And_Safety', 0.11134494841098785)","('NON-ESG', 0.17773665487766266)","('NON-ESG', 0.1773422807455063)","('NON-ESG', 0.11134494841098785)"
Line 833,"Patient videos are also   shown in new hire orientations around the globe.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7804961800575256)","('Access_And_Affordability', 0.05939013138413429)","('Customer_Welfare', 0.01391650177538395)","(['Human Capital Development'], 0.7804961800575256)","('NON-ESG', 0.05939013138413429)","('NON-ESG', 0.01391650177538395)"
Line 834,"For more information on other    patient engagements, please see the Patient Experience & Voice section of this report.
","('Access_And_Affordability', 0.2573646306991577)","('Human_Rights_And_Community_Relations', 0.23817454278469086)","('Employee_Engagement_Inclusion_And_Diversity', 0.06592433899641037)","('NON-ESG', 0.2573646306991577)","('NON-ESG', 0.23817454278469086)","('NON-ESG', 0.06592433899641037)"
Line 835,"Training and Leadership Development Our greatest asset is our employees, and the unique knowledge and skills they provide.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8746522068977356)","('Employee_Health_And_Safety', 0.021915407851338387)","('Human_Rights_And_Community_Relations', 0.014120660722255707)","(['Human Capital Development'], 0.8746522068977356)","('NON-ESG', 0.021915407851338387)","('NON-ESG', 0.014120660722255707)"
Line 836,"We host several Professional Development programs designed to provide resources to  support the growth of our company’s talent, including:  •  Tuition assistance for job-related continuing education and degree programs   at higher educational institutions  •  Edwards University, an online platform, offers our employees a wide variety of  training, education and other resources, as well as learning partnerships with   University of California, Irvine; eCornell; MIT; and Mind Tools  •  Aspire, our global leadership development curriculum, offers skill-based open   enrollment workshops, including topics such as critical thinking, strategic   execution, career development strategy, effective conversations, powerful   speaking, communicating among different personalities, leveraging diversity   and emotional intelligence  •  A variety of nomination-based programs, including our new Accelerated   Development Program, are designed to build leaders for the future by   offering emerging and senior leaders challenging programming, coaching   and assessments  •  Global Talent Management and Learning architects and develops career   broadening experiences for critical talent populations across Edwards’   businesses and globallyTalent Development Review (TDR) Our Human Capital Management (HCM) governance includes a global TDR process   as well as an HCM dashboard.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6515390872955322)","('Access_And_Affordability', 0.1309822052717209)","('Customer_Welfare', 0.023634951561689377)","(['Human Capital Development'], 0.6515390872955322)","('NON-ESG', 0.1309822052717209)","('NON-ESG', 0.023634951561689377)"
Line 837,"We host several Professional Development programs designed to provide resources to  support the growth of our company’s talent, including:  •  Tuition assistance for job-related continuing education and degree programs   at higher educational institutions  •  Edwards University, an online platform, offers our employees a wide variety of  training, education and other resources, as well as learning partnerships with   University of California, Irvine; eCornell; MIT; and Mind Tools  •  Aspire, our global leadership development curriculum, offers skill-based open   enrollment workshops, including topics such as critical thinking, strategic   execution, career development strategy, effective conversations, powerful   speaking, communicating among different personalities, leveraging diversity   and emotional intelligence  •  A variety of nomination-based programs, including our new Accelerated   Development Program, are designed to build leaders for the future by   offering emerging and senior leaders challenging programming, coaching   and assessments  •  Global Talent Management and Learning architects and develops career   broadening experiences for critical talent populations across Edwards’   businesses and globallyTalent Development Review (TDR) Our Human Capital Management (HCM) governance includes a global TDR process   as well as an HCM dashboard.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9617070555686951)","('Business_Model_Resilience', 0.0035409803967922926)","('Human_Rights_And_Community_Relations', 0.0030637283343821764)","(['Human Capital Development'], 0.9617070555686951)","('NON-ESG', 0.0035409803967922926)","('NON-ESG', 0.0030637283343821764)"
Line 838,"We host several Professional Development programs designed to provide resources to  support the growth of our company’s talent, including:  •  Tuition assistance for job-related continuing education and degree programs   at higher educational institutions  •  Edwards University, an online platform, offers our employees a wide variety of  training, education and other resources, as well as learning partnerships with   University of California, Irvine; eCornell; MIT; and Mind Tools  •  Aspire, our global leadership development curriculum, offers skill-based open   enrollment workshops, including topics such as critical thinking, strategic   execution, career development strategy, effective conversations, powerful   speaking, communicating among different personalities, leveraging diversity   and emotional intelligence  •  A variety of nomination-based programs, including our new Accelerated   Development Program, are designed to build leaders for the future by   offering emerging and senior leaders challenging programming, coaching   and assessments  •  Global Talent Management and Learning architects and develops career   broadening experiences for critical talent populations across Edwards’   businesses and globallyTalent Development Review (TDR) Our Human Capital Management (HCM) governance includes a global TDR process   as well as an HCM dashboard.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9384272694587708)","('Business_Model_Resilience', 0.00635430496186018)","('Employee_Health_And_Safety', 0.004683786537498236)","(['Human Capital Development'], 0.9384272694587708)","('NON-ESG', 0.00635430496186018)","('NON-ESG', 0.004683786537498236)"
Line 839,"The purpose of our TDR process is to align our talent   strategies with business strategy, assess talent against future organizational needs,  evaluate critical talent populations, and enhance the strength of our succession   planning.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9123637676239014)","('Business_Model_Resilience', 0.01180446520447731)","('Employee_Health_And_Safety', 0.007898518815636635)","(['Human Capital Development'], 0.9123637676239014)","('NON-ESG', 0.01180446520447731)","('NON-ESG', 0.007898518815636635)"
Line 840,"Our HCM dashboard is generated quarterly and provides insights on key   metrics related to areas such as attraction and growth rates, retention trends, diversity,  and employee sentiment.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9748709797859192)","('Employee_Health_And_Safety', 0.0021527931094169617)","('Business_Model_Resilience', 0.0015094215050339699)","(['Human Capital Development'], 0.9748709797859192)","('NON-ESG', 0.0021527931094169617)","('NON-ESG', 0.0015094215050339699)"
Line 841,"Our CEO meets with the Chief Human Resources Officer and  Corporate Vice President of each business unit, function and region to conduct a full   annual review of their respective organizations’ talent and talent needs for Edwards   to pursue its life-saving work and patient-focused strategy.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9495536684989929)","('Employee_Health_And_Safety', 0.004875347949564457)","('Business_Model_Resilience', 0.003997413441538811)","(['Human Capital Development'], 0.9495536684989929)","('NON-ESG', 0.004875347949564457)","('NON-ESG', 0.003997413441538811)"
Line 842,"Active and Expanding Mentoring Programs Mentors can help employees identify personal and professional goals, access resources   and reach individual potential.
","('Access_And_Affordability', 0.42512741684913635)","('Employee_Engagement_Inclusion_And_Diversity', 0.31318899989128113)","('Human_Rights_And_Community_Relations', 0.03911030292510986)","('NON-ESG', 0.42512741684913635)","('NON-ESG', 0.31318899989128113)","('NON-ESG', 0.03911030292510986)"
Line 843,"We leverage various mentoring approaches and programs  across Edwards to build internal talent, share knowledge and increase employee   engagement and satisfaction.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9680661559104919)","('Employee_Health_And_Safety', 0.0031767087057232857)","('Human_Rights_And_Community_Relations', 0.002084452426061034)","(['Human Capital Development'], 0.9680661559104919)","('NON-ESG', 0.0031767087057232857)","('NON-ESG', 0.002084452426061034)"
Line 844,"In tracking our mentoring initiatives over the years,   we found a strong correlation between mentorship participation and employee   retention.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9213728904724121)","('Employee_Health_And_Safety', 0.011821306310594082)","('Access_And_Affordability', 0.007917655631899834)","(['Human Capital Development'], 0.9213728904724121)","('NON-ESG', 0.011821306310594082)","('NON-ESG', 0.007917655631899834)"
Line 845,"Flash mentoring is also being utilized to drive development through less   formal, more rapid mentoring connections.
","('Access_And_Affordability', 0.5414389371871948)","('Employee_Engagement_Inclusion_And_Diversity', 0.11971824616193771)","('Human_Rights_And_Community_Relations', 0.04191557690501213)","(['Health Outcome Contribution'], 0.5414389371871948)","('NON-ESG', 0.11971824616193771)","('NON-ESG', 0.04191557690501213)"
Line 846,"Total Well-being at Edwards Edwards believes that better health leads to better performance, and the company   ensures that we regularly sponsor wellness initiatives for employees.
","('Employee_Health_And_Safety', 0.5576213002204895)","('Access_And_Affordability', 0.16108328104019165)","('Employee_Engagement_Inclusion_And_Diversity', 0.04284391924738884)","(['Operational Eco-Efficiency'], 0.5576213002204895)","('NON-ESG', 0.16108328104019165)","('NON-ESG', 0.04284391924738884)"
Line 847,"Edwards also   offers a competitive employee benefits package that includes health and welfare   insurance, health savings accounts and on-site programs.
","('Employee_Health_And_Safety', 0.2516201138496399)","('Access_And_Affordability', 0.23825481534004211)","('Labor_Practices', 0.1414748579263687)","('NON-ESG', 0.2516201138496399)","('NON-ESG', 0.23825481534004211)","('NON-ESG', 0.1414748579263687)"
Line 848,"Recognizing that mental well-being is as important as physical health, Edwards   is dedicated to helping our global employees focus on their mental well-being.
","('Employee_Health_And_Safety', 0.9447833895683289)","('Access_And_Affordability', 0.007669388782233)","('Employee_Engagement_Inclusion_And_Diversity', 0.006013959180563688)","(['Operational Eco-Efficiency'], 0.9447833895683289)","('NON-ESG', 0.007669388782233)","('NON-ESG', 0.006013959180563688)"
Line 849,"In October 2021, in alignment with World Mental Health Day, we launched Mind+,   which is designed to elevate employee mindsets on mental well-being by helping   to reduce the stigma surrounding mental health and creating awareness regarding   the tools and resources Edwards has available to support them.
","('Employee_Health_And_Safety', 0.7466220855712891)","('Access_And_Affordability', 0.08251401782035828)","('Product_Quality_And_Safety', 0.024554893374443054)","(['Operational Eco-Efficiency'], 0.7466220855712891)","('NON-ESG', 0.08251401782035828)","('NON-ESG', 0.024554893374443054)"
Line 850,"In early 2022, we re-branded Total Wellness to Total Well-being, which is designed   to create a more holistic and unified approach to addressing the whole person.
","('Access_And_Affordability', 0.4872092008590698)","('Employee_Health_And_Safety', 0.14745691418647766)","('Human_Rights_And_Community_Relations', 0.09739036858081818)","('NON-ESG', 0.4872092008590698)","('NON-ESG', 0.14745691418647766)","('NON-ESG', 0.09739036858081818)"
Line 851,"We   encourage employees to leverage their comprehensive benefits package and the   lifestyle programs and resources offered by Edwards as tools to support all aspects   of their well-being.
","('Access_And_Affordability', 0.37419259548187256)","('Human_Rights_And_Community_Relations', 0.21865680813789368)","('Employee_Engagement_Inclusion_And_Diversity', 0.10760734230279922)","('NON-ESG', 0.37419259548187256)","('NON-ESG', 0.21865680813789368)","('NON-ESG', 0.10760734230279922)"
Line 852,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Edwards’ pillars for total well-being were updated in 2022: Prevention, Nutrition,   Physical Activity, Mind+, Financial Fitness, and Community Service.
","('Employee_Health_And_Safety', 0.32353538274765015)","('Access_And_Affordability', 0.2679847180843353)","('Employee_Engagement_Inclusion_And_Diversity', 0.056943390518426895)","('NON-ESG', 0.32353538274765015)","('NON-ESG', 0.2679847180843353)","('NON-ESG', 0.056943390518426895)"
Line 853,"The education   pillar, which was critical when the wellness program launched to create more   understanding and awareness, was removed as education now flows through all   of the well-being pillars.
","('Access_And_Affordability', 0.848831832408905)","('Employee_Health_And_Safety', 0.03098588064312935)","('Human_Rights_And_Community_Relations', 0.024825161322951317)","(['Health Outcome Contribution'], 0.848831832408905)","('NON-ESG', 0.03098588064312935)","('NON-ESG', 0.024825161322951317)"
Line 854,"The Mind+ pillar was added to reinforce the importance   of mental well-being.
","('Employee_Health_And_Safety', 0.2967306077480316)","('Access_And_Affordability', 0.2709400951862335)","('Human_Rights_And_Community_Relations', 0.1416907012462616)","('NON-ESG', 0.2967306077480316)","('NON-ESG', 0.2709400951862335)","('NON-ESG', 0.1416907012462616)"
Line 855,"We offer many programs to support our team members within each pillar.
","('Employee_Engagement_Inclusion_And_Diversity', 0.20758743584156036)","('Director_Removal', 0.1091698631644249)","('Business_Model_Resilience', 0.10537289083003998)","('NON-ESG', 0.20758743584156036)","('NON-ESG', 0.1091698631644249)","('NON-ESG', 0.10537289083003998)"
Line 856,"Please see   our 2022 Total Wellness Lookbook for some of our offerings.
","('Customer_Welfare', 0.41426852345466614)","('Product_Design_And_Lifecycle_Management', 0.11252439767122269)","('Product_Quality_And_Safety', 0.1068185567855835)","('NON-ESG', 0.41426852345466614)","('NON-ESG', 0.11252439767122269)","('NON-ESG', 0.1068185567855835)"
Line 857,"All benefits and wellness  programs are reviewed annually, and recommendations made to our Administrative   and Investment Committee for their review and approval.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5519410967826843)","('Access_And_Affordability', 0.1466170698404312)","('Product_Quality_And_Safety', 0.06807617843151093)","(['Corporate Governance'], 0.5519410967826843)","('NON-ESG', 0.1466170698404312)","('NON-ESG', 0.06807617843151093)"
Line 858,"We aim to offer a high performing, cost-effective healthcare program that encourages  a healthy workforce.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4644869863986969)","('Access_And_Affordability', 0.2717091739177704)","('Employee_Health_And_Safety', 0.05741013213992119)","('NON-ESG', 0.4644869863986969)","('NON-ESG', 0.2717091739177704)","('NON-ESG', 0.05741013213992119)"
Line 859,"We hope to move employees from passively consuming health care   services to owning their health and wellness.
","('Employee_Health_And_Safety', 0.4915405213832855)","('Access_And_Affordability', 0.17553018033504486)","('Employee_Engagement_Inclusion_And_Diversity', 0.04946248233318329)","('NON-ESG', 0.4915405213832855)","('NON-ESG', 0.17553018033504486)","('NON-ESG', 0.04946248233318329)"
Line 860,"We participate in custom industry surveys  to benchmark our programs to ensure these programs remain competitive.
","('Competitive_Behavior', 0.9203630089759827)","('Management_Of_Legal_And_Regulatory_Framework', 0.011290576308965683)","('Systemic_Risk_Management', 0.008394201286137104)","(['Business Ethics'], 0.9203630089759827)","('NON-ESG', 0.011290576308965683)","('NON-ESG', 0.008394201286137104)"
Line 861,"In addition,  each region prioritizes and reviews their risk factors and develops programs to address  their specific health population needs.
","('Employee_Health_And_Safety', 0.22251476347446442)","('Access_And_Affordability', 0.10541195422410965)","('Critical_Incident_Risk_Management', 0.09970355778932571)","('NON-ESG', 0.22251476347446442)","('NON-ESG', 0.10541195422410965)","('NON-ESG', 0.09970355778932571)"
Line 862,"Wellness and Charity Physical activity has been proven to enhance brain function, improve sleep, help   protect against certain cancers and strengthen heart health.
","('Employee_Health_And_Safety', 0.5521835088729858)","('Employee_Engagement_Inclusion_And_Diversity', 0.12333343923091888)","('Access_And_Affordability', 0.04182087257504463)","(['Operational Eco-Efficiency'], 0.5521835088729858)","('NON-ESG', 0.12333343923091888)","('NON-ESG', 0.04182087257504463)"
Line 863,"To help employees stay   in motion, we offer several programs including our Global Movement Challenge,   featured in our highlight story in this section.
","('Human_Rights_And_Community_Relations', 0.35830190777778625)","('Labor_Practices', 0.20498795807361603)","('Employee_Health_And_Safety', 0.11419522017240524)","('NON-ESG', 0.35830190777778625)","('NON-ESG', 0.20498795807361603)","('NON-ESG', 0.11419522017240524)"
Line 864,"As part of this program, Edwards offers  opportunities for employees to support charity as they work toward their movement  goals.
","('Human_Rights_And_Community_Relations', 0.5980455279350281)","('Access_And_Affordability', 0.10107224434614182)","('Employee_Engagement_Inclusion_And_Diversity', 0.07000356912612915)","(['Community Relations'], 0.5980455279350281)","('NON-ESG', 0.10107224434614182)","('NON-ESG', 0.07000356912612915)"
Line 865,"Those who reach the top two tiers within our global movement challenge will   be entered into a raffle where two winners have the opportunity to direct a charitable   contribution to a charity of their choice on behalf of the Edwards Foundation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6715653538703918)","('Access_And_Affordability', 0.06686260551214218)","('Business_Ethics', 0.026760393753647804)","(['Corporate Governance'], 0.6715653538703918)","('NON-ESG', 0.06686260551214218)","('NON-ESG', 0.026760393753647804)"
Line 866,"Workplace Health & Safety At Edwards, we are committed to providing a safe and healthy workplace for all of   our employees, visitors and guests at our facilities.
","('Employee_Health_And_Safety', 0.9805060625076294)","('Employee_Engagement_Inclusion_And_Diversity', 0.0029195358511060476)","('Critical_Incident_Risk_Management', 0.0015975545393303037)","(['Operational Eco-Efficiency'], 0.9805060625076294)","('NON-ESG', 0.0029195358511060476)","('NON-ESG', 0.0015975545393303037)"
Line 867,"We believe that a safe and healthy  workplace not only helps prevent injuries, but it also helps us recruit, retain and   engage talented employees while driving employee satisfaction.
","('Employee_Health_And_Safety', 0.9821312427520752)","('Employee_Engagement_Inclusion_And_Diversity', 0.0026751416735351086)","('Critical_Incident_Risk_Management', 0.0013995368499308825)","(['Operational Eco-Efficiency'], 0.9821312427520752)","('NON-ESG', 0.0026751416735351086)","('NON-ESG', 0.0013995368499308825)"
Line 868,"To achieve a safe  and healthy workplace, we believe in establishing robust EHS management systems,  implementing strong EHS governance and driving a culture of ownership and   accountability.
","('Business_Ethics', 0.35288891196250916)","('Employee_Health_And_Safety', 0.13036072254180908)","('Human_Rights_And_Community_Relations', 0.12462250143289566)","('NON-ESG', 0.35288891196250916)","('NON-ESG', 0.13036072254180908)","('NON-ESG', 0.12462250143289566)"
Line 869,"Please see our supplemental Environment Health & Safety (EHS)   report for more information.
","('Employee_Health_And_Safety', 0.6112610697746277)","('Product_Quality_And_Safety', 0.25669312477111816)","('Product_Design_And_Lifecycle_Management', 0.013582703657448292)","(['Operational Eco-Efficiency'], 0.6112610697746277)","('NON-ESG', 0.25669312477111816)","('NON-ESG', 0.013582703657448292)"
Line 870,"Our safety record is in the top quartile of performance for our industry.
","('Product_Quality_And_Safety', 0.6444150805473328)","('Employee_Health_And_Safety', 0.2209494709968567)","('Product_Design_And_Lifecycle_Management', 0.016719477251172066)","(['Product Quality & Recall Management'], 0.6444150805473328)","('NON-ESG', 0.2209494709968567)","('NON-ESG', 0.016719477251172066)"
Line 871,"Our two   safety targets are: 1) by 2025, achieve a 35 percent reduction in injury rates and 2) all  manufacturing facilities achieve certification against the internationally recognized   ISO 14001 Environmental Management System and ISO 45001 Occupational Health   & Safety Management System standards by 2023.
","('Employee_Health_And_Safety', 0.9839203953742981)","('Employee_Engagement_Inclusion_And_Diversity', 0.0019698666874319315)","('Product_Quality_And_Safety', 0.001215447555296123)","(['Operational Eco-Efficiency'], 0.9839203953742981)","('NON-ESG', 0.0019698666874319315)","('NON-ESG', 0.001215447555296123)"
Line 872,"New manufacturing plants are   given three years from date of start-up to achieve certification.
","('Product_Design_And_Lifecycle_Management', 0.28652411699295044)","('Product_Quality_And_Safety', 0.2099003940820694)","('Access_And_Affordability', 0.06002521514892578)","('NON-ESG', 0.28652411699295044)","('NON-ESG', 0.2099003940820694)","('NON-ESG', 0.06002521514892578)"
Line 873,"These targets align   with UN SDG 8: Decent Work and Economic Growth.
","('Labor_Practices', 0.7952160239219666)","('Management_Of_Legal_And_Regulatory_Framework', 0.040685564279556274)","('Human_Rights_And_Community_Relations', 0.03130047395825386)","(['Labor Practice Indicators'], 0.7952160239219666)","('NON-ESG', 0.040685564279556274)","('NON-ESG', 0.03130047395825386)"
Line 874,"Edwards focuses on workplace design, early intervention and overall prevention   of injuries and illnesses.
","('Employee_Health_And_Safety', 0.9812419414520264)","('Critical_Incident_Risk_Management', 0.003750441363081336)","('Employee_Engagement_Inclusion_And_Diversity', 0.001313160639256239)","(['Operational Eco-Efficiency'], 0.9812419414520264)","('NON-ESG', 0.003750441363081336)","('NON-ESG', 0.001313160639256239)"
Line 875,"We track and report injury rates and consistently perform   favorably when compared with our industry benchmarks.
","('Employee_Health_And_Safety', 0.9788814783096313)","('Critical_Incident_Risk_Management', 0.0027993288822472095)","('Employee_Engagement_Inclusion_And_Diversity', 0.0016031683189794421)","(['Operational Eco-Efficiency'], 0.9788814783096313)","('NON-ESG', 0.0027993288822472095)","('NON-ESG', 0.0016031683189794421)"
Line 876,"We strive to ensure   employees who are injured on the job receive appropriate medical care to help them   recover and return to work in a healthy and productive manner.
","('Employee_Health_And_Safety', 0.9728686809539795)","('Critical_Incident_Risk_Management', 0.0031872009858489037)","('Employee_Engagement_Inclusion_And_Diversity', 0.002434675581753254)","(['Operational Eco-Efficiency'], 0.9728686809539795)","('NON-ESG', 0.0031872009858489037)","('NON-ESG', 0.002434675581753254)"
Line 877,"For example, while   all of our locations provide access to off‐site medical clinics, our larger locations   also employ on‐site nurses and medical professionals to assist in both work and   non-work-related injury and personal health needs.
","('Employee_Health_And_Safety', 0.9748950004577637)","('Critical_Incident_Risk_Management', 0.0032891284208744764)","('Employee_Engagement_Inclusion_And_Diversity', 0.0022546618711203337)","(['Operational Eco-Efficiency'], 0.9748950004577637)","('NON-ESG', 0.0032891284208744764)","('NON-ESG', 0.0022546618711203337)"
Line 878,"Edwards has not experienced   a work-related fatality by either full-time employees, temporary hires or on-site   contractors since we began operating as an independent business in 2000.
","('Employee_Health_And_Safety', 0.9739943146705627)","('Labor_Practices', 0.004028978291898966)","('Critical_Incident_Risk_Management', 0.0032537346705794334)","(['Operational Eco-Efficiency'], 0.9739943146705627)","('NON-ESG', 0.004028978291898966)","('NON-ESG', 0.0032537346705794334)"
Line 879,"Please   see our annual EHS Report for more detailed occupational injury and illness   prevention strategies and the ergonomics program.
","('Employee_Health_And_Safety', 0.9840330481529236)","('Employee_Engagement_Inclusion_And_Diversity', 0.0013845977373421192)","('Critical_Incident_Risk_Management', 0.0012099726591259241)","(['Operational Eco-Efficiency'], 0.9840330481529236)","('NON-ESG', 0.0013845977373421192)","('NON-ESG', 0.0012099726591259241)"
Line 880,"During the COVID-19 pandemic, there was heightened focus on keeping employees  safe and healthy.
","('Employee_Health_And_Safety', 0.9049625396728516)","('Critical_Incident_Risk_Management', 0.02284027636051178)","('Access_And_Affordability', 0.011488142423331738)","(['Operational Eco-Efficiency'], 0.9049625396728516)","('NON-ESG', 0.02284027636051178)","('NON-ESG', 0.011488142423331738)"
Line 881,"To accomplish this, Edwards focused on a multi-layered effort,   involving improved ventilation and sanitation in Edwards’ facilities, masking   requirements indoors, promotion of vaccination and onsite COVID-19 vaccination   clinics, timely case management and contact tracing, and heightened efforts to   educate employees.
","('Employee_Health_And_Safety', 0.7208688855171204)","('Access_And_Affordability', 0.060718730092048645)","('Critical_Incident_Risk_Management', 0.033756088465452194)","(['Operational Eco-Efficiency'], 0.7208688855171204)","('NON-ESG', 0.060718730092048645)","('NON-ESG', 0.033756088465452194)"
Line 882,"Edwards’ employees had far higher vaccination rates than their  surrounding communities, exceeding 90 percent in much of the globe.
","('Employee_Health_And_Safety', 0.5628547668457031)","('Labor_Practices', 0.09043297171592712)","('Access_And_Affordability', 0.057940203696489334)","(['Operational Eco-Efficiency'], 0.5628547668457031)","('NON-ESG', 0.09043297171592712)","('NON-ESG', 0.057940203696489334)"
Line 883,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT HIGHLIGHT STORY Employee Programs Prioritize   Staying Fit – Mentally and Physically Now more than ever, emphasis on mental and physical well-being is critical   to a healthy workforce.
","('Employee_Health_And_Safety', 0.8778926730155945)","('Employee_Engagement_Inclusion_And_Diversity', 0.03825867176055908)","('Access_And_Affordability', 0.013148167170584202)","(['Operational Eco-Efficiency'], 0.8778926730155945)","('NON-ESG', 0.03825867176055908)","('NON-ESG', 0.013148167170584202)"
Line 884,"Our mental well-being is as important as physical health;  in fact, the two are interconnected.
","('Employee_Health_And_Safety', 0.8554865717887878)","('Access_And_Affordability', 0.031173216179013252)","('Product_Design_And_Lifecycle_Management', 0.013234803453087807)","(['Operational Eco-Efficiency'], 0.8554865717887878)","('NON-ESG', 0.031173216179013252)","('NON-ESG', 0.013234803453087807)"
Line 885,"Mental well-being includes emotional,   psychological, and social well-being, and it affects how employees think, feel,   and respond to life’s stressors.
","('Employee_Health_And_Safety', 0.353392630815506)","('Human_Rights_And_Community_Relations', 0.23681855201721191)","('Access_And_Affordability', 0.10541195422410965)","('NON-ESG', 0.353392630815506)","('NON-ESG', 0.23681855201721191)","('NON-ESG', 0.10541195422410965)"
Line 886,"We recently launched two pivotal programs at Edwards to inspire and support   our teams to nourish their mind and bodies.
","('Access_And_Affordability', 0.24954217672348022)","('Employee_Health_And_Safety', 0.18653982877731323)","('Ecological_Impacts', 0.06097417324781418)","('NON-ESG', 0.24954217672348022)","('NON-ESG', 0.18653982877731323)","('NON-ESG', 0.06097417324781418)"
Line 887,"Mind+ Leader Video Series The Mind+ Leader video series features Edwards Lifesciences senior leaders in a  casual and open conversation with Dr. Tista Ghosh, Vice President of Employee  Health, sharing unique advice for elevating their mindsets and those of their teams.
","('Employee_Engagement_Inclusion_And_Diversity', 0.33340322971343994)","('Employee_Health_And_Safety', 0.12318675220012665)","('Business_Model_Resilience', 0.10620474815368652)","('NON-ESG', 0.33340322971343994)","('NON-ESG', 0.12318675220012665)","('NON-ESG', 0.10620474815368652)"
Line 888,"These leaders openly share real examples in their lives of how they think   about mental well-being, tactics to nurture it, times they grappled with stress   or well-being and how they recommend focusing on their own, and colleagues’   mental health.
","('Employee_Health_And_Safety', 0.7526465654373169)","('Access_And_Affordability', 0.07170890271663666)","('Human_Rights_And_Community_Relations', 0.02400156296789646)","(['Operational Eco-Efficiency'], 0.7526465654373169)","('NON-ESG', 0.07170890271663666)","('NON-ESG', 0.02400156296789646)"
Line 889,"Videos are shared regularly with employees, along with other educational   resources available to support their mental health.
","('Employee_Health_And_Safety', 0.44059139490127563)","('Access_And_Affordability', 0.2802627980709076)","('Employee_Engagement_Inclusion_And_Diversity', 0.05521649867296219)","('NON-ESG', 0.44059139490127563)","('NON-ESG', 0.2802627980709076)","('NON-ESG', 0.05521649867296219)"
Line 890,"Global Movement Challenge A partnership with Walkingspree has   made staying active easy and engaging   for Edwards employees as part of our   Global Movement Challenge.
","('Human_Rights_And_Community_Relations', 0.3628617525100708)","('Employee_Health_And_Safety', 0.08881031721830368)","('Employee_Engagement_Inclusion_And_Diversity', 0.0839371532201767)","('NON-ESG', 0.3628617525100708)","('NON-ESG', 0.08881031721830368)","('NON-ESG', 0.0839371532201767)"
Line 891,"Walkingspree is a digital app that does   the heavy lifting for employees who can   set steps goals, track steps, log activity,  challenge co-workers and earn prizes.
","('Labor_Practices', 0.39681029319763184)","('Competitive_Behavior', 0.13884618878364563)","('Business_Ethics', 0.12498904764652252)","('NON-ESG', 0.39681029319763184)","('NON-ESG', 0.13884618878364563)","('NON-ESG', 0.12498904764652252)"
Line 892,"Employees simply engage in physical   activity and the Walkingspree app   automatically syncs from their device.
","('Labor_Practices', 0.18930575251579285)","('Employee_Health_And_Safety', 0.17423687875270844)","('Customer_Privacy', 0.1280587911605835)","('NON-ESG', 0.18930575251579285)","('NON-ESG', 0.17423687875270844)","('NON-ESG', 0.1280587911605835)"
Line 893,"Points are earned for different activities  and achieving program milestones,   all incentives for staying active.
","('Management_Of_Legal_And_Regulatory_Framework', 0.31727126240730286)","('Access_And_Affordability', 0.14793936908245087)","('Human_Rights_And_Community_Relations', 0.05289609357714653)","('NON-ESG', 0.31727126240730286)","('NON-ESG', 0.14793936908245087)","('NON-ESG', 0.05289609357714653)"
Line 894,"The   camaraderie and competitive fun   of tracking results against co-workers   has had a ripple effect, with close to   80 percent of participating employees   averaging more than 7,000 steps per day,  better than the U.S. national average.
","('Competitive_Behavior', 0.8535339832305908)","('Labor_Practices', 0.035138629376888275)","('Business_Ethics', 0.014451542869210243)","(['Business Ethics'], 0.8535339832305908)","('NON-ESG', 0.035138629376888275)","('NON-ESG', 0.014451542869210243)"
Line 895,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Annual Performance   COVID-19 Pandemic Response As we entered the second year of the COVID-19 pandemic, Edwards’ team continued to  display its flexibility and resilience.
","('Business_Model_Resilience', 0.903227686882019)","('Physical_Impacts_Of_Climate_Change', 0.019084742292761803)","('Supply_Chain_Management', 0.010427950881421566)","(['Codes of Business Conduct'], 0.903227686882019)","('NON-ESG', 0.019084742292761803)","('NON-ESG', 0.010427950881421566)"
Line 896,"Our resilient global supply chain team continued to  come to work in-person at our manufacturing facilities around the world, ensuring that we  could continue to uphold our companies’ mission and bring our most important lifesaving  technologies to patients in need.
","('Supply_Chain_Management', 0.9105345010757446)","('Business_Model_Resilience', 0.017707539722323418)","('Product_Design_And_Lifecycle_Management', 0.01636189967393875)","(['Supply Chain Management'], 0.9105345010757446)","('NON-ESG', 0.017707539722323418)","('NON-ESG', 0.01636189967393875)"
Line 897,"Our committed field teams continued to develop new  ways to support physicians, and finally our engineers never ceased in their innovation of  our array of technologies.
","('Product_Design_And_Lifecycle_Management', 0.24455681443214417)","('Competitive_Behavior', 0.13354936242103577)","('Customer_Welfare', 0.09229384362697601)","('NON-ESG', 0.24455681443214417)","('NON-ESG', 0.13354936242103577)","('NON-ESG', 0.09229384362697601)"
Line 898,"In 2021, Edwards continued to support our global employees in the face of the uncertainty  of the ongoing pandemic.
","('Employee_Health_And_Safety', 0.20326939225196838)","('Access_And_Affordability', 0.12541359663009644)","('Critical_Incident_Risk_Management', 0.11814515292644501)","('NON-ESG', 0.20326939225196838)","('NON-ESG', 0.12541359663009644)","('NON-ESG', 0.11814515292644501)"
Line 899,"We have continued to do so through:   •  Specific COVID-19 communication strategies for people leaders and employees,   which were communicated on a regular basis  •  A dedicated Edwards COVID-19 Global Information Website containing global   and regional resources for all employees, such as news updates, internal policies   and key announcements, guidebooks, videos, IT help resources, volunteer   opportunities information, and HR resources  •  A partnership with Providence to provide a facility, staff and funding to operate   a COVID-19 vaccination clinic at the Edwards headquarters campus over several   months, giving approximately 9,000 vaccine doses for free – and the promise   of more as the effort turned mobile in local communities throughout Orange   County, Calif.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5083079934120178)","('Employee_Health_And_Safety', 0.11502587050199509)","('Human_Rights_And_Community_Relations', 0.11366792023181915)","(['Human Capital Development'], 0.5083079934120178)","('NON-ESG', 0.11502587050199509)","('NON-ESG', 0.11366792023181915)"
Line 900,"We have continued to do so through:   •  Specific COVID-19 communication strategies for people leaders and employees,   which were communicated on a regular basis  •  A dedicated Edwards COVID-19 Global Information Website containing global   and regional resources for all employees, such as news updates, internal policies   and key announcements, guidebooks, videos, IT help resources, volunteer   opportunities information, and HR resources  •  A partnership with Providence to provide a facility, staff and funding to operate   a COVID-19 vaccination clinic at the Edwards headquarters campus over several   months, giving approximately 9,000 vaccine doses for free – and the promise   of more as the effort turned mobile in local communities throughout Orange   County, Calif.
","('Access_And_Affordability', 0.4512594938278198)","('Product_Quality_And_Safety', 0.09375343471765518)","('Employee_Health_And_Safety', 0.09361366182565689)","('NON-ESG', 0.4512594938278198)","('NON-ESG', 0.09375343471765518)","('NON-ESG', 0.09361366182565689)"
Line 901,"Remote Work During the Pandemic Throughout the global pandemic in 2020, 2021 and into 2022, Edwards has provided   continuing opportunities for employees to have flexible and, where needed and possible,   remote work schedule options.
","('Employee_Health_And_Safety', 0.5298446416854858)","('Labor_Practices', 0.14796140789985657)","('Critical_Incident_Risk_Management', 0.04643309861421585)","(['Operational Eco-Efficiency'], 0.5298446416854858)","('NON-ESG', 0.14796140789985657)","('NON-ESG', 0.04643309861421585)"
Line 902,"While we continue to focus on ensuring collaboration to   support our ability to serve patients worldwide,  we are pleased to have employees working  on site at our facilities around the world.
","('Access_And_Affordability', 0.5257214903831482)","('Customer_Welfare', 0.07074375450611115)","('Employee_Engagement_Inclusion_And_Diversity', 0.0455964133143425)","(['Health Outcome Contribution'], 0.5257214903831482)","('NON-ESG', 0.07074375450611115)","('NON-ESG', 0.0455964133143425)"
Line 903,"We have also maintained flexibility in response   to local conditions and regulations to promote the health and safety of our employees.
","('Employee_Health_And_Safety', 0.9800823330879211)","('Employee_Engagement_Inclusion_And_Diversity', 0.0022435663267970085)","('Product_Quality_And_Safety', 0.0017520720139145851)","(['Operational Eco-Efficiency'], 0.9800823330879211)","('NON-ESG', 0.0022435663267970085)","('NON-ESG', 0.0017520720139145851)"
Line 904,"Employee Engagement Survey and Charitable Activity Eighty two percent of professional employees who responded to our 2021 employee   engagement survey reported participating in charitable activities within the past 12  months.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3679691553115845)","('Human_Rights_And_Community_Relations', 0.17312707006931305)","('Employee_Health_And_Safety', 0.11612889915704727)","('NON-ESG', 0.3679691553115845)","('NON-ESG', 0.17312707006931305)","('NON-ESG', 0.11612889915704727)"
Line 905,"These results support our target to drive Edwards’ aspiration of 100 percent global  employee participation in charitable activity with participation goals of 100 percent for   the SLT and an increase in global participation as measured by the employee engagement survey.
","('Employee_Engagement_Inclusion_And_Diversity', 0.753871738910675)","('Employee_Health_And_Safety', 0.061502743512392044)","('Access_And_Affordability', 0.028342150151729584)","(['Human Capital Development'], 0.753871738910675)","('NON-ESG', 0.061502743512392044)","('NON-ESG', 0.028342150151729584)"
Line 906,"Not only are most of our employees having a positive impact on our community,  but we have also detected a relationship between charitable activity participation and  how our employees perceive working at Edwards.
","('Human_Rights_And_Community_Relations', 0.6004105806350708)","('Access_And_Affordability', 0.0874326080083847)","('Employee_Health_And_Safety', 0.0497085303068161)","(['Community Relations'], 0.6004105806350708)","('NON-ESG', 0.0874326080083847)","('NON-ESG', 0.0497085303068161)"
Line 907,"Those who indicated they participated  in charitable activities have significantly higher engagement results than those that did  not participate.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5547283291816711)","('Access_And_Affordability', 0.11791019141674042)","('Business_Ethics', 0.042700204998254776)","(['Corporate Governance'], 0.5547283291816711)","('NON-ESG', 0.11791019141674042)","('NON-ESG', 0.042700204998254776)"
Line 908,"In addition to being more engaged, those that participated in charitable  activities also reported a higher sense of patient focus, culture and belonging.
","('Access_And_Affordability', 0.18942907452583313)","('Human_Rights_And_Community_Relations', 0.18652479350566864)","('Management_Of_Legal_And_Regulatory_Framework', 0.17976771295070648)","('NON-ESG', 0.18942907452583313)","('NON-ESG', 0.18652479350566864)","('NON-ESG', 0.17976771295070648)"
Line 909,"These results  support our target to have a highly engaged workforce that exceeds industry, region and  high performing benchmarks for employee engagement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9640267491340637)","('Employee_Health_And_Safety', 0.004058105871081352)","('Labor_Practices', 0.0031395298428833485)","(['Human Capital Development'], 0.9640267491340637)","('NON-ESG', 0.004058105871081352)","('NON-ESG', 0.0031395298428833485)"
Line 910,"This target aligns with UN SDG 8:  Decent Work and Economic Growth.
","('Labor_Practices', 0.3694915473461151)","('Management_Of_Legal_And_Regulatory_Framework', 0.22904901206493378)","('Human_Rights_And_Community_Relations', 0.15087443590164185)","('NON-ESG', 0.3694915473461151)","('NON-ESG', 0.22904901206493378)","('NON-ESG', 0.15087443590164185)"
Line 911,"Edwards is dedicated to the communities that matter most to employees and encourages  employees to participate in charitable events and take advantage of our company match- ing donation program to increase charitable giving.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5490861535072327)","('Human_Rights_And_Community_Relations', 0.1064317598938942)","('Access_And_Affordability', 0.09854499995708466)","(['Corporate Governance'], 0.5490861535072327)","('NON-ESG', 0.1064317598938942)","('NON-ESG', 0.09854499995708466)"
Line 912,"For more information, please see our  Volunteerism & Giving section.
","('Human_Rights_And_Community_Relations', 0.3011469841003418)","('Labor_Practices', 0.10640544444322586)","('Employee_Health_And_Safety', 0.10565932840108871)","('NON-ESG', 0.3011469841003418)","('NON-ESG', 0.10640544444322586)","('NON-ESG', 0.10565932840108871)"
Line 913,"Patients First In 2021, we shared patient stories and interactions with the vast majority of our employees  through virtual meetings, as well as at Edwards’ regional headquarters and manufacturing  facilities as in-person gatherings were resumed.
","('Employee_Health_And_Safety', 0.1817033737897873)","('Access_And_Affordability', 0.1688515692949295)","('Employee_Engagement_Inclusion_And_Diversity', 0.08803252875804901)","('NON-ESG', 0.1817033737897873)","('NON-ESG', 0.1688515692949295)","('NON-ESG', 0.08803252875804901)"
Line 914,"To estimate the number of employees  who experienced a patient story, we rely on the leaders of each regional office and plant to  assess the types of patient exposure methods used at their respective sites.
","('Employee_Health_And_Safety', 0.4322720468044281)","('Product_Quality_And_Safety', 0.09309550374746323)","('Access_And_Affordability', 0.05644102394580841)","('NON-ESG', 0.4322720468044281)","('NON-ESG', 0.09309550374746323)","('NON-ESG', 0.05644102394580841)"
Line 915,"We estimate  that 97 percent of our global employees were able to experience at least one patient story  in 2021, and believe the majority had the opportunity to interact with multiple stories or  patient speakers during the year.
","('Access_And_Affordability', 0.5311487913131714)","('Employee_Engagement_Inclusion_And_Diversity', 0.09122713655233383)","('Customer_Welfare', 0.04889202117919922)","(['Health Outcome Contribution'], 0.5311487913131714)","('NON-ESG', 0.09122713655233383)","('NON-ESG', 0.04889202117919922)"
Line 916,"This target aligns to UN SDG 3: Good Health & Well-Being.
","('Access_And_Affordability', 0.4568932354450226)","('Employee_Health_And_Safety', 0.17113997042179108)","('Human_Rights_And_Community_Relations', 0.09391850233078003)","('NON-ESG', 0.4568932354450226)","('NON-ESG', 0.17113997042179108)","('NON-ESG', 0.09391850233078003)"
Line 917,"In our 2021 employee survey, 90 percent of employees agreed that at Edwards, we consider  what is important to patients when making decisions.
","('Employee_Health_And_Safety', 0.2850862741470337)","('Access_And_Affordability', 0.12515048682689667)","('Human_Rights_And_Community_Relations', 0.10740509629249573)","('NON-ESG', 0.2850862741470337)","('NON-ESG', 0.12515048682689667)","('NON-ESG', 0.10740509629249573)"
Line 918,"Below are some examples of our  2021 “patients first” activities:  •  The annual meetings for field personnel are mandatory and patient stories   and/or in-person patient testimonials are a content item at each  •  During regional all-employee meetings, employees engage with patients   through patient videos and panels featuring physicians and local   Edwards representatives discussing patient care  •  Professionals and Front Line Professionals at our regional offices and   manufacturing facilities are provided time away from their roles to attend   the employee meetings where patient stories are always featured  •  Our online platforms including NewHeartValve.com and ReachForTheHeart.com   include patient stories  •  Dedicated internal website, Dose of Edwards Goodness, sharing uplifting stories   from Edwards colleagues and patients around the world to all employeesEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Training and Leadership Development Initiatives In 2020, due to the COVID-19 pandemic all training and development continued as live   virtual formats across the globe.
","('Access_And_Affordability', 0.47405317425727844)","('Customer_Welfare', 0.08195236325263977)","('Employee_Health_And_Safety', 0.06116614490747452)","('NON-ESG', 0.47405317425727844)","('NON-ESG', 0.08195236325263977)","('NON-ESG', 0.06116614490747452)"
Line 919,"Below are some examples of our  2021 “patients first” activities:  •  The annual meetings for field personnel are mandatory and patient stories   and/or in-person patient testimonials are a content item at each  •  During regional all-employee meetings, employees engage with patients   through patient videos and panels featuring physicians and local   Edwards representatives discussing patient care  •  Professionals and Front Line Professionals at our regional offices and   manufacturing facilities are provided time away from their roles to attend   the employee meetings where patient stories are always featured  •  Our online platforms including NewHeartValve.com and ReachForTheHeart.com   include patient stories  •  Dedicated internal website, Dose of Edwards Goodness, sharing uplifting stories   from Edwards colleagues and patients around the world to all employeesEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Training and Leadership Development Initiatives In 2020, due to the COVID-19 pandemic all training and development continued as live   virtual formats across the globe.
","('Access_And_Affordability', 0.6026676297187805)","('Employee_Health_And_Safety', 0.08989739418029785)","('Product_Quality_And_Safety', 0.043848127126693726)","(['Health Outcome Contribution'], 0.6026676297187805)","('NON-ESG', 0.08989739418029785)","('NON-ESG', 0.043848127126693726)"
Line 920,"Below are some examples of our  2021 “patients first” activities:  •  The annual meetings for field personnel are mandatory and patient stories   and/or in-person patient testimonials are a content item at each  •  During regional all-employee meetings, employees engage with patients   through patient videos and panels featuring physicians and local   Edwards representatives discussing patient care  •  Professionals and Front Line Professionals at our regional offices and   manufacturing facilities are provided time away from their roles to attend   the employee meetings where patient stories are always featured  •  Our online platforms including NewHeartValve.com and ReachForTheHeart.com   include patient stories  •  Dedicated internal website, Dose of Edwards Goodness, sharing uplifting stories   from Edwards colleagues and patients around the world to all employeesEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Training and Leadership Development Initiatives In 2020, due to the COVID-19 pandemic all training and development continued as live   virtual formats across the globe.
","('Energy_Management', 0.18331021070480347)","('Competitive_Behavior', 0.1438208967447281)","('Product_Design_And_Lifecycle_Management', 0.0818435475230217)","('NON-ESG', 0.18331021070480347)","('NON-ESG', 0.1438208967447281)","('NON-ESG', 0.0818435475230217)"
Line 921,"New skills were required for leaders and employees in  terms of new remote working environments.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6928610801696777)","('Labor_Practices', 0.1276533156633377)","('Employee_Health_And_Safety', 0.03821222111582756)","(['Human Capital Development'], 0.6928610801696777)","('NON-ESG', 0.1276533156633377)","('NON-ESG', 0.03821222111582756)"
Line 922,"In 2021, we incorporated hybrid working   environments and continued to enable training to go to the employees rather than have  the employees come to the training.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3071581721305847)","('Labor_Practices', 0.2716197967529297)","('Employee_Health_And_Safety', 0.23791314661502838)","('NON-ESG', 0.3071581721305847)","('NON-ESG', 0.2716197967529297)","('NON-ESG', 0.23791314661502838)"
Line 923,"Our virtual training methodologies removed capacity  and time zone constraints.
","('Supply_Chain_Management', 0.3833554983139038)","('Systemic_Risk_Management', 0.09577552229166031)","('Business_Model_Resilience', 0.07150658220052719)","('NON-ESG', 0.3833554983139038)","('NON-ESG', 0.09577552229166031)","('NON-ESG', 0.07150658220052719)"
Line 924,"We expanded upon existing programs, including:  •  Global individualized coaching  •  Remote worker training series  •  Exploring leadership for individual contributors  •  Webinars and targeted skills in live online development sessions These programs continue to have a positive business impact.
","('Access_And_Affordability', 0.437168687582016)","('Employee_Engagement_Inclusion_And_Diversity', 0.19744545221328735)","('Employee_Health_And_Safety', 0.07226159423589706)","('NON-ESG', 0.437168687582016)","('NON-ESG', 0.19744545221328735)","('NON-ESG', 0.07226159423589706)"
Line 925,"For example, through our   TDP and University Engineering programs in 2021, 50 percent of eligible interns were   hired for full-time positions with a 95 percent offer acceptance rate.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4475651979446411)","('Labor_Practices', 0.386520653963089)","('Employee_Health_And_Safety', 0.015843136236071587)","('NON-ESG', 0.4475651979446411)","('NON-ESG', 0.386520653963089)","('NON-ESG', 0.015843136236071587)"
Line 926,"We have found that  these employees are more than twice as likely to become designated as top talent as   those who did not intern.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9069501757621765)","('Employee_Health_And_Safety', 0.009322098456323147)","('Labor_Practices', 0.008604438975453377)","(['Human Capital Development'], 0.9069501757621765)","('NON-ESG', 0.009322098456323147)","('NON-ESG', 0.008604438975453377)"
Line 927,"Individuals hired through the TDP and University Engineering  programs have an 83 percent combined retention rate.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9453607797622681)","('Labor_Practices', 0.010152062401175499)","('Employee_Health_And_Safety', 0.004267544485628605)","(['Human Capital Development'], 0.9453607797622681)","('NON-ESG', 0.010152062401175499)","('NON-ESG', 0.004267544485628605)"
Line 928,"Also in 2021, we launched our newest global nomination-based development program,   the Accelerated Development Program, which offers a unique opportunity to accelerate   select employees’ leadership capabilities through rich and targeted development and   executive support.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8218658566474915)","('Business_Model_Resilience', 0.026109416037797928)","('Director_Removal', 0.023214206099510193)","(['Human Capital Development'], 0.8218658566474915)","('NON-ESG', 0.026109416037797928)","('NON-ESG', 0.023214206099510193)"
Line 929,"The program also includes a charitable leadership element that is   focused on linking their future leadership behaviors with our patient-focused culture   and innovation business strategy.
","('Business_Model_Resilience', 0.3899519443511963)","('Employee_Engagement_Inclusion_And_Diversity', 0.2609202265739441)","('Product_Design_And_Lifecycle_Management', 0.043963365256786346)","('NON-ESG', 0.3899519443511963)","('NON-ESG', 0.2609202265739441)","('NON-ESG', 0.043963365256786346)"
Line 930,"Mentoring Programs In 2021, we continued to expand our mentoring opportunities beyond the traditional   programs, offering flash, speed and circles mentoring.
","('Employee_Engagement_Inclusion_And_Diversity', 0.365975022315979)","('Access_And_Affordability', 0.28649505972862244)","('Employee_Health_And_Safety', 0.046470850706100464)","('NON-ESG', 0.365975022315979)","('NON-ESG', 0.28649505972862244)","('NON-ESG', 0.046470850706100464)"
Line 931,"These additional modes of   mentoring allow employees to receive just-in-time and/or specific development   without having to be in a formal program.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3829810321331024)","('Access_And_Affordability', 0.30154380202293396)","('Employee_Health_And_Safety', 0.04153348132967949)","('NON-ESG', 0.3829810321331024)","('NON-ESG', 0.30154380202293396)","('NON-ESG', 0.04153348132967949)"
Line 932,"Flash mentoring provides a fast and flexible   option for one-time mentoring discussions.
","('Access_And_Affordability', 0.5516799688339233)","('Management_Of_Legal_And_Regulatory_Framework', 0.08165054023265839)","('Employee_Engagement_Inclusion_And_Diversity', 0.07492515444755554)","(['Health Outcome Contribution'], 0.5516799688339233)","('NON-ESG', 0.08165054023265839)","('NON-ESG', 0.07492515444755554)"
Line 933,"Speed mentoring is delivered as part of   large team events, where participants are exposed to many different mentors in quick   succession.
","('Access_And_Affordability', 0.3203084468841553)","('Employee_Engagement_Inclusion_And_Diversity', 0.2885075807571411)","('Human_Rights_And_Community_Relations', 0.04864950105547905)","('NON-ESG', 0.3203084468841553)","('NON-ESG', 0.2885075807571411)","('NON-ESG', 0.04864950105547905)"
Line 934,"Circles mentoring is coordinated in a small group cohort format over time   that creates a support system for skill and leadership development and ideal for scaling  across employee populations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8756158351898193)","('Access_And_Affordability', 0.026219144463539124)","('Employee_Health_And_Safety', 0.011982724070549011)","(['Human Capital Development'], 0.8756158351898193)","('NON-ESG', 0.026219144463539124)","('NON-ESG', 0.011982724070549011)"
Line 935,"We have implemented Circles programs in University   Relations and in our women’s ERG, Edwards Network of Women.Total Well-being Every year, Edwards becomes stronger in our mission to improve health – starting with   our workforce.
","('Employee_Health_And_Safety', 0.4512694478034973)","('Access_And_Affordability', 0.30597564578056335)","('Human_Rights_And_Community_Relations', 0.06996378302574158)","('NON-ESG', 0.4512694478034973)","('NON-ESG', 0.30597564578056335)","('NON-ESG', 0.06996378302574158)"
Line 936,"In 2015 and 2016, 93 percent of U.S. Edwards employees participated in free  biometrics screenings.
","('Customer_Privacy', 0.5148870348930359)","('Data_Security', 0.07924254238605499)","('Labor_Practices', 0.06945998221635818)","(['Privacy Protection'], 0.5148870348930359)","('NON-ESG', 0.07924254238605499)","('NON-ESG', 0.06945998221635818)"
Line 937,"Participation in this program increased to 94 percent for 2017/2018  and has remained steady at that participation rate for 2018/2019 and 2019/2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4236159026622772)","('Access_And_Affordability', 0.1726558655500412)","('Human_Rights_And_Community_Relations', 0.06631068140268326)","('NON-ESG', 0.4236159026622772)","('NON-ESG', 0.1726558655500412)","('NON-ESG', 0.06631068140268326)"
Line 938,"In order  to mitigate additional burden on the healthcare system during the pandemic, Edwards  pivoted our biometric screening program for 2020/2021 to include only a voluntary Health  Risk Assessment.
","('Critical_Incident_Risk_Management', 0.31787407398223877)","('Physical_Impacts_Of_Climate_Change', 0.18675433099269867)","('Systemic_Risk_Management', 0.0884501188993454)","('NON-ESG', 0.31787407398223877)","('NON-ESG', 0.18675433099269867)","('NON-ESG', 0.0884501188993454)"
Line 939,"The biometric screening program resumed as normal for 2021/2022.
","('Customer_Privacy', 0.6185035109519958)","('Management_Of_Legal_And_Regulatory_Framework', 0.051393937319517136)","('Data_Security', 0.049573324620723724)","(['Privacy Protection'], 0.6185035109519958)","('NON-ESG', 0.051393937319517136)","('NON-ESG', 0.049573324620723724)"
Line 940,"Please note that our benefit plan year runs from July through June.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47643229365348816)","('Systemic_Risk_Management', 0.0767989456653595)","('Ecological_Impacts', 0.05498746037483215)","('NON-ESG', 0.47643229365348816)","('NON-ESG', 0.0767989456653595)","('NON-ESG', 0.05498746037483215)"
Line 941,"U.S. Well-being Numbers for 2020-We believe the well-being of our employees has a direct correlation with the success   of our company.
","('Employee_Health_And_Safety', 0.46964892745018005)","('Human_Rights_And_Community_Relations', 0.17853790521621704)","('Access_And_Affordability', 0.10209908336400986)","('NON-ESG', 0.46964892745018005)","('NON-ESG', 0.17853790521621704)","('NON-ESG', 0.10209908336400986)"
Line 942,"Each of our seven global manufacturing locations provide benefits   associated with occupational health commensurate to their worker population, culture,  and availability of such programs in their local communities.
","('Employee_Health_And_Safety', 0.9814714193344116)","('Employee_Engagement_Inclusion_And_Diversity', 0.00259544444270432)","('Critical_Incident_Risk_Management', 0.00155646784696728)","(['Operational Eco-Efficiency'], 0.9814714193344116)","('NON-ESG', 0.00259544444270432)","('NON-ESG', 0.00155646784696728)"
Line 943,"In 2021, our occupational  health staff hosted numerous COVID-19 and flu shot clinics across our global locations   to ensure our employees had convenient access to vaccinations.
","('Employee_Health_And_Safety', 0.9141123294830322)","('Access_And_Affordability', 0.013537781313061714)","('Employee_Engagement_Inclusion_And_Diversity', 0.010704033076763153)","(['Operational Eco-Efficiency'], 0.9141123294830322)","('NON-ESG', 0.013537781313061714)","('NON-ESG', 0.010704033076763153)"
Line 944,"In addition, employee  health benefits include weight-loss coaching, lactation consulting, and smoking cessation   programs, among others.
","('Employee_Health_And_Safety', 0.8533830046653748)","('Employee_Engagement_Inclusion_And_Diversity', 0.05303789675235748)","('Product_Quality_And_Safety', 0.010671382769942284)","(['Operational Eco-Efficiency'], 0.8533830046653748)","('NON-ESG', 0.05303789675235748)","('NON-ESG', 0.010671382769942284)"
Line 945,"At some of our locations we provide on‐site fitness centers,   basketball courts, bicycle facilities and large fields for soccer and other outdoor activities.
","('Access_And_Affordability', 0.27138930559158325)","('Employee_Engagement_Inclusion_And_Diversity', 0.19099439680576324)","('Employee_Health_And_Safety', 0.09620445221662521)","('NON-ESG', 0.27138930559158325)","('NON-ESG', 0.19099439680576324)","('NON-ESG', 0.09620445221662521)"
Line 946,"Workplace Safety We continue to invest in the development of tools, systems and our EHS professionals to  help us achieve our EHS objectives.
","('Employee_Health_And_Safety', 0.9577201008796692)","('Product_Quality_And_Safety', 0.00952894240617752)","('Employee_Engagement_Inclusion_And_Diversity', 0.004815571941435337)","(['Operational Eco-Efficiency'], 0.9577201008796692)","('NON-ESG', 0.00952894240617752)","('NON-ESG', 0.004815571941435337)"
Line 947,"Our commitment to preventing injury and illness and  promoting well-being extends to both manufacturing and non-manufacturing operations  and includes all employees, as well as contractors and visitors present at our facilities.
","('Employee_Health_And_Safety', 0.9846928119659424)","('Employee_Engagement_Inclusion_And_Diversity', 0.0015316116623580456)","('Critical_Incident_Risk_Management', 0.0013539021601900458)","(['Operational Eco-Efficiency'], 0.9846928119659424)","('NON-ESG', 0.0015316116623580456)","('NON-ESG', 0.0013539021601900458)"
Line 948,"In  2021, Edwards’ recordable incident rate was 0.68 and our lost time incident rate was 0.28,  continuing an overall declining trend in work-related injuries over the course of the last  several years.
","('Employee_Health_And_Safety', 0.9831479787826538)","('Critical_Incident_Risk_Management', 0.003187081078067422)","('Employee_Engagement_Inclusion_And_Diversity', 0.0013146591372787952)","(['Operational Eco-Efficiency'], 0.9831479787826538)","('NON-ESG', 0.003187081078067422)","('NON-ESG', 0.0013146591372787952)"
Line 949,"U.S. Employee Participation in Biometric Screenings194% U.S. Employees Enrolled in an Edwards-Sponsored Medical Plan 90% Health Costs Per Employee Per Year (PEPY) 2.6% 1The 2020-21 program was a voluntary HRA, so the reported number is the same as 2019.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Cumulative trauma illnesses represent 51 percent of Edwards’ work-related injuries and  illnesses.
","('Employee_Health_And_Safety', 0.9832042455673218)","('Critical_Incident_Risk_Management', 0.002053794451057911)","('Employee_Engagement_Inclusion_And_Diversity', 0.001988132018595934)","(['Operational Eco-Efficiency'], 0.9832042455673218)","('NON-ESG', 0.002053794451057911)","('NON-ESG', 0.001988132018595934)"
Line 950,"The majority of our cumulative trauma illnesses come from our valve network  manufacturing locations, where manual sewing of tissue valves introduces the ergonomic  risk factors of repetition, force, and sustained postures.
","('Employee_Health_And_Safety', 0.9516052603721619)","('Critical_Incident_Risk_Management', 0.011783428490161896)","('Employee_Engagement_Inclusion_And_Diversity', 0.003803011728450656)","(['Operational Eco-Efficiency'], 0.9516052603721619)","('NON-ESG', 0.011783428490161896)","('NON-ESG', 0.003803011728450656)"
Line 951,"As such, we pursue aggressive  strategies in our manufacturing plants and engineering departments that aim to address  ergonomic risks with appropriate prevention and control measures throughout the design  and manufacturing process.
","('Supply_Chain_Management', 0.4511988162994385)","('Systemic_Risk_Management', 0.13322150707244873)","('Employee_Health_And_Safety', 0.08651991188526154)","('NON-ESG', 0.4511988162994385)","('NON-ESG', 0.13322150707244873)","('NON-ESG', 0.08651991188526154)"
Line 952,"In 2021, 164 new ergonomic workstations were installed at our  Irvine, Calif., manufacturing plant.
","('Energy_Management', 0.43308642506599426)","('Product_Design_And_Lifecycle_Management', 0.3178778290748596)","('Supply_Chain_Management', 0.040748268365859985)","('NON-ESG', 0.43308642506599426)","('NON-ESG', 0.3178778290748596)","('NON-ESG', 0.040748268365859985)"
Line 953,"The new workstations include adjustable microscopes  and chairs to adjust posture-related injury risks from valve sewing.
","('Employee_Health_And_Safety', 0.9818427562713623)","('Employee_Engagement_Inclusion_And_Diversity', 0.002039060927927494)","('Critical_Incident_Risk_Management', 0.001583530567586422)","(['Operational Eco-Efficiency'], 0.9818427562713623)","('NON-ESG', 0.002039060927927494)","('NON-ESG', 0.001583530567586422)"
Line 954,"Please see our 2021 EHS  Report for more information.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6322587728500366)","('Access_And_Affordability', 0.058986764401197433)","('Business_Ethics', 0.02662171609699726)","(['Corporate Governance'], 0.6322587728500366)","('NON-ESG', 0.058986764401197433)","('NON-ESG', 0.02662171609699726)"
Line 955,"Global Lost Time Injury Rate for 2011-2021  Edwards defines a recordable injury as any work-related injury requiring treatment beyond first aid, as defined  in the U.S. OSHA recordkeeping standard 29 CFR 1904.
","('Employee_Health_And_Safety', 0.9840258955955505)","('Employee_Engagement_Inclusion_And_Diversity', 0.0014523901045322418)","('Critical_Incident_Risk_Management', 0.0012406795285642147)","(['Operational Eco-Efficiency'], 0.9840258955955505)","('NON-ESG', 0.0014523901045322418)","('NON-ESG', 0.0012406795285642147)"
Line 956,"For corporate reporting purposes, this definition is   applied at all Edwards locations, regardless of local agency reporting guidelines.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9162659645080566)","('Energy_Management', 0.008856336586177349)","('Access_And_Affordability', 0.006826567929238081)","(['Corporate Governance'], 0.9162659645080566)","('NON-ESG', 0.008856336586177349)","('NON-ESG', 0.006826567929238081)"
Line 957,"Edwards defines a lost-time  case as any work-related injury that results in a full day or more away from work, in accordance with the U.S.  OSHA recordkeeping standard 29 CFR 1904.
","('Employee_Health_And_Safety', 0.9703881740570068)","('Labor_Practices', 0.006060589570552111)","('Employee_Engagement_Inclusion_And_Diversity', 0.002086853375658393)","(['Operational Eco-Efficiency'], 0.9703881740570068)","('NON-ESG', 0.006060589570552111)","('NON-ESG', 0.002086853375658393)"
Line 958,"ISO Certification As of 2021, six of our seven manufacturing sites are certified to ISO 14001, with our   newest manufacturing plant in Ireland expected to achieve certification in 2023.
","('Product_Quality_And_Safety', 0.3652113974094391)","('Product_Design_And_Lifecycle_Management', 0.33570554852485657)","('Management_Of_Legal_And_Regulatory_Framework', 0.03433832898736)","('NON-ESG', 0.3652113974094391)","('NON-ESG', 0.33570554852485657)","('NON-ESG', 0.03433832898736)"
Line 959,"In   addition, our European Field and Commercial Region also holds ISO 14001 certification.
","('Product_Quality_And_Safety', 0.3760150969028473)","('Product_Design_And_Lifecycle_Management', 0.13732382655143738)","('Management_Of_Legal_And_Regulatory_Framework', 0.12501461803913116)","('NON-ESG', 0.3760150969028473)","('NON-ESG', 0.13732382655143738)","('NON-ESG', 0.12501461803913116)"
Line 960,"Our manufacturing plants are now working toward achieving ISO 45001 certification.
","('Product_Quality_And_Safety', 0.40124574303627014)","('Product_Design_And_Lifecycle_Management', 0.3498496115207672)","('Management_Of_Legal_And_Regulatory_Framework', 0.03240177780389786)","('NON-ESG', 0.40124574303627014)","('NON-ESG', 0.3498496115207672)","('NON-ESG', 0.03240177780389786)"
Line 961,"Currently, four of our seven manufacturing sites are certified, with our Irvine plant   recently achieving certification in 2021.
","('Product_Design_And_Lifecycle_Management', 0.3537038266658783)","('Product_Quality_And_Safety', 0.31688401103019714)","('Supply_Chain_Management', 0.04366382583975792)","('NON-ESG', 0.3537038266658783)","('NON-ESG', 0.31688401103019714)","('NON-ESG', 0.04366382583975792)"
Line 962,"The remaining three sites are on schedule   to become certified on time with our internal deadlines.2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Global Lost Time Injury Rate Over Time (Days away from work cases per 100 employees) 0.20 0.62 0.42 0.32 0.36 0.35 0.51 0.49 0.33 0.32 0.Global Recordable Case (Injury) Rate Over Time (Cases per 100 employees) 0.78 1.83 1.42 1.28 1.13 1.23 0.99 1.04 0.79 0.63 0.External awards and recognition received for 2021:  •  Most Sustainable Companies (Barron’s)  •  Management Top 250 (Wall Street Journal)  •  America’s Most Responsible Companies (Newsweek)  •  America’s Most Just Companies “JUST 100” (JUST Capital/Forbes magazine)  •  Top 100 Companies Supporting Healthy Families and Communities   (JUST Capital)  •  World’s Most Ethical Company (Ethisphere)  •  America’s Best Large Employers (Forbes magazine)  •  Best Employers for New Graduates (Forbes magazine)  •  World’s Top Female-Friendly Companies (Forbes magazine)  •  Trendsetter in Corporate Political Disclosure and Accountability   (CPA Zicklin Index)EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Diversity, Inclusion & Belonging Edwards Lifesciences’ diversity, inclusion, and belonging initiatives uplift   our employees and customers, while supporting our aspiration of fostering   an inclusive culture where all employees grow and thrive.
","('Employee_Health_And_Safety', 0.983519971370697)","('Employee_Engagement_Inclusion_And_Diversity', 0.00155762885697186)","('Labor_Practices', 0.0013694250956177711)","(['Operational Eco-Efficiency'], 0.983519971370697)","('NON-ESG', 0.00155762885697186)","('NON-ESG', 0.0013694250956177711)"
Line 963,"The remaining three sites are on schedule   to become certified on time with our internal deadlines.2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Global Lost Time Injury Rate Over Time (Days away from work cases per 100 employees) 0.20 0.62 0.42 0.32 0.36 0.35 0.51 0.49 0.33 0.32 0.Global Recordable Case (Injury) Rate Over Time (Cases per 100 employees) 0.78 1.83 1.42 1.28 1.13 1.23 0.99 1.04 0.79 0.63 0.External awards and recognition received for 2021:  •  Most Sustainable Companies (Barron’s)  •  Management Top 250 (Wall Street Journal)  •  America’s Most Responsible Companies (Newsweek)  •  America’s Most Just Companies “JUST 100” (JUST Capital/Forbes magazine)  •  Top 100 Companies Supporting Healthy Families and Communities   (JUST Capital)  •  World’s Most Ethical Company (Ethisphere)  •  America’s Best Large Employers (Forbes magazine)  •  Best Employers for New Graduates (Forbes magazine)  •  World’s Top Female-Friendly Companies (Forbes magazine)  •  Trendsetter in Corporate Political Disclosure and Accountability   (CPA Zicklin Index)EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Diversity, Inclusion & Belonging Edwards Lifesciences’ diversity, inclusion, and belonging initiatives uplift   our employees and customers, while supporting our aspiration of fostering   an inclusive culture where all employees grow and thrive.
","('Systemic_Risk_Management', 0.16600261628627777)","('Business_Model_Resilience', 0.12699542939662933)","('Employee_Health_And_Safety', 0.08696511387825012)","('NON-ESG', 0.16600261628627777)","('NON-ESG', 0.12699542939662933)","('NON-ESG', 0.08696511387825012)"
Line 964,"The remaining three sites are on schedule   to become certified on time with our internal deadlines.2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Global Lost Time Injury Rate Over Time (Days away from work cases per 100 employees) 0.20 0.62 0.42 0.32 0.36 0.35 0.51 0.49 0.33 0.32 0.Global Recordable Case (Injury) Rate Over Time (Cases per 100 employees) 0.78 1.83 1.42 1.28 1.13 1.23 0.99 1.04 0.79 0.63 0.External awards and recognition received for 2021:  •  Most Sustainable Companies (Barron’s)  •  Management Top 250 (Wall Street Journal)  •  America’s Most Responsible Companies (Newsweek)  •  America’s Most Just Companies “JUST 100” (JUST Capital/Forbes magazine)  •  Top 100 Companies Supporting Healthy Families and Communities   (JUST Capital)  •  World’s Most Ethical Company (Ethisphere)  •  America’s Best Large Employers (Forbes magazine)  •  Best Employers for New Graduates (Forbes magazine)  •  World’s Top Female-Friendly Companies (Forbes magazine)  •  Trendsetter in Corporate Political Disclosure and Accountability   (CPA Zicklin Index)EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Diversity, Inclusion & Belonging Edwards Lifesciences’ diversity, inclusion, and belonging initiatives uplift   our employees and customers, while supporting our aspiration of fostering   an inclusive culture where all employees grow and thrive.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9756661653518677)","('Employee_Health_And_Safety', 0.002375067910179496)","('Human_Rights_And_Community_Relations', 0.0015985470963642001)","(['Human Capital Development'], 0.9756661653518677)","('NON-ESG', 0.002375067910179496)","('NON-ESG', 0.0015985470963642001)"
Line 965,"Definition   Promoting diversity in Edwards’ leadership, employee population, and   suppliers by fostering an inclusive culture; evaluating and providing fair pay   and equal opportunity for all employees regardless of background.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9740479588508606)","('Employee_Health_And_Safety', 0.0022756983526051044)","('Labor_Practices', 0.002010663505643606)","(['Human Capital Development'], 0.9740479588508606)","('NON-ESG', 0.0022756983526051044)","('NON-ESG', 0.002010663505643606)"
Line 966,"Management Approach At Edwards, our Diversity, Inclusion and Belonging (DIB) mission is to ensure   that we foster a culture that embraces diversity through inclusion and belonging.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9746201038360596)","('Employee_Health_And_Safety', 0.002520065987482667)","('Human_Rights_And_Community_Relations', 0.001639598049223423)","(['Human Capital Development'], 0.9746201038360596)","('NON-ESG', 0.002520065987482667)","('NON-ESG', 0.001639598049223423)"
Line 967,"Our goal is to improve patient care and business results through the attraction,   development and retention of great talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.891832172870636)","('Business_Ethics', 0.009944799356162548)","('Employee_Health_And_Safety', 0.009448950178921223)","(['Human Capital Development'], 0.891832172870636)","('NON-ESG', 0.009944799356162548)","('NON-ESG', 0.009448950178921223)"
Line 968,"Our culture of inclusion and belonging,  along with the retention of great talent, also enhances our brand and reputation,   and supports overall employee engagement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9692436456680298)","('Employee_Health_And_Safety', 0.003211217001080513)","('Human_Rights_And_Community_Relations', 0.002272897632792592)","(['Human Capital Development'], 0.9692436456680298)","('NON-ESG', 0.003211217001080513)","('NON-ESG', 0.002272897632792592)"
Line 969,"Diversity, Inclusion and Belonging Programs Fostering a diverse, inclusive culture where all of our employees can grow and   thrive is central to who we are as an organization.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9756203293800354)","('Employee_Health_And_Safety', 0.002110737841576338)","('Human_Rights_And_Community_Relations', 0.0017219751607626677)","(['Human Capital Development'], 0.9756203293800354)","('NON-ESG', 0.002110737841576338)","('NON-ESG', 0.0017219751607626677)"
Line 970,"We are deeply committed to   passionate employee engagement that strengthens our communities.
","('Human_Rights_And_Community_Relations', 0.6484967470169067)","('Employee_Engagement_Inclusion_And_Diversity', 0.18876971304416656)","('Employee_Health_And_Safety', 0.027620438486337662)","(['Community Relations'], 0.6484967470169067)","('NON-ESG', 0.18876971304416656)","('NON-ESG', 0.027620438486337662)"
Line 971,"Edwards’   vision is to foster a culture that actively and consistently values diversity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9717705249786377)","('Human_Rights_And_Community_Relations', 0.0022657259833067656)","('Employee_Health_And_Safety', 0.0020645279437303543)","(['Human Capital Development'], 0.9717705249786377)","('NON-ESG', 0.0022657259833067656)","('NON-ESG', 0.0020645279437303543)"
Line 972,"We aim   to become a leading workplace for diversity and inclusion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9732950329780579)","('Employee_Health_And_Safety', 0.0023483100812882185)","('Human_Rights_And_Community_Relations', 0.0018402087735012174)","(['Human Capital Development'], 0.9732950329780579)","('NON-ESG', 0.0023483100812882185)","('NON-ESG', 0.0018402087735012174)"
Line 973,"We consider diversity critical to our mission of transforming patient care through   medical breakthroughs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.41006916761398315)","('Access_And_Affordability', 0.22826386988162994)","('Customer_Welfare', 0.047888386994600296)","('NON-ESG', 0.41006916761398315)","('NON-ESG', 0.22826386988162994)","('NON-ESG', 0.047888386994600296)"
Line 974,"At Edwards, we understand that there is true value in diversity  of thought.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6091567277908325)","('Business_Ethics', 0.07467377930879593)","('Competitive_Behavior', 0.054859459400177)","(['Human Capital Development'], 0.6091567277908325)","('NON-ESG', 0.07467377930879593)","('NON-ESG', 0.054859459400177)"
Line 975,"Companies with diverse talent have a wider range of perspectives, which  can foster a stronger pool of ideas, creativity and innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9373401999473572)","('Business_Model_Resilience', 0.005774366669356823)","('Employee_Health_And_Safety', 0.004962247330695391)","(['Human Capital Development'], 0.9373401999473572)","('NON-ESG', 0.005774366669356823)","('NON-ESG', 0.004962247330695391)"
Line 976,"Embracing a diverse  workforce helps drive Edwards’ commitment to innovation and allows our company  to be more adaptable in the evolving business environment.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9642696380615234)","('Business_Model_Resilience', 0.0041152858175337315)","('Human_Rights_And_Community_Relations', 0.0025115953758358955)","(['Human Capital Development'], 0.9642696380615234)","('NON-ESG', 0.0041152858175337315)","('NON-ESG', 0.0025115953758358955)"
Line 977,"We have created a   culture that understands the strength of diversity, the power that comes from   an inclusive environment and the impact that we can have on so many patients   if we listen to the ideas and diverse thinking of those around us.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9677364826202393)","('Human_Rights_And_Community_Relations', 0.0038627071771770716)","('Employee_Health_And_Safety', 0.002283174078911543)","(['Human Capital Development'], 0.9677364826202393)","('NON-ESG', 0.0038627071771770716)","('NON-ESG', 0.002283174078911543)"
Line 978,"In 2019, Edwards signed the CEO Action Pledge for Diversity and Inclusion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9709219336509705)","('Human_Rights_And_Community_Relations', 0.002324954839423299)","('Employee_Health_And_Safety', 0.002303061308339238)","(['Human Capital Development'], 0.9709219336509705)","('NON-ESG', 0.002324954839423299)","('NON-ESG', 0.002303061308339238)"
Line 979,"This pledge demonstrates our commitment to advancing diversity and inclusion  within our organization and recognizing that change starts at the executive level.
","('Employee_Engagement_Inclusion_And_Diversity', 0.97517991065979)","('Employee_Health_And_Safety', 0.0021196783054620028)","('Human_Rights_And_Community_Relations', 0.001723584602586925)","(['Human Capital Development'], 0.97517991065979)","('NON-ESG', 0.0021196783054620028)","('NON-ESG', 0.001723584602586925)"
Line 980,"Every year, we expand our diversity and inclusion through programs focused on   attracting, engaging and developing diverse talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.974193274974823)","('Employee_Health_And_Safety', 0.002003576373681426)","('Human_Rights_And_Community_Relations', 0.0017875212943181396)","(['Human Capital Development'], 0.974193274974823)","('NON-ESG', 0.002003576373681426)","('NON-ESG', 0.0017875212943181396)"
Line 981,"Sample activities include:  •  Career fairs for engaging traditionally underrepresented groups at conferences  and university chapters (e.g., National Society of Black Engineers and the   Society of Women Engineers)  •  Active engagement with MedTech Color and MedTechWomen, and in the   MedTech and BioTech Veterans Program, which connects transitioning military  professionals with careers in lifesciences companies  •  Project Search partnership program provides internship opportunities for   young adults with intellectual and developmental disabilities to foster career   development and work experience with a goal of transitioning into permanent  employment  •  Panel discussions about managing career opportunities at Edwards   featuring guests from our executive or senior leadership teams  •  Global individualized coaching   •  Leadership development classes, in-person and virtual  •  Hospital observation opportunities to see our products in clinical use  •  Monthly networking events  •  Variety of remote work opportunities  •  Employee listening sessions  •  Virtual interview, assessment, and on-boarding capabilitiesEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Employee Resource Group  Description  Informs, involves and inspires all employees on the value of gender diversity and inclusion to the   Edwards culture, where employees grow and thrive.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8869215846061707)","('Employee_Health_And_Safety', 0.013361956924200058)","('Business_Model_Resilience', 0.009766917675733566)","(['Human Capital Development'], 0.8869215846061707)","('NON-ESG', 0.013361956924200058)","('NON-ESG', 0.009766917675733566)"
Line 982,"Sample activities include:  •  Career fairs for engaging traditionally underrepresented groups at conferences  and university chapters (e.g., National Society of Black Engineers and the   Society of Women Engineers)  •  Active engagement with MedTech Color and MedTechWomen, and in the   MedTech and BioTech Veterans Program, which connects transitioning military  professionals with careers in lifesciences companies  •  Project Search partnership program provides internship opportunities for   young adults with intellectual and developmental disabilities to foster career   development and work experience with a goal of transitioning into permanent  employment  •  Panel discussions about managing career opportunities at Edwards   featuring guests from our executive or senior leadership teams  •  Global individualized coaching   •  Leadership development classes, in-person and virtual  •  Hospital observation opportunities to see our products in clinical use  •  Monthly networking events  •  Variety of remote work opportunities  •  Employee listening sessions  •  Virtual interview, assessment, and on-boarding capabilitiesEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Employee Resource Group  Description  Informs, involves and inspires all employees on the value of gender diversity and inclusion to the   Edwards culture, where employees grow and thrive.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8680610060691833)","('Access_And_Affordability', 0.026393461972475052)","('Employee_Health_And_Safety', 0.017739903181791306)","(['Human Capital Development'], 0.8680610060691833)","('NON-ESG', 0.026393461972475052)","('NON-ESG', 0.017739903181791306)"
Line 983,"Sample activities include:  •  Career fairs for engaging traditionally underrepresented groups at conferences  and university chapters (e.g., National Society of Black Engineers and the   Society of Women Engineers)  •  Active engagement with MedTech Color and MedTechWomen, and in the   MedTech and BioTech Veterans Program, which connects transitioning military  professionals with careers in lifesciences companies  •  Project Search partnership program provides internship opportunities for   young adults with intellectual and developmental disabilities to foster career   development and work experience with a goal of transitioning into permanent  employment  •  Panel discussions about managing career opportunities at Edwards   featuring guests from our executive or senior leadership teams  •  Global individualized coaching   •  Leadership development classes, in-person and virtual  •  Hospital observation opportunities to see our products in clinical use  •  Monthly networking events  •  Variety of remote work opportunities  •  Employee listening sessions  •  Virtual interview, assessment, and on-boarding capabilitiesEDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Employee Resource Group  Description  Informs, involves and inspires all employees on the value of gender diversity and inclusion to the   Edwards culture, where employees grow and thrive.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9755759835243225)","('Employee_Health_And_Safety', 0.0021362905390560627)","('Business_Model_Resilience', 0.0015755932545289397)","(['Human Capital Development'], 0.9755759835243225)","('NON-ESG', 0.0021362905390560627)","('NON-ESG', 0.0015755932545289397)"
Line 984,"Fosters a community that attracts and enables Edwards’ employees across cultures to be   connected and empowered and reach their full potential.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7290633916854858)","('Human_Rights_And_Community_Relations', 0.14977791905403137)","('Access_And_Affordability', 0.011844241991639137)","(['Human Capital Development'], 0.7290633916854858)","('NON-ESG', 0.14977791905403137)","('NON-ESG', 0.011844241991639137)"
Line 985,"This ERG includes our African Heritage   Forum (AHF), Asian Society for Inclusion and Awareness (ASIA), Hispanic Organization for Leadership   and Advancement (HOLA), and Middle Eastern Employee Resource Group (MEERG) chapters.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9628264307975769)","('Employee_Health_And_Safety', 0.0040464564226567745)","('Human_Rights_And_Community_Relations', 0.0037896030116826296)","(['Human Capital Development'], 0.9628264307975769)","('NON-ESG', 0.0040464564226567745)","('NON-ESG', 0.0037896030116826296)"
Line 986,"Fosters a community of veterans and veteran-minded employees at Edwards to enhance   employee engagement, drive veterans’ talent strategy and serve the veterans community.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9541276097297668)","('Employee_Health_And_Safety', 0.0065078940242528915)","('Human_Rights_And_Community_Relations', 0.005221363622695208)","(['Human Capital Development'], 0.9541276097297668)","('NON-ESG', 0.0065078940242528915)","('NON-ESG', 0.005221363622695208)"
Line 987,"Supports issues around work/life integration, parenting, elder care and family caregiving.
","('Access_And_Affordability', 0.842933714389801)","('Employee_Health_And_Safety', 0.025977633893489838)","('Human_Rights_And_Community_Relations', 0.020528707653284073)","(['Health Outcome Contribution'], 0.842933714389801)","('NON-ESG', 0.025977633893489838)","('NON-ESG', 0.020528707653284073)"
Line 988,"Chapters include Fertility, Adoption, and Fostering HOPE; Working Parents; and NexGen   (early career professionals).
","('Employee_Engagement_Inclusion_And_Diversity', 0.4150836765766144)","('Access_And_Affordability', 0.2844669222831726)","('Employee_Health_And_Safety', 0.05828290805220604)","('NON-ESG', 0.4150836765766144)","('NON-ESG', 0.2844669222831726)","('NON-ESG', 0.05828290805220604)"
Line 989,"Creates a community of LGBTQ+ members and allies that fosters employee engagement and   diversity of thought within Edwards through education, support, visibility and advocacy; together,   striving to cultivate an environment of acceptance and respect for all employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9720295071601868)","('Employee_Health_And_Safety', 0.00282309390604496)","('Human_Rights_And_Community_Relations', 0.002686323830857873)","(['Human Capital Development'], 0.9720295071601868)","('NON-ESG', 0.00282309390604496)","('NON-ESG', 0.002686323830857873)"
Line 990,"Supports employees directly and indirectly affected by disabilities, identify ways to recruit and employ   individuals affected by disabilities.Network of Women (E.NOW)Engaging Employees in Diversity, Inclusion and Belonging Our Employee Resource Groups (ERG) provide resources and support to Edwards employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9744051098823547)","('Employee_Health_And_Safety', 0.0031758733093738556)","('Human_Rights_And_Community_Relations', 0.0018533470574766397)","(['Human Capital Development'], 0.9744051098823547)","('NON-ESG', 0.0031758733093738556)","('NON-ESG', 0.0018533470574766397)"
Line 991,"The four focus points of the ERG program are professional development, networking and  mentoring; education and awareness; recruiting; and community outreach.
","('Human_Rights_And_Community_Relations', 0.3851838707923889)","('Access_And_Affordability', 0.24987880885601044)","('Employee_Engagement_Inclusion_And_Diversity', 0.13273225724697113)","('NON-ESG', 0.3851838707923889)","('NON-ESG', 0.24987880885601044)","('NON-ESG', 0.13273225724697113)"
Line 992,"Our employees  are welcome and encouraged to participate in ERGs that celebrate and advance diversity,   inclusion and belonging.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9726479649543762)","('Employee_Health_And_Safety', 0.0022541543003171682)","('Human_Rights_And_Community_Relations', 0.002089717425405979)","(['Human Capital Development'], 0.9726479649543762)","('NON-ESG', 0.0022541543003171682)","('NON-ESG', 0.002089717425405979)"
Line 993,"These include:ERGs improve employees’ experiences – research has shown that ERG and mentor   program participants are more likely to perceive Edwards positively.
","('Employee_Engagement_Inclusion_And_Diversity', 0.461096853017807)","('Access_And_Affordability', 0.12955676019191742)","('Employee_Health_And_Safety', 0.11368454992771149)","('NON-ESG', 0.461096853017807)","('NON-ESG', 0.12955676019191742)","('NON-ESG', 0.11368454992771149)"
Line 994,"The ERGs also   provide avenues for Edwards employees to engage with communities, particularly  groups within communities with whom we might not have otherwise connected.
","('Human_Rights_And_Community_Relations', 0.9504533410072327)","('Access_And_Affordability', 0.006836352404206991)","('Employee_Engagement_Inclusion_And_Diversity', 0.005581363569945097)","(['Community Relations'], 0.9504533410072327)","('NON-ESG', 0.006836352404206991)","('NON-ESG', 0.005581363569945097)"
Line 995,"Overall, ERGs deepen our understanding of different cultures, people and experiences.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6426565647125244)","('Human_Rights_And_Community_Relations', 0.20622101426124573)","('Customer_Privacy', 0.01527461688965559)","(['Human Capital Development'], 0.6426565647125244)","('NON-ESG', 0.20622101426124573)","('NON-ESG', 0.01527461688965559)"
Line 996,"They allow us to support and empower employees to expand their networks and   accelerate their own growth and development.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Annual Performance   Diversity, Inclusion and Belonging Programs In 2021, DIB bolstered its program with additional resources and a new DIB leadership   role, a Vice President of Diversity, Inclusion & Belonging, to drive strategy throughout   the organization.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9741724729537964)","('Employee_Health_And_Safety', 0.002340532373636961)","('Human_Rights_And_Community_Relations', 0.001826547202654183)","(['Human Capital Development'], 0.9741724729537964)","('NON-ESG', 0.002340532373636961)","('NON-ESG', 0.001826547202654183)"
Line 997,"This role is responsible for the vision, leadership, and strategic planning  of initiatives that promote DIB as essential elements of our culture and Credo.
","('Business_Model_Resilience', 0.2124611735343933)","('Human_Rights_And_Community_Relations', 0.1955069601535797)","('Employee_Engagement_Inclusion_And_Diversity', 0.11261733621358871)","('NON-ESG', 0.2124611735343933)","('NON-ESG', 0.1955069601535797)","('NON-ESG', 0.11261733621358871)"
Line 998,"The Vice  President is also a member of our Sustainability Council, which is described more in depth  in the Corporate Governance section of the report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.20534168183803558)","('Business_Model_Resilience', 0.1846218854188919)","('Director_Removal', 0.15448014438152313)","('NON-ESG', 0.20534168183803558)","('NON-ESG', 0.1846218854188919)","('NON-ESG', 0.15448014438152313)"
Line 999,"This year we have continued to build upon our strong foundation and focus on longer-   term DIB strategy development and actions.
","('Business_Model_Resilience', 0.41058894991874695)","('Management_Of_Legal_And_Regulatory_Framework', 0.15830275416374207)","('Human_Rights_And_Community_Relations', 0.07482824474573135)","('NON-ESG', 0.41058894991874695)","('NON-ESG', 0.15830275416374207)","('NON-ESG', 0.07482824474573135)"
Line 1000,"In 2021 we created an internal online   Community of Support offering tools and resources designed to provide support for   employees to engage in meaningful discussions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23736535012722015)","('Access_And_Affordability', 0.20886866748332977)","('Employee_Engagement_Inclusion_And_Diversity', 0.09730655699968338)","('NON-ESG', 0.23736535012722015)","('NON-ESG', 0.20886866748332977)","('NON-ESG', 0.09730655699968338)"
Line 1001,"Edwards recognizes the importance   of inclusion and understanding diverse perspectives and this Community offers   resources and materials to help employees learn tactics and take action to build an   even more inclusive culture at Edwards.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9738919734954834)","('Human_Rights_And_Community_Relations', 0.002656408119946718)","('Employee_Health_And_Safety', 0.0017584161832928658)","(['Human Capital Development'], 0.9738919734954834)","('NON-ESG', 0.002656408119946718)","('NON-ESG', 0.0017584161832928658)"
Line 1002,"In 2021 , we further expanded the ERG network within the six ERG categories:   Multi-Cultural, Friends of Veterans, Generations, Edwards Network of Women, Edwards  Rainbow Alliance and Enable.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7485297918319702)","('Human_Rights_And_Community_Relations', 0.08232436329126358)","('Access_And_Affordability', 0.04187528416514397)","(['Human Capital Development'], 0.7485297918319702)","('NON-ESG', 0.08232436329126358)","('NON-ESG', 0.04187528416514397)"
Line 1003,"Generations chapters now include Boomers; Caregivers;   Fertility, Adoption, and Fostering HOPE; NexGen (early career professionals); Working   Parents and Let’s Talk (mental wellbeing).
","('Access_And_Affordability', 0.5283370018005371)","('Employee_Engagement_Inclusion_And_Diversity', 0.13936439156532288)","('Employee_Health_And_Safety', 0.09019464254379272)","(['Health Outcome Contribution'], 0.5283370018005371)","('NON-ESG', 0.13936439156532288)","('NON-ESG', 0.09019464254379272)"
Line 1004,"We now have 13 ERGs and 39 chapters with   established budgets and enhanced tools and resources.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9145468473434448)","('GHG_Emissions', 0.008953777141869068)","('Human_Rights_And_Community_Relations', 0.008920693770051003)","(['Corporate Governance'], 0.9145468473434448)","('NON-ESG', 0.008953777141869068)","('NON-ESG', 0.008920693770051003)"
Line 1005,"Each month, our ERGs are the   driving force behind several recognized commemorative month activities, such as   Black History Month, AAPI Month, Women’s History Month, Pride Month and Autism   Acceptance Month.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6549587845802307)","('Human_Rights_And_Community_Relations', 0.05099068209528923)","('Employee_Health_And_Safety', 0.03160136938095093)","(['Human Capital Development'], 0.6549587845802307)","('NON-ESG', 0.05099068209528923)","('NON-ESG', 0.03160136938095093)"
Line 1006,"These are opportunities to celebrate the cultures, identities and   backgrounds of employees and patients.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9633781909942627)","('Human_Rights_And_Community_Relations', 0.004986482672393322)","('Employee_Health_And_Safety', 0.004756170324981213)","(['Human Capital Development'], 0.9633781909942627)","('NON-ESG', 0.004986482672393322)","('NON-ESG', 0.004756170324981213)"
Line 1007,"Building awareness and promoting initiatives  across a variety of affinity groups, our ERGs held more than 125 global events in 2021.
","('Employee_Engagement_Inclusion_And_Diversity', 0.29939016699790955)","('Business_Ethics', 0.09362775832414627)","('Human_Rights_And_Community_Relations', 0.09237135201692581)","('NON-ESG', 0.29939016699790955)","('NON-ESG', 0.09362775832414627)","('NON-ESG', 0.09237135201692581)"
Line 1008,"New in 2021, ERGs power our Connection Groups, which provide support and   deepening our work in the community and include:  •  In support of Attention Deficient Hyperactivity Disorder (ADHD) and Autism   Spectrum Disorder (ASD), monthly connections providing support and opportunity   to share, listen and learn  •  Raising Rainbows, a support group focused on parents of those who are members   of the LGBTQ+ community  •  Fertility, Adoption and Fostering HOPE, monthly connections for a time of sharing   and support with others who have similar journeysPreventing Unconscious Bias Unconscious bias refers to the underlying beliefs, perceptions and assumptions we   develop based on our past experiences and can frame the way we look at the world.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7997365593910217)","('Access_And_Affordability', 0.06859542429447174)","('Human_Rights_And_Community_Relations', 0.022357184439897537)","(['Human Capital Development'], 0.7997365593910217)","('NON-ESG', 0.06859542429447174)","('NON-ESG', 0.022357184439897537)"
Line 1009,"New in 2021, ERGs power our Connection Groups, which provide support and   deepening our work in the community and include:  •  In support of Attention Deficient Hyperactivity Disorder (ADHD) and Autism   Spectrum Disorder (ASD), monthly connections providing support and opportunity   to share, listen and learn  •  Raising Rainbows, a support group focused on parents of those who are members   of the LGBTQ+ community  •  Fertility, Adoption and Fostering HOPE, monthly connections for a time of sharing   and support with others who have similar journeysPreventing Unconscious Bias Unconscious bias refers to the underlying beliefs, perceptions and assumptions we   develop based on our past experiences and can frame the way we look at the world.
","('Business_Ethics', 0.18588319420814514)","('Employee_Engagement_Inclusion_And_Diversity', 0.14021307229995728)","('Human_Rights_And_Community_Relations', 0.13427209854125977)","('NON-ESG', 0.18588319420814514)","('NON-ESG', 0.14021307229995728)","('NON-ESG', 0.13427209854125977)"
Line 1010,"As Edwards advances our culture of inclusion, it is important we educate employees  around the identification and adjustment of unconscious biases in the workplace.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9550926089286804)","('Employee_Health_And_Safety', 0.004564483184367418)","('Human_Rights_And_Community_Relations', 0.0045160255394876)","(['Human Capital Development'], 0.9550926089286804)","('NON-ESG', 0.004564483184367418)","('NON-ESG', 0.0045160255394876)"
Line 1011,"Achieving Edwards’ patient-focused innovation strategy requires an inclusive   culture where our employees can bring their best ideas to solve challenges and achieve  business goals.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6302197575569153)","('Business_Model_Resilience', 0.09268386662006378)","('Product_Design_And_Lifecycle_Management', 0.04041563346982002)","(['Human Capital Development'], 0.6302197575569153)","('NON-ESG', 0.09268386662006378)","('NON-ESG', 0.04041563346982002)"
Line 1012,"The role of our leaders is to understand the power of leveraging diversity  of thought within teams to encourage innovation to emerge at every level of the   company.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9285602569580078)","('Business_Model_Resilience', 0.00937169324606657)","('Director_Removal', 0.005828277673572302)","(['Human Capital Development'], 0.9285602569580078)","('NON-ESG', 0.00937169324606657)","('NON-ESG', 0.005828277673572302)"
Line 1013,"•  Our Cultivate Curiosity: Unconscious Bias e-learning module gives employees   flexibility in modality and location.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3575708866119385)","('Competitive_Behavior', 0.18748877942562103)","('Customer_Welfare', 0.06296835094690323)","('NON-ESG', 0.3575708866119385)","('NON-ESG', 0.18748877942562103)","('NON-ESG', 0.06296835094690323)"
Line 1014,"Objectives of the course include:  •  Identify Bias: Understand the neuroscience behind bias, build awareness   and recognize the impact of bias on behavior and decision-making  •  Choose Courage: Increase cultural competency skills to work effectively across   similarities and differences  •  Cultivate Curiosity: Develop the skillset of curiosity and empathy to build   connections, mitigate bias and accelerate performance and that of others Edwards’ Commitment to Employees and Fair and Equitable Pay Edwards tracks remuneration patterns among our employees worldwide, and we   continually look for ways to ensure fair and equitable pay practices.
","('Business_Ethics', 0.4537511467933655)","('Employee_Engagement_Inclusion_And_Diversity', 0.1686633825302124)","('Competitive_Behavior', 0.12365000694990158)","('NON-ESG', 0.4537511467933655)","('NON-ESG', 0.1686633825302124)","('NON-ESG', 0.12365000694990158)"
Line 1015,"Objectives of the course include:  •  Identify Bias: Understand the neuroscience behind bias, build awareness   and recognize the impact of bias on behavior and decision-making  •  Choose Courage: Increase cultural competency skills to work effectively across   similarities and differences  •  Cultivate Curiosity: Develop the skillset of curiosity and empathy to build   connections, mitigate bias and accelerate performance and that of others Edwards’ Commitment to Employees and Fair and Equitable Pay Edwards tracks remuneration patterns among our employees worldwide, and we   continually look for ways to ensure fair and equitable pay practices.
","('Labor_Practices', 0.9630847573280334)","('Business_Ethics', 0.0049220360815525055)","('Director_Removal', 0.0040201484225690365)","(['Labor Practice Indicators'], 0.9630847573280334)","('NON-ESG', 0.0049220360815525055)","('NON-ESG', 0.0040201484225690365)"
Line 1016,"Our ELT and Board  recognize that fair and equitable pay is integral to achieving our goal of being a preferred  employer.
","('Labor_Practices', 0.9525458216667175)","('Business_Ethics', 0.005827000830322504)","('Employee_Engagement_Inclusion_And_Diversity', 0.00499737448990345)","(['Labor Practice Indicators'], 0.9525458216667175)","('NON-ESG', 0.005827000830322504)","('NON-ESG', 0.00499737448990345)"
Line 1017,"Please review Edwards’ Commitment to Fair and Equitable Pay policy for  information on our approach, governance and the Global Career Framework.
","('Labor_Practices', 0.4630473852157593)","('Management_Of_Legal_And_Regulatory_Framework', 0.20397497713565826)","('Business_Ethics', 0.1177670806646347)","('NON-ESG', 0.4630473852157593)","('NON-ESG', 0.20397497713565826)","('NON-ESG', 0.1177670806646347)"
Line 1018,"We have  taken steps toward our efforts on pay equity in the U.S. and developed plans that detail  our strategy for working toward pay equity in our global locations.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT We continue to expand our ERG programs, initiatives and resources, particularly in  alignment with our diversity and inclusion goals.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9745737910270691)","('Employee_Health_And_Safety', 0.0020575597882270813)","('Human_Rights_And_Community_Relations', 0.0016826232895255089)","(['Human Capital Development'], 0.9745737910270691)","('NON-ESG', 0.0020575597882270813)","('NON-ESG', 0.0016826232895255089)"
Line 1019,"We aim to achieve year-over-year  positive trends globally of women in leadership positions, and to achieve year-over   year positive trends in ethnically diverse talent in leadership positions in the U.S.   As of 2021, the E.NOW Amplify Global Development program has had nearly 800   global participants.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9738949537277222)","('Business_Model_Resilience', 0.0022407241631299257)","('Human_Rights_And_Community_Relations', 0.0019035821314901114)","(['Human Capital Development'], 0.9738949537277222)","('NON-ESG', 0.0022407241631299257)","('NON-ESG', 0.0019035821314901114)"
Line 1020,"The Amplify program is a learning journey focusing on the habits  and behaviors that help women grow their careers.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8341956734657288)","('Employee_Health_And_Safety', 0.02510402351617813)","('Human_Rights_And_Community_Relations', 0.019579477608203888)","(['Human Capital Development'], 0.8341956734657288)","('NON-ESG', 0.02510402351617813)","('NON-ESG', 0.019579477608203888)"
Line 1021,"Through self-driven learning,   targeted topics and peer mentoring, participants clarify their vision, plan intentional  actions and widen their influence, impact, and network.
","('Human_Rights_And_Community_Relations', 0.27196648716926575)","('Employee_Engagement_Inclusion_And_Diversity', 0.14090195298194885)","('Access_And_Affordability', 0.10228832811117172)","('NON-ESG', 0.27196648716926575)","('NON-ESG', 0.14090195298194885)","('NON-ESG', 0.10228832811117172)"
Line 1022,"During the year, we also refined and expanded our ENOW mentoring program to include  peer-to-peer Mentoring Circles.
","('Employee_Engagement_Inclusion_And_Diversity', 0.28505295515060425)","('Access_And_Affordability', 0.19016847014427185)","('Management_Of_Legal_And_Regulatory_Framework', 0.07861974090337753)","('NON-ESG', 0.28505295515060425)","('NON-ESG', 0.19016847014427185)","('NON-ESG', 0.07861974090337753)"
Line 1023,"These are small peer groups that meet monthly to  share experiences, create an environment for growth and empowerment, keep each  other accountable and offer support and coaching for one another.
","('Human_Rights_And_Community_Relations', 0.5749772191047668)","('Access_And_Affordability', 0.15950541198253632)","('Employee_Engagement_Inclusion_And_Diversity', 0.10039377212524414)","(['Community Relations'], 0.5749772191047668)","('NON-ESG', 0.15950541198253632)","('NON-ESG', 0.10039377212524414)"
Line 1024,"Each circle has one  to two moderators and six to eight participants with a six-month commitment.
","('Management_Of_Legal_And_Regulatory_Framework', 0.20586352050304413)","('Employee_Engagement_Inclusion_And_Diversity', 0.1580062061548233)","('Labor_Practices', 0.11622444540262222)","('NON-ESG', 0.20586352050304413)","('NON-ESG', 0.1580062061548233)","('NON-ESG', 0.11622444540262222)"
Line 1025,"In 2021,  we had 13 circles piloted in the U.S with approximately 130 participants.
","('Competitive_Behavior', 0.22020910680294037)","('Management_Of_Legal_And_Regulatory_Framework', 0.21239612996578217)","('Business_Ethics', 0.053088344633579254)","('NON-ESG', 0.22020910680294037)","('NON-ESG', 0.21239612996578217)","('NON-ESG', 0.053088344633579254)"
Line 1026,"In 2022, we are  expanding this program to all our global ENOW regions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5168236494064331)","('Business_Model_Resilience', 0.09079532325267792)","('Human_Rights_And_Community_Relations', 0.04861326143145561)","(['Corporate Governance'], 0.5168236494064331)","('NON-ESG', 0.09079532325267792)","('NON-ESG', 0.04861326143145561)"
Line 1027,"Edwards’ Social Impact Investment Fund In 2021, Edwards announced the Social Impact Investment fund, to expand access  to capital in underserved communities.
","('Access_And_Affordability', 0.9435540437698364)","('Human_Rights_And_Community_Relations', 0.00699112843722105)","('Critical_Incident_Risk_Management', 0.0046189348213374615)","(['Health Outcome Contribution'], 0.9435540437698364)","('NON-ESG', 0.00699112843722105)","('NON-ESG', 0.0046189348213374615)"
Line 1028,"The $100 million fund aims to advance racial  equity through economic development, especially in predominantly Black and un- derserved communities in the U.S. Edwards committed to a range of investments to  provide additional capital for targeted programs, economic initiatives and community  development projects.
","('Access_And_Affordability', 0.8697464466094971)","('Human_Rights_And_Community_Relations', 0.042355477809906006)","('Employee_Engagement_Inclusion_And_Diversity', 0.011250294744968414)","(['Health Outcome Contribution'], 0.8697464466094971)","('NON-ESG', 0.042355477809906006)","('NON-ESG', 0.011250294744968414)"
Line 1029,"For example, in October 2021, $25 million was allocated to the  Providing Real Opportunities for Progress by Edwards Lifesciences (PROPEL) Fund,   a New Markets Tax Credit (NMTC) equity fund focused on advancing progress towards  racial equity by closing the health, wealth, and opportunity gaps in communities of  color.
","('Employee_Engagement_Inclusion_And_Diversity', 0.955528199672699)","('Human_Rights_And_Community_Relations', 0.006019645370543003)","('Access_And_Affordability', 0.004223877564072609)","(['Human Capital Development'], 0.955528199672699)","('NON-ESG', 0.006019645370543003)","('NON-ESG', 0.004223877564072609)"
Line 1030,"To read more about the Social Impact Investment Fund, please see the   press release and an interview with Scott Ullem, CFO.
","('Business_Model_Resilience', 0.4117121696472168)","('Human_Rights_And_Community_Relations', 0.09383945167064667)","('Systemic_Risk_Management', 0.09201210737228394)","('NON-ESG', 0.4117121696472168)","('NON-ESG', 0.09383945167064667)","('NON-ESG', 0.09201210737228394)"
Line 1031,"Edwards’ Workforce Representation Edwards hires top talent, offers employee wellbeing and engagement and fosters a  diverse and inclusive culture to help employees deliver their best.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9758086204528809)","('Employee_Health_And_Safety', 0.0018975769635289907)","('Labor_Practices', 0.0018534668488427997)","(['Human Capital Development'], 0.9758086204528809)","('NON-ESG', 0.0018975769635289907)","('NON-ESG', 0.0018534668488427997)"
Line 1032,"We are proud that  our talented and passionate workforce exceeds industry, region and high performing  benchmarks for employee engagement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9666181206703186)","('Employee_Health_And_Safety', 0.004102240316569805)","('Human_Rights_And_Community_Relations', 0.002644612453877926)","(['Human Capital Development'], 0.9666181206703186)","('NON-ESG', 0.004102240316569805)","('NON-ESG', 0.002644612453877926)"
Line 1033,"More in-depth information on our workforce  can be found in our 2021 EEO-1 statement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9131730794906616)","('Labor_Practices', 0.009477406740188599)","('Employee_Health_And_Safety', 0.006461138371378183)","(['Human Capital Development'], 0.9131730794906616)","('NON-ESG', 0.009477406740188599)","('NON-ESG', 0.006461138371378183)"
Line 1034,"n	Female n Male 41% 59%  U.S. Employees by Ethnicity in 2021* n White - 35.8%    n	Asian - 34.9% n Hispanic - 22.6%     n Black/African American - 2.3% n Two or more races - 2.2% n	Native Hawaiian/Pacific Islander - .7% n American Indian/Alaskan Native - .4%  n Not Specified - 1% Global Employees by Type in 2021  n	Professional  n Hourly40% 60%Global Employees by Gender in *In 2021, we included ethnicity data for Puerto Rico along with the rest of the United States.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Women’s Ranks in Leadership Globally* As part of our CEO’s performance management objectives, we measure the number   of female people leaders that are at the level of Sr. Manager and above with the target of  year-over-year positive trending globally of women in leadership positions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9701728224754333)","('Customer_Privacy', 0.002541725290939212)","('Employee_Health_And_Safety', 0.0021995834540575743)","(['Human Capital Development'], 0.9701728224754333)","('NON-ESG', 0.002541725290939212)","('NON-ESG', 0.0021995834540575743)"
Line 1035,"n	Female n Male 41% 59%  U.S. Employees by Ethnicity in 2021* n White - 35.8%    n	Asian - 34.9% n Hispanic - 22.6%     n Black/African American - 2.3% n Two or more races - 2.2% n	Native Hawaiian/Pacific Islander - .7% n American Indian/Alaskan Native - .4%  n Not Specified - 1% Global Employees by Type in 2021  n	Professional  n Hourly40% 60%Global Employees by Gender in *In 2021, we included ethnicity data for Puerto Rico along with the rest of the United States.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Women’s Ranks in Leadership Globally* As part of our CEO’s performance management objectives, we measure the number   of female people leaders that are at the level of Sr. Manager and above with the target of  year-over-year positive trending globally of women in leadership positions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8091740012168884)","('Director_Removal', 0.037888456135988235)","('Business_Model_Resilience', 0.029153984040021896)","(['Human Capital Development'], 0.8091740012168884)","('NON-ESG', 0.037888456135988235)","('NON-ESG', 0.029153984040021896)"
Line 1036,"We monitor  this specific population because these roles have strong influence over the culture and   future success at Edwards.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5988660454750061)","('Human_Rights_And_Community_Relations', 0.1364526003599167)","('Business_Model_Resilience', 0.05037138983607292)","(['Human Capital Development'], 0.5988660454750061)","('NON-ESG', 0.1364526003599167)","('NON-ESG', 0.05037138983607292)"
Line 1037,"Our people leaders at Sr. Manager and above are responsible for  leading and making decisions regarding our talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9108803868293762)","('Employee_Health_And_Safety', 0.010450786910951138)","('Human_Rights_And_Community_Relations', 0.008126159198582172)","(['Human Capital Development'], 0.9108803868293762)","('NON-ESG', 0.010450786910951138)","('NON-ESG', 0.008126159198582172)"
Line 1038,"These people leaders impact company  culture through their leadership responsibilities related to hiring, engagement and   development of our employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9471944570541382)","('Human_Rights_And_Community_Relations', 0.008472501300275326)","('Employee_Health_And_Safety', 0.004890041891485453)","(['Human Capital Development'], 0.9471944570541382)","('NON-ESG', 0.008472501300275326)","('NON-ESG', 0.004890041891485453)"
Line 1039,"We consistently monitor our performance on this metric   to ensure that we have the diverse perspectives necessary among our leadership ranks to  fuel our innovation, solve patients’ unmet healthcare needs, and continue to stay agile in   a rapidly evolving industry.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4887089431285858)","('Business_Model_Resilience', 0.15865647792816162)","('Customer_Welfare', 0.046646323055028915)","('NON-ESG', 0.4887089431285858)","('NON-ESG', 0.15865647792816162)","('NON-ESG', 0.046646323055028915)"
Line 1040,"Percent of Women in Leadership   *Senior manager and above female people leaders globally.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7910809516906738)","('Director_Removal', 0.04632367938756943)","('Business_Model_Resilience', 0.022608648985624313)","(['Human Capital Development'], 0.7910809516906738)","('NON-ESG', 0.04632367938756943)","('NON-ESG', 0.022608648985624313)"
Line 1041,"Note the percentage change also reflects   a year-over-year growing employee population.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8183742761611938)","('Labor_Practices', 0.04574071243405342)","('Employee_Health_And_Safety', 0.01876160502433777)","(['Human Capital Development'], 0.8183742761611938)","('NON-ESG', 0.04574071243405342)","('NON-ESG', 0.01876160502433777)"
Line 1042,"In addition, we annually benchmark our performance utilizing select McKinsey data sets.
","('Systemic_Risk_Management', 0.35868608951568604)","('Business_Model_Resilience', 0.1881292760372162)","('Competitive_Behavior', 0.1216307133436203)","('NON-ESG', 0.35868608951568604)","('NON-ESG', 0.1881292760372162)","('NON-ESG', 0.1216307133436203)"
Line 1043,"While we include the proportion of female people managers in our CEO’s performance   objectives, the McKinsey report includes all women in management (including those   who do not manage people).
","('Employee_Engagement_Inclusion_And_Diversity', 0.5397430062294006)","('Director_Removal', 0.09736315160989761)","('Labor_Practices', 0.06476251780986786)","(['Human Capital Development'], 0.5397430062294006)","('NON-ESG', 0.09736315160989761)","('NON-ESG', 0.06476251780986786)"
Line 1044,"For 2021, our comparable female leadership population   was equal to or exceeded the benchmark average in four of five levels when compared   to the McKinsey Women in the Workplace Report 2021.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9231201410293579)","('Labor_Practices', 0.007604256272315979)","('Human_Rights_And_Community_Relations', 0.007220780942589045)","(['Human Capital Development'], 0.9231201410293579)","('NON-ESG', 0.007604256272315979)","('NON-ESG', 0.007220780942589045)"
Line 1045,"Preventing Unconscious Bias As of 2019, 100 percent of ELT, SLT and their Director and above direct reports completed  the Unconscious Bias Training.
","('Employee_Health_And_Safety', 0.24285255372524261)","('Business_Ethics', 0.21402607858181)","('Employee_Engagement_Inclusion_And_Diversity', 0.1156219020485878)","('NON-ESG', 0.24285255372524261)","('NON-ESG', 0.21402607858181)","('NON-ESG', 0.1156219020485878)"
Line 1046,"Our current target states: by 2022, all global employees   will have completed unconscious bias training, and new hires complete the training within  six months of employment.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7953524589538574)","('Labor_Practices', 0.08803489059209824)","('Employee_Health_And_Safety', 0.024810124188661575)","(['Human Capital Development'], 0.7953524589538574)","('NON-ESG', 0.08803489059209824)","('NON-ESG', 0.024810124188661575)"
Line 1047,"At the end of 2021,100 percent of Associate Managers and  above were trained, and we are on track to achieve this goal in 2022.2021 2020 2019 2018 2017  34.3% 33.7% 33.1% 31.8% 30.9%HIGHLIGHT STORY Creating Community  and Encouraging   Authenticity Edwards aspires to be a global leader dedicated    to fostering an inclusive culture where all   employees grow and thrive.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8882954120635986)","('Human_Rights_And_Community_Relations', 0.026756754145026207)","('Business_Model_Resilience', 0.00947739090770483)","(['Human Capital Development'], 0.8882954120635986)","('NON-ESG', 0.026756754145026207)","('NON-ESG', 0.00947739090770483)"
Line 1048,"Our Employee   Resource Groups (ERGs) bring employees with  common interests together and play a central role in advancing Diversity,   Inclusion & Belonging (DIB).
","('Employee_Engagement_Inclusion_And_Diversity', 0.975950300693512)","('Employee_Health_And_Safety', 0.0023274363484233618)","('Human_Rights_And_Community_Relations', 0.00189472665078938)","(['Human Capital Development'], 0.975950300693512)","('NON-ESG', 0.0023274363484233618)","('NON-ESG', 0.00189472665078938)"
Line 1049,"These groups typically represent a marginalized   community and support our workforce with a sense of belonging.
","('Human_Rights_And_Community_Relations', 0.7378689646720886)","('Employee_Engagement_Inclusion_And_Diversity', 0.13008157908916473)","('Access_And_Affordability', 0.01911492645740509)","(['Community Relations'], 0.7378689646720886)","('NON-ESG', 0.13008157908916473)","('NON-ESG', 0.01911492645740509)"
Line 1050,"Enable ERG - Autism Spectrum Disorder and   Attention-Deficit/Hyperactivity Disorder   The Edwards Enable ERG celebrated Autism Awareness Month in a profound way,  hosting an education and awareness event featuring guest speaker, Temple   Grandin.
","('Employee_Engagement_Inclusion_And_Diversity', 0.32163432240486145)","('Access_And_Affordability', 0.25720250606536865)","('Employee_Health_And_Safety', 0.12642808258533478)","('NON-ESG', 0.32163432240486145)","('NON-ESG', 0.25720250606536865)","('NON-ESG', 0.12642808258533478)"
Line 1051,"Diagnosed with autism in 1950, she is a renowned professor, autism   activist, and author of The Autistic Brain, among other books.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6481119394302368)","('Employee_Health_And_Safety', 0.08812718838453293)","('Access_And_Affordability', 0.04128072038292885)","(['Human Capital Development'], 0.6481119394302368)","('NON-ESG', 0.08812718838453293)","('NON-ESG', 0.04128072038292885)"
Line 1052,"This flagship event was co-hosted with another ERG, Edwards Network of   Women.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3669719398021698)","('Management_Of_Legal_And_Regulatory_Framework', 0.09249832481145859)","('Director_Removal', 0.07033100724220276)","('NON-ESG', 0.3669719398021698)","('NON-ESG', 0.09249832481145859)","('NON-ESG', 0.07033100724220276)"
Line 1053,"Grandin’s message – those on the autism spectrum are valuable   contributors to society and the working world – was inspiring for all.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2862913906574249)","('Access_And_Affordability', 0.28618791699409485)","('Employee_Health_And_Safety', 0.11377247422933578)","('NON-ESG', 0.2862913906574249)","('NON-ESG', 0.28618791699409485)","('NON-ESG', 0.11377247422933578)"
Line 1054,"Parents can  teach their autistic child at various ages to develop important skills for life and  work.
","('Access_And_Affordability', 0.6875311136245728)","('Employee_Engagement_Inclusion_And_Diversity', 0.09300900250673294)","('Human_Rights_And_Community_Relations', 0.043996721506118774)","(['Health Outcome Contribution'], 0.6875311136245728)","('NON-ESG', 0.09300900250673294)","('NON-ESG', 0.043996721506118774)"
Line 1055,"The event had the largest online attendance of all Edwards ERG programs   and was recorded for future viewing by all global employees.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1338464468717575)","('Labor_Practices', 0.07650545239448547)","('Director_Removal', 0.07377681881189346)","('NON-ESG', 0.1338464468717575)","('NON-ESG', 0.07650545239448547)","('NON-ESG', 0.07377681881189346)"
Line 1056,"Our Enable ERG provides education and support for employees directly and    indirectly affected by disabilities, including Autism Spectrum Disorder and   attention-deficit/hyperactivity disorder.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5083317160606384)","('Access_And_Affordability', 0.18219901621341705)","('Employee_Health_And_Safety', 0.08032044768333435)","(['Human Capital Development'], 0.5083317160606384)","('NON-ESG', 0.18219901621341705)","('NON-ESG', 0.08032044768333435)"
Line 1057,"Enable strives to identify ways to recruit  and employ individuals with disabilities and focuses on ways to contribute to the  company and community-at-large.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9504334330558777)","('Human_Rights_And_Community_Relations', 0.007047666702419519)","('Employee_Health_And_Safety', 0.005505262408405542)","(['Human Capital Development'], 0.9504334330558777)","('NON-ESG', 0.007047666702419519)","('NON-ESG', 0.005505262408405542)"
Line 1058,"In 2021, Enable’s partnership with Project  Search helped to place several employees with disabilities in meaningful careers   at Edwards.
","('Employee_Engagement_Inclusion_And_Diversity', 0.798823356628418)","('Employee_Health_And_Safety', 0.079612135887146)","('Access_And_Affordability', 0.03324400261044502)","(['Human Capital Development'], 0.798823356628418)","('NON-ESG', 0.079612135887146)","('NON-ESG', 0.03324400261044502)"
Line 1059,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Fertility, Adoption & Fostering HOPE (FAFH) “The road to parenthood can be a rollercoaster with many ups and downs …   the journey can be such an isolating experience, and even those with the best of   intentions, can’t relate.
","('Access_And_Affordability', 0.5960028767585754)","('Employee_Engagement_Inclusion_And_Diversity', 0.10110693424940109)","('Employee_Health_And_Safety', 0.048331454396247864)","(['Health Outcome Contribution'], 0.5960028767585754)","('NON-ESG', 0.10110693424940109)","('NON-ESG', 0.048331454396247864)"
Line 1060,"But having the support of those who have been in your   shoes is like a warm blanket wrapped around you to keep you warm in your coldest  moments,” one FAFH member shared.
","('Employee_Health_And_Safety', 0.3270464837551117)","('Water_And_Wastewater_Management', 0.07191964238882065)","('Physical_Impacts_Of_Climate_Change', 0.05164443701505661)","('NON-ESG', 0.3270464837551117)","('NON-ESG', 0.07191964238882065)","('NON-ESG', 0.05164443701505661)"
Line 1061,"FAFH connects and supports those whose lives have been touched by fertility,   adoption and/or fostering.
","('Access_And_Affordability', 0.7490410804748535)","('Employee_Engagement_Inclusion_And_Diversity', 0.05659078434109688)","('Employee_Health_And_Safety', 0.03605369105935097)","(['Health Outcome Contribution'], 0.7490410804748535)","('NON-ESG', 0.05659078434109688)","('NON-ESG', 0.03605369105935097)"
Line 1062,"Not only do they share their own personal journeys   Edwards launched a 20-day ally challenge in support of Pride month to   deepen employees allyship and understanding of LGBTQ+ communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9146591424942017)","('Human_Rights_And_Community_Relations', 0.02326492965221405)","('Employee_Health_And_Safety', 0.007181912194937468)","(['Human Capital Development'], 0.9146591424942017)","('NON-ESG', 0.02326492965221405)","('NON-ESG', 0.007181912194937468)"
Line 1063,"Employee teams took on daily micro-challenges, each about 10 minutes,  which underscored LGBTQ+ equity and identity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9676278829574585)","('Human_Rights_And_Community_Relations', 0.003925526514649391)","('Employee_Health_And_Safety', 0.002803556388244033)","(['Human Capital Development'], 0.9676278829574585)","('NON-ESG', 0.003925526514649391)","('NON-ESG', 0.002803556388244033)"
Line 1064,"There were videos, coming   out stories, pronoun education, insights on LGBTQ+ laws, a day to wear pride  and more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8874461054801941)","('Human_Rights_And_Community_Relations', 0.02331731468439102)","('Employee_Health_And_Safety', 0.0074628922156989574)","(['Human Capital Development'], 0.8874461054801941)","('NON-ESG', 0.02331731468439102)","('NON-ESG', 0.0074628922156989574)"
Line 1065,"Employees were encouraged to share reflections after each   challenge, with many responses including messages of inspiration and insight.of building their families; the group also provides resources, education and   awareness, and guest speakers, and the group participates in community events   to give back to fertility, adoption and foster organizations.
","('Access_And_Affordability', 0.712855875492096)","('Human_Rights_And_Community_Relations', 0.07192156463861465)","('Employee_Engagement_Inclusion_And_Diversity', 0.0523003451526165)","(['Health Outcome Contribution'], 0.712855875492096)","('NON-ESG', 0.07192156463861465)","('NON-ESG', 0.0523003451526165)"
Line 1066,"Recently, guest speakers from Holt International shared how to meet the needs   of vulnerable children, barriers to attachment, intercountry adoption perspectives   and insights from an adoptee.
","('Access_And_Affordability', 0.835455060005188)","('Human_Rights_And_Community_Relations', 0.02886567823588848)","('Employee_Engagement_Inclusion_And_Diversity', 0.02198641560971737)","(['Health Outcome Contribution'], 0.835455060005188)","('NON-ESG', 0.02886567823588848)","('NON-ESG', 0.02198641560971737)"
Line 1067,"Rainbow Alliance / Raising Rainbows The mission of the Edwards Rainbow Alliance  is to create a community   of LGBTQ+ members and their allies that fosters employee engagement and   diversity of thought through education, support, visibility, and advocacy.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9720589518547058)","('Employee_Health_And_Safety', 0.002599321072921157)","('Human_Rights_And_Community_Relations', 0.00212940014898777)","(['Human Capital Development'], 0.9720589518547058)","('NON-ESG', 0.002599321072921157)","('NON-ESG', 0.00212940014898777)"
Line 1068,"Within this resource group is a unique body of support, Raising Rainbows,   dedicated to parents and others whose loved ones are either young adult   members of the LGBTQ+ community or whose children are exploring their   sexuality or gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.933415949344635)","('Employee_Health_And_Safety', 0.008557675406336784)","('Human_Rights_And_Community_Relations', 0.008319194428622723)","(['Human Capital Development'], 0.933415949344635)","('NON-ESG', 0.008557675406336784)","('NON-ESG', 0.008319194428622723)"
Line 1069,"The purpose is to offer encouragement and empathy to   one another so that employees can bring their best selves home to the ones   they love.
","('Human_Rights_And_Community_Relations', 0.5727294683456421)","('Access_And_Affordability', 0.06254392862319946)","('Customer_Privacy', 0.05016173794865608)","(['Community Relations'], 0.5727294683456421)","('NON-ESG', 0.06254392862319946)","('NON-ESG', 0.05016173794865608)"
Line 1070,"The monthly meetings include informal sharing and, frequently, guest   speakers from the community who can offer education and advice for those   navigating a new or challenging chapter in their family’s story.
","('Access_And_Affordability', 0.4209054708480835)","('Human_Rights_And_Community_Relations', 0.1544049084186554)","('Employee_Engagement_Inclusion_And_Diversity', 0.06874583661556244)","('NON-ESG', 0.4209054708480835)","('NON-ESG', 0.1544049084186554)","('NON-ESG', 0.06874583661556244)"
Line 1071,"In early 2022,  LGBTQ Center OC shared tips and resources to help our employees support   their young loved ones on their journeys.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9497073292732239)","('Human_Rights_And_Community_Relations', 0.006411141715943813)","('Access_And_Affordability', 0.0056559862568974495)","(['Human Capital Development'], 0.9497073292732239)","('NON-ESG', 0.006411141715943813)","('NON-ESG', 0.0056559862568974495)"
Line 1072,"Allyship for Pride Allyship (noun) – efforts by a group to advocate for the interests of   marginalized groups in society.
","('Human_Rights_And_Community_Relations', 0.7635771632194519)","('Access_And_Affordability', 0.06455280631780624)","('Labor_Practices', 0.04420735314488411)","(['Community Relations'], 0.7635771632194519)","('NON-ESG', 0.06455280631780624)","('NON-ESG', 0.04420735314488411)"
Line 1073,"HIGHLIGHT STORIES EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Volunteerism & Giving Edwards Lifesciences’ work to encourage employee charitable activity and giving   supports our culture and aspiration of passionate engagement that strengthens   our communities.
","('Human_Rights_And_Community_Relations', 0.4718938171863556)","('Employee_Health_And_Safety', 0.10862783342599869)","('Employee_Engagement_Inclusion_And_Diversity', 0.09074811637401581)","('NON-ESG', 0.4718938171863556)","('NON-ESG', 0.10862783342599869)","('NON-ESG', 0.09074811637401581)"
Line 1074,"Definition   Dedicating time, talent and resources to communities where Edwards’ employees live   and work and supporting community health and well-being.
","('Human_Rights_And_Community_Relations', 0.8463541865348816)","('Access_And_Affordability', 0.040922340005636215)","('Employee_Health_And_Safety', 0.03244813159108162)","(['Community Relations'], 0.8463541865348816)","('NON-ESG', 0.040922340005636215)","('NON-ESG', 0.03244813159108162)"
Line 1075,"Our charitable activities   and giving efforts focus on impacting underserved structural heart and critically ill patients  through our Every Heartbeat Matters initiative which increases access to healthcare via  humanitarian care, as well as strengthens the communities where we live and work.
","('Access_And_Affordability', 0.9469549655914307)","('Human_Rights_And_Community_Relations', 0.005154790822416544)","('Critical_Incident_Risk_Management', 0.005032368004322052)","(['Health Outcome Contribution'], 0.9469549655914307)","('NON-ESG', 0.005154790822416544)","('NON-ESG', 0.005032368004322052)"
Line 1076,"Management Approach   Our commitment to charitable giving and participation in philanthropic causes is   one of the defining elements of Edwards Lifesciences’ culture.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6289916634559631)","('Human_Rights_And_Community_Relations', 0.06652186810970306)","('Access_And_Affordability', 0.0424276739358902)","(['Corporate Governance'], 0.6289916634559631)","('NON-ESG', 0.06652186810970306)","('NON-ESG', 0.0424276739358902)"
Line 1077,"We believe our work   can inspire hope and contribute to better lives for our patients, employees and   communities.
","('Human_Rights_And_Community_Relations', 0.8101860284805298)","('Access_And_Affordability', 0.08133825659751892)","('Employee_Health_And_Safety', 0.014839867129921913)","(['Community Relations'], 0.8101860284805298)","('NON-ESG', 0.08133825659751892)","('NON-ESG', 0.014839867129921913)"
Line 1078,"Many of our employees feel personally connected to our philanthropy   and identify this commitment as a key reason why they are proud to work at Edwards.
","('Human_Rights_And_Community_Relations', 0.5994884967803955)","('Management_Of_Legal_And_Regulatory_Framework', 0.05516574904322624)","('Access_And_Affordability', 0.030654754489660263)","(['Community Relations'], 0.5994884967803955)","('NON-ESG', 0.05516574904322624)","('NON-ESG', 0.030654754489660263)"
Line 1079,"Philanthropy at Edwards Lifesciences At Edwards, we champion important health-related and community causes to   improve the lives of underserved patients and strengthen communities.
","('Access_And_Affordability', 0.9436855912208557)","('Human_Rights_And_Community_Relations', 0.006857386790215969)","('Product_Quality_And_Safety', 0.004610815551131964)","(['Health Outcome Contribution'], 0.9436855912208557)","('NON-ESG', 0.006857386790215969)","('NON-ESG', 0.004610815551131964)"
Line 1080,"Through our  Global Corporate Giving,  Edwards Lifesciences Foundation supports advancements in  knowledge and improvements in quality of life.
","('Access_And_Affordability', 0.31508567929267883)","('Product_Design_And_Lifecycle_Management', 0.1129864975810051)","('Employee_Engagement_Inclusion_And_Diversity', 0.1012691929936409)","('NON-ESG', 0.31508567929267883)","('NON-ESG', 0.1129864975810051)","('NON-ESG', 0.1012691929936409)"
Line 1081,"We leverage our expertise in structural  heart disease and critical care monitoring to elevate the impact of our philanthropic   efforts.
","('Access_And_Affordability', 0.5151262879371643)","('Employee_Health_And_Safety', 0.08123369514942169)","('Critical_Incident_Risk_Management', 0.06228141114115715)","(['Health Outcome Contribution'], 0.5151262879371643)","('NON-ESG', 0.08123369514942169)","('NON-ESG', 0.06228141114115715)"
Line 1082,"Some examples of initiatives include grants from the Edwards Lifesciences   Foundation, passionate employee charitable activity, donation of our medical   innovations, corporate donations and employee gift matching from our Foundation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7670202255249023)","('Access_And_Affordability', 0.03711971640586853)","('Ecological_Impacts', 0.02193712629377842)","(['Corporate Governance'], 0.7670202255249023)","('NON-ESG', 0.03711971640586853)","('NON-ESG', 0.02193712629377842)"
Line 1083,"We also sponsor several employee matching gift programs including dollar-for-dollar  match programs, an additional match for employees serving in leadership positions   with non-profits, and an match for our United Way Giving Campaign.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5490518808364868)","('Labor_Practices', 0.09201369434595108)","('Access_And_Affordability', 0.05049328878521919)","(['Human Capital Development'], 0.5490518808364868)","('NON-ESG', 0.09201369434595108)","('NON-ESG', 0.05049328878521919)"
Line 1084,"The purpose   and goals of our philanthropy include:  •  Improve the lives of underserved patients by increasing access to   healthcare and our donated technologies  •  Execute our Every Heartbeat Matters philanthropic initiative with a target   to improve the lives of 2.5 million additional underserved structural heart   and critical care patients by the end of  • Inspire passionate employee engagement in charitable activity  • Strengthen the communities where our employees live and work  • Live by the principles of Edwards Lifesciences’ Credo Edward continues to make serving our local communities a top priority of our giving   efforts.
","('Access_And_Affordability', 0.9411025643348694)","('Human_Rights_And_Community_Relations', 0.006056090816855431)","('Product_Quality_And_Safety', 0.005224364809691906)","(['Health Outcome Contribution'], 0.9411025643348694)","('NON-ESG', 0.006056090816855431)","('NON-ESG', 0.005224364809691906)"
Line 1085,"The purpose   and goals of our philanthropy include:  •  Improve the lives of underserved patients by increasing access to   healthcare and our donated technologies  •  Execute our Every Heartbeat Matters philanthropic initiative with a target   to improve the lives of 2.5 million additional underserved structural heart   and critical care patients by the end of  • Inspire passionate employee engagement in charitable activity  • Strengthen the communities where our employees live and work  • Live by the principles of Edwards Lifesciences’ Credo Edward continues to make serving our local communities a top priority of our giving   efforts.
","('Human_Rights_And_Community_Relations', 0.8719627857208252)","('Access_And_Affordability', 0.026526061818003654)","('Employee_Health_And_Safety', 0.011886653490364552)","(['Community Relations'], 0.8719627857208252)","('NON-ESG', 0.026526061818003654)","('NON-ESG', 0.011886653490364552)"
Line 1086,"At our offices around the world, we open our facilities to host programs,   fundraisers and meetings for local non-profit organizations, such as United Way   and American Heart Association.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3173544108867645)","('Access_And_Affordability', 0.12816064059734344)","('Human_Rights_And_Community_Relations', 0.07890034466981888)","('NON-ESG', 0.3173544108867645)","('NON-ESG', 0.12816064059734344)","('NON-ESG', 0.07890034466981888)"
Line 1087,"We also provide externships for members of local   organizations such as Girls Inc.
","('Employee_Engagement_Inclusion_And_Diversity', 0.555797815322876)","('Access_And_Affordability', 0.10538425296545029)","('Labor_Practices', 0.05093105509877205)","(['Human Capital Development'], 0.555797815322876)","('NON-ESG', 0.10538425296545029)","('NON-ESG', 0.05093105509877205)"
Line 1088,"and Achievement Institute of Scientific Studies and   regularly bring students onto our campuses to tour and learn about what it means to  work in medical technology and understand the paths our employees took to get   where they are today.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4501391649246216)","('Employee_Health_And_Safety', 0.13117361068725586)","('Product_Design_And_Lifecycle_Management', 0.08140286803245544)","('NON-ESG', 0.4501391649246216)","('NON-ESG', 0.13117361068725586)","('NON-ESG', 0.08140286803245544)"
Line 1089,"Our foundation and philanthropy work to navigate international granting dynamics,  laws and regulations, and maintain compliance with reporting requirements related   to healthcare professionals.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9400487542152405)","('Business_Ethics', 0.015606523491442204)","('Product_Quality_And_Safety', 0.004803479183465242)","(['Corporate Governance'], 0.9400487542152405)","('NON-ESG', 0.015606523491442204)","('NON-ESG', 0.004803479183465242)"
Line 1090,"Employee Charitable Activity and Giving Our employees embody Edwards’ focus on improving lives and our communities.
","('Human_Rights_And_Community_Relations', 0.8959017992019653)","('Access_And_Affordability', 0.02853238955140114)","('Management_Of_Legal_And_Regulatory_Framework', 0.008679453283548355)","(['Community Relations'], 0.8959017992019653)","('NON-ESG', 0.02853238955140114)","('NON-ESG', 0.008679453283548355)"
Line 1091,"The authentic commitment to giving and charitable activity spans from leadership  across all employee populations, cultivating a strong, employee-led culture of   helping others.
","('Human_Rights_And_Community_Relations', 0.3938656449317932)","('Access_And_Affordability', 0.1770588904619217)","('Employee_Health_And_Safety', 0.09763078391551971)","('NON-ESG', 0.3938656449317932)","('NON-ESG', 0.1770588904619217)","('NON-ESG', 0.09763078391551971)"
Line 1092,"Edwards’ commitment to this culture is shown by providing the infrastructure for   employees to feel supported and encouraged to participate in charitable activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3784010410308838)","('Human_Rights_And_Community_Relations', 0.20207884907722473)","('Access_And_Affordability', 0.1617090106010437)","('NON-ESG', 0.3784010410308838)","('NON-ESG', 0.20207884907722473)","('NON-ESG', 0.1617090106010437)"
Line 1093,"We provide monthly opportunities for participation in charitable activities during   their workday and encourage employees to give a few hours of Edwards time a   few times a year.
","('Labor_Practices', 0.9200961589813232)","('Employee_Health_And_Safety', 0.01726914756000042)","('Management_Of_Legal_And_Regulatory_Framework', 0.004927529487758875)","(['Labor Practice Indicators'], 0.9200961589813232)","('NON-ESG', 0.01726914756000042)","('NON-ESG', 0.004927529487758875)"
Line 1094,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Our more than 25 global Strengthen Our Community committees are cross-   functional groups of passionate employees dedicated to living Edwards’ Credo   of “creating a community unified in its mission to improve the quality of life   around the world.” These committees organize our global volunteerism efforts,  connecting Edwards’ volunteers with organizations that are addressing community  needs, often funded by the Edwards Foundation.
","('Human_Rights_And_Community_Relations', 0.3945406973361969)","('Employee_Health_And_Safety', 0.1930191069841385)","('Access_And_Affordability', 0.12447523325681686)","('NON-ESG', 0.3945406973361969)","('NON-ESG', 0.1930191069841385)","('NON-ESG', 0.12447523325681686)"
Line 1095,"Each committee is empowered to   give their time and talents according to both local community needs and the   interest of employees in their region.
","('Human_Rights_And_Community_Relations', 0.9510409235954285)","('Access_And_Affordability', 0.0067148334346711636)","('Management_Of_Legal_And_Regulatory_Framework', 0.0033150312956422567)","(['Community Relations'], 0.9510409235954285)","('NON-ESG', 0.0067148334346711636)","('NON-ESG', 0.0033150312956422567)"
Line 1096,"Notably, Edwards provides platforms, tools  and resources for our employees to find a way to give back that is meaningful   and relevant to them.
","('Human_Rights_And_Community_Relations', 0.3430344760417938)","('Access_And_Affordability', 0.18486492335796356)","('Management_Of_Legal_And_Regulatory_Framework', 0.14262720942497253)","('NON-ESG', 0.3430344760417938)","('NON-ESG', 0.18486492335796356)","('NON-ESG', 0.14262720942497253)"
Line 1097,"Edwards’ culture of giving also comes to life through our ERGs, organizations   that lead communities of employees from similar backgrounds or interest areas.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5351018905639648)","('Human_Rights_And_Community_Relations', 0.16064228117465973)","('Access_And_Affordability', 0.08667061477899551)","(['Human Capital Development'], 0.5351018905639648)","('NON-ESG', 0.16064228117465973)","('NON-ESG', 0.08667061477899551)"
Line 1098,"Please find more information about our ERGs in our Human Capital Management   section of this report.
","('Business_Model_Resilience', 0.48825570940971375)","('Systemic_Risk_Management', 0.1875573694705963)","('Competitive_Behavior', 0.04524479806423187)","('NON-ESG', 0.48825570940971375)","('NON-ESG', 0.1875573694705963)","('NON-ESG', 0.04524479806423187)"
Line 1099,"Governance Map   The governance map below outlines the Foundation’s governance structure.
","('Management_Of_Legal_And_Regulatory_Framework', 0.916158139705658)","('Director_Removal', 0.013448010198771954)","('Business_Ethics', 0.008239386603236198)","(['Corporate Governance'], 0.916158139705658)","('NON-ESG', 0.013448010198771954)","('NON-ESG', 0.008239386603236198)"
Line 1100,"Corporate Governance Environmental Health & Safety Ethics & Compliance Product Safety & QualityFoundationSupply  Chain Management Human Capital  Management click to viewAnnual Performance   During 2021, our employees have continued to show up and give more.
","('Business_Ethics', 0.8772048354148865)","('Product_Quality_And_Safety', 0.038837458938360214)","('Management_Of_Legal_And_Regulatory_Framework', 0.011651670560240746)","(['Business Ethics'], 0.8772048354148865)","('NON-ESG', 0.038837458938360214)","('NON-ESG', 0.011651670560240746)"
Line 1101,"Amid   unprecedented challenges for underserved patients and communities, the Edwards   Foundation provided $21 million to charitable causes around the world, including:  •  Approximately $8.5 million in donated Edwards technologies   for urgent humanitarian patient support  •  Launch of the Heart-to-Heart Employee Relief Fund, supporting   employees during times of financial hardship or natural disaster  •  Employees supporting the needs of our EHM partners via the   first-ever EHM Pro Bono Corps, providing knowledge and expertise  • Foundation funding focusing on increasing healthcare access and equity  • Amplified employee giving through our Employee Matching Gift program  •  Increased in-kind donations including food, refurbished computers   and personal protective equipment Employee Charitable Activity and Giving Edwards is energized by our work to support those in need, and we seek to embed   this spirit throughout our culture by encouraging our employees to support others  and give back.
","('Access_And_Affordability', 0.9144076108932495)","('Critical_Incident_Risk_Management', 0.015783363953232765)","('Human_Rights_And_Community_Relations', 0.010097899474203587)","(['Health Outcome Contribution'], 0.9144076108932495)","('NON-ESG', 0.015783363953232765)","('NON-ESG', 0.010097899474203587)"
Line 1102,"Amid   unprecedented challenges for underserved patients and communities, the Edwards   Foundation provided $21 million to charitable causes around the world, including:  •  Approximately $8.5 million in donated Edwards technologies   for urgent humanitarian patient support  •  Launch of the Heart-to-Heart Employee Relief Fund, supporting   employees during times of financial hardship or natural disaster  •  Employees supporting the needs of our EHM partners via the   first-ever EHM Pro Bono Corps, providing knowledge and expertise  • Foundation funding focusing on increasing healthcare access and equity  • Amplified employee giving through our Employee Matching Gift program  •  Increased in-kind donations including food, refurbished computers   and personal protective equipment Employee Charitable Activity and Giving Edwards is energized by our work to support those in need, and we seek to embed   this spirit throughout our culture by encouraging our employees to support others  and give back.
","('Access_And_Affordability', 0.684226930141449)","('Human_Rights_And_Community_Relations', 0.08224117755889893)","('Management_Of_Legal_And_Regulatory_Framework', 0.048670101910829544)","(['Health Outcome Contribution'], 0.684226930141449)","('NON-ESG', 0.08224117755889893)","('NON-ESG', 0.048670101910829544)"
Line 1103,"In 2021, we had a 90 percent response rate on our engagement survey with over  13,000 employees responding.
","('Employee_Engagement_Inclusion_And_Diversity', 0.21871963143348694)","('Employee_Health_And_Safety', 0.21012704074382782)","('Human_Rights_And_Community_Relations', 0.14085941016674042)","('NON-ESG', 0.21871963143348694)","('NON-ESG', 0.21012704074382782)","('NON-ESG', 0.14085941016674042)"
Line 1104,"We found that Edwards employee engagement   scores outpaced the global top performing companies benchmark and those in   our industry.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8090286254882812)","('Employee_Health_And_Safety', 0.057959262281656265)","('Labor_Practices', 0.02590995654463768)","(['Human Capital Development'], 0.8090286254882812)","('NON-ESG', 0.057959262281656265)","('NON-ESG', 0.02590995654463768)"
Line 1105,"Coming in above this benchmark showcases our workforces’  high   level of engagement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9417928457260132)","('Human_Rights_And_Community_Relations', 0.008280125446617603)","('Employee_Health_And_Safety', 0.006354025565087795)","(['Human Capital Development'], 0.9417928457260132)","('NON-ESG', 0.008280125446617603)","('NON-ESG', 0.006354025565087795)"
Line 1106,"Not only are our employees incredibly engaged, but they are also firm believers in  giving back to the communities we serve.
","('Human_Rights_And_Community_Relations', 0.7669450044631958)","('Employee_Engagement_Inclusion_And_Diversity', 0.04345007985830307)","('Employee_Health_And_Safety', 0.03199174627661705)","(['Community Relations'], 0.7669450044631958)","('NON-ESG', 0.04345007985830307)","('NON-ESG', 0.03199174627661705)"
Line 1107,"According to the same survey, 82 percent  of our employees stated they participated in charitable activities over the prior 12  months, through volunteering Edwards’ or their personal time, or donating money   or goods to non-profit organizations.
","('Human_Rights_And_Community_Relations', 0.3395332396030426)","('Access_And_Affordability', 0.1965249478816986)","('Labor_Practices', 0.07504896819591522)","('NON-ESG', 0.3395332396030426)","('NON-ESG', 0.1965249478816986)","('NON-ESG', 0.07504896819591522)"
Line 1108,"This brings us closer to our company-wide  aspiration to have 100 percent employee participation in engagement in charitable  activities each year.
","('Human_Rights_And_Community_Relations', 0.2897627651691437)","('Management_Of_Legal_And_Regulatory_Framework', 0.10255025327205658)","('Access_And_Affordability', 0.09729776531457901)","('NON-ESG', 0.2897627651691437)","('NON-ESG', 0.10255025327205658)","('NON-ESG', 0.09729776531457901)"
Line 1109,"Across the Senior Leadership Team, 100 percent stated they   participated in charitable activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.26753976941108704)","('Access_And_Affordability', 0.15310345590114594)","('Human_Rights_And_Community_Relations', 0.07557368278503418)","('NON-ESG', 0.26753976941108704)","('NON-ESG', 0.15310345590114594)","('NON-ESG', 0.07557368278503418)"
Line 1110,"Of those individuals who participated in a   charitable activity, they reported having a higher level of patient focus, engagement,  culture, belonging, empowerment, and innovation than individuals who did not   participate in charitable activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.32177069783210754)","('Human_Rights_And_Community_Relations', 0.19329425692558289)","('Access_And_Affordability', 0.13303987681865692)","('NON-ESG', 0.32177069783210754)","('NON-ESG', 0.19329425692558289)","('NON-ESG', 0.13303987681865692)"
Line 1111,"This is a testament to how integral philanthropy   is to Edwards and our workforce.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT HIGHLIGHT STORYHighlights of 2021 global employee community giving activities and in-kind donations:  •  Our Edwards New Zealand team provided one classroom with books and equipment  for the entire school year, providing 40 backpacks with books, pencils, glue and other  essentials for the school year  •  Members of our University programs in Orange County, Calif., worked with   elementary aged students to complete a STEAM “supertower” project, supporting   the next generation of STEAM leaders  •  Employees from our office in Germany built a garden and benches at a facility that  supports families with children who are suffering with mental health issues  •  Our Irvine employees individually decorated and filled 144 holiday food boxes to be  passed out to families at our adopted elementary school with predominantly at-risk  students, Washington Elementary  •  Edwards employees in the Dominican Republic uplifted a local community center   and library by doing wall repairs and painted the center for local children to have a   new space  •  Employees from India cooked and served 76,000 nutritious meals to patients,   staff and caregivers who were treating COVID-19 patients The Edwards Lifesciences Foundation In 2021, Edwards’ global giving totaled nearly $21 million with over $8 million in cash   grants from our Foundation, and approximately $8.5 million in donations of technologies    for humanitarian aid.
","('Access_And_Affordability', 0.25105276703834534)","('Management_Of_Legal_And_Regulatory_Framework', 0.2094009816646576)","('Employee_Health_And_Safety', 0.053857073187828064)","('NON-ESG', 0.25105276703834534)","('NON-ESG', 0.2094009816646576)","('NON-ESG', 0.053857073187828064)"
Line 1112,"This is a testament to how integral philanthropy   is to Edwards and our workforce.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT HIGHLIGHT STORYHighlights of 2021 global employee community giving activities and in-kind donations:  •  Our Edwards New Zealand team provided one classroom with books and equipment  for the entire school year, providing 40 backpacks with books, pencils, glue and other  essentials for the school year  •  Members of our University programs in Orange County, Calif., worked with   elementary aged students to complete a STEAM “supertower” project, supporting   the next generation of STEAM leaders  •  Employees from our office in Germany built a garden and benches at a facility that  supports families with children who are suffering with mental health issues  •  Our Irvine employees individually decorated and filled 144 holiday food boxes to be  passed out to families at our adopted elementary school with predominantly at-risk  students, Washington Elementary  •  Edwards employees in the Dominican Republic uplifted a local community center   and library by doing wall repairs and painted the center for local children to have a   new space  •  Employees from India cooked and served 76,000 nutritious meals to patients,   staff and caregivers who were treating COVID-19 patients The Edwards Lifesciences Foundation In 2021, Edwards’ global giving totaled nearly $21 million with over $8 million in cash   grants from our Foundation, and approximately $8.5 million in donations of technologies    for humanitarian aid.
","('Employee_Health_And_Safety', 0.4935683608055115)","('Access_And_Affordability', 0.27275872230529785)","('Product_Quality_And_Safety', 0.05161655694246292)","('NON-ESG', 0.4935683608055115)","('NON-ESG', 0.27275872230529785)","('NON-ESG', 0.05161655694246292)"
Line 1113,"This is a testament to how integral philanthropy   is to Edwards and our workforce.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT HIGHLIGHT STORYHighlights of 2021 global employee community giving activities and in-kind donations:  •  Our Edwards New Zealand team provided one classroom with books and equipment  for the entire school year, providing 40 backpacks with books, pencils, glue and other  essentials for the school year  •  Members of our University programs in Orange County, Calif., worked with   elementary aged students to complete a STEAM “supertower” project, supporting   the next generation of STEAM leaders  •  Employees from our office in Germany built a garden and benches at a facility that  supports families with children who are suffering with mental health issues  •  Our Irvine employees individually decorated and filled 144 holiday food boxes to be  passed out to families at our adopted elementary school with predominantly at-risk  students, Washington Elementary  •  Edwards employees in the Dominican Republic uplifted a local community center   and library by doing wall repairs and painted the center for local children to have a   new space  •  Employees from India cooked and served 76,000 nutritious meals to patients,   staff and caregivers who were treating COVID-19 patients The Edwards Lifesciences Foundation In 2021, Edwards’ global giving totaled nearly $21 million with over $8 million in cash   grants from our Foundation, and approximately $8.5 million in donations of technologies    for humanitarian aid.
","('Access_And_Affordability', 0.8233697414398193)","('Customer_Welfare', 0.02538510411977768)","('Product_Quality_And_Safety', 0.019413964822888374)","(['Health Outcome Contribution'], 0.8233697414398193)","('NON-ESG', 0.02538510411977768)","('NON-ESG', 0.019413964822888374)"
Line 1114,"This is a testament to how integral philanthropy   is to Edwards and our workforce.EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT HIGHLIGHT STORYHighlights of 2021 global employee community giving activities and in-kind donations:  •  Our Edwards New Zealand team provided one classroom with books and equipment  for the entire school year, providing 40 backpacks with books, pencils, glue and other  essentials for the school year  •  Members of our University programs in Orange County, Calif., worked with   elementary aged students to complete a STEAM “supertower” project, supporting   the next generation of STEAM leaders  •  Employees from our office in Germany built a garden and benches at a facility that  supports families with children who are suffering with mental health issues  •  Our Irvine employees individually decorated and filled 144 holiday food boxes to be  passed out to families at our adopted elementary school with predominantly at-risk  students, Washington Elementary  •  Edwards employees in the Dominican Republic uplifted a local community center   and library by doing wall repairs and painted the center for local children to have a   new space  •  Employees from India cooked and served 76,000 nutritious meals to patients,   staff and caregivers who were treating COVID-19 patients The Edwards Lifesciences Foundation In 2021, Edwards’ global giving totaled nearly $21 million with over $8 million in cash   grants from our Foundation, and approximately $8.5 million in donations of technologies    for humanitarian aid.
","('Critical_Incident_Risk_Management', 0.5252828598022461)","('Human_Rights_And_Community_Relations', 0.16299918293952942)","('Access_And_Affordability', 0.07828406989574432)","(['Risk & Crisis Management'], 0.5252828598022461)","('NON-ESG', 0.16299918293952942)","('NON-ESG', 0.07828406989574432)"
Line 1115,"Additionally, we align our Foundation giving with employee   engagement through our foundation’s employee matching gift program, which matches  donations to non-profit organizations up to $5,000 per employee each year.
","('Management_Of_Legal_And_Regulatory_Framework', 0.18828438222408295)","('Employee_Engagement_Inclusion_And_Diversity', 0.18220801651477814)","('Labor_Practices', 0.14669500291347504)","('NON-ESG', 0.18828438222408295)","('NON-ESG', 0.18220801651477814)","('NON-ESG', 0.14669500291347504)"
Line 1116,"View list of partners and grants.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8082136511802673)","('Access_And_Affordability', 0.03232765570282936)","('Ecological_Impacts', 0.025444258004426956)","(['Corporate Governance'], 0.8082136511802673)","('NON-ESG', 0.03232765570282936)","('NON-ESG', 0.025444258004426956)"
Line 1117,"Every Heartbeat Matters Our philanthropic initiative, EHM  focuses on improving the lives of underserved patients.
","('Access_And_Affordability', 0.9453182816505432)","('Human_Rights_And_Community_Relations', 0.00510435551404953)","('Critical_Incident_Risk_Management', 0.004924194421619177)","(['Health Outcome Contribution'], 0.9453182816505432)","('NON-ESG', 0.00510435551404953)","('NON-ESG', 0.004924194421619177)"
Line 1118,"Between 2014-2020, the EHM community impacted the global burden of heart valve   disease by educating, screening and treating over 1.7 million underserved people,   surpassing our initial goal of  1 million.
","('Access_And_Affordability', 0.9456319212913513)","('Critical_Incident_Risk_Management', 0.004944927990436554)","('Product_Quality_And_Safety', 0.004702042788267136)","(['Health Outcome Contribution'], 0.9456319212913513)","('NON-ESG', 0.004944927990436554)","('NON-ESG', 0.004702042788267136)"
Line 1119,"Based on the accumulated knowledge and experience over the previous six years on how to  have the greatest impact on patients, Edwards is now focused on its next phase of EHM: we  will improve the lives of 2.5 million additional underserved structural heart and critical care  patients by the end of 2025.
","('Access_And_Affordability', 0.948041558265686)","('Human_Rights_And_Community_Relations', 0.00470713060349226)","('Critical_Incident_Risk_Management', 0.00455434387549758)","(['Health Outcome Contribution'], 0.948041558265686)","('NON-ESG', 0.00470713060349226)","('NON-ESG', 0.00455434387549758)"
Line 1120,"This target aligns with UN SDG 3: Good Health & Well-Being.
","('Access_And_Affordability', 0.4653412401676178)","('Employee_Health_And_Safety', 0.1928529143333435)","('Human_Rights_And_Community_Relations', 0.08053729683160782)","('NON-ESG', 0.4653412401676178)","('NON-ESG', 0.1928529143333435)","('NON-ESG', 0.08053729683160782)"
Line 1121,"Together with more than 50 current charitable partners we have: 1.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7038875818252563)","('Business_Ethics', 0.04341805726289749)","('Access_And_Affordability', 0.04079531133174896)","(['Corporate Governance'], 0.7038875818252563)","('NON-ESG', 0.04341805726289749)","('NON-ESG', 0.04079531133174896)"
Line 1122,"Broadened the initiative’s focus from heart valve disease to all structural heart   diseases and critical care support;  Meeting Partner Needs   with Edwards’ Expertise:   EHM Pro Bono Corps Through our EHM initiative, we worked   with our partners--including Cincinnati   Children’s Hospital, Pyxera Global and the   incredible medical team at Fort Apache Native American Indian Reservation –   to launch the first ever EHM Pro Bono Corps in Whiteriver, Arizona.
","('Employee_Health_And_Safety', 0.3859139084815979)","('Access_And_Affordability', 0.21985749900341034)","('Critical_Incident_Risk_Management', 0.07871289551258087)","('NON-ESG', 0.3859139084815979)","('NON-ESG', 0.21985749900341034)","('NON-ESG', 0.07871289551258087)"
Line 1123,"As a part of   this initiative, a dedicated group of Edwards employees is giving Edwards’ time   and their talents in communication, clinical knowledge, economics and research   to analyze opportunities for the Reservation to provide a cardiac echo screening  program to all the residents of the community.
","('Access_And_Affordability', 0.5579302310943604)","('Employee_Engagement_Inclusion_And_Diversity', 0.06284169107675552)","('Employee_Health_And_Safety', 0.052421342581510544)","(['Health Outcome Contribution'], 0.5579302310943604)","('NON-ESG', 0.06284169107675552)","('NON-ESG', 0.052421342581510544)"
Line 1124,"In June 2022, the team returned   to the Reservation to continue their charitable work, that began in 2021.
","('Access_And_Affordability', 0.34587937593460083)","('Human_Rights_And_Community_Relations', 0.14669030904769897)","('Management_Of_Legal_And_Regulatory_Framework', 0.12278762459754944)","('NON-ESG', 0.34587937593460083)","('NON-ESG', 0.14669030904769897)","('NON-ESG', 0.12278762459754944)"
Line 1125,"We   are excited to continue to identify potential opportunities to bring Edwards’  knowledge and expertise to our EHM partners and increase impact for the   humanitarian patients they serve.
","('Access_And_Affordability', 0.3412133753299713)","('Employee_Engagement_Inclusion_And_Diversity', 0.2358069270849228)","('Customer_Welfare', 0.04550781846046448)","('NON-ESG', 0.3412133753299713)","('NON-ESG', 0.2358069270849228)","('NON-ESG', 0.04550781846046448)"
Line 1126,"HIGHLIGHT STORY 2.
","('Systemic_Risk_Management', 0.1975918859243393)","('Competitive_Behavior', 0.09605680406093597)","('Business_Model_Resilience', 0.08109062910079956)","('NON-ESG', 0.1975918859243393)","('NON-ESG', 0.09605680406093597)","('NON-ESG', 0.08109062910079956)"
Line 1127,"Impacted each stage of the patient journey from detection to treatment, with an   additional emphasis of recovery, and; 3.
","('Access_And_Affordability', 0.40036001801490784)","('Employee_Health_And_Safety', 0.30722111463546753)","('Critical_Incident_Risk_Management', 0.040675029158592224)","('NON-ESG', 0.40036001801490784)","('NON-ESG', 0.30722111463546753)","('NON-ESG', 0.040675029158592224)"
Line 1128,"Established an enhanced product donation program that provides EHM partners   and others doing humanitarian care with access to donated Edwards products to   provide humanitarian treatment for underserved patients outside the U.S. in   partnership with MAP International; this includes donations of our most advanced   surgical heart valves, heart valve repair rings, and critical care monitors and sensors.
","('Access_And_Affordability', 0.8266224265098572)","('Product_Design_And_Lifecycle_Management', 0.02437112107872963)","('Customer_Welfare', 0.017918353900313377)","(['Health Outcome Contribution'], 0.8266224265098572)","('NON-ESG', 0.02437112107872963)","('NON-ESG', 0.017918353900313377)"
Line 1129,"Since launching this new phase of EHM in 2020, the charitable partners of this   philanthropic community have impacted over 400,000 underserved patients.
","('Access_And_Affordability', 0.945832371711731)","('Critical_Incident_Risk_Management', 0.005091651808470488)","('Human_Rights_And_Community_Relations', 0.005017871502786875)","(['Health Outcome Contribution'], 0.945832371711731)","('NON-ESG', 0.005091651808470488)","('NON-ESG', 0.005017871502786875)"
Line 1130,"Despite   the challenges faced by the COVID-19 pandemic in providing global humanitarian care for  underserved patients, our charitable partners have preserved and innovated opportunities   to improve patient lives.
","('Access_And_Affordability', 0.9480122923851013)","('Critical_Incident_Risk_Management', 0.005079393740743399)","('Human_Rights_And_Community_Relations', 0.004372875206172466)","(['Health Outcome Contribution'], 0.9480122923851013)","('NON-ESG', 0.005079393740743399)","('NON-ESG', 0.004372875206172466)"
Line 1131,"From virtual clinical education platforms to distance mentorship   and support of clinicians from under-resourced institutions as they treat complex patient  cases, to pushing forward with global travel as the opportunity becomes available, this  charitable community remains committed to its patients.
","('Access_And_Affordability', 0.8891034126281738)","('Human_Rights_And_Community_Relations', 0.012866977602243423)","('Product_Quality_And_Safety', 0.010347542352974415)","(['Health Outcome Contribution'], 0.8891034126281738)","('NON-ESG', 0.012866977602243423)","('NON-ESG', 0.010347542352974415)"
Line 1132,"For more on EHM, including stories of impact, please see our dedicated web page.
","('Systemic_Risk_Management', 0.4141786992549896)","('Management_Of_Legal_And_Regulatory_Framework', 0.11508573591709137)","('Access_And_Affordability', 0.0969761535525322)","('NON-ESG', 0.4141786992549896)","('NON-ESG', 0.11508573591709137)","('NON-ESG', 0.0969761535525322)"
Line 1133,"EDWARDS LIFESCIENCES    2021 SUSTAINABILITY REPORT Edwards Lifesciences conducts business with care and respect for the environment.
","('Ecological_Impacts', 0.450525164604187)","('Human_Rights_And_Community_Relations', 0.08950725942850113)","('Management_Of_Legal_And_Regulatory_Framework', 0.0696803480386734)","('NON-ESG', 0.450525164604187)","('NON-ESG', 0.08950725942850113)","('NON-ESG', 0.0696803480386734)"
Line 1134,"Our environmental annual performance is captured in our Environmental Health &   Safety (EHS) Report.
","('Employee_Health_And_Safety', 0.9141446352005005)","('Product_Quality_And_Safety', 0.021786248311400414)","('Critical_Incident_Risk_Management', 0.013496620580554008)","(['Operational Eco-Efficiency'], 0.9141446352005005)","('NON-ESG', 0.021786248311400414)","('NON-ESG', 0.013496620580554008)"
Line 1135,"This report covers all of our business operations and contains our  management approach and annual performance for the following material topics:  •  Energy & emissions • Waste  • Water • Environmental compliance  EHS Policy At Edwards Lifesciences, we recognize that safe and environmentally responsible   operations bring shared value to our patients, our employees, our stakeholders, and the  communities in which we operate.
","('Water_And_Wastewater_Management', 0.21329551935195923)","('Ecological_Impacts', 0.11876091361045837)","('Product_Design_And_Lifecycle_Management', 0.0930984690785408)","('NON-ESG', 0.21329551935195923)","('NON-ESG', 0.11876091361045837)","('NON-ESG', 0.0930984690785408)"
Line 1136,"We are committed to providing a safe and healthy workplace by identifying and controlling  hazards and risks, minimizing our impact on the environment through pollution   prevention efforts, and operating in compliance with legal requirements and applicable  standards.
","('Employee_Health_And_Safety', 0.8759966492652893)","('Ecological_Impacts', 0.01652095466852188)","('Critical_Incident_Risk_Management', 0.015079687349498272)","(['Operational Eco-Efficiency'], 0.8759966492652893)","('NON-ESG', 0.01652095466852188)","('NON-ESG', 0.015079687349498272)"
Line 1137,"Through a culture of engagement and ownership, we will set goals and   communicate our progress on a journey of continual improvement.
","('Human_Rights_And_Community_Relations', 0.3687475323677063)","('Business_Model_Resilience', 0.15695731341838837)","('Employee_Engagement_Inclusion_And_Diversity', 0.1053185760974884)","('NON-ESG', 0.3687475323677063)","('NON-ESG', 0.15695731341838837)","('NON-ESG', 0.1053185760974884)"
Line 1138,"Environment Governance Map Our Governance Map illustrates the accountability structure for managing   Environmental Health and Safety, including Energy and Emissions, Waste,   Water and Environmental Compliance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5904614329338074)","('Ecological_Impacts', 0.16590209305286407)","('Human_Rights_And_Community_Relations', 0.07796657085418701)","(['Corporate Governance'], 0.5904614329338074)","('NON-ESG', 0.16590209305286407)","('NON-ESG', 0.07796657085418701)"
Line 1139,Corporate Governance Environmental Health & Safety Ethics & Compliance Product Safety & QualityFoundationSupply  Chain Management Human Capital  Managementclick to view Achieve carbon neutrality    by 2030  and 1.5˚C   science-based targets,"('Product_Quality_And_Safety', 0.6145230531692505)","('Business_Ethics', 0.2009911686182022)","('Employee_Health_And_Safety', 0.03913513198494911)","(['Product Quality & Recall Management'], 0.6145230531692505)","('NON-ESG', 0.2009911686182022)","('NON-ESG', 0.03913513198494911)"
